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Abstract 
Background  In childhood, cerebral arteriopathy causes cerebral ischaemia 
and infarction via two related mechanisms.  The first, thrombotic vaso-occlusive 
stroke is the more typical mechanism of stroke in childhood.  The second 
mechanism of infarction related to arteriopathy and not seen in other forms of 
ischaemic stroke is that of chronic hypoperfusion of the brain. The infarcts in 
this case are typically located in watershed zones and can accumulate 
gradually over time. Moyamoya is the prototypic arteriopathy representing the 
hypoperfusion injury.  It is characterized by chronic progressive narrowing of the 
distal internal carotid, proximal middle cerebral and anterior cerebral arteries; 
chronic low flow infarction with accumulating ‘string of pearls’ in the white matter 
(Fig 1).  It is this chronic hypoperfusion of the brain that is the subject of my 
PhD thesis.  Cerebrovascular reactivity is a marker of cerebrovascular reserve 
and has been shown to be a biomarker of ischaemic risk in adults.   
Objectives The primary objectives were to, in a group of children with 
moyamoya:  
1) Validate the use of a qualitative measure of cerebrovascular reactivity as 
a biomarker of ischaemic risk, namely, hypercapnic challenge BOLD MRI CVR 
(hBOLD CVR) via two methods: a) breath-holding and b) induced hypercapnia 
during general anaesthesia as reliable and repeatable for use in the paediatric 
population 
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2)  Assess the utility of qualitative assessment of cerebrovascular reactivity 
using hBOLD CVR as a tool for the identification of the risk of ischaemia in 
children with arteriopathy 
Method Hypercapnic challenge hBOLD CVR studies were obtained in children 
with steno-occlusive arteriopathy prospectively enrolled in The Hospital for Sick 
Children Stroke Registry.  Semi-quantitative methods of measuring CVR were 
devised and used for the purpose of analysis.  hBOLD CVR studies were 
analysed for reliability and reproducibility of the method of analysis.  Clinical and 
radiologic data were collected and hBOLD CVR findings described for all 
children enrolled.  Exploratory analysis of hBOLD CVR as a potential biomarker 
of ischaemic risk in the paediatric population were conducted.  In particular 
association of hBOLD CVR with clinical symptomatology; parenchymal and 
vascular indicators of arteriopathy; neuropsychological outcome and cortical 
thickness were examined.   
Results  Forty seven children (37 Bilateral or unilateral Moyamoya arteriopathy, 
6 Unilateral Non-moyamoya arteriopathy [Transient Cerebral Arteriopathy] and 
4 Bilateral Non-moyamoya arteriopathy [2 PHACE(S), 1 Takayasu arteritis, 1 
Sickle Cell Disease]) were enrolled and had hBOLD CVR studies.  The mean 
age of diagnosis of arteriopathy across all groups was 8.1 years (SD 4.2) (range 
7 months - 18 years).  Clinical and radiographic features differed across 
arteriopathy groups.  Most presented with acute stroke, however, among 
children with NF1-MM most (almost 50%) were asymptomatic and diagnosed 
on screening MRIs.  Infarction patterns differed, with deep watershed infarction 
being the typical pattern in the moyamoya group in contrast to thrombotic vaso-
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occlusive infarction pattern in the Non-moyamoya groups.  Qualitative hBOLD 
CVR abnormalities were concordant with moyamoya laterality, and in unilateral 
moyamoya demonstrated tissue level microvascular dysfunction in the 
contralateral unaffected hemisphere.  Qualitative hBOLD CVR abnormalities 
demonstrated concordance with clinically important manifestations of ischaemia 
including stroke, transient ischaemic attacks, cortical thinning and IQ.  There 
was a lack of concordance with indices of executive function.  In addition the 
moderate to severe steno-occlusive arteriopathy seen in the children with 
Transient Cerebral Arteriopathy was not associated with abnormality of hBOLD 
CVR.   
Conclusion  The thesis studies demonstrated that qualitative assessment of 
hBOLD CVR using breath-hold or general anaesthetic is feasible, reproducible 
and reliable in paediatric population. The utility of hBOLD CVR as a measure of 
tissue level microvascular dysfunction and thus a biomarker of ischaemic risk 
was demonstrated.  However, larger longitudinal studies are required to 
characterize this further.  
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Figure 1  MRIs Showing Left Middle Cerebral Artery Ischaemic Stroke (left figure) 
and Bilateral Deep Watershed Strokes (right figure) 
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1. Introduction 
1.1. Overview 
The current World Health Organisation definition of stroke is “rapidly developing 
clinical signs of focal (or global) disturbance of cerebral function, lasting more 
than 24 hours or leading to death, with no apparent cause other than that of 
vascular origin” (WHO 1971).  This classic definition is mainly clinical.  Updated 
definitions have sought to incorporate tissue criteria of cell death or infarction 
within the central nervous system, attributable to ischemia, which in vivo 
requires neuroimaging confirmation. (Sacco et al. 2013). Broadly, clinical 
definitions of stroke include ischaemic (arterial or venous) stroke, intracerebral 
haemorrhage and sub-arachnoid haemorrhage. Ischaemic stroke occurs when 
there is critical i) compromise of the vessel lumen secondary to: i) arterial wall 
pathology such as dissection or stenosis ii) thrombo-embolic occlusion of the 
artery or vein, or critical hypoperfusion.   
The incidence of paediatric arterial stroke (Figure 1) ranges from 2 – 13 per 100 
000 person years in developed countries (Giroud et al. 1997, Lynch et al. 2002, 
Fullerton et al. 2003, Chung and Wong 2004).  It is one of the top ten causes of 
death in childhood.  Morbidity is high, as is the cost to families and society (Lo 
et al. 2008, Goldenberg et al. 2009).  Unlike in adults who mostly have 
atheromatous disease, childhood risk factors are multiple, often occur 
concurrently and include cardiac disease, sickle cell disease, arteriopathy and 
infection to name a few (Ganesan et al. 2003, Fullerton et al. 2007, Mackay et 
al. 2011). Figure 2  Around two thirds of previously healthy children presenting 
with their first arterial ischaemic stroke (AIS) have a stenosing arteriopathy the 
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presence of which is one of the strongest predictors of recurrence and outcome 
(Dobson et al. 2002, Strater et al. 2002, Danchaivijitr et al. 2006, Ganesan et al. 
2006, Braun et al. 2009) and determinate of secondary prevention (Group 
2004).  There are three main specific sub-types of arteriopathy in paediatrics of 
which transient cerebral arteriopathy (25%), dissection (20%) and moyamoya 
(22%) are the commonest (Ganesan et al. 2003, Amlie-Lefond et al. 2009, 
Tolani et al. 2015). 
Figure 2  Stroke Types 
 
 
 
 
 
 
Table 1  Aetiologic Mechanisms of Arterial Ischaemic Stroke  
Adults Children 
Vessel wall 
   Arterial   atherosclerosis 
                  dissection 
                  inflammatory 
                  moyamoya 
Vessel wall 
   Arterial    inflammatory eg. TCA*,  
                  Vasculitis* 
                  dissection* 
                  moyamoya* 
Luminal 
    Cardioembolic eg. atrial fibrillation 
 
     
 Luminal 
   Cardioembolic* eg. congential heart    
        disease 
   Prothrombotic states eg. primary   
       prothrombotic conditions such as  
       anti-thrombin III deficiency, or  
STROKE 
  ISCHAEMIC HAEMORRHAGIC 
Arterial  Venous Intracerebral  Sub-arachnoid 
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       acquired prothrombotic  
       conditions such as in dehydration 
Hypoperfusion  Hypoperfusion 
Other Other 
   Sickle cell disease* 
   Mitochondrial disease eg. MELAS 
TCA=transient cerebral arteriopathy; MELAS=mitochondrial myopsthy, 
encephalopathy, lactic acidosis and stroke-like episodes * common causes in 
childhood 
 
Moyamoya arteriopathy is one of the most devastating conditions in paediatric 
cerebrovascular disease.  It is common, poorly understood and associated with 
early death in childhood due to chronic hypoperfusion of the brain rather than 
thrombotic vaso-occlusion. The pathology of the primary arteriopathy is poorly 
understood and there are no current treatments that halt it’s progression.  Anti-
thrombotic agents – the mainstay of treatment in thrombotic stroke – are not 
adequate for prevention since occlusion is not the principal pathological 
mechanism.  Moyamoya disease is therefore a good model for the investigation 
of the effects of chronic hypoperfusion, and the natural history of progressive 
cerebral infarction over years compels us to increase our understanding of the 
mechanism of injury and explore opportunities for early intervention.  If we are 
able to identify tissue level poor perfusion and quantify ischaemic risk primary 
preventative strategies could be employed to prevent stroke and ischaemic 
demise.  Hypercapnic challenge blood oxygen level dependent cerebrovascular 
reactivity may be a useful tool for the evaluation of ischaemic risk in children 
with moyamoya arteriopathy.  I set out to explore this in my thesis.  
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My primary objectives were to:  
1) Validate the use of a qualitative measure of cerebrovascular reactivity, 
namely, hypercapnic challenge blood oxygen level dependent magnetic 
resonance imaging cerebrovascular reactivity  (hBOLD CVR) via two methods: 
a) breath-holding and b) induced hypercapnia during general anaesthesia as 
reliable and repeatable for use in the paediatric population 
2)  Assess the clinical utility of qualitative assessment of cerebrovascular 
reactivity using hBOLD CVR as a tool for the identification of the risk of 
ischaemia in children with arteriopathy 
 
In this chapter I will briefly describe our current knowledge of the cerebral 
arteriopathies and more specifically moyamoya, its natural history and its 
pathophysiological mechanisms of injury.  I will discuss the rationale for current 
therapeutic approaches and the use of techniques – historical and new – 
available for the assessment of ischaemic risk within this population.  
 
1.2. Childhood arteriopathy – the non-progressive and 
progressive arteriopathies  
Diagnostic criteria for the arteriopathies have been proposed by Sebire et al 
(Sebire et al. 2004).  Another approach to classification is by dividing the 
arteriopathies into non-progressive and progressive groups.  However, at 
presentation determination of likelihood of future progression is difficult, even in 
unilateral arteriopathy. Hence a further revision to classification of the 
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arteriopathies was proposed by the International Pediatric Stroke Society 
(Amlie-Lefond et al. 2009, Braun et al. 2009). Focal cerebral arteriopathy may 
be defined as cerebral arterial stenosis not attributed to the specific sub-types.  
This term allows descriptive labeling at the onset of the illness (unlike transient 
cerebral arteriopathy (TCA)) and will include all patients including those with 
TCA in whom a focal arterial cerebral stenosing arteriopathy is documented on 
vascular imaging.  
Transient cerebral arteriopathy, intracranial dissection and fibromuscular 
dysplasia are considered to represent the non-progressive arteriopathies.  
Diffuse cerebral vasculitis, moyamoya disease and some of the genetic 
arteriopathies form the progressive arteriopathy group. Classification between 
and within groups may still be challenging which is not unexpected given the 
commonality of underlying pathological mechanisms in some eg inflammation in 
TCA, primary angiitis of the central nervous system (PACNS) and moyamoya; 
reliance on imaging; the temporal nature of the arteriopathies, and the co-
existence of arteriopathy sub-types (Chabrier et al. 1998, Aviv et al. 2006, 
Benseler et al. 2006, Sebire 2006, Braun et al. 2009, Kraemer and Berlit 2010, 
Kirton et al. 2013, Mineyko and Kirton 2013, Skeik et al. 2013, Wintermark et al. 
2014).  However, disease course, treatment strategies and prognosis differ 
between the groups (Fung et al. 2005, Benseler et al. 2006, Roach et al. 2008, 
Amlie-Lefond et al. 2009).  Hence I describe the arteriopathies in the context of 
these two broad categories.   
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1.3. NON-PROGRESSIVE ARTERIOPATHIES 
The non-progressive group of arteriopathies is typically unilateral (Sebire et al. 
2004, Amlie-Lefond et al. 2009, Braun et al. 2009, Yeon et al. 2014).   
 
1.3.1. Transient cerebral arteriopathy 
Transient cerebral arteriopathy (TCA) was described by the French group at the 
end of the last century (Chabrier et al. 1998) and is one of the commonest types 
of arteriopathy. This aetiologically monophasic arteriopathy is characterized by 
non-progressive unilateral disease, affecting the supraclinoid internal carotid 
artery and its proximal branches, resulting typically in lenticulostriate infarction. 
TCA probably involves an inflammatory response to infections such as Varicella 
(Sebire et al. 1999, Askalan et al. 2001, Antachopoulos et al. 2002, Klingebiel et 
al. 2002). Cerebral imaging typically shows small subcortical infarcts located in 
the basal ganglia and internal capsule and on conventional or magnetic 
resonance arteriography, there are multifocal lesions of the arterial wall, with 
narrowing in the distal internal carotid and the proximal anterior, middle or 
posterior cerebral arteries. Similar angiographic findings exist in TCA 
associated with sickle cell disease (SCD) (Kirkham et al. 2001), although the 
pathophysiology might be different as histology provides evidence of endothelial 
proliferation and fibroblast infiltration (Rothman et al. 1986). Although the 
inciting mechanism of injury to the arterial wall is transient the arterial injury and 
consequences threreof are not.  Recurrence occurs, particularly in the first year 
after stroke (Chabrier et al. 1998), and it is difficult to predict those at risk 
(Braun et al. 2009).  
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1.3.2. Carotid arterial dissection 
In children arterial dissection in the anterior circulation is more frequent the 
posterior circulation (Fullerton et al. 2001, Rafay et al. 2006). Dissections (which 
may be multiple) occur as a result of blood penetrating and splitting the wall of 
an artery supplying the brain, most frequently the internal carotid (ICA) artery 
(Fullerton et al. 2001). Risk factors include trauma and infection. The diagnosis 
of dissection still requires a high index of suspicion in the absence of a 
suggestive history or neurological examination, as there remains a significant 
risk of misclassification (Tan et al. 2009). In addition intracranial dissections 
may be difficult to distinguish from TCA (Dlamini et al. 2011). Conventional 
angiography may still be required to confirm the diagnosis (Ganesan et al. 
1999, Chamoun et al. 2008). Awareness of possible late complications is 
important for follow-up (Fullerton et al. 2001, Tan et al. 2009). Dissection 
causes local pathology through direct pressure effects and disruption of nutrient 
blood supply.  Thrombo-embolism is the most important mechanism in 
dissection-related stroke. Moyamoya may occasionally develop in children who 
have had a dissection. 
 
1.3.3. Vertebrobasilar stenosis and dissection 
Vertebral artery dissection should be considered in children with posterior 
circulation stroke and cervico-vertebral abnormalities (Cushing et al. 2001, 
Halevy et al. 2008), particularly in boys (Ganesan et al. 2002) and if there is a 
history of trauma. Eighty percent of posterior circulation dissections are 
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extracranial. Stenosis and occlusion of uncertain aetiology also occur in the 
vertebrobasilar circulation but moyamoya is very rarely associated with 
posterior circulation vasculopathy. 
 
1.3.4. Fibromuscular dysplasia 
The classification of fibromuscular dysplasia (FMD) denotes a group of 
idiopathic, non-inflammatory arteriopathies with distinct pathological and 
angiographic findings (Slovut and Olin 2004). The most commonly described 
form of fibromuscular dysplasia is medial fibroplasia/dysplasia, typically 
affecting young adult females with renal and cerebral vessel involvement, 
distinct ‘string of beads’ angiography, refractory hypertension, and stroke 
(Slovut and Olin 2004, Touze et al. 2010). Pathologically this differs from the 
finding of intimal fibroplasia in the majority of cases of fibromuscular dysplasia 
in childhood stroke proven at autopsy (Harrison and McCormack 1971, Slovut 
and Olin 2004, Touze et al. 2010, Kirton et al. 2013). Diagnosis in childhood is 
difficult and requires pathological confirmation (Kirton et al. 2013).  Clinical and 
radiological differences exist between the pathologically proven and not proven 
groups.  The majority present early (under 12 months) with ischaemic 
(thrombotic vaso-occlusive) stroke, although some are haemorrhagic.  Systemic 
arteriopathy, hypertension and moyamoya may co-exist.  Treatment strategies 
are mixed and in one series included anti-thrombotic (35%) and anti-
inflammatory (30%) approaches, with revascularisation surgery in 4%. 
Understanding of the underlying pathology and natural history remains limited 
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and whether FMD represents a congenital arteriopathy with or without a genetic 
predisposition is worth further exploration (Kirton et al. 2013).   
 
1.4. PROGRESSIVE ARTERIOPATHIES 
The progressive group of arteriopathies is typically bilateral although cerebral 
vasculitis and moyamoya may present as unilateral disease and progress to 
bilateral disease (Kawano et al. 1994, Houkin et al. 1996, Hirotsune et al. 1997, 
Lanthier et al. 2001, Benseler et al. 2006, Kelly et al. 2006, Elbers and Benseler 
2008). 
 
1.4.1. Cerebral Vasculitis 
Multiple approaches to the classification of cerebral vasculitis in childhood exist 
and may be according to whether the vasculitis is primary or secondary, 
whether there is large or small vessel involvement or whether the temporal 
course is mono-phasic or progressive,  hence the need for diagnostic 
algorithms.  In 1959 Craviato and Feigin described “Noninfectious 
granulomatous angiitis with a predilection for the central nervous system” as the 
single entity now known as primary angiitis of the central nervous system 
(PACNS). (Cravioto and Feigin 1959) . In 1988 Calabrese and Mallek described 
8 cases and proposed diagnostic criteria for PACNS in adults which have been 
adapted to childhood central nervous system vasculitis (Calabrese and Mallek 
1988, Benseler et al. 2006). PACNS is characterized by evidence of cerebral 
vessel abnormality affecting proximal and distal segments on initial angiography 
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with evidence of neuroradiologial disease progression beyond 3 months when 
untreated (Benseler et al. 2006). Angiography typically reveals vascular 
stenosis, beading, tortuosity, and/or arterial occlusion (Aviv et al. 2006, Aviv et 
al. 2007).  Children typically present with stroke-like neurological deficits such 
as hemiparesis or hemisensory deficit, which may be preceded by periods of 
headache, cognitive dysfunction, seizures and behavioral abnormality (Benseler 
et al. 2006).  It is a chronic, progressive inflammatory disease and hence the 
mainstay of treatment is immunosuppression with anti-platelet agents used for 
secondary stroke prophylaxis (Benseler et al. 2006, Cellucci and Benseler 
2010, Sen et al. 2010). 
 
1.4.2. Genetic and Syndromic Arteriopathies  
This is a heterogeneous group of cerebral arteriopathies with a genetic basis.  
Arteriopathy may be non-progressive or progressive, moyamoya-like or non-
moyamoya-like, clinically symptomatic or asymptomatic (Milewicz et al. 2010, 
Munot et al. 2011).  The literature is often limited and based on case reports.  
Both occlusive and aneurysmal disease can occur within the same patient and 
family.  An example of a single gene mutation which leads to both occlusive and 
arterial aneurysmal disease in multiple vascular beds is seen in ACTA2 
vasculopathy (Guo et al. 2009, Milewicz et al. 2010).  Despite the moyamoya-
like appearances, the natural history of the vasculopathy is not yet well 
characterized (Munot et al. 2012).  PHACE(S) (Posterior fossa malformations, 
Haemangiomas, Arterial anomalies, Cardiac defects and Coarctation of the 
Aorta, Eye abnormalities, and Sternal abnormalities or ventral developmental 
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defects) is an example of a syndromic arteriopathy.  The neurological features 
of PHACE(S) based on limited case reports can be divided into of two 
categories: i) congenital, structural anomalies which include malformations of 
the cerebrum, cerebellum and cerebral vasculature and ii) steno-occlusive 
arterial disease and a moyamoya-like vasculopathy.  Cerebrovascular 
anomalies occurred more frequently on the side of the facial haemangioma, but 
not exclusively.  Stroke may occur, although it is not commonly reported 
(Burrows et al. 1998, Drolet et al. 2006, Heyer et al. 2006, Heyer et al. 2008). 
1.4.3. Moyamoya  
1.4.3.1. Definitions   
‘Moyamoya’ is the Japanese term for the angiographic ‘puff of smoke’ 
appearance (Suzuki and Takaku 1969) and is defined as a bilateral progressive 
intracranial arteriopathy involving the distal internal carotid (dICA), proximal 
middle cerebral (MCA) and proximal anterior cerebral (ACA) arteries of the 
circle of Willis (COW) (Amlie-Lefond et al. 2009).  Unilateral cases are defined 
as probable moyamoya, 40% of which will progress to bilateral disease (Kelly et 
al. 2006).  In a Japanese population, Suzuki defined 6 stages, from initial 
narrowing of the dICA to the ‘puff of smoke’ appearance of the lenticulostriate 
(LS) collaterals and finally to the disappearance of this network of collaterals 
(Figure 3) (Suzuki and Takaku 1969). 
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Figure 3 Angiographic Findings in Moyamoya    
 
Moyamoya disease (MMD) refers to patients, typically of Japanese or other 
Asian origin, who have no previously diagnosed condition, and are likely to have 
a family history and autosomally dominant or recessive genes as the aetiology 
of their cerebrovascular disease (Suzuki and Takaku 1969, Ikeda and Hosoda 
1992, Hoffman 1997). Moyamoya syndrome (MMS) is the occurrence of 
moyamoya in association with an acquired or inherited disorder such as sickle 
cell disease, neurofibromatosis type-1 or Trisomy 21.  MMS represents an 
heterogenous group of disorders.  The prevalence and incidence of MMS is 
most likely related to the epidemiology and frequency of the underlying disease 
or risk factor and screening may be recommended in certain populations.  
(Rajakulasingam et al. 1979, Gadoth and Hirsch 1980, Pearson et al. 1985, 
Outwater et al. 1989, Rachmel et al. 1989, Drew et al. 1993, Ganesan and 
Kirkham 1997, Hoffman 1997, Matsuki et al. 1997, Lutterman et al. 1998, Rea 
et al. 2009, Duat-Rodriguez et al. 2014) MMS is proportionally more common in 
European and North American communities than MMD. Conversely in East 
Asian populations where this has been studied, the prevalence and incidence of 
MMS is up to ten times lower than that of MMD (Goto and Yonekawa 1992, 
A. Normal   
B. Narrowing of ICA    
C. ‘Puff of smoke’ collaterals  
D. Disappearance of ‘puff of smoke’ 
collaterals 
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Yonekawa et al. 1997, Khan et al. 2003, Uchino et al. 2005, Hayashi et al. 
2013)  
 
1.4.3.2. Epidemiology and Genetics of Moyamoya 
The relative frequency of MM varies between populations. Incidence of MM 
demonstrates geographic and ethnic variation and is estimated as 3/100 000 in 
the Japanese, and 0.086/100 000 in North America. In a Chinese study, more 
than 50% of the children with arteriopathy-associated AIS had Moyamoya 
disease (MMD) (Wang et al. 2009). Around 10% of Asian cases are familial 
(Kuriyama et al. 2008). Age at presentation is bi-modal, with peaks occurring at 
5 and 40 years of age.  However, the childhood age peak and male 
predominance are not replicated in comparative European or American 
populations (Kraemer et al. 2008). 
Liu et al. (Liu et al. 2010, Liu et al. 2011) demonstrated a major founder 
susceptibility gene at p. R4810K on the ring finger protein 213 gene (RNF 213).  
However, this finding has not been replicated in the Caucasian Idiopathic 
moyamoya population and no major cofounder susceptibility genes have been 
identified. Candidate genes of interest include MYRIP which is highly expressed 
in the brain, located around the suggestive association region for cerebral 
infarction and has its C-terminal domain directly bound to actin which is 
encoded by ACTA2 (Fukuda and Kuroda 2002, Liu et al. 2013).  This could be 
responsible for the progression of vascular disease in Caucasian Idiopathic 
moyamoya.   
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Further novel genes of interest include the BRCC3 and MTCP1 genes.  BRCC3 
encodes for a nuclear DNA repair complex and a cytoplasmic complex that 
might have a role in cardiomyocyte protection.  Knockdown studies in Zebrafish 
suggest that BRCC3 plays an important role in angiogenesis.  The function of 
MTCP1 is yet unknown (Herve et al. 2010, Miskinyte et al. 2011).   
 
1.4.3.3. Natural History and Consequences of MMD   
The natural history of moyamoya is not well understood. However, vascular 
progression often occurs in childhood even if asymptomatic (Suzuki and Takaku 
1969, Imaizumi et al. 1998, Kuroda et al. 2000) (Moritake et al. 1986, Lin et al. 
2011). Adult MMD is considered to be relatively more stable, although recent 
studies have challenged this notion. (Kuroda et al. 2007, Yang et al. 2014)  
Distal stenosis of the arteries of the COW results in reduction of cerebral 
perfusion pressure (CPP) and cerebral blood flow (CBF) distal to the stenosis.  
Collateral networks from the deep thalamoperforating and lenticulostriate 
perforating arteries – giving rise to the angiographic ‘puff of smoke’ appearance 
- form adjacent to the stenosed vessels; pial collateral arteries from the 
posterior circulation; and transdural collateral arteries from the external carotid 
arteries supply the compromised brain in an attempt to maintain adequate CPP.  
Reduction in CPP may ensue with or without a compensatory rise in systemic 
blood pressure.  Subsequent failure of CPP may result in cortical and sub-
cortical ischaemia, with the clinical consequence of covert or overt arterial 
ischaemic stroke (AIS).  
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Haemorrhagic syndromes dominate clinical presentation in Asian MMD in 
contrast to clinical presentation in non-Asian adults or children which is usually 
with ischaemic symptoms, including dysarthria, hemiparesis, choreiform 
movements, cognitive decline, headache and seizures (Hallemeier et al. 2006, 
Kraemer et al. 2008, Scott and Smith 2009).  Precipitants include 
hyperventilation and dehydration. 
 
1.4.3.4. Moyamoya and neurocognitive outcome  
Cognitive decline over time is now well recognized in paediatric MMD (Ishii et 
al. 1984, Kurokawa et al. 1985, Imaizumi et al. 1998, Imaizumi et al. 1999, Lee 
et al. 2011).  The majority of early studies examining neurocognitive outcome in 
moyamoya disease were conducted in Japanese populations.  Factors 
consistent with a poor outcome include early age at onset, transient ischaemic 
attacks followed by stroke, diffuse arteriographic occlusion, and bilateral or left 
hemisphere lesions (Maki et al. 1976). In one of the first longitudinal studies of 
intelligence in MMD, Imaizumi et al demonstrated a drop in full scale 
intelligence quotient (FSIQ) in the first 5-9 years after symptom onset, followed 
by a plateauing of intellectual function (Imaizumi et al. 1998), replicating a 
previous observation (Kurokawa et al. 1985).  A longitudinal study in a UK 
population of the effect of moyamoya on IQ over time was conducted by Hogan 
et al in children with and without sickle cell disease, mainly homozygous sickle 
cell anaemia (SCA) compared with controls matched for age, gender and 
ethnicity (Hogan et al. 2005).  They demonstrated similar effects although 
follow-up did not go beyond 5 years for the majority of patients (Hogan et al. 
2005).  In addition, the majority of studies (including the above) have been 
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conducted in symptomatic children, i.e. those presenting with stroke or transient 
ischaemic attack (TIA).  In Hogan’s series, children with bilateral clinical strokes 
had lower IQs when compared to those with unilateral stroke (Hogan et al. 
2005).  A number of their children also had recurrent TIAs.  A more recent study 
by Williams et al in patients with MM examined the relationship between MM, IQ 
and higher indices of cognitive outcome in patients with and without stroke and 
demonstrated that MM arteriopathy itself has a deleterious effect on cognitive 
outcome independent of stroke (Williams et al. 2012).  However, the relative 
importance of MM angiopathy, the associated perfusion deficits and cerebral 
infarction on IQ and indices of higher cognitive function are not fully explored in 
these studies. 
 
1.4.3.5. Moyamoya disease, baseline cerebral blood flow and 
cognition  
Ishii et al.(Ishii et al. 1984) found that preoperative IQ was related to baseline 
regional cerebral blood flow (rCBF) measured using a 133Xe inhalation method 
in children with MMD.  There are few other data. 
 
1.4.3.6. Conventional Imaging Techniques in moyamoya  
Conventional anatomical imaging techniques focus on accurate 
neuroradiological identification of acute or chronic ischaemic parenchymal 
disease and the presence and extent of moyamoya arteriopathy.  Brain CT and 
MRI are able to demonstrate areas of overt or covert parenchymal ischaemia 
recognised as areas of gliosis or encephalomalacia within vascular territories or 
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in the distal vascular bed supplied by penetrating arteries of the MCA and ACA 
and related to border-zone infarction.  Altthough the geographic use of the term 
watershed relates to a ridge formed for example by a range of mountains, which 
sends water to different rivers on each side, the terms border-zone and 
watershed infarction, are often used interchangeably. They refer to the border 
between cerebral vascular territories where the tissue is furthest from arterial 
supply and thus most vulnerable to reductions in perfusion.   However, the 
typical vascular territories shift in the face of the vascular occlusionand 
collateralisation seen in moyamoya (Lee et al. 2005) Acutely, brain CT and MRI 
detect cytotoxic oedema, or the effects thereof.  CT, which is faster and usually 
obviates the need for sedation or general anaesthesia, requires ionising 
radiation with the associated small but significant risk of cancer and cataracts.  
Early (1 – 3 hours) non-contrast CT changes post stroke include loss of grey-
white matter differentiation, hypoattenuation of deep nuclei and cortical 
hypodensity with associated parenchymal swelling and gyral effacement.  
These changes are evident in 60-70% of adults with stroke in the first 6 hours. 
(Lev et al. 1999)  MRI has a higher sensitivity and specificity than CT in the 
early diagnosis of ischaemic stroke.  The use of diffusion weighted imaging 
(DWI) and apparent diffusion co-efficient (ADC) allows for imaging detection of 
ischaemia within minutes of onset.  (Srinivasan et al. 2006) Additional MRI 
sequences useful, but less sensitive, for the detection of ischaemia include T1-
weighted, T2-weighted and FLAIR sequences.   
The inferred mechanism of ischaemia by MRI or CT may be embolic and/or 
haemodynamic.  Hence recognition of patterns of ischaemic stroke in 
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moyamoya may be informative of aetiology and direct management (Rafay et 
al. 2015). 
Furthermore, inferences about cortical perfusion can be made from the linear 
hyperintensities in a sulcal pattern seen on FLAIR sequences and called the 
“ivy sign” (Chabbert et al. 1998, Maeda and Tsuchida 1999).  Diffuse 
leptomeningeal enhancement was first reported in contrast-enhanced T1-
weighted image in patients with moyamoya disease by Ohta et al (Ohta et al. 
1995).  Fronto-parietal predominance is reported.  Studies have not found a 
significant correlation between the angiographic severity of moyamoya and the 
presence of the ivy sign.  The presence of the ivy sign may be a useful indicator 
of moyamoya in the absence of moyamoya collaterals (Fujiwara et al. 2005).  In 
addition, the presence of the ivy sign has been shown to be positively correlated 
with ischaemic symptoms and negatively correlated with CBF and CVR (Mori et 
al. 2009). 
MRA tends to overestimate stenosis and underestimate collaterals (Yamada et 
al. 1992, Saeki et al. 2000).  Plain CT, CT with contrast, T1 and T2-weighted 
MRI, MR angiography, CT angiography and conventional angiography provide 
indirect and direct information about the anatomical state of the vessels.  
Conventional angiography allows for a more dynamic and hence functional 
assessment by registration of the temporal arterial-venous cycle. However, 
interpretation of these findings with respect to the risk of stroke occurrence or 
recurrence is limited (Ganesan et al. 2006, Fullerton et al. 2007, Amlie-Lefond 
et al. 2009, Braun et al. 2009).  
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1.4.3.7. Treatment of moyamoya   
Medical treatment strategies for the primary prevention of stroke are limited and 
include the use of Aspirin, Acetazolamide or anticoagulants such as Warfarin or 
Heparin (Monagle et al. 2008, Roach et al. 2008) and in children with sickle cell 
disease, blood transfusion (Dobson et al. 2002).  Calcium antagonists may be 
used with caution to treat intractable headache (Hossain and Evers 1994). 
There are currently no known treatments to prevent the vascular progression, 
which occurs in the majority even if asymptomatic (Suzuki and Takaku 1969, 
Imaizumi et al. 1998, Kuroda et al. 2000). 
Moyamoya disease spares the external carotid arteries (ECA) and its branches.  
The aim of surgical treatment is to improve CBF in the impaired region.  
Surgical methods aim to improve the cerebral circulation either by bypassing 
the area of occlusion (direct anastomosis) or encouraging the formation of 
collaterals (indirect anastomosis).  Cerebral neovascularisation from the ECA is 
the basis for indirect revascularisation surgery (Kuroda and Houkin 2012).  
Indirect procedures are more commonly used in children and are typically a 
type of synangiosis procedure such as encephaloduroarteriosynangiosis 
(EDAS) or encephalomyosynangiosis (EMS). During these procedures, tissues 
containing ECA branch (dura mater, temporal muscle, galeal tissue, or 
superficial temporal artery) are put in direct contact with the ischaemic brain.  
Neovascularisation occurs with neoangiogenesis requiring a minimum period of 
3 months.  Direct procedures are more commonly used in adults and involve the 
anastomosis of a branch of the ECA, typically the superficial temporal artery 
(STA), and the MCA or ACA. Hence, improvement in CBF is immediate.  There 
is however an increased risk of post-operative haemorrhagic infarction 
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presumed to be secondary to hyperperfusion.  Combined (direct and indirect) 
revascularisation procedures may more effectively improve cerebral circulation 
than single direct or indirect procedures (Matsushima et al. 1992, Ikezaki et al. 
1994).  
Current indicators for surgery include acute arterial ischaemic stroke, transient 
ischaemic attack, cognitive decline, and evidence of vascular or parenchymal 
progression of disease (Kronenburg et al. 2014). Given that medical options are 
limited in number and efficacy, primary revascularization surgery is usually the 
intervention of choice. There appears to be a reduction in symptomatic 
progression from 66% in those receiving no treatment to 2.6% following surgery 
and there is a 96% probability of remaining stroke free 5 years following surgery 
(Choi et al. 1997, Fung et al. 2005).  However, surgery is not without risk. In one 
study by Guzman et al of the effect of revascularization surgery on the clinical 
outcome of 450 patients with MMD they found a surgical morbidity rate of 3.5% 
and a mortality rate of 0.7% per treated hemisphere (Guzman et al. 2009). 
There are no published observational cohort studies comparing disease 
progression and outcome in patients with and without surgical revascularization.  
Demonstration of true benefit from revascularization surgery would require a 
randomized controlled trial with revascularization surgery as an intervention. 
Feasibility of this would be challenging.   
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1.4.3.8. Surgery for Primary Prevention of Stroke and Cognitive 
Decline in MMD   
Pre and post-surgical SPECT studies in children with MMD demonstrated 
abnormalities in cerebral haemodynamics pre-operatively, even in the absence 
of infarction, with improvement post combination (direct and indirect) 
revascularisation surgery (Ohtaki et al. 1998).  Improvements in CBF have also 
been documented in children with stroke (Matsushima et al. 1990, Bowen et al. 
1998). 
It has been proposed that the stage of cerebrovascular haemodynamic 
compromise at the time of operation may be an important determinant of 
surgical success.  Patients with no clinical signs of infarction and a decreased 
regional cerebral blood flow (rCBF), increased regional oxygen extraction 
fraction (rOEF), and regional cerebral blood volume (rCBV) without any change 
in regional cerebral metabolic rate of oxygen consumption (rCMRO2) on PET 
scans may be good candidates for bypass surgery in MMD.  Matsushima et al 
suggested that if surgery is performed in a brain with normal blood flow or 
following an extreme reduction in rCMRO2, i,e. too early or too late, collateral 
vessels may not form (Matsushima et al. 1990). A number of PET and SPECT 
studies have demonstrated improvement in regional CBF and CBV post 
revascularization surgery, mostly in the area surrounding the bypass (Ikezaki et 
al. 1994), coupled with improvements in clinical symptoms. In a recent large 
study, Kim et al found that baseline rCBV from perfusion MRI and rCBF using 
SPECT predicted surgical outcome in univariable analysis but they were not in 
the final multivariable model, although measurement of reserve using 
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acetazolamide (see 1.9.1, p.78) and SPECT remained an independent predictor 
(Tamaki and Yoji 2010). 
Other studies have suggested that children may be more likely than adults to 
self-collateralize, as well as to develop neovascularisation from anastomosis, as 
cerebral circulation and oxygen metabolism tend to decline with age (Pantano 
et al. 1984, Kuwabara et al. 1990).  A longitudinal study of children with 
asymptomatic and/or incidentally diagnosed moyamoya by Lin et al (Lin et al. 
2011) demonstrated that radiographic progression occurs in the majority (SCD 
more than NF1) and heralds clinical progression.  However, given that not all 
children with progressive moyamoya have acute clinically evident ischaemic 
events, tools to predict ischaemic risk and hence guide timing of surgery would 
be invaluable in this population.  
 
1.5. Normal Cerebral Haemodynamics  
1.5.1. Cerebral blood flow equation 
Cerebral blood flow can be described as the relationship between cerebral 
perfusion pressure (CPP) and cerebrovascular resistance (CVRE):  
CBF = CPP/CVRE 
CPP is equal to mean arterial blood pressure (MABP) – intracranial pressure 
(ICP):  
CPP=MABP-ICP  
In the absence of pathologic cerebral conditions, ICP is negligible and CPP is 
roughly equivalent to MABP.  CVRE is inversely proportional to blood viscosity 
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and proportional to the fourth power of the radius of the vessel (Poiseuille's 
Law). Poiseuille’s Law can be applied to describe the relationship between 
factors which affect cerebral blood flow. It describes the laminar flow of an 
incompressible uniformly viscous fluid through a cylindrical tube with constant 
circular cross-section.  Although this equation is not fully applicable to the 
cerebrovascular bed as it is not a rigid system, it’s effective total length is not 
known, and blood is not a uniformly viscous (newtonian) fluid, it describes the 
relationship between CBF, blood pressure and resistance. It also serves to 
highlight how small changes in the radius of cerebral blood vessels can produce 
marked alterations of CVR, largely by variation in the degree of constriction of 
the cerebral resistance vessels.  
 
1.5.2. Normal cerebral blood flow 
The brain has high energy requirements with limited intracellular energy 
resources.  Hence it is highly reliant on cerebral blood flow and perfusion to 
meet its metabolic requirements.  Cerebral blood flow is regulated to match the 
regional metabolic demands of the brain.  This essential nutrient and oxygen 
exchange occurs mainly in the capillary bed - at the level of the microcirculation. 
Penetrating arterioles branch perpendicularly from the pial arterioles and 
penetrate the parenchyma of the brain where they form an extensive network of 
capillaries within the brain parenchyma.  Factors that effect this exchange and 
therefore microcirculatory CBF are the path length, red blood cell capillary 
transit time and neuronal activity (Zlokovic 2008).  
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Although there are several techniques for measuring CBF in animals and Man, 
there are problems with methodology (for review see Kirsch et al. 1985) and 
even if these can be solved, none is suitable for routine use in children because 
they are all complicated and time-consuming and require dedicated personnel.  
Most methods of measurement of CBF involve delivery of an amount of tracer 
substance to the brain and measurement of uptake or loss of tracer over a time 
period. There are serious doubts about the validity of techniques which rely 
upon the equilibration of a tracer between blood and brain, as the partition 
coefficient for damaged brain may well be different from that for normal brain 
and may change during the course of the illness.  Several rely on the use of 
radioactive isotopes, and the techniques cannot therefore be repeated 
frequently because of the cumulative dosage and because the isotope must be 
cleared from the body before the next dose is given. 
 
CBF in normal adults is approximately 50 ml 100g-1 min-1 whether measured by 
the Kety-Schmidt, intra-arterial, intravenous or inhalation 133xenon techniques, 
or by near infrared spectroscopy.  There are few data available in normal 
children (Kennedy and Sokoloff 1957, Settergren et al. 1980) because of the 
ethical difficulties so that the interpretation of abnormal results may be very 
difficult. Kennedy and Sokolof (1957) found CBF to be much higher in 
conscious normal children than in adults, in the order of 100 ml 100g-1min-1, but 
as much of their data had to be discarded because the subjects were unco-
operative; it is possiblethat their values were higher because of the childrens' 
anxiety.  However, even under anaesthesia, values for CBF in children appear 
to be slightly higher than those for adults (Settergren et al, 1980) although there 
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is considerable variation. Despite methodological concerns there is general 
agreement that in the healthy brain it appears that CBF is maximal, around 
100ml/100g/min, in mid childhood, i.e. around 8 years of age, following which it 
declines, approaching adult values (50ml/100g/min) in the teenage years 
(Kennedy and Sokoloff 1957, Biagi et al. 2007). The Kety-Schmidt technique 
was modified for repeated use in intensive care and has been used to show low 
CBF in children who have recently had a traumatic brain injury (Sharples et al 
1991). Cerebral metabolic rate and cerebral oxygen extraction are maximal 
shortly after injury in children (Sharples et al. 1995), which means that the brain 
is very vulnerable to ischaemic injury at this stage. 
 
A number of intrinsic safeguarding mechanisms exist to ensure adequate 
cerebral blood supply.  These include the vascular network which incorporates 
a high degree of redundancy (del Zoppo and Hallenbeck 2000, Blinder et al. 
2010, Hirsch et al. 2012, Blinder et al. 2013) as well as cerebral autoregulation 
and functional hyperaemia.   
 
1.5.2.1. Cerebral autoregulation  
Cerebral autoregulation is one of the most important factors allowing CBF to 
remain relatively constant despite fluctuations in arterial blood pressure.  This is 
thought to be mediated at the level of the smooth muscle arterioles in the 
vascular bed, which are exquisitely sensitive to changes in blood pressure and 
pCO2 (Figure 4) (Ogawa et al. 1990).  
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Figure 4 Normal Cerebral Blood Flow Autoregulation 
 
1.5.2.2. Functional hyperaemia or neurovascular coupling  
Functional hyperaemia or neurovascular coupling actively pairs cerebral blood 
flow to changes in neural activity.  Synaptic activity stimulates the release of 
signalling molecules that initiate changes in vascular tone. Although 
neurovascular coupling remains incompletely understood it is known to be 
influenced by neurotransmitters, ion flux, endothelial cells, astrocytes and 
pericytes. (Hamel 2006, Lok et al. 2007, Jackman and Iadecola 2015)      
Several studies performed in steady-state animal preparations and in healthy 
human volunteers reported a linear relationship between neural activity and the 
BOLD signal (Logothetis and Wandell 2004).  The haemodynamic response can 
vary across populations, cortical areas, and stimuli duration (Birn et al. 2001, 
D'Esposito et al. 2003).  Hence functional hyperemia or neurovascular coupling 
also forms the basis of functional imaging (Figure 5).   
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Figure 5 Neurovascular Regulation in the Ischaemic Brain. From Jackman and 
Iadecola, Antiioxidants and Redox Signaling, Vol 22, Number 2, 2015 
 
1.5.3. Cerebral Metabolism   
Studies of healthy anaesthetized children suggest age-related increases in 
cerebral metabolic rate for oxygen (CMRO2) after infancy up to 14 years old 
(Biagi et al. 2007).  Similar to CMRO2, cerebral metabolic rate for glucose 
(CMRglu) is lower in children at birth and increases during childhood but peaks 
by 3 years to 4 years, and remains high until 9 years of age. Thereafter CMRglu 
decreases and approaches adult rates (Chugani et al. 1987).  Under normal 
conditions, CBF is tightly coupled to CMRO2, at global as well as regional 
levels. Central nervous system activation results in an increase in CBF more 
than CMRO2, resulting in a decrease in the cerebral oxygen extraction fraction 
(OEF) (Fox and Raichle 1986, Philip et al. 2009), a quantification of the 
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matching of CBF to cerebral metabolism and an indicator of brain tissue 
vulnerability to reduction in CPP.  
 
1.6. Haemodynamics in Cerebral Arteriopathy 
1.6.1. Effect of vascular disease on distal cerebral blood flow 
Stenosis or occlusion of major cerebral arteries reduces the arterial pressure in 
the distal circulation which then becomes dependent on collateral vessels; if this 
is not sufficient to maintain cerebral perfusion pressure, the result is reflex 
vasodilatation (stage 1 haemodynamic compromise) (Derdeyn et al. 1999) If 
perfusion pressure falls further, there is an increase in the oxygen extracting 
capacity of the brain (the oxygen extraction fraction (OEF)) in order to maintain 
normal cerebral metabolic function (stage 2 haemodynamic compromise) 
(Gibbs et al. 1984) also described as ‘misery perfusion’ (Baron et al. 1981, 
Yamashita et al. 1996). Once OEF is maximal, further reductions in perfusion 
pressure lead to disruptions in tissue metabolism and ultimately to brain 
infarction. 
The majority (~ 98%) of the oxygen in blood is reversibly bound to haemoglobin. 
This is also the case in the microcirculation.  The oxyhaemaglobin curve 
describes the relationship between oxygen saturation and partial pressure of 
oxygen in the blood.  It is a tool for understanding how blood carries and 
releases oxygen and is determined by the affinity of haemoglobin for oxygen.  
The ‘driving force’ for oxygen movement from blood to tissue is the partial 
pressure of oxygen of the tissue to which the haemoglobin is exposed.  Hence 
when there is a drop in tissue partial oxygen pressure the affinity of Hb for 
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oxygen drops and the release of oxygen bound to Hb is triggered.  Oxygen 
passes from blood to tissue cells by diffusion, and the amount of oxygen moving 
across the capillary wall is equal to the amount consumed by the tissue 
supplied by that capillary.  The amount of oxygen consumed as a fraction of 
oxygen delivery defines the oxygen extraction ratio or fraction, which in turn is a 
quantification of CBF and oxygen exchange as invoked by CMRO2 (Duling et al 
1970, Pittman et al 2005, Pittman 2013).  Multiple factors can affect the affinity 
of Hb for oxygen, causing shifts of the oxyhaemaglobin curve to the left 
(increased oxygen affinity) or right (reduced oxygen affinity). Fig 6 
Figure 6  Oxyhemoglobin Dissociation Curve 
 
2-3 DPG – 2-3 diphosphoglycerate; CO - carbon monoxide 
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1.6.2. Effect of moyamoya on distal cerebral blood flow 
In moyamoya, blood flow distal to the stenotic vessels is thought to be 
maintained by a drop in vascular resistance mediated by small artery and 
arteriolar vasodilation.  Systemic hypertension is commonly seen in moyamoya 
and is probably compensatory in an attempt to maintain CPP and CBF.  As the 
disease progresses, however, the ability of this autoregulatory system to 
preserve adequate perfusion is lost when compensatory arteriolar dilation 
reaches a maximum. Further increases in vascular resistance at the stenosis 
ultimately lead to tissue oligaemia and possible ischaemia (Ishii et al. 1984, 
Grant et al. 2005).   
Reduced baseline rCBF distal to the stenosis in the arteries of the COW has 
been demonstrated in MMD. Early PET studies of cerebral circulation 
demonstrated disruption in cerebral haemodynamics even in the absence of 
infarction (Ohtaki et al. 1998).  In pre-infarctive ischaemia, regional reduction in 
cortical CBF and vascular reserve correspond to areas of increased CBV and 
tissue OEF, compensating for low CPP and maintaining the rCMRO2, i.e. 
‘misery perfusion’ (Ikezaki et al. 1994).  Loss of vascular reserve and 
haemodynamic compromise, as seen on CBF-SPECT studies, is compatible 
with ‘misery perfusion’ as seen on PET (Baron et al. 1981). Such tissue with low 
or ‘misery’ perfusion can be considered as tissue at risk of silent or overt 
infarction, and most likely to benefit from early interventional strategies (Ohtaki 
et al. 1998).   
There are many ways of defining penumbra (Symon et al. 2007). A pragmatic 
therapy directed definition is that of ischaemic tissue that is potentially 
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salvageable as distinguished from the ischaemic core that has already 
sustained irreversible injury (Fisher 1997). Modified criteria have been 
presented by (Donnan et al. 2007).   
Figure 7  Criteria for the Ischaemic Penumbra 
 
There are multiple mechanisms of cell death that may occur in response to 
ischaemia: 1) necrosis  2) apoptosis  and  3) autophagy.(Xu and Zhang 2011)  
Necrosis is the final endpoint of energy failure resulting in neuronal cell death 
secondary to ischaemia.  Although traditionally thought to be a passive form of 
cell death, further research suggests the existence of a programmed necrosis, 
called ‘necroptosis’ by one group (Degterev et al. 2005)  Delayed cell death 
caused by ischaemia is characterized by apoptosis – a process of cell suicide or 
programmed cell death, regulated by different cell signaling pathways  
Autophagy is a highly regulated cellular mechanism that leads to degradation of 
long-lived proteins and dysfunctional organelles.  Whether it is protective or 
destructive appears to depend on the levels of hypoxia or ischemia.  Whereby 
necrosis appears to dominate the ischaemic core, apoptosis and autophagy 
appear to dominate the penumbra.  (Xu and Zhang 2011)  
rCBF is typically reduced in children with MMD compared with controls in a 
regional (fronto-parietal) distribution, with concomitant increases in OEF and 
regional cerebral blood volume (rCBV) but maintenance of rCMRO2 (Ikezaki et 
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al. 1994, Kuroda et al. 1995, Ishikawa et al. 1997). Increased rCBV represents 
both compensatory vasodilatation related to the reduced rCBF and the blood 
contained within the collateral circulation. In patients with more advanced 
disease, there is a progressive fall in rCBF and eventually a decrease in 
rCMRO2.  
Haemodynamic abnormalities improve but may still be outside the normal range 
after surgical revascularization (Nakagawara et al. 1997). Clinical improvement 
is not directly related to the improvement in haemodynamic studies. Similar 
changes do not appear to occur in the adult moyamoya population, although in 
this age group, there is a slight reduction in global rather than regional CBF and 
no significant increase in rCMRO2, OEF or rCBV (Kuwabara et al. 1990, 
Ishikawa et al. 1998).  
1.7. Cerebrovascular Reactivity  
CVR is the measurement of vessel reactivity to changing partial pressure of 
carbon dioxide (pCO2) and is defined as the change in blood flow per unit 
change in pCO2. It is an important marker of brain vascular reserve and the 
ability to augment and maintain CBF under conditions of stress.  CVR studies 
are the brain equivalent of a cardiac stress test. Impaired CVR is an indicator of 
tissue at risk of decline in function, typically but perhaps not always, related to 
ischaemia.  There are relatively few studies in conditions affecting children 
(Davis et al. 1983, Clifton et al. 1988, Kuwabara et al. 1997, Prohovnik et al. 
2009, Heyn et al. 2010). 
As smooth-muscle tone in the arterioles is profoundly influenced by arterial 
carbon dioxide tension (PaCO2), small vessel arterioles dilate in response to an 
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increase and constrict with a decrease in the PaCO2, increasing or decreasing 
CBF in parallel (Figure 5 left)  (Kety and Schmidt 1948).  Under certain 
conditions such as hypotension (Harper and Glass 1965) (Fig 5 central, right), 
or after traumatic brain injury (TBI) (Philip et al. 2009), or in Sickle Cell Anaemia 
(SCA) (Prohovnik et al. 2009) arteriolar dilatation reaches a maximum  and 
exhaustion of vasodilatory capacity may ensue resulting in flattening of the 
curve, with the risk of a decrease in CBF and CPP despite increasing PaCO2, 
and consequent ischaemia (Philip et al. 2009, Prohovnik et al. 2009). Impaired 
CVR is associated with conditions of cognitive decline such as Alzheimer’s 
disease (Marshall 2012).  Patients with SCA have marked global cerebral 
hyperaemia secondary to anaemia, when compared to controls. Blood pressure 
is relatively low and autoregulation may be abnormal, although this is relatively 
difficult to test (Prengler et al. 2002).  In addition, the response of the cerebral 
circulation to increasing carbon dioxide tension, which is normally positive, is 
often very abnormal in SCA, with negative reactivity (steal) reported in a quarter 
of patients in a recent study from Steven Pavlakis’ group (Prohovnik et al. 
2009). This abnormal response is related to the anaemia and the resultant 
adaptive vasodilatation. Untransfused children with SCA approach the upper 
limit of cerebral vasodilatation with chronically increased cerebral perfusion.  
Hence, despite increased globally increased CBF in the context of the anaemia, 
ischaemia may occur under any condition where there is an additional 
requirement for oxygen supply (e.g., increased metabolic demand due to fever 
or seizure, hypotension), putting the child at risk of brain damage, including 
progressive white matter injury and neurocognitive decline. 
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Figure 8  Percentage Change in cerebral blood flow with changing arterial                                                                                  
carbon dioxide in dogs with normal (left) and progressively reducing                                                                                                    
blood pressure (central, right) (Harper and Glass 1965) 
 
 
1.7.1. Measurement of Cerebrovascular Reactivity 
These changes may be monitored using a number of techniques (Harper and 
Glass 1965, Kirkham et al. 1986). 
Studies of cerebrovascular reactivity in childhood arteriopathy are limited. In a 
PET study of 20 patients with moyamoya (7 children), using 15O H2O as the 
tracer, Kuwabara et al found reduced cerebrovascular reactivity to changing  
PCO2 compared with controls (Kuwabara et al. 1997). A recent study by Heyn 
et al of 9 adults and 2 children (aged 10 and 11 years respectively) 
demonstrated that cerebrovascular response to changing pCO2, as measured 
using BOLD signal, correlated with the severity of moyamoya disease (Heyn et 
al. 2010).  In addition Han et al demonstrated in children that CVR measures 
can provide information about cerebral haemodynamic compromise beyond 
ischaemic lesions, even into normal appearing brain parenchyma (Han et al. 
2011).    
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1.8. Direct and Indirect Methods of Quantification of 
Cerebral Blood Flow 
1.8.1. BOLD MRI  
As it is non-invasive and does not require ionizing radiation, MRI is particularly 
well-suited for paediatric studies, which is especially advantageous for when 
repeated studies are required. Deoxyhaemoglobin (dHb) is paramagnetic and is 
hence a naturally occurring contrast agent for magnetic resonance imaging.  
Arterial blood comprises a relatively small fraction (~ 25%) of total CBV and 
contains negligible amounts of dHb. (Schmidt and Thews 1983)Therefore, MRI-
relevant changes in total CBV are primarily due to passive inflation of venules 
caused by the elevation of venous blood pressure occurring when arteriolar 
resistance is lowered (Hoge et al. 1999, Mandeville et al. 1999) 
Deoxyhaemoglobin may be accentuated using gradient-echo techniques in high 
fields to image brain microvasculature.  Oxyhaemoglobin (OxHb) has little effect 
on the signal (Ogawa et al. 1990, Buxton et al. 2004, He and Yablonskiy 2007). 
The blood oxygenation level-dependent (BOLD) contrast follows blood oxygen 
changes induced under various circumstances, including alteration of inhaled 
gas mixtures that alter metabolic demand or blood flow, such as carbon dioxide 
(Graham et al. 1994). BOLD MR imaging is sensitive to the dHb concentration 
in blood (Ogawa et al. 1990) and it’s signal is dependent on the concentration in 
the venous blood and the blood volume fraction of tissue. (Boxerman et al. 
1995)  An increase in dHb causes a reduction in MR signal due to magnetic 
susceptibility effects and increased T2* relaxation. In functional MR studies, 
increased CBF secondary to increased neuronal activation is associated with 
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decreased dHb and increased Hb concentrations. Under these conditions, 
oxygen delivery exceeds increased oxygen consumption by the tissue, resulting 
in increased BOLD signal intensity (Davis et al. 1998). A similar effect can be 
achieved in BOLD CVR experiments. Because increased PCO2 causes 
vasodilation of cerebral blood vessels without increasing the metabolic rate of 
brain parenchyma, it can also be used to change the dHb concentrations within 
the cerebral vasculature.  In healthy vessels, the MR signal intensity increases 
when pCO2 increases due to dilution of dHb resulting from increased O2 
delivery with constant tissue O2 utilization. In areas of negative reactivity, the 
MR signal decreases with increased PCO2. BOLD contrast can be used to 
provide in vivo real-time maps of blood oxygenation in the brain under normal 
physiological conditions and in relation to regional neural activity.  
Using arterial spin labelling (ASL) as a reference standard for measuring CBF 
and comparing ASL CVR with BOLD CVR, BOLD MRI can accurately 
discriminate between normal and abnormal hemispheric CVR. Regions of 
paradoxical CVR on BOLD MRI have been shown to have a moderate positive 
predictive value (73%) for true paradoxical CVR. Importantly, complete lack of 
paradoxical CVR on BOLD MRI had a high negative predictive value (100%) 
(Hoge et al. 1999, Mandell et al. 2008).(Mandell et al. 2008). 
Arterial partial pressure of carbon dioxide (PaCO2) is directly proportional to 
end-tidal PCO2 hence under normal physiological circumstances (Kirkham et al. 
1986), control of end-tidal PCO2 through manipulation of inhaled CO2 (e.g. 
breath-holding, rebreathing circuit, ventilator adjustment) will result in 
proportional changes in CBF that can be indirectly imaged using BOLD MR 
sequences (Vesely et al. 2001).  Quantitative MRI measures of CVR can 
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therefore provide ‘parametric maps’, which enables the interrogation of regional 
vascular dysfunction at the tissue level and reserve capacity of the cerebral 
vasculature through manipulation of alveolar PCO2 (Graham et al. 1994, Detre 
and Wang 2002, Mandell et al. 2008, Kassner et al. 2010, Mandell et al. 2011, 
Donahue et al. 2013, Thomas et al. 2013). 
 
1.8.2. CVR-ASL 
In addition to semi-quantitative delineation of regional perfusion with gadolinium 
(Calamante et al. 2001, Kirkham et al. 2001), ASL can be used to assess CVR 
and CBF.  ASL uses water protons in endogenous blood as a perfusion tracer.  
Labeled capillary intravascular spins do exchanges with brain tissue through the 
blood-brain barrier altering tissue magnetization making it possible to obtain 
images in which contrast is proportional to cerebral perfusion.  Images are 
required distal to the labeling plane and perfusion maps obtained by subtracting 
labeled and control images.  In contrast to BOLD MRI signal, ASL signal is 
independent of CBV, cerebral metabolic rate of oxygen consumption and PaO2 
(Ogawa et al. 1993, Hoge et al. 1999, Thomas et al. 2001, Petersen et al. 
2006).  
Despite the advantages of ASL clinical application in the assessment of 
perfusion and CBF is problematic in steno-occlusive cerebrovascular disease.  
Limited signal-to-noise ratio and complex flow kinetics, requiring measurements 
of T1 values for blood and tissue, labeling efficiency and arterial transit time for 
absolute CBF quantification are barriers to the application of ASL for the 
assessment of CVR in moyamoya (Golay et al. 2007, Mandell et al. 2008). 
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T2* dynamic susceptibility contrast imaging (DSC) and T1 dynamic contrast 
enhancement (DCE) are MR perfusion techniques used in adults. However, 
concerns include the invasive nature of the contrast administration (high volume 
bolus in small venous channels), risk of anaphylaxis, nephrotoxicity, slow 
clearance and, in the case of repeated administrations, retention of gadolinium 
contrast in the brain (Levin, Kaufman et al. 1995, Kaewlai and Abujudeh 2012, 
Kanda, Ishii et al. 2014, Kanda, Oba et al. 2016).   
Another MR based approach to measuring perfusion consists of a high-spatial-
resolution 3D gradient echo MR sequence employing susceptibility weighted 
imaging (SWI). This technique has been employed to measure perfusion in 
healthy and asphyxiated newborns (Boudes, Gilbert et al. 2014) and recently, to 
measure penumbra in neonatal stroke (Watson, Dehaes et al. 2016).  However, 
further exploration of this modality is required in the paediatric population. 
1.8.3. Nuclear Medicine Techniques and CT  
 
CT perfusion studies are widely used in adults, however they too require the 
use of contrast.  In addition there is often a need for serial imaging in children 
with steno-occlusive arteriopathy, hence CT based techniques of measuring 
perfusion and cerebral blood flow are not usually employed in children.  
CT perfusion studies are widely used in adults, however they too require the 
use of contrast.  In addition there is often a need for serial imaging in children 
with steno-occlusive arteriopathy, hence CT based techniques of measuring 
perfusion and cerebral blood flow are not usually employed in children.  
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Techniques measuring CBF are based on original research by Kety and 
Schmidt, who developed a quantitative method to measure whole-brain CBF 
and the CMRO2 using nitrous oxide, in humans, based on the Fick principle. 
Fick’s principle states that blood flow to an organ must equal the rate in which 
the organ metabolizes a blood constituent, divided by the constituent’s vascular 
concentration — its arterial-venous difference. More simply put - that the 
amount of a substance taken up or eliminated by an organ is equal to the 
difference between the amount in the arterial blood and the amount in the 
venous blood supplying that organ, in the same time period.  
The measurement of global cerebral blood flow with nitrous oxide required the 
following assumptions: (1) blood flow is in a steady state during the period of 
study and is not affected by the tracer. (2) the venous blood from the superior 
internal jugular vein is representative of the mixed cerebral venous blood with 
no contamination from extracerebral blood, (3) the period of measurement is 
long enough to allow equilibration of gas in the brain with the cerebral venous 
blood, (4) no significant arterial-venous shunts are present in the brain, and (5) 
the value of the partition coefficient of the inert gas is representative of the 
entire brain. The initial studies with nitrous oxide demonstrated that blood flow 
studies with this tracer did meet the above assumptions under most situations, 
the exception being in a region of disturbed physiology, where arteriovenous 
shunting may be significant and where the partition coefficient is likely to be 
altered.  
Kety and Schmidt’s (1948a,b) landmark papers established the foundational 
principle for most measurements of CBF ie. delivery of an amount of tracer 
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substance to the brain and measurement of uptake or loss of tracer over a time 
period, and provided the basis for the field of functional brain imaging.  
Nuclear medicine techniques such as 133Xenon clearance, positron emission 
tomography (PET), single photon emission computed tomography (SPECT), as 
well as stable Xenon-enhanced computed tomography (Xe/CT) have all been 
important in the early measurement and understanding of CVR.  These 
techniques typically exploit the properties of the radioisotope.  Although these 
techniques can provide accurate regional measures of baseline CBF and the 
CBF response to vasoactive stimuli, all require inhalation or injection (Ikezaki et 
al. 1994, Horowitz et al. 1995, Kuroda et al. 1995, McAuley et al. 2004) (Lee et 
al. 2009). 
 
1.8.3.1. Single photon emission tomography (SPECT) 
Repeated measures required for SPECT results in increased exposure to 
radiation and (again) increased errors due to head motion artifact and 
differences in washout of tracer.  It too is often used in conjunction with a 
vasodilatory stimulus (Moretti et al. 1995).   
 
1.8.3.2. Stable Xenon CT 
 
1.8.3.3. 133 Xe/Stable Xenon CT 
Xe/CT has been widely used in the study of moyamoya in conjunction with the 
acetazolamide challenge (see 1.9.1, p.78). 133Xe has a low solubility in blood 
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and is rapidly cleared from the blood, thus allowing further studies to be 
performed within a short period of time (approximately 30 min). It does not 
require repeat blood sampling and allows for calculation of regional flow rates. 
Disadvantages include a relatively long acquisition time therefore increasing the 
probability of motion artifacts and tolerability.  Furthermore, due to regulatory 
issues, the Xe-CT CBF technique is not readily available at present in many 
countries, including the US (Horowitz et al. 1995, Nambu et al. 1995, Suzuki et 
al. 1996, McAuley et al. 2004). Further disadvantages include poor spatial and 
temporal resolution and a concomitant increase in CBF as a result of stable 
xenon inhalation. 
 
An additional disadvantage is the relatively long acquisition time therefore 
increasing the probability of motion artifacts and tolerability.  Furthermore, due 
to regulatory issues, the Xe-CT CBF technique is not readily available at 
present in many countries, including the US (Horowitz et al. 1995, Nambu et al. 
1995, Suzuki et al. 1996, McAuley et al. 2004). Further disadvantages include 
poor spatial and temporal resolution and a concomitant increase in CBF as a 
result of stable xenon inhalation. 
 
1.8.4. Transcranial Doppler (TCD)  
Although the diameter of the vessel is typically not known, transcranial Doppler 
can measure CBF in conditions where diameter can be assumed to be constant 
(Kirkham et al. 1986) and quantification of CVR relies on measuring the change 
in mean blood flow velocity or pulsatility index within the major arteries of the 
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circle of Willis in response to a vasoactive stimulus such as carbon dioxide 
(Kirkham et al. 1986, Philip et al. 2009, Wu et al. 2011).  However, TCD only 
provides an indirect measure of CVR in the large intracerebral vessels, one that 
is remote from the actual site of vascular dysfunction in the arteriolar bed. In 
childhood stroke, the large vessels are typically very abnormal in a variety of 
ways which are difficult to diagnose using TCD. As a result, TCD measures of 
CBF may include a large contribution from collateral sources, which can lead to 
false negative CVR measurements (Pindzola et al. 2001) and is unable to 
provide information about the extent of CVR impairment at the tissue level. The 
technique is very operator dependent and cannot delineate precise regions of 
compromised CVR.   
 
1.9. Vasoactive Challenge Techniques for Mapping of 
Cerebrovascular Reactivity 
The magnitude of the change in blood flow in response to vasoactive agents 
such as CO2 or acetazolamide provides information concerning the intrinsic 
capacity of the cerebral vasculature to regulate blood flow.  Hence, CVR 
response to a prescribed challenge can be documented CVR using a number of 
available techniques:   
 
1.9.1. Acetazolamide challenge 
This method requires intravenous injection of Acetazolamide, a selective 
carbonic anhydrase inhibitor.  Acetazolamide reduces the conversion rate of 
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CO2 to bicarbonate resulting in increased CO2 in brain tissue, a change in 
extracellular pH and a rapid increase in CBF without a change in CMRO2 or 
arterial blood pressure (Vorstrup et al. 1984).  However the need for injection, 
associated dizziness and TIA like symptoms and a poorly understood time to 
and mechanism for vasodilation remain as disadvantages to the use of this 
technique (Dahl et al. 1995, Saito et al. 2011). 
1.9.2. Breath-holding  
This is the simplest hypercapnic CVR technique.  It does not require a source of 
CO2 or special equipment.  Underlying arteriopathy, in particular MMD, 
increases anaesthetic risk so one advantage is that the child does not require 
general anaesthetic (GA) as it is performed in the awake state.  Breath-holding 
(to simulate apnoea) results in an increase in PaCO2 and vasodilation 
(Thomason et al. 2005).  Interspersing breath-holds with regular breathing for 
controlled periods of time and synchronization of these timelines with the BOLD 
signal generated on MRI allows for the generation of BOLD signal-CVR fit 
curves.  However, as delivery of the vasoactive stimulus CO2 is difficult to 
quantify and respiratory information is minimal, repeatability of such data is 
challenging. 
With the breath-holding technique, patients breathe room air hence there is no 
control (between breath hold [BH] and normal respiration [NR]) for PaO2 and 
any possible effects on CBF.  The normal response to increase in inhaled CO2 
is increased tidal volume with a concomitant increase in PaCO2.  One study 
(Prisman et al. 2008) showed that the BOLD response to O2 change is 
0.006%/mmHg, with a sensitivity 50 times lower than that for CO2 
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(0.3%/mmHg).  Hence, the effect of increase in O2 with the interspersed NRs is 
probably minimal.  This minimal effect is likely to be because of the binding 
properties of haemoglobin and oxygen in the blood and the oxygen dissociation 
curve.  Consequently apparently large increases of pulmonary O2 are not 
mirrored in the blood or the cerebral circulation.  
 
1.9.3. Fixed (5-7%) CO2 inhalational techniques  
Fixed CO2 inhalational techniques with measurement of end-tidal CO2 have 
increased the available respiratory data and improved the repeatability of 
studies.  However, this technique is not always well tolerated in adults and, 
despite reductions in inhalational CO2 time epochs, not well tolerated in 
children.   
 
1.9.4. Hypercapnic CO2 challenge under GA  
Many children are too young or non-compliant for evaluation while awake and 
often require MRI examination under anesthesia.  Hence, a modified version of 
the inhalation CO2 technique has been simulated and successfully evaluated 
under these conditions whereby EtCO2 levels checked at baseline are 
increased by reducing the ventilator rate during MRI acquisition, allowing for 
rise in CO2, followed by reinstitution of ventilatory settings so as to produce an 
end expiratory pCO2 in the range of 35 – 40 mmHg.  Effects of anaesthetic 
agents commonly used eg Propofol and inhalational anaesthetics are not fully 
understood.  
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1.9.5. Computer aided delivery of vasoactive substance  
Quantitative techniques suitable for the awake state have been trialed with 
encouraging results in the adult cerebrovascular disease population (Mikulis et 
al. 2005, Heyn et al. 2010).  One of the most promising of these is the RespirAct 
re-breathing system.  This is a computer-controlled gas delivery system which 
allows the delivery of a quantifiable and repeatable vasoactive substance.  
Hence, targeted partial pressures of EtCO2 (e.g. hypercapnia) may be delivered 
to patients whilst simultaneously maintaining constant O2 levels, and hence 
eliminating changing pO2 as a confounder.  The CVR maps generated are 
useful for inter-patient comparison. 
 
1.10. Objectives 
My primary objectives were to:  
1) Validate the use of qualitative hypercapnic challenge BOLD MRI CVR 
(hBOLD CVR) using breath-hold and general anaesthetic methods as reliable 
and repeatable for use in the paediatric population 
2)  Assess the utility of hBOLD CVR as a tool for the identification of the risk 
of ischaemia in children with arteriopathy 
 
A series of studies were hence conducted with the aim to answer specific 
questions to address the objectives of the research.   
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1.11. Research Questions 
1.11.1. Study Questions and Study Chapters: 
Chapter 2:  Methodology 
Chapter 3:  Population Description and Clnical Presentation 
Chapter 4:  Reliability and Repeatability of hBOLD CVR Method of 
Analysis  
Study 1 
 Are direct and indirect quantitative measures of qualitative hBOLD CVR 
reliable and repeatable? 
Chapter 5 Population hBOLD CVR Measures 
 What range of quantitative hBOLD CVR measures are seen in a 
population of children with cerebrovascular disease?  
Chapter 6:  Comparison of hBOLD CVR with Conventional Angiography 
and Measures of Moyamoya Severity 
Study 2                                                                         
 Does CVR abnormality as demonstrated by quantitative hBOLD CVR 
measures correspond with the region of abnormality as demonstrated on 
conventional angiography  
 Is hBOLD CVR abnormality associated with the severity of moyamoya as 
assessed by indices of disease severity? 
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Chapter 6:  Pre and post-surgical hBOLD CVR 
 Study 3                                                                    
 Do measures of hBOLD CVR change following revascularization surgery, 
and if they do are the changes concordant with change as demonstrated 
on conventional angiography and clinical change?  
 
Chapter 7:  hBOLD CVR and Neuropsychological Outcomes 
Study 4                                                                                                      
 Does hBOLD CVR predict neuropsychological outcome?  
Chapter 8:  hBOLD CVR and Cortical Thickness 
Study 5 
 Is abnormality in hBOLD CVR associated with abnormality in cortical 
thickness? 
Chapter 9:   hBOLD CVR and Chronic arterial stenosis 
Study 6                                                                                  
 Does chronic non-progressive stenosis result in changes in hBOLD CVR 
beyond the stenosis? 
 
1.12. Study Hypotheses: 
1)  Qualitative measures of hBOLD CVR studies are reproducible when 
repeated and reliable between observers. 
2)  Region of abnormality on hBOLD CVR corresponds with the region of 
abnormality as demonstrated on CA.  
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3)   Measures of hBOLD CVR are proportional to severity of moyamoya as 
assessed by the modified Suzuki scale and grade of stenosis. 
4)  Changes in hBOLD CVR predict changes in clinical outcome. 
5)  Measures of hBOLD CVR are predictive of neurocognitive outcome in 
childhood MMD, specifically: 
i)  abnormal left hemisphere hBOLD CVR measures are associated with 
reduced verbal IQ 
ii)  abnormal right hemisphere hBOLD CVR measures are associated with 
reduced performance IQ 
iii) abnormal hBOLD CVR measures are associated with reduction in 
processing speed 
iv)  abnormal hBOLD CVR measures are associated with abnormality in 
indices of executive function 
6)  Measures of hBOLD CVR are predictive of changes in cortical thickness 
7)  Chronic non-progressive steno-occlusive arteriopathy does not result in 
hBOLD CVR abnormality distal to the stenosis    
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2.  Methodology 
2.1. Introduction 
In this chapter I describe the populations; study terms and definitions; and 
methodology common to all the studies.  
 
2.2. Population 
This was an unfunded study of a convenience sample of prospectively enrolled 
patients with clinically acquired hBOLD CVR studies. The data were analysed 
retrospectively. Hence, there was no sample size calculation.  
hBOLD CVR became available at The Hospital for Sick Children, Toronto, 
Canada in 2000, after which the technique was employed in children with 
moyamoya referred to the Stroke Programme, as well is those returning for 
follow-up.  hBOLD CVR studies were not conducted primarily when i) age of 
diagnosis and management decisions principally occurred before 1997 ii) 
revascularization surgery was not considered an option for management iii)  
consent was not obtained.   In the early years of the study revascularization 
surgery was not considered an option for management for children with sickle 
cell disease.   However, this changed in the latter years.   
Children with moyamoya arteriopathy referred to the stroke clinic at The 
Hospital for Sick Children between August 2008 and December 2010 were 
prospectively enrolled in the Stroke Research Registry and had hBOLD CVR 
studies. Moyamoya patients had either unilateral or bilateral moyamoya 
arteriopathy.  In parallel the Stroke Research Registry database was reviewed 
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to retrospectively identify patients with moyamoya and bilateral non-moyamoya 
arteriopathy who had hBOLD CVR studies. All symptomatic and asymptomatic 
children enrolled in Stroke Research Registry database and diagnosed with 
moyamoya arteriopathy were eligible for inclusion.   
I decided to use children with a diagnosis of Transient Cerebral Arteriopathy as 
a model for unilateral non-moyamoya arteriopathy as it is the commonest 
unilateral intracranial arteriopathy of childhood.   Hence, the brain MRI scans of 
all children on The Hospital for Sick Children Stroke Registry database with a 
previous diagnosis of Transient Cerebral Arteriopathy were reviewed.  Children 
with a persistent moderate to severe stenosis (Grade 3 – 4) as defined below 
were approached for inclusion in the study.  hBOLD CVR studies were 
conducted in those that consented.  Clinical and radiographic information was 
obtained and reviewed in all.  Medications at time of enrolment and hBOLD 
CVR study were noted.  
Therefore, children were included according to 2 main arteriopathy groups i) 
and ii) and 1 sample of convenience iii): 
i) Moyamoya arteriopathy – unilateral and bilateral 
ii) Unilateral non-moyamoya arteriopathy 
iii) Bilateral non-moyamoya arteriopathy 
 
Specifically, studies included patients as follows:     
1. Children with moyamoya and non-moyamoya arteriopathy who had hBOLD 
CVR studies.  (Study 1) 
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2. Children with moyamoya arteriopathy who had hBOLD CVR studies and 
conventional angiograms.  (Study 2) 
3. Children with moyamoya arteriopathy who underwent revascularization 
surgery and had hBOLD CVR, MRI brain, MR angiography and/or 
conventional catheter angiogram (CA) studies prior to and following 
revascularisation surgery. (Study 3) 
4. Children with moyamoya arteriopathy who had hBOLD CVR studies and 
neuropsychological assessment using standardized Wechsler scales of 
intelligence and Parent and Teacher BRIEF scores of executive function at 
at least one time point. (Study 4) 
5. Children with moyamoya arteriopathy who had hBOLD CVR studies and no 
history of stroke at the time of the included hBOLD CVR study.  (Study 5) 
6. Children with unilateral persistent, non-progressive, moderate to severe, 
steno-occlusive arteriopathy and a history of unilateral stroke confined to the 
sub-cortical structures  (Study 6) 
2.3. Ethical Approval 
Ethical permission was granted by the Institutional Review Board of the Hospital 
for Sick Children, Toronto, and consent was obtained from all families according 
to institutional guidelines. 
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2.4. Arteriopathy Diagnosis 
2.4.1. Range of vasculopathies in childhood 
2.4.1.1. Moyamoya Disease and Moyamoya Syndrome 
Children were diagnosed with moyamoya arteriopathy if conventional 
angiography demonstrated stenosis or occlusion of the terminal ICA and/or the 
proximal MCA and/or MCA with the appearance of moyamoya/lenticulostriate 
collaterals.  Children with unilateral moyamoya with collaterals (probable 
moyamoya) were included in this group (Fukui 1997).  
Children without a previously diagnosed condition were diagnosed as having 
moyamoya disease (MMD) or idiopathic MM. Children with a previously 
diagnosed condition were diagnosed as having moyamoya syndrome (MMS).   
Diseases associated with syndromic diagnosis included: 
 
2.4.1.1.1. Neurofibromatosis Type 1  
Children with Neurofibromatosis Type 1 (NF1) diagnosed according to accepted 
criteria (1988) and attending the Paediatric Neurofibromatosis Clinic at The 
Hospital for Sick Children, Toronto with MM were enrolled.  Moyamoya 
diagnosis was made following targeted screening MRI and MRA imaging 
protocols based on the recommendations of the National Neurofibromatosis 
Foundation Optic Pathway Task Force and the American Academy of Pediatrics 
Committee on Genetics. Patients with a history of radiotherapy for optic 
pathway gliomas associated with NF1 were excluded from the group.  
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2.4.1.1.2. Sickle Cell Disease 
Children with HbSS disease (SCD) with moyamoya and referred from The 
Hospital for Sick Children Haemoglobinopathy Clinic were included.  HbSS 
diagnosis was confirmed by haemoglobin electrophoresis. 
 
2.4.1.1.3. Trisomy 21 and other Chromosomal  
Children referred to The Hospital for Sick Children Stroke Service with a 
diagnosis of Trisomy 21, Turner Syndrome, and other chromosomal abnormality 
MMS were included. 
 
2.4.1.1.4. Radiation Vasculopathy  
Children with a history of focussed cranial irradiation for treatment of a head 
and/or neck tumour were included.  
A number of asymptomatic children were identified as a result of current 
vascular imaging surveillance protocols for children with NF-1 (Rea et al. 2009) 
and SCD and were included in the study. 
2.4.1.2. Non-moyamoya Vasculopathy 
2.4.1.2.1. Transient Cerebral Arteriopathy 
Children diagnosed with Transient Cerebral Arteriopathy according to 
established criteria (Chabrier et al. 1998, Sebire 2006) were included as a non-
moyamoya, non-progressive steno-occlusive arteriopathy control group.  
Specifically children with persistent moderate to severe stenosis on 
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conventional angiography of unilateral pMCA, pACA and/or dICA, plus infarcts 
limited to unilateral sub-cortical structures with spared cortex were enrolled. 
 
2.4.1.2.2. Bilateral Non-moyamoya Arteriopathy 
Children with bilateral non-moyamoya arteriopathies including PHACES 
syndrome (Posterior fossa malformations, Haemangiomas, Arterial anomalies, 
Cardiac defects and Coarctation of the Aorta, Eye abnormalities, and Sternal 
abnormalities or ventral developmental defects), bilateral Takayasu’s arteritis 
and Sickle cell disease with bilateral non-moyamoya arteriopathy were enrolled 
in the study following referral to The Hospital for Sick Children Stroke Service, 
and included as a comparative sample of convenience. 
 
2.4.2. Definitions of terms used are as follows: 
i)   Moyamoya arteriopathy (MM) – this was used to describe all patients 
with moyamoya arteriopathy 
ii)   Moyamoya disease (MMD) – this was used to describe patients with 
idiopathic moyamoya   
iii) Moyamoya syndrome (MMS) – this was used to describe all patients with 
moyamoya in the context of another disease diagnosis eg Sickle Cell Disease 
(SCD-MM), Neurofibromatosis Type 1 (NF1-MM), a chromosomal disorder 
(Chromosomal-MM) or radiation induced moyamoya secondary to treatment for 
a head and/or neck tumour (Tumour-MM). 
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iv) Stroke (AIS) was defined as presence of a focal neurological deficit 
(which could be less than 24 hours) with radiological evidence of new focal 
area(s) of infarction on neuroimaging within a vascular territory 
v) Transient ischaemic attack (TIA) was defined as presence of transient 
focal neurological deficits, lasting less than 24 hours, without radiological 
evidence of new focal area(s) of infarction on neuroimaging and that are not 
because of seizure or migraine.  
vi) Recurrent ischaemic stroke was defined as a confirmed clinical and 
radiological ischaemic event that occurs following an initial stroke. 
vii) Paediatric Stroke Outcome Measure (PSOM) - the neurological outcome 
was determined based on the data collected for the Canadian Paediatric 
Ischaemic Stroke Registry on the standardized Paediatric Stroke Outcome 
Measure examination, which has been validated for use in children (Kitchen et 
al. 2012). The PSOM represents a structured, classical, pediatric neurological 
examination containing 115 test items encompassing cognition, language, 
cranial nerve, motor, sensory, cerebellar, and gait functions. Test items are 
organized sequentially across development from early infancy to teenage years 
with a scoring option of “not age-appropriate” for each item. For infants 2 years, 
primitive reflexes and developmental examination items are included. On 
completion of the PSOM examination, the neurologist scores a Summary of 
Impressions containing 5 subscales: right sensorimotor, left sensorimotor (each 
with subcategories), language production, language comprehension, and 
cognitive/behavioral. 
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The PSOM has a five domain scoring system.  Each domain can have a 
maximum of 2 points as follows: 
0 = normal with no neurological deficits 
1 = mild with no impact on function 
2 = moderate with some functional limitation, and severe or profound with 
absence of function.  
A summary of impressions is calculated out of 10 so that the PSOM total score 
is the sum of the 5 subscale scores. Ten is the worst possible score (maximum 
deficit) and 0 (no deficit) the best possible score.   
 
2.4.3. Imaging techniques for diagnosis of vasculopathy 
2.4.3.1. Brain MRI and 3D TOF MR Angiography  
MRI was performed on a 1.5 or 3.0 Tesla scanner (Achieva, Philips, Best, 
Netherlands).  For co-registration with the MRI CVR measures, 25 T1-weighted 
anatomical images were acquired using a three-dimensional spoiled gradient 
echo pulse sequence (slice thickness: 5 mm; no inter-slice gap). 25 BOLD MRI 
CVR images were acquired with a T2*-weighted single-shot gradient echo pulse 
sequence (field of view: 220 or 230 mm; matrix: 64x64; TR: 2000 ms; TE: 30 
ms; flip angle: 85; slice thickness: 5.0 mm; no inter-slice gap; number of 
temporal frames = 180 or 240).  
MRI brain scans conducted at the time closest to moyamoya diagnosis were 
reviewed by reviewers (GdV and ND) blinded to clinical information.  Infarction 
was categorized as cortical ischaemic (implying a vaso-occlusive mechanism of 
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injury) or watershed (implying perfusion failure as the mechanism of injury).  
Watershed infarction was further divided into deep watershed when the 
ischaemic injury was predominantly within the white matter and cortical 
watershed when the ischaemic injury was predominantly cortical and at the 
border zones of the major cerebral arteries.  The ‘ivy sign’ was noted as being 
present or absent on Axial T2 FLAIR sequences.  
3D TOF MRA was conducted in all at the same time as the MRI.  Staging and 
grading of stenosis on MRA was as described below. 
2.4.3.2. Conventional catheter angiography  
In all cases with MM diagnosis was made following 4 vessel conventional 
catheter angiography. Four vessel CAs were obtained under GA pre and (where 
applicable) post-operatively.  In addition, those that had surgery had 
superselective angiography, where a smaller catheter is passed through a 
larger one into a branch artery supplying a small area of tissue. Lateral internal 
carotid artery, external carotid artery, superficial temporal artery, and 
moyamoya arteriopathy angiograms were analyzed in the late arterial phase to 
assess the relative contributions of the superficial temporal artery and 
moyamoya arteriopathy to overall revascularization as determined by the 
external carotid artery injection (King et al. 2010).   
 
2.4.4. Staging of Moyamoya Arteriopathy 
Moyamoya on CA and MRA was staged using a modified Suzuki (Suzuki and 
Takaku 1969, Tzika et al. 1997) staging scheme (Table 2) by ND and the study 
interventional radiologist (DA) blinded to the CVR data.   
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Table 2 Modified angiographic staging of moyamoya disease (Suzuki and Takaku 
1969, Tzika et al. 1997) 
Stage      Angiographic Findings  
1             Narrowing of internal carotid artery bifurcation without     
               Collaterals 
2             Initiation of moyamoya collaterals 
3             Intensification of moyamoya collaterals 
4             Minimization of moyamoya collaterals 
5             Reduction of moyamoya collaterals 
6             Disappearance of moyamoya collaterals 
 
2.4.5. Grading of Moyamoya Arteriopathy 
Arterial stenosis on CA and where CA was not available, MRA, was scored 
according to the degree of vessel narrowing expressed as a percentage ie. 1 = 
0-25%; 2 = 26-49%; 3=50-74%; 4=75-100%.  If multiple vessels of the COW 
were involved, the worst vessel was scored and used for the purpose of 
analysis.  
The moyamoya grading and staging system were used as imaging markers of 
the severity of moyamoya. 
 
2.5. Revascularization Surgery  
Clinical factors used to assess suitability for surgery included clinical 
presentation, MRI findings of ischaemic injury within a vascular territory, deep 
white matter or watershed gliosis, severity of vascular disease, progression of 
vascular disease and CVR.  Children had a combination of direct and indirect 
procedures.  Direct procedures included external carotid – internal carotid 
bypass (EC-IC).  Indirect procedures included pial and inter-hemispheric 
synangiosis.   
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2.6. Cerebrovascular reactivity using a hypercapnic 
challenge 
Three methods of increasing carbon dioxide tension were used, (a) breath-
holding and (b) rebreathing in awake children and (c) altering carbon dioxide 
tension under general anaesthesia using ventilator changes. 
 
2.6.1. Awake: Breath holding and Re-breathe mask 
A block design was employed in the different methods described below (Fig 6): 
2.6.1.1. Breath-holding (BH)  
In a modification of the technique used in adults (Markus and Harrison 1992), 
children were instructed to hold their breath for as long as they could (usually 
between 15 and 30 seconds), then breathe for 30 seconds, hold their breath, 
then breathe for 60 seconds in repetitive cycles during MRI acquisition (Thomas 
et al. 2013).   
 
2.6.1.2. Re-breathe mask (RM) 
During BOLD-CVR imaging controlled amounts of CO2 mixed with medical air 
was delivered to subjects via an anaesthetic mask and rebreathing circuit. The 
circuit was connected to a computer-controlled gas sequencer (RespirAct; 
Thornhill Research Inc., Toronto, Canada) (Slessarev et al. 2007) that regulated 
both the quantity and composition of gas that was provided to the subject 
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(Prisman et al. 2008). The sequencer utilizes a prospective, feed-forward 
design that enables precise and independent targeting of partial pressures of 
end-tidal CO2 (PetCO2) and O2 (PetO2), irrespective of the subject’s breathing 
patterns. Controlled changes to PetCO2 were achieved through a nine minute 
block sequence run in synchrony with the BOLD-CVR acquisition. The 
sequence alternated between 60 seconds of normocapnia (target PetCO2 = 40 
mmHg) and 60 seconds of hypercapnia (target PetCO2 = 45 mmHg), while 
subject PetO2 levels were maintained at 100 mmHg. Partial pressures of CO2 
and O2 exhaled by the subjects were monitored through sampling tubes in the 
rebreathing mask. The subsequent PetCO2 and PetO2 values, defined as the 
sampled pressures at the end of each expired breath, were plotted to generate 
end-tidal waveforms. 
 
2.6.1.3. General Anaesthetic (GA) 
Children were anaesthetized with propofol, intubated and paralyzed. The CO2 
level was increased by decreasing ventilation for 60-120 seconds two or three 
times during an MRI acquisition time of six to eight minutes.  Between the 
episodes of CO2 increase, the ventilation was reinstituted at the baseline level 
that had been found to produce an end expiratory pCO2 in the range of 35 – 40 
mmHg.  The baseline epochs were 60-150 sec duration. There was 
electrocardiogram (ECG), blood pressure (BP), oxygen saturation (SpO2) and 
carbon dioxide (pCO2) monitoring throughout the studies. 
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Figure 9  Block Design Demonstrating CVR Method Principles 
 
The Respiract controls respiration so that end-tidal carbon dioxide (ETCO2) steps between 
periods at 40 mmHg and at 45 mmHg. End-tidal oxygen (ETO2) stays at 100 mmHg. Courtesy 
of Andrea Kassner 
2.6.2. hBOLD CVR Mapping  
Two different methods were applied depending on the hypercapnic challenge: 
2.6.2.1. Breath-holding and general anaesthetic (BH and GA) 
MRI data were analyzed using STIMULATE software. Motion correction, spatial 
and temporal filtering were performed automatically prior to analysis.   Using 
correlation analysis, a co-efficient of correlation (r value) was calculated for 
each voxel between the time series data and the square wave reference form.  
The correlation (r) values above a given threshold were colour-coded.  Positive 
correlation values above the threshold were colour-coded yellow, colourless 
indicated no correlation (i.e. no change in BOLD signal with changes in CO2) 
and purple indicated negative correlation or paradoxical reactivity.  A decrease 
in BOLD signal (purple) represented a redistribution of blood flow away from the 
corresponding vascular territory during the global vasodilatory stimulus of 
increased CO2, thus indicating “vascular steal”.  The colour coded BOLD signal 
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maps were then co-registered with the high resolution anatomical scans to 
produce the final CVR maps. 
To determine the haemaodynamic response curve eight axial brain slices were 
chosen as regions of interest (ROI) and a corresponding time course of signal 
intensity plotted (Figure 10).  
In neural activation functional MRI the timing of the neuronal activity is often 
assumed to the timing of the stimulus paradigm because the propagation of the 
neural signal (<100ms) is often much faster than the repetition time (TR) of the 
sequence.  However, in breath-hold induced hypercapnia it would take 30 
seconds for the PaCO2 to change.  Furthermore, there is a lag of the BOLD 
signal behind the change in PaCO2, which is the time taken for blood to travel 
form the pulmonary vascular system to the heart and then to the brain vessels.  
Typically this time lag is around 15 seconds. (Yezhuvath et al. 2009, Blockley et 
al. 2011). To account for this for each individual child, preliminary analysis was 
performed by manually drawing a ROI in the posterior fossa (usually spared in 
MMD) and the BOLD time course within this region correlated with the CO2 
breath-hold/normal respiration epochs.  The shift which produced the best 
BOLD fit curve was used as the comparative normal trace for each child.  Not 
properly accounting for this time delay could result in false-positive or false-
negative results leading to incorrect interpretation of CVR. We assumed that the 
arterial arrival time to the posterior fossa was similar to other brain regions, and 
any differences accounted for by the temporal resolution used in the study. 
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Figure 10 An Illustrative Case of hBOLD CVR CVR BOLD Signal Curves and 
Parametric Maps 
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 A) Normal MRI of 5 year old Chinese girl with headache and paroxysmal 
episodes of limb paraesthesia. B) MRA showed signal drop-out in the 
right dICA, MCA and ACA.  C) The conventional arteriogram showed right 
internal carotid artery stenosis with initial avascularity D) arrow and red 
circle then E) slow filling of the anterior circulation from the posterior 
circulation.  The pre-surgery cerebrovascular reactivity is shown from F) 
to I).  Hypercapnic BOLD CVR was colour coded so that yellow indicates 
positive (normal) response, and purple indicates abnormal (negative) 
‘steal’.  G) is the hBOLD CVR signal and CO2 map for the left cerebral 
hemisphere (X axis – time and respiratory course, Y axis – BOLD signal).  
Inspection of the BOLD signal map I is suggestive of reduced positive 
pixels i.e. impaired positive CVR in the right hemisphere when compared 
to the left (unaffected) hemisphere.  The linear BOLD MRI signal curves 
demonstrate a positive normal response for the left hemisphere.  J is the 
linear BOLD MRI signal curve for the right (affected) hemisphere. It still 
demonstrates positive but attenuated reactivity.   O and K Selection of the 
right hemisphere as the region of interest (ROI) demonstrated more 
negative pixels on the right than on the left, and an abnormal negative 
BOLD signal curve consistent with predominantly right sided reduction in 
positive reactivity and right sided steal. 
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2.6.2.2. Targeted end-tidal CO2 (RM) 
BOLD-CVR and end-tidal waveform data were transferred onto an independent 
workstation for further analysis using FSL v4.1.1 (FMRIB Software Library; 
FMRIB Analysis Group, Oxford, UK) (Smith et al. 2004). Images were first 
corrected for motion and then temporarily filtered to remove signal drift. To 
adjust for timing discrepancies between the end-tidal and BOLD-CVR data in 
each subject, the PetCO2 waveform was temporally shifted to maximize signal 
correlation with the whole-brain average of the BOLD-CVR data. Statistical 
parametric mapping (SPM) is a statistical tool that uses general linear modelling 
to analyze or characterize brain function.  It allows the expression of a response 
variable such as the haemodynamic response in terms of a linear sum of 
explanatory variables or effects in a design matrix (Friston 1998). Using these 
principles a voxel-wise map of CVR values was computed by performing a 
least-squares fit of the BOLD-CVR data with the PetCO2 waveform on a voxel-
by-voxel basis. The calculated correlation factors were further normalized by the 
time-averaged voxel signal intensities to express CVR as a percent signal 
change per mmHg of PetCO2. CVR maps were then co-registered to the high 
resolution anatomical images to allow for qualitative clinical assessment. 
 
2.6.3. Qualitative and Quantitative Measures of hBOLD-CVR  
Two quantitative methods, designed by ND and WL, were used to score the 
qualitative parametric maps (a) hemispheric pixel ratios (b) scoring by 
inspection.  Infarcts were not excluded from BOLD analysis. 
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2.6.3.1. Hemispheric Pixels  
The first axial slice of the hBOLD CVR parametric map above the ventricles was 
chosen for the purpose of scoring of the parametric maps containing cortical 
grey matter only (Thomas et al. 2014) However, the 5mm slice thickness of 
each slice means that it is possible for the parametric maps to have been 
subject to partial volume effects with each voxel containing several tissue types 
or substrate, such as CSF or white matter. Each axial slice was scored by the 
counting of hemispheric pixels at two thresholds.  The first threshold was that at 
which a total of 200 (or as near to 200 as possible) pixels with a positive 
correlation to the time course were generated in the whole brain.  The number 
of positive and negative pixels at this threshold were counted for each 
hemisphere and expressed as a ratio:  
 
Number of positive pixels in hemisphere/200 positive pixels = 
nP/200Ps and 
Number of negative pixels in hemisphere/200 positive pixels =  
nN/200P 
The second threshold was that at which a total of 200 (or as near to 200 as 
possible) pixels with a negative correlation to the time course were generated.  
Not all cases had sufficient negative signal to produce 200 pixels even at the 
lowest correlation threshold.  The number of negative pixels at this threshold 
were counted for each hemisphere and expressed as a ratio: 
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Number of negative pixels in hemisphere/200 negative pixels =  
nN/200N  
   where n = number, P = positive pixels, N = negative pixels   (Fig 11 and 12) 
Figure 11 Example of Hemispheric Pixel Scoring (see text below for explanation)  
  
 
 
 
Figure 12 Example of Hemispheric Scoring by Pixels 
 
 
 
 
The threshold was set so as to generate 200 positive pixels in the axial slice 
above the level of the ventricles:  
A) Positive threshold positive pixels parametric map (affected side):  the green 
box represents right hemisphere region of interest (side of moyamoya).  
Number of positive pixels in right hemisphere = 69.   
Therefore nP/200Ps = 69/200 = .35 
A B C 
D E F 
105 
ie Right positive threshold positive pixel ratio = RPTPP ratio = .35 
B) Positive threshold negative pixels parametric map:   negative pixels counted 
at this threshold.  The green box represents the same right hemisphere region 
of interest (side of moyamoya).  Number of negative pixels in right hemisphere 
= 28. 
Therefore nN/200Ps = 29/200 = .15 
ie. Right positive threshold negative pixel ratio = RPTNP ratio = .15 
C) Represents the composite parametric map. 
D)  Positive threshold positive pixels (unaffected side):   Number of positive 
pixels in left hemisphere = 121. 
Therefore nP/200Ps = 121/200 = .65 
ie. Left sided positive threshold positive pixels = L PTPP ratio = .65 
E)  Positive threshold negative pixels (unaffected side):  Number of negative 
pixels in left hemisphere = 3. 
Therefore nN/200Ns = 3/200 = L PTNP ratio = .02  
F)  Represents the composite scoring map (same as C).                                                                                                                                  
Therefore, in the presence of right sided tissue level CVR abnormality, the 
expected right sided PTPP hemispheric ratio would be less than 0.5, and the 
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further away from 0.5 toward 0 the greater the right sided CVR impairment.  As 
right and left hemispheric ratio measures were reciprocal calculations (ratios 
added up to 1), the left sided PTPP hemispheric ratio would deviate from 0.5 
toward 1.0.  The reverse would apply for more left sided tissue level CVR 
abnormality i.e. right PTPP greater than 0.5 and left PTPP less than 0.5 (Table 
3 and Fig11). 
The presence of negative pixels (other than artefact) is indicative of negative 
reactivity and directly infers tissue level impairment of CVR.  Therefore, the 
expected findings for negative pixels generated at thresholds targeting 200 
negative pixels (NTNP) in a child with right sided tissue level CVR abnormality 
would be a higher NTNP ratio (greater than 0.5) on the right side, and lower on 
the left.  The reverse would apply for more left sided tissue level CVR 
abnormality ie. right NTNP less than 0.5 and left NTNP greater than 0.5 (Fig 11 
and Table 3). 
Similar to NTNP, negative pixels generated at thresholds targeting 200 positive 
pixels ie. PTNP would be higher in the hemisphere with tissue level CVR 
impairment.  However, the hemispheric ratios are not reciprocal measures and 
therefore would not necessarily add up to one (Fig 7, 8, 9 explanation of pixels) 
 
Table 3 Examples of Hemispheric Pixel Ratios and Laterality of CVR Abnormality 
 
Laterality of CVR Abnormality 
 
 Normal Right Left Bilateral 
PTPP 
Right:Left 
 
0.5:0.5 
 
.25:.75 .25:.75 0.5:0.5 
PTNP 
Right:Left 
 
0:0 
 
>0:0 0:>0 >0:>0 
NTNP  .75:.25 .75:.25 .5:.5 
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Right:Left 0:0 
 
 
2.6.3.2. Scoring by Inspection  
We devised the inspection scoring system in-house. Combined (positive and 
negative) BOLD parametric maps (A+B=C; D+E=F; C=F)) were generated and 
scored per hemisphere as follows: 
i) Normal CVR = 1  
ii) Reduced positive reactivity +/- steal >2%<10% = 2 
iii) Steal > 10% with or without reduced positive reactivity = 3 
Therefore, the best possible total score would be 2 and the worst possible total 
score would be 6. 
 
Figure 13 Example of Hemispheric Scoring by Inspection 
   
A)                        B)                           C) 
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Therefore, in Fig 13 example A) the highlighted region of interest inspection 
score would be 2 (reduced positivity) for the right hemisphere and 1 for the left 
hemisphere (total score 3) B) the right hemispheric inspection score is 3 and left 
hemispheric inspection score 1 (total score 4)    C) Bilateral hemispheric scores 
of 3 (total score 6) 
 
2.6.3.2.1. Asymmetry index (AI) 
Asymmetry indices (AI) were calculated for positive and negative pixels at 
positive and negative thresholds using the following formula: 
Right hemisphere PTPP – Left hemisphere PTPP/Right hemisphere PTPP + 
Left hemisphere PTPP ie. 
RPTPP – LPTPP/RPTPP+LPTPP 
As RPTPP + LPTPP was preset at 200 (or as near to 200 as possible), then 
RPTPP ratio – LPTPP ratio = PTPP AI 
The same formula was applied for negative pixels at a positive and negative 
threshold ie. PTNP AI and NTNP AI. 
The resulting scores range from -1 to 1 with values indicating the following: 
 
Table 4 Interpretation of Asymmetry Index 
 
 
Positive Values (>0≤1) 
Interpretation 
Negative Values (>-1<0) 
Interpretation 
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PTPP 
 
  
PTNP 
 
 
NTNP 
 
Higher right hemispheric pixels 
Better reactivity right 
hemisphere 
Higher right hemispheric pixels 
Worse reactivity right 
hemisphere 
                                          
Higher right hemispheric   pixels 
Worse reactivity right 
hemisphere 
Higher left hemispheric pixels 
Better reactivity left    
hemisphere  
Higher left hemispheric pixels 
Worse reactivity left 
hemisphere     
                                            
Higher left hemispheric pixels 
Worse reactivity left 
hemisphere  
 
2.6.3.2.2. Quantitative Measures of hBOLD CVR 
The BOLD MRI signal time course was inspected and Δ BOLD MRI signal per 
∆PCO2 and BOLD MRI signal baseline recorded for bilateral hemispheres (or 
‘whole brain’) and right and left hemispheres. 
Cerebrovascular reactivity was calculated (where possible) using the following 
formula: 
% Δ BOLD MRI signal/∆PCO2 
 
2.6.4. Statistical Analysis 
Statistical analysis was performed using SPSS version 20.  Coefficient of 
variation was calculated as the ratio of the standard deviation to the mean, 
expressed as a percentage, to assess repeatability and kappa to assess 
reliability of method of analysis between observers. When data were normally 
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distributed T-test was used to compare 2 means and one-way ANOVA was 
used to compare means for >2 groups with post hoc analysis using Scheffe’s 
test.  Mann-Whitney or Kruskal-Wallis tests were used for comparison of non-
parametric values. Pearson’s correlation coefficient to assess association 
between parametric variables and Spearman’s correlation coefficient for non-
parametric variables. The Bonferroni correction was used to correct for multiple 
comparisons.  Linear regression was used to explore associations with 
continuous variables.  The value of p<.05 was used to indicate significance and 
p<.1≥.05   to indicate a trend. 
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3.  Population: Clinical and Radiological 
Characteristics 
3.1. Abstract   
3.1.1. Background   
Moyamoya arteriopathy is an angiographic description of a steno-occlusive 
arteriopathy which typically involves the anterior circulation arteries of the circle 
of Willis.  Characteristically the arteriopathy is bilateral and progressive, 
although unilateral (probable moyamoya) cases are included in the 
classification.   
3.1.2. Objective   
To describe and compare the clinical characteristics and radiological findings of 
children enrolled in the thesis studies with idiopathic moyamoya disease 
(MMD), moyamoya syndrome (MMS) and non-moyamoya arteriopathy who had 
hBOLD CVR studies. 
3.1.3. Method    
There were three study groups. Two main groups of children were enrolled from 
the stroke programme’s database 1) children with moyamoya arteriopathy and 
representative of a progressive (often bilateral, ocassionally unilateral) 
arteriopathy and 2) children with Transient cerebral arteriopathy and 
representative of non-progressive unilateral arteriopathy.  A third group of 
children with bilateral non-moyamoya arteriopathy were enrolled prospectively 
as sample of convenience for comparison with the other two groups. For all 
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patients, clinical and radiographic data were collected and hBOLD CVR studies 
were obtained. 
3.1.4. Results    
A total of 47 children (Group 1: 37 Bilateral or unilateral Moyamoya arteriopathy, 
Group 2: 6 Unilateral Non-moyamoya arteriopathy [Transient Cerebral 
Arteriopathy] and Group 3: 4 Bilateral Non-moyamoya arteriopathy [2 
PHACE(S), 1 Takayasu arteritis, 1 Sickle Cell Disease]) were enrolled and had 
hBOLD CVR studies.  The mean age of diagnosis of arteriopathy across all 
groups was 8.1 years (SD 4.2) (range 7 months - 18 years).  Clinical and 
radiographic features differed across arteriopathy groups.  Most presented with 
acute stroke, however among children with NF1-MM (Unilateral Moyamoya) 
most were asymptomatic at presentation and diagnosed on screening MRIs 
(almost 50%) or presented with headache alone.  Infarction patterns differed, 
with deep watershed infarction being the typical pattern in the moyamoya group 
in contrast to thrombotic vaso-occlusive infarction pattern in the Non-moyamoya 
groups.   
3.1.5. Conclusions   
In a single center study I was able to differentiate two sub-groups of 
arteriopathy representative of the two main mechanisms of brain ischaemia in 
arterial ischaemic stroke.  Specifically these were the moyamoya group as a 
prototype of progressive arteriopathy causing chronic hypoperfusion mediated 
ischaemic injury and Transient cerebral arteriopathy as a prototype of unilateral 
non-progressive arteriopathy causing acute vaso-occlusive ischaemic injury.  
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In this study clinical presentation with acute stroke (abrupt focal deficits) alone 
did not predict stroke aetiology or discriiminate between the moyamoya and 
non-moyamoya arteriopathy groups.  A notable exception to this was the that 
children with NF1-MM had a more benign and indolent course.  Radiographic 
presentation did differentiate across all three groups, with the imaging signature 
of deep watershed infarction seen within the moyamoya arteriopathy group. The 
latter is in keeping with hypoperfusion as the main mechanism of injury in 
moyamoya proposed in my thesis and supported by the published literature. 
Current medical treatments to prevent stroke (antithrombotic agents) are aimed 
at reducing thrombotic vaso-occlusive mechanisms and cannot inadequate 
adequately reduce the ongoing risk of ischaemic demise in this group. This 
treatment concern highlights the need to explore tools that can identify children 
at risk of ischaemia at the tissue level in the context of chronic hypoperfusion as 
seen in our population, the main motivation for my thesis studies. 
 
3.2. Introduction  
Arteriopathy is common in childhood stroke occurring in up to 80% of otherwise 
healthy children (Danchaivijitr, Cox et al. 2006, Amlie-Lefond, Bernard et al. 
2009).  It is a predictor of recurrence and poor short-term outcome (Ganesan, 
Prengler et al. 2003, Amlie-Lefond, Bernard et al. 2009, Goldenberg, Bernard et 
al. 2009). Arteriopathies can be logically divided into progressive or non-
progressive types (Braun, Bulder et al. 2009) (Sebire, Fullerton et al. 2004).  
Diffuse cerebral vasculitis and moyamoya disease are examples of the 
progressive childhood arteriopathies (Fung, Thompson et al. 2005, Benseler, 
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Silverman et al. 2006), whereas TCA is an example of a non-progressive 
arteriopathy.  Efforts continue to improve understanding of the aetiologic nature 
of the arteriopathies linking them with putative mechanisms including 
chromosomal and genetic abnormalities and inflammation (infectious and non-
infectious (Munot, Crow et al. 2011, Mineyko and Kirton 2013, Wintermark, Hills 
et al. 2014).  However therapeutic strategies are thus far inadequate at 
preventing the adverse outcomes associated with both progressive and non-
progressive arteriopathy groups. The progressive arteriopathy group in 
particular, has an exceedingly high rate of recurrent stroke and poor 
neurological outcomes.(Amlie-Lefond, Bernard et al. 2009, Braun, Bulder et al. 
2009).   
Within the moyamoya arteriopathy group there appear to be subgroups with a 
different nature of and natural history of moyamoya disease (Fung, Thompson 
et al. 2005, Benseler, Silverman et al. 2006, Braun, Bulder et al. 2009).  
Children with progressive bilateral moyamoya with recurrent ischaemic events 
are more likely to be of South East Asian origin.  Experience in our institution 
and published data suggests that children with Neurofibromatosis Type 1 
moyamoya are more likely to have a unilateral moyamoya arteriopathy with a 
more indolent course and are frequently of Caucasian origin, and typically 
(Cairns and North 2008, Rea, Brandsema et al. 2009, Lin, Baird et al. 2011, 
Duat-Rodriguez, Carceller et al. 2014).  Children with Sickle Cell Disease and 
moyamoya are more likely to be of African and/or Caribbean origin and they, 
similar to children with certain chromosomal syndromes such as Downs 
syndrome, tend to have a more typical bilateral (moyamoya disease-like) 
progressive arteriopathy with recurrent ischaemic events (Dobson, Holden et al. 
115 
2002, Jea, Smith et al. 2005, Pysden, Fallon et al. 2010, See, Ropper et al. 
2015).  Another sub-group are children with infantile moyamoya, who appear to 
have a very aggressive form of the disease, with fulminant recurrent large 
ischaemic strokes (Jackson, Lin et al. 2014, Al-Yassin, Saunders et al. 2015).   
More severe subgroups may warrant earlier surgical intervention. However, in 
determining the appropriateness and timing of surgical intervention multiple 
additional factors are relevant beyond clinical presentation, whether aggressive 
or benign. These include case-by-case consideration of increased peri-
operative risk associated with disease severity, technical aspects of vascular 
surgery and anaesthetic risk (Soriano, Sethna et al. 1993, Imaizumi, Hayashi et 
al. 1998, Kim, Seol et al. 2004, Heyer, Dowling et al. 2008).  Improved 
understanding of the natural history, clinical and radiological features of the 
moyamoya arteriopathies will provide further insight into the mechanisms of 
injury and allow for improved therapeutic strategies (Braun, Rafay et al. 2007, 
Mineyko and Kirton 2013, Rafay, Armstrong et al. 2015). Beyond these factors, 
there is a need for a valid and reliable method of measuring ischaemic brain risk 
in individual children with moyamoya to provide relevant and specific data to 
guide selection for revascularization surgery. The hBold-CVR method warrants 
consideration as such a method, as studied in this thesis. 
In this chapter I describe the frequency, clinical and radiological characteristics 
of our study population which includes children with a progressive steno-
occlusive arteriopathy: moyamoya arteriopathy (idiopathic and syndromic 
moyamoya) and non-progressive arteriopathy controls: non-moyamoya 
arteriopathy (TCA, PHACE(S), Takayasu arteritis and SCD).  I do this to 
demonstrate the similarities and differences between these sub-groups 
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highlighting the complexity in managing children with arteriopathy for whom the 
most frequently asked question by parent and medical professional alike is, 
‘”What is my/this child’s risk of a stroke?”.  The assessment of CVR provides an 
opportunity to answer this question for these individual children. 
 
3.3. Population Ascertainment 
The study population is a combination of prospectively enrolled patients and a 
retrospective sample of patients with clinically acquired hBOLD CVR studies as 
outlined in Figure 10.  
Between August 2008 and December 2010, 17 children with moyamoya 
arteriopathy (idiopathic and syndromic) referred to the stroke clinic at The 
Hospital for Sick Children had clinical hBOLD CVR studies.  Consent was not 
obtained in four; hence 13 were consecutively enrolled in the Stroke Registry 
database.   
Retrospective review of children on the Stroke Registry database prior to 
August 2008 (with children enrolled from 1992 – 2008) identified 73 children 
with a recorded diagnosis of moyamoya arteriopathy.  Following further review 
of clinical and imaging data, the arteriopathy was confirmed to be moyamoya in 
63 children.  hBOLD CVR studies were not conducted primarily when i) age of 
diagnosis and management decisions principally occurred before 1997 ii) 
revascularization surgery was not considered an option for management iii) 
consent was not obtained. Consequently, of the children with moyamoya 
arteriopathy on the Stroke Registry database from 1992 to 2008, thirty-three 
(median age 6.5, range 1.17-17.5 years) did not have hBOLD CVR studies for 
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reasons listed above. hBOLD CVR studies were hence available in 30 children 
with moyamoya arteriopathy.  Three of these studies were not analysable due 
to technical difficulties and consent was not obtained in three.  Therefore, 
following retrospective review of the Stroke Registry database hBOLD CVR 
studies in 24 children with moyamoya arteriopathy were available for analysis.   
Four children with Bilateral Non-moyamoya arteriopathy (Bilateral Non-MM) 
were retrospectively identified as having hBOLD CVR studies and included as a 
sample of convenience for comparison.  
We also conducted prospective hBOLD CVR studies on six children with a 
diagnosis of Transient Cerebral Arteriopathy that were previously enrolled in the 
Stroke Registry database. To select these children for hBOLD CVR studies, we 
screened 45 children with TCA reviewing MRI brain, MR angiography and 
conventional angiograms to identify children with 1) confirmed TCA 2) moderate 
to severe (Grade 3 – 4) stenosis of the MCA +/- ACA and 3) infarction sparing 
the cortex (because hBOLD CVR is non-informative in zones of infarction).  
Eleven children were approached for inclusion and 6 consented to undergo 
hBOLD CVR studies. These 6 were included as non-progressive, Unilateral 
Non-moyamoya arteriopathy (TCA, Unilateral Non-MM) controls. 
 
In summary 37 children with moyamoya arteriopathy (21 female, 16 male) had 
initial or follow-up hBOLD CVR studies (109 total studies, 54 under General 
Anaesthesia (GA); 49 Breath-hold (BH); 6 Re-breathe Mask (RM)) between 
November 2000 and December 2010 are reported and included in the study. 
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In addition, ten children were included as either Bilateral (4) or Unilateral (6) 
Non-MM controls. These 10 children (5 female, 5 male) had hBOLD CVR 
studies (3 under GA; 1 BH and 6 RM) which are also reported (Figure 11). 
 
 
3.4. Statistical Analysis 
One way ANOVA and the T-test were used to compare means when the data 
were distributed normally, and Kruskal-Wallis and Mann-Whitney U test used to 
compare medians when the data were not normally distributed. When some 
data, e.g. pixel counts, were distributed both normally and non-normally in 
different analyses, parametric and non-parametric statistics are reported. 
Categorical data were analysed using Χ2 or, if there were <5 in a cell, with 
Fisher’s exact test.  A significance level of p<.05 was accepted.  
Figure 14  Flow Diagram of Study Population 
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3.5. Results 
3.5.1. Group Description 
The total number of children with arteriopathy was 47 (25 male). Thirty seven 
had moyamoya arteriopathy (16 male, 21 females, 13 prospective and 24 
retrospective).  The proportional distribution of all arteriopathies (non-
moyamoya and moyamoya) and moyamoya arteriopathies (idiopathic and 
syndromic) are presented in Figure 15 and Figure 16 respectively.  The largest 
arteriopathy group was of those with idiopathic moyamoya (MMD) (n=13) 
followed by Neurofibromatosis type 1 (NF1-MM) (n=9) and sickle cell disease 
(SCD-MM) (n=5) moyamoya.   
 
Figure 15  Pie Chart of Arteriopathies (non-moyamoya and moyamoya) 
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Figure 16  Pie chart of Idiopathic and Syndromic Moyamoyas 
 
 
3.5.2. Clinical and Radiological Description of All Arteriopathy 
Groups 
Table 4 describes the clinical features of the Moyamoya, Bilateral Non-MM and 
Unilateral Non-MM Arteriopathy Groups at time of arteriopathy diagnosis.  
3.5.2.1. Age at Arteriopathy Diagnosis 
The mean age at arteriopathy diagnosis (moyamoya and non-moyamoya) was 
8.1 years (SD 4.2).  The mean age of diagnoses was 8.6, 3.7 and 4.5 years for 
the Moyamoya, Bilateral Non-MM and Unilateral Non-MM Arteriopathy groups 
respectively.  The Kruskal-Wallis test demonstrated a statistically significant 
difference in age of arteriopathy diagnosis between the Moyamoya, Bilateral 
Non-MM and Unilateral Non-MM arteriopathy groups χ2(2) = 11.6, p = 0.003. 
Post-hoc tests by Mann-Whitney U test (chosen because the group sizes were 
disparate) revealed that the mean age of diagnosis of arteriopathy was 
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statistically higher in the Moyamoya arteriopathy group compared to the 
Bilateral Non-MM arteriopathy U=22, p = 0.02 and Unilateral Non-MM 
arteriopathy groups U=39.5, p=.012.  There was no statistically significant 
difference in age of arteriopathy diagnosis between the Bilateral and Unilateral 
Non-MM arteriopathy groups U=10.5, p=.75. (Table 4) 
Figure 17  Mean Age of Diagnosis by Arteriopathy 
 
 
 
3.5.2.1.1. Infantile arteriopathy                                                                                                             
Out of 47 children, five (1 Moyamoya disease, 1 SCD-MM, 1 Takayasu arteritis 
and 2 TCA) had a diagnosis under the age of two years. The youngest child 
aged two months, had a diagnosis of Takayasu arteritis (Bilateral Non-
moyamoya).  The earliest age of diagnosis in the moyamoya arteriopathy group 
was seven months.  
Both of the very young children with MM arteriopathy presented with seizures.  
All the very young children with non-moyamoya arteriopathy presented with a 
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focal hemiparesis (Fig 18). All received anti-coagulation, one (Moyamoya 
disease) had revascularisation surgery, one (SCD moyamoya syndrome) a 
bone marrow transplant and one immunosuppressive therapy.  
Figure 18  Parenchymal and Vascular Imaging of Children with Infantile 
Arteriopathy 
 
Figures show Axial MRI DWI (1a, 3a, 4a and 5a) and FLAIR sequences (2a) in first row, and 3D 
TOF MRA in the second row (1b-5b). Figs 1and 2: Bilateral MM arteriopathy; Fig 3: Bilateral 
Non-MM arteriopathy (Takayasu arteritis); Figs 4 and 5: Unilateral Non-MM arteriopathy 
(Transient Cerebral Arteriopathy). 
 
3.5.2.2. Clinical Presentation 
Clinical records were reviewed and data collected on clinical status at time of 
diagnosis of arteriopathy.  
 
3.5.2.2.1. Moyamoya arteriopathy 
Twelve of the thirty-seven children (32%) presented with acute stroke (10 
ischaemic, 2 haemorrhagic); 8/37 TIA; 4/37 seizures; 12/37 headache; and 2/37 
other paroxysmal sensory symptoms at the time of moyamoya diagnosis.  Six 
(16%) were asymptomatic at the time of diagnosis.   
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3.5.2.2.2. Bilateral Non-MM arteriopathy  
Of the 4 children with Bilateral Non-MM arteriopathy, one child presented with a 
stroke and seizures, one with headache and two were asymptomatic at time of 
diagnosis of arteriopathy.  Diagnosis in the asymptomatic children (one SCD, 
one PHACEs) was made following disease specific MRI brain screening 
protocols.  
 
3.5.2.2.3. Unilateral Non-MM arteriopathy 
All (6/6) of the children with Unilateral Non-MM arteriopathy presented with 
acute arterial ischaemic stroke.  In addition, one had seizures and another 
headache at the time of presentation.  
 
3.5.2.3. Arteriopathy Laterality 
Arteriopathy was mostly left sided in the children with Unilateral Non-MM 
arteriopathy (4/6 left sided, 2/6 right sided); bilateral (23/37) in the children with 
Moyamoya arteriopathy and (by definition) bilateral in all (4/4) the Bilateral Non-
MM arteriopathy group. 
 
3.5.2.4. Radiographic Findings 
3.5.2.4.1. Moyamoya arteriopathy group 
Fourteen of the thirty-seven children had a pattern suggestive of watershed and 
cortical infarction, 12 watershed only, 3 cortical only and 7 not ischaemic (4 NF1 
lesions, 3 normal).  One child had hemiatrophy of the cerebellum.  In total 
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twenty six of the 37 children (70%) had watershed infarcts (21 deep watershed, 
4 deep and cortical watershed, 1 cortical watershed).   
 
3.5.2.4.2. Bilateral Non-MM arteriopathy group 
Two of the four children had a cortical vaso-occlusive pattern of infarcts (one 
PHACE(S) and one Takayasu’s disease); one deep white matter watershed 
ischaemia (SCD) and one had no radiological evidence of ischaemia, but a 
dysplastic and hypoplastic cerebellum (PHACE(S)).  
 
3.5.2.4.3. Unilateral Non-MM arteriopathy 
Five of the six of the children had a pattern of middle cerebral artery perforator 
territory ischaemia, with sparing of the cortex.  One child had a normal brain 
MRI scan.    
 
3.5.2.5. Grade of Stenosis 
Conventional angiograms (available in 34 with Moyamoya arteriopathy, all with 
Unilateral Non-MM and two with Bilateral Non-MM) one CT angiogram (Bilateral 
Non-MM) and four 3D TOF MR angiograms (3 with Moyamoya arteriopathy, 1 
with Bilateral Non-MM) were reviewed and vessels graded from 0-4 according 
to the degree of stenosis by myself (ND) and the study radiologist (DA)(Ref 
Methods, Grading of Stenosis).  
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3.5.2.5.1. Moyamoya arteriopathy 
Grade of stenosis was moderate to severe (Grade 3-4) in all 37.    
 
3.5.2.5.2. Bilateral Non-MM arteriopathy 
Two children (one PHACE(S), one Takayasu’s disease) had Grade 4 stenosis 
on conventional angiography. One child with SCD had tortuosity of the vessels 
of the circle of Willis and a hypoplastic anterior cerebral artery on MR 
angiography.   One child with PHACE(S) had bilateral agenesis of the internal 
carotid arteries on CT angiography.  Arteriopathy was hence graded as 4.  
 
3.5.2.5.3. Unilateral Non-MM arteriopathy 
Three of the six children had severe stenosis (Grade 4), one moderate (Grade 
3), one mild (Grade 1) and one no stenosis (Grade 1).  
 
3.5.2.5.4. Medication Use 
The majority of the children were on an anti-platelet agent: 38/47 Aspirin and 
3/47 Clopidogrel.  Other moyamoya related medications included 
Acetazolamide, Carbamazepine for seizures and Topiramate for seizures or 
headache. 
126 
Table 5 Population Demographics *Recoded as Idiopathic moyamoya  ** Recoded as Other Chromosomal moyamoya 
# Two following radiation for rhabdomyosarcoma and a suprasellar germinoma.  One hypothalamic hamartoma 
 
Clinical Information Moyamoya 
with CVR (37) 
Bilateral non 
moyamoya 
arteriopathy 
(4) 
Unilateral focal 
arteriopathy 
(6) 
No consent 
(10) 
Not found (3) Not done (33) 
Age diagnosis years 
(median, range) 
8.61 (0.6-16.7) 3.7 (.17-8.25) 4.51 (0.54-9.7) 9.12 (0.9-
17.0) 
15 (14.1-
16.2) 
6.5 (1.17-
17.5) 
Age first CVR years 
(median, range) 
10.76 (1.08-
17.7) 
6.0 (4.0-8.78) 15.1 (7.44-
27.9) 
11.0 (1.9-
18.0) 
16.0 (15.5-
16.7) 
- 
Male 16 (43%) 0 5 (83%) 4 (40%) 0 10 (33%) 
Co-morbidities       
-Trisomy 21 4    1  
-Neurofibromatosis I 9   2  1 
-Hypomelanosis of 
Ito 
     1 
-Turner’s 1**      
-β-thalassaemia    1   
-Sickle cell disease 5 1  1 1 5 
-Tumour 3#    1 1 
-Schimke’s      2 
-Chromosomal 2**     1 
-Biliary atresia      1 
-Epilepsy 1*      
-Hyperprolactinaemia 1*      
-Factor IX deficiency 1*      
-Takayashu arteritis  1     
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 Moyamoya 
with CVR (37) 
Bilateral non 
moyamoya 
arteriopathy 
(4) 
Unilateral focal 
arteriopathy 
(6) 
No consent 
(10) 
Not found (3) Not done (33) 
Treatment       
-PHACES  2     
-Familial 2*      
-Idiopathic 8* 0 6 6 0 21 
Treatment       
    Aspirin 28 4 6    
    Clopidogrel 3      
    Acetazolamide 2      
    Carbamazepine 4 1     
    Topiramate 1      
Other 
   Blood Transfusion 
   Penicillin V 
   Enalapril 
   DDAVP 
   Thyroxine 
   Vasotec 
   Propranolol 
   Radiotherapy 
   Chemotherapy 
   
Immunosuppression 
   Clobazam 
 
5 
5 
1 
1 
1 
1 
 
1 
1 
 
1 
 
 
 
 
 
1 
 
 
1 
1 
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Table 6 Clinical and Radiographic Description of All Arteriopathy Groups 
 Moyamoya 
arteriopathy 
 
n=37 (%) 
Bilateral 
Non-MM 
arteriopathy  
n= 4 (%) 
Unilateral Non-
MM 
arteriopathy 
n=6 (%) 
Clinical Presentation 
    Yes (%) 
              Stroke   
    (Yes:No) 
              TIA 
              Seizures 
              Headache 
              Other 
     Asymptomatic                   
 
 
12 (32) 
 
8 (22) 
4 (11) 
12 (32) 
2 (5) 
6 (16) 
 
 
*1 (25) 
 
0 (0) 
*1 (25) 
1 (25) 
0 
**2 (50) 
 
 
5 (83) 
    
   1 (17) 
1 (17)  
0 
0 
0 
Arteriopathy Laterality 
    Bilateral  
    Right 
    Left 
 
23 (62) 
6  (16) 
8  (22) 
 
4 (0) 
0 (0) 
0 (0) 
 
0 
2 (33) 
4 (66) 
Radiographic Findings 
(Y:N) 
    Not ischaemic 
    Cortical 
    Watershed 
       (Deep white matter) 
       (Cortical) 
    Cortical ischaemic and     
    Watershed 
    IVY 
 
 
7 
3 
12 
(12) 
(1) 
14 
 
26:7 (79:21) 
 
 
1 
2 
1 
 
 
0 
 
0 
 
 
1 
5† 
0 
 
 
0 
 
0 
Vascular Findings 
    Grade of Stenosis 
1 
2 
3 
4  
 
 
0 
0 
4 
30 
 
 
1 
0 
0 
3 
 
 
2  
1 
0 
3 
CVR Method 18 GA 17 BH 
2RM 
3 GA 1 BH 6 RM 
* same patient 
**  SCD patient – MRI pick up because of raised TCD 
**  PHACES patient – MRI pick up on screening 
† sub-cortical and/or deep grey matter 
GA General anaesthetic  BH Breath hold  RM Re-breathing Mask 
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3.5.2.6. Ethnicity 
Of the 47 children the majority were Caucasian (53.2%) followed by South East 
Asian (19.1%) (Table 7, Figure 18).  Similar proportions remained in the 
moyamoya arteriopathy group (n=37) (Table 8, Figure 19).  Children of South East 
Asian origin were of Japanese, Chinese and/or Korean parentage.  Children of 
South Asian origin were of Indian sub-continent origin.   
 
Table 7 Ethnicity Frequencies in All arteriopathy (n=47) 
Ethnicity  Frequency  Percent 
Caucasian  25  53.2 
South East Asian  9  19.1 
Black  6  12.8 
South Asian  4  8.5 
Middle Eastern  2  4.3 
Caucasian/ South East Asian  1  2.1 
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Figure 19  Ethnicity Frequency Pie Chart in All Arteriopathy
 
 
Table 8 Ethnicity Frequencies in Moyamoya Group (n=37) 
Ethnicity  Frequency  Percent 
Caucasian  17  45.9 
South East Asian  8  21.6 
Black  5  13.5 
South Asian  4  10.8 
Middle Eastern  2  5.4 
Caucasian/  
South East Asian 
 
 
1  2.7 
131 
Figure 20 Ethnicity Frequency Pie Chart in Moyamoya Arteriopathy Group 
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Table 9 Moyamoya Classification by Ethnicity 
 Moyamoya Classification  
Ethnicity Idiopathic 
 
 
N=13 
Neurofibrom
atosis Type 1 
 
N=9 
Sickle Cell 
Disease 
 
N=5 
All 
Chromosomal 
 
N=7 
Tumours 
 
 
N=3 
Total 
Caucasian  3 6 - 6 2 17 
South East Asian  6 1 - - 1 8 
Black  - - 4 1 - 5 
South Asian 3 1 - - - 4 
Middle Eastern and 
Caucasian/South 
East Asian 
1 1 1 - - 3 
Total 13 9 5 7 3 37 
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Figure 21  Moyamoya Classification by Ethnicity 
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3.5.3. Clinical and Radiological Description Moyamoya 
Arteriopathy Group 
3.5.3.1. Moyamoya Classification 
Moyamoya arteriopathy was classified as idiopathic (MMD) or syndromic (MMS).  
The syndromic groups were further divided by comorbidity.  Initial syndromic 
categories were Neurofibromatosis Type 1 (NF1-MM), Sickle Cell Disease (SCD-
MM), Trisomy 21 (Trisomy 21-MM), Other chromosomal (Other Chromosomal-MM) 
and Tumours (Tumour-MM).    Thirteen children had MMD, two (out of two tested) 
within the same family had confirmed RNF213 mutation analysis. Nine children had 
NF1-MM, five SCD-MM, four Trisomy 21-MM, three other chromosomal 
abnormalities and three Tumour related MMS (Tumour-MMS). Due to small 
numbers the Trisomy 21 and Other Chromosomal categories were collapsed into 
one All Chromosomal group (All Chromosomal-MM) (Table 9). 
 
3.5.3.2. Age at Moyamoya (idiopathic and syndromic) Diagnosis  
The mean age of MM diagnosis was 9.1 (SD 3.9) years. There was no statistically 
significant difference in age of MM diagnosis between the MM arteriopathy 
idiopathic and syndromic groups χ2(4) = 4, p > 0.05 (Table 9). 
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3.5.3.3. Clinical Presentation  
Twenty-three of 37 (62%) children had an arterial ischaemic stroke at at least one 
time point (12 acute at time of diagnosis, 3 remote at time of diagnosis, 8 new [7/8 
recurrent]; 7 male; 11 right, 7 left and 5 bilateral; mean age at stroke 8.3; SD 4.7; 
range 0.58 – 16.58) years.  Ten of the 23 (43%) had Moyamoya Disease and the 
rest Moyamoya Syndrome (5/23 [22%] All Chromosomal; 3/23 [13%] Sickle Cell 
Disease; 3 [13%] Tumour; and 2 [9%] Neurofibromatosis Type 1 (Table 9 and 
Figure 21).   
 
Figure 22 Frequency of Comorbidities in Stroke Group (n=23) 
 
 
 
 
 
 
 
Clinical presentation was examined by ethnicity and moyamoya classification.  
Ethnicity groups were collapsed into Caucasian, Black and Asian (10) which 
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included South East Asian, South Asian, Middle Eastern and Caucasian/South 
East Asian.   
 
Figure 23  Clinical Presentation within Moyamoya Groups by Ethnicity 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 10 Clinical and Radiological Characteristics of Moyamoya Arteriopathy 
Groups 
 
 
Moyamoya Arteriopathy 
n=37 
 Idiopathic 
n=13 
NF-1 
n=9 
SCD 
n=5 
Trisomy 
21 
n=4 
Other 
Chromosomal 
n=3 
Tumour 
 
n=3 
Female: Male 7:6 3:6 3:2 4:0 2:1 2:1 
Mean Age at MM 
Diagnosis 
8.2 9.4 7.8 11.8 8.4 12.2 
MM Laterality 
  Bilateral 
  Right 
  Left 
 
10 
2 
1 
 
2 
2 
5 
 
5 
0 
0 
 
3 
1 
0 
 
1 
1 
1 
 
3 
- 
- 
Clinical 
Presentation 
Stroke 
  Laterality 
    Bilateral 
    Right  
    Left 
TIA 
Headache 
 
 
3 
 
1 
0 
2 
5 
3 
 
 
1 
 
0 
0 
1 
1 
3 
 
 
3 
 
1 
1 
1 
0 
1 
 
 
4 
 
0 
4 
0 
0 
0 
 
 
1 
 
          0 
          1 
0 
0 
1 
 
 
0 
 
0 
0 
0 
2 
1 
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Seizures 
Other 
Asymptomatic 
 2† 
  2 ^ 
1 
0 
0 
4 
0 
0 
1 
0 
0 
0 
0 
0 
1 
0 
0 
0 
 
 
 
Moyamoya Arteriopathy 
n=37 
 Idiopathic 
 
n=13 
NF-1 
n=9 
SCD 
n=5 
Trisomy 
21 
n=4 
Other 
Chromosomal 
n=3 
Tumou
r 
 
n=3 
Course 
Surgery 
Recurrent stroke 
Recurrent TIA 
PSOM 
 
11 
2 
3 
1.4 
 
7 
1 (new) 
0 
1.1 
 
 0 * 
1 
0 
.75 
 
3 
0 
0 
2.8 
 
2 
0 
0 
3 
 
2 
1 
0 
2 
Conventional 
Angiography 
  Vessels 
  Stage 
            1 
            2 
            3 
            4 
            5 
            6 
 
  Grade  
           3 
           4 
 
 
 
 
0 
3 
9 
1 
0 
0 
 
 
1 
12 
 
 
 
 
0 
4 
3 
1 
1 
0 
 
 
1 
8 
 
 
 
 
1 
1 
1 
- 
- 
- 
 
 
0 
3 
 
 
 
 
1 
2 
1 
0 
0 
0 
 
 
2 
2 
 
 
 
 
- 
2 
- 
- 
- 
- 
 
 
- 
2 
 
 
 
 
 
0 
0 
2 
0 
0 
1 
 
 
- 
3 
MRI 
  Not ischaemic 
  Watershed 
      Deep  
      Cortical  
  Cortical 
ishaemic 
  Watershed and   
   cortical 
ischaemic 
  Ivy 
  Other 
 
2 
3 
(3) 
(3) 
1 
6 
 
11 
1 
(hemiatrophy
) 
 
5 
2 
(4) 
(0) 
0 
2 
 
7 
0 
 
0 
3 
(4) 
(2) 
1 
1 
 
2 
0 
 
0 
1 
(4) 
(0) 
0 
3 
 
4 
0 
 
0 
1 
(2) 
(0) 
1 
1 
 
1 
0 
 
0 
2 
(3) 
(0) 
0 
1 
 
2 
0 
* blood transfusion, 1 bone marrow transplantation, ^ 1 paroxysmal sensory 
symptoms, 1 remote AIS on investigation for hyperprolactinemia, † one with 
remote AIS NF-1 Neurofibromatosis type 1 SCD sickle cell disease 
 
3.5.3.3.1. Idiopathic moyamoya  
Ten (10/13; 77%) of the children were Asian and three (3/13; 23%) Caucasian.   
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Of the Asian children 5/10 (50%); 2/10 (20%); 2/10 (20%) and 1/10 (10%) 
presented with TIA, stroke, headache and seizures respectively.  Of the Caucasian 
children, 1/3 (33%) presented with stroke, headache and seizures.  One child 
(Asian) presented with haemorrhagic stroke at fourteen years of age.   
Three (3/13; 23%) presented with an acute arterial ischaemic stroke (one 
haemorrhagic).  Two (2/13; 15%) had remote strokes diagnosed at the time of 
investigation of seizures (1) and hyperprolactinemia (1). Five (38%) children 
presented with TIAs (1 only; 1 with headache and seizures; 3 with headache).  One 
(1/13; 8%) presented with headache only, one (1/13; 8%) with paroxysmal sensory 
symptoms only, and one (1/13; 8%) with seizures only (Fig 23). 
 
3.5.3.3.2. Moyamoya syndromes 
Nine (9/24; 38% [4/4 Trisomy 21-MM; 3/5 SCD-MM; 1/3 Other chromosomal; 1/9 
NF1-MM]) presented with an acute arterial stroke; three TIA (3/24; 13% [1/9 NF1-
MM; 2/3 Tumour-MM]); five with headache only (5/24; 21% [2/9 NF1-MM; 1/5 SCD-
MM; 1/3 Other chromosomal; 1/3 Tumour-MM]); one (1/24; 4% [1/9 NF1-MM]) 
presented with headache and seizures and six (6/24; 25% [4/9 NF1-MM; 1/5 SCD-
MM; 1/3 Other chromosomal-MM]) were asymptomatic at presentation (Fig 24).  
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Figure 24 Clinical Presentation by Moyamoya Classification 
 
There was a difference in frequency of MMD and MMS between the stroke and no 
stroke group but this was not significant (p=0.166) (Table 11).  Platelet numbers 
were significantly lower in the stroke than in the no stroke group (p=0.024) (Table 
10).  There was no significant difference in mean age at MM diagnosis, age at first 
hBOLD CVR study, age at revascularization surgery, haemoglobin or haematocrit 
between the stroke and no stroke groups in the children (Table 11). 
Table 11 Population by Stroke Occurrence  *significant at a level of p<0.05   
 
 Stroke 
n=23 
No Stroke 
n=14 
t-test 
p value 
MMD: MMS (%) 10:13 3:11 .166 
Age at MM Diagnosis 9.03 9.3 >0.05 
Age at First hBOLD CVR Study 11 10.2 >0.05 
Age at Revascularization 
Surgery 
9.6 9.7 >0.05 
Haemoglobin 126 127 >0.05 
Haematocrit .374 .38 >0.05 
Platelets 287 352 .024* 
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3.5.3.4. Laterality of Arteriopathy   
Moyamoya laterality was bilateral in 10/13 of the idiopathic moyamoya group, 2/9 
of the NF1-MM group, 5/5 of the SCD-MM group, 3/4 of the Trisomy 21-MM group, 
1/3 of the Other chromosomal-MM group and 3/3 of the Tumour group.  The NF1 
and Other chromosomal-MM groups had a principally unilateral moyamoya which 
was left sided in 5/9 NF1-MM and 1/3 Other chromosomal-MM. 
 
3.5.3.5. Radiographic Findings 
Thirty-six children had an MRI brain scan and one CT followed by MRI at the time 
of clinical presentation and moyamoya diagnosis.  MRI demonstrated no ischaemic 
changes in 8/37 (22%: 3/13 Idiopathic moyamoya and 5/9 NF1-MM). The pattern of 
ischaemic changes was a combination of watershed and cortical ischaemic in the 
majority (14/37, 38%: 6/13 Idiopathic-MM; 2/9 NF1-MM; 1/5 SCD-MM; 3 Trisomy 
21-MM; 1 Other Chromosomal-MM; 1 Tumour-MM).   The pattern of watershed 
infarction was mostly deep (20/37), and occurred in combination with cortical 
watershed ischaemia in 5/37 (Table 10 and Fig 24). 
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Figure 25  Radiographic Patterns of Ischaemic Injury in Group 
 
 
 
3.5.3.6. Moyamoya Stage and Grade of Stenosis 
Conventional angiograms for staging of moyamoya disease were available in 34 
children.  Sixteen (16/34, 47%) had Modified Moyamoya Stage 3 disease, and 12 
(12/34; 35%) Stage 2 disease.  The rest were distributed between the remaining 
stages (Table 10). 
Grade of stenosis was 4 (75-100% occluded) in 30/34 and 3 (50-74% occluded) in 
4/34. 
 
                      A                                         B                                           C               
Axial FLAIR (A and B) and DWI (C) image showing deep watershed (white 
arrows), deep and cortical watershed (yellow arrow) and cortical (dashed white 
arrows) pattern of ischaemic infarction.  
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Figure 26  MR Angiography of Patient's Shown in Figure 24 
 
 
 
 
3.5.3.7. Clinical Course and Outcome 
Eight (8/37) children had new ischaemic (seven recurrent) events following 
diagnosis (5 stroke, 3 TIA). Five with Idiopathic moyamoya (three TIA, two stroke); 
one NF1-MM stroke (previously asymptomatic); one Tumour-MM stroke, and one 
SCD-MM stroke.   
 
3.5.3.7.1. Pediatric Stroke Outcome Measure 
Recurrence and outcome data was obtained from Pediatric Stroke Outcome 
Measure Clinical Outcome data routinely collected in the stroke clinic setting.  
Twenty-five children had Paediatric Stroke Outcome Measures data collected 
(mean time to PSOM from moyamoya diagnosis 1.96 years, SD 2.32, range 0-8.42 
years) (Table 12).  A score of 1 or above is given when there their function within a 
                              A                                     B                                                C     
Corresponding MR angiograms of MRIs shown in Figure 21 of three children 
with moyamoya.                       
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specific domain is impaired to a level where there is impact on function, and is 
considered a poor outcome; higher scores indicate poorer outcome. 
Children with Chromosomal-MM, followed by Tumour-MM had the highest mean 
and median scores (2.6:3.0; 2.0:2.0).  
 
Table 12 Paediatric Stroke Outcome Measures by Moyamoya Classification 
 Idiopathic NF1 SCD All Chr Tumour 
Mean 1.4 1.1 .75 2.6 2.0 
Median .5 1.0 1.0 3.0 2.0 
Range .0 - 6.5 .0 – 3.0 .00 – 1.0 .5 – 4.0 2.0 
 
3.5.3.7.2. Revascularization Surgery 
Twenty-five children had revascularization surgery (mean 9.63, SD 4 years; 6 
bilateral, 10 right, 9 left procedures), ten had second surgeries (mean 8.9 years, 
SD 3.71 years).  Pial synangiosis was the most commonly performed initial 
procedure (17/25).  Other procedures included EC-IC bypass (3 only, 1 in 
combination with pial synangiosis); EDAS (225), EMS (2/25) and TMS (1/25).  The 
mean time interval between surgeries was 0.56 years (6.7 months) with a 
maximum interval of 1.67 years.  The youngest age at surgery was 2.17 years, 
oldest 16.42 years. Ten children (6 with stroke) had revascularization surgery prior 
to their first hBOLD CVR study. None of the children with SCD-MM had 
revascularization surgery.  One had a bone marrow transplant for SCD.  
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Figure 27  Paediatric Stroke Outcome Measures by Moyamoya Classification
 
 
3.6. Discussion 
3.6.1. Non-moyamoya Arteriopathy and Infantile Arteriopathy 
Published reports on the natural history of arteriopathies (progressive and non-
progressive) are variable and subject to many factors (Sebire et al. 2004, Braun et 
al. 2009, Beslow and Jordan 2010).  The non-progressive arteriopathies are 
typically unilateral and the progressive arteriopathies bilateral, although they may 
start as unilateral.  In my study the Non-moyamoya arteriopathy group represents 
the non-moyamoya, non-progressive (unilateral) and non-moyamoya, progressive 
(bilateral) arteriopathies. 
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The Unilateral Non-MM group all had a diagnosis of Transient Cerebral 
Arteriopathy (TCA).  The majority were male and presented with an acute arterial 
stroke with a radiological pattern of injury suggestive of vaso-occlusion.  Despite 
the similarity in degree of stenosis between the Unilateral Non-moyamoya/TCA 
and moyamoya arteriopathy groups the natural history of the groups differ in as 
much as TCA being a monophasic disease with an intial stuttering clinical course, 
which is typically not progressive with a low recurrence risk.  Conversely the risk of 
stroke in moyamoya is lifelong, the disease itself progressive and the recurrence 
risk high.  This group will be discussed in more detail in Chapter 9.  All the children 
with Bilateral Non-MM were female. They are an aetiologically heterogenous group 
of children with bilateral arteriopathy, one of whom had a progressive vasculitis 
(Takayasu), all of whom had similar radiological appearances suggestive of vaso-
occlusion. The stroke risk associated with vasculitis and SCD is high (Earley et al. 
1998, Benseler et al. 2006, Switzer et al. 2006).  However, published literature 
does not address the variable stroke risk associated with the range of 
vasculopathies seen in SCD which includes intra and extra-cranial tortuosity, 
aneurysms and dissection (Verlhac et al. 2014) (Kirkham and DeBaun 2004).  
Similarly PHACES syndrome is associated with a range of vasculopathies 
including moyamoya, and is therefore likely to be associated with a variable stroke 
risk.  However the observed risk in Heyer’s study was low (Heyer et al. 2008).   
The infantile arteriopathy (moyamoya and non-moyamoya) represent a poorly 
characterized group of children who typically have a malignant course and poor 
outcomes (Jackson et al. 2014, Al-Yassin et al. 2015). The majority of our infantile 
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arteriopathy (diagnosed under two years of age) group did not have moyamoya 
arteriopathy and presented with an acute arterial ischaemic stroke.   
Overall the non-moyamoya group appeared to share a similar clinical (focal motor 
stroke or TIA) and radiological (vaso-occlusive pattern) presentation, but have a 
variable natural history and stroke risk profile.  This need to quantify stroke risk in a 
child with symptomatic or asymptomatic arteriopathy remains a challenge 
particularly in the asymptomatic patient and may be addressed by the assessment 
of CVR. 
 
3.6.2. Moyamoya Arteriopathy 
3.6.2.1. Moyamoya Disease 
The childhood peak of presentation in moyamoya is five years of age, with a 
female preponderance (Wakai et al. 1997, Yonekawa et al. 1997, Chiu et al. 1998, 
Han et al. 2000, Baba et al. 2008).  However, the epidemiological descriptions of 
the disease are mostly of Asian moyamoya disease or non-Asian (European or 
American) adult moyamoya disease (Hallemeier et al. 2006, Kraemer et al. 2008).  
The female preponderance is replicated in our population, however the later age of 
moyamoya diagnosis may reflect historical delays in diagnosis of the disease.   
The majority of children with MMD were of South East Asian origin, whereas the 
majority of children with syndromic MM were Caucasian.  The exception to this was 
the black children of African or Caribbean origin, who mostly had SCD-MM.  None 
had MMD.  The ethnic variability in our population is similar to that in published 
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literature which reports the highest prevalence of MMD in people of East Asian 
origin, with a relatively low prevalence in European and North American countries 
(Goto and Yonekawa 1992, Chiu et al. 1998, Hallemeier et al. 2006, Kraemer et al. 
2008, Kuroda and Houkin 2008, Krischek et al. 2011, Liu et al. 2013).  Children of 
African or Caribbean origin more commonly have SCD-MM.  However, Urchino et 
al demonstrated that the prevalence of moyamoya in the Afro-American and 
Caucasian people was similar when patients with sickle cell disease were excluded 
(Uchino et al. 2005).  
In adult literature important differences in clinical presentation are reported within 
the MMD group and ethnicity appears to be a major determinant of this.  In the 
Kraemer et al study (Kraemer et al. 2008) of Caucasian adults with MMD, all 
patients presented with a cerebral ischaemic event, none presented with 
haemorrhagic stroke and none were asymptomatic. This is in contrast to the 
second peak of stroke in Asian MMD which typically presents with haemorrhage 
(Han et al. 1997, Han et al. 2000).  The majority (77%) of our MMD population 
were Asian in ethnicity.  The majority of the Asian MMD group in my study 
presented with focal motor deficits (TIA [50%] or stroke [20%]).  The frequency of 
presentation with focal motor deficits was thus higher in the Asian MM group than 
the Caucasian MM group of whom 33% presented with focal motor deficits (stroke 
only).  Seizures, headache and paroxysmal symptoms were present in the rest of 
the Caucasian MMD group. It is of interest that the only child to present with 
haemorrhagic stroke in our group was an Asian boy of fourteen years.  The 
predominance of Asian children in our MMD group and the suggestion of a more 
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severe (as defined by TIA and stroke presentation) phenotype would be 
concordant with published literature (Kraemer et al. 2008, Scott and Smith 2009) 
(Guey et al. 2015).  In a study of 21 Caucasian adults with moyamoya disease 
Kraemer et al demonstrated a mean age of onset of symptoms of 31 years.  Only 
one presentation was at 4 years of age and four were 16 to 19 years.  Therefore, 
differences by ethnicity in natural history and stroke risk seem to exist within the 
MMD group.  However, publications on childhood Caucasian MMD are scarce and 
often embedded in adult reports (Graham and Matoba 1997, Yonekawa et al. 
1997, Uchino et al. 2005, Kraemer et al. 2008, Kleinloog et al. 2012, Kossorotoff et 
al. 2012, Chen et al. 2014).  Further exploration of the clinical features of MMD in 
in a large cohort of non-Asian children with MMD is thus warranted.   
3.6.2.2. Moyamoya Syndrome 
Presentation in the MMS group was variable and seemed dependent on syndromic 
association.  The majority of children with SCD are diagnosed as a result of the 
newborn baby screening programme following which screening with TCD, MRI and 
MRA allows for early, pre-symptomatic detection of arteriopathy.  However, despite 
the neonatal screening and post-natal TCD all the SCD-MM group in my study 
presented with AIS.  Children with Trisomy 21-MM, Other chromosomal-MM and 
Tumour-MM mostly presented with ischaemic symptoms (stroke or TIA).  In a 
report of the surgical experience in 32 children with Trisomy 21-MM a higher rate of 
pre-surgical stroke and higher age of diagnosis was noted (See et al. 2015).  Age 
of diagnosis was higher than the average for our moyamoya population and all 
presented with ischaemic stroke.  This is in contrast to the NF1-MM group in whom 
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almost half were asymptomatic at diagnosis, and only one progressed to having a 
stroke (prior to surgery).  The cutaneous manifestations of NF1 coupled with 
recommendations for screening allows for pre-symptomatic detection of moyamoya 
arteriopathy and a true opportunity to prevent stroke and alter outcome (Rea et al. 
2009, Lin et al. 2011). 
 
3.6.3. Radiological and Vascular Findings 
The predominant neuroimaging pattern of deep watershed infarction, suggestive of 
perfusion failure, in the moyamoya arteriopathy group is in striking contrast to the 
cortical ischaemia typically seen in vaso-occlusive arterial ischaemic stroke and 
exemplified by the non-progressive arteriopathies and PACNS. This has been 
noted in previous publications (Ringelstein et al. 1994, Rafay et al. 2015).  
Increased susceptibility to ischaemia as a result of perfusion failure and 
hypotension has been demonstrated in animal experimental models (Brierley and 
Excell 1966, Howard et al. 1987) Further studies, including those of autopsy series 
have demonstrated an important link between microemobli, hypoperfusion and 
infarction Hence, despite the common vascular pathology of steno-occlusion 
between the non-progressive arteriopathies, PACNS and moyamoya, the final 
implicated injurious mechanisms are  of prinicipally of hypoperfusion causing 
ischaemia and deep border zone infarction or microembolism coupled with 
hypoperfusion or reduced washout in cortical border zone infarction (Romanul and 
Abramowicz 1964, Pollanen and Deck 1990, Masuda et al. 1994, Caplan and 
Hennerici 1998).  Furthermore the presence of deep border zone infarction is 
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associated with a poor prognosis and clinical deterioration, in contrast to the finding 
of cortical border zone infarction which seemingly is associated with a more benign 
course. (Moriwaki et al. 1997, Krapf et al. 1998) 
The timing of clinical presentation is in part thought to be related to the severity of 
vasculopathy and the occurrence of occlusion in the parent arteries (Kraemer et al. 
2008, Sultan et al. 2015).  However, despite the finding of moderate to severe 
stenosis in our group, there was no difference in vascular severity measures 
(Modified Moyamoya Stage or Grade of Stenosis) between the asymptomatic and 
symptomatic at time of moyamoya diagnosis.  Hence, our arteriopathy severity 
measures alone could not be used as a reliable indicator of ischaemic risk and 
guide for timing of intervention. 
Moyamoya laterality was predominantly bilateral or right sided.  Unilateral, and in 
particular left sided moyamoya was a feature of the NF1-MM group. Duat-
Rodriguez et al. (Duat-Rodriguez et al. 2014) reported a similar observation.  Our 
findings are somewhat in contrast to the study by Koss et al, in which the reported 
NF1-MM is clinically and radiologically similar to that of idiopathic moyamoya (Koss 
et al. 2013).  This was not our experience. 
 
3.6.4. Treatment 
The use of anticoagulants and anti-platelet agents in MM does not adequately 
address the primary pathological mechanism although anti-platelet treatment has 
been shown to be helpful (Scott et al. 2004, Roach et al. 2008, Research 
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Committee on the et al. 2012). The only significant difference between the stroke 
and no stroke groups was the platelet number which was unexpectedly higher in 
the non-stroke group.  All children would have been on antiplatelet therapy.  The 
platelet number itself was however normal for each group.  Furthermore the use of 
tissue plasminogen activator in MM is contraindicated in acute stroke because of 
the risk of intracranial haemorrhage (Research Committee on the et al. 2012).  
Carbonic anhydrase inhibitors such as Acetazolamide and Topiramate are known 
for their vasodilatory effects and were used in addition to Aspirin in a few patients.  
In retrospective analysis medical treatments have been shown to not be as 
effective as surgical intervention.   
Lin et al. (Lin et al. 2011) retrospectively reviewed the natural history of a cohort of 
83 children who were asymptomatic at the time of diagnosis of moyamoya.  All 
children had a syndromic diagnosis of either SCD-MM or NF1-MM.  Radiographic 
progression occurred in 75% of the SCD-MM group and 59% of the NF1-MM group 
within a mean of 5.4 years of follow-up.  Clinical progression was typically 
preceded by radiographic progression and occurred in 65% of the SCD moyamoya 
group and 44% of the NF1 moyamoya group (Lin et al. 2011).  Consequently their 
suggestion was that the majority of children with moyamoya arteriopathy would 
benefit from revascularization surgery even if asymptomatic at presentation (Lin et 
al. 2011, Koss et al. 2013).  However, revascularization surgery is not without risk 
which is highest in the first 30 days after surgery (approximately 4% per 
hemisphere) and decreases considerably after the initial period (Scott and Smith 
2009).   The same group reported a review of 477 hospitalizations for surgery and 
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demonstrated an increased risk of complication associated with a comorbid 
diagnosis of Down syndrome, Nf-1, SCD and pre-existing neurological deficits (Lin 
et al. 2011).  The ultimate aim would be to prevent new overt or covert ischaemic 
demise within this population.  Hence the opportunity to prevent occurrence of 
ischaemia in the early asymptomatic diagnosis of moyamoya or recurrence in the 
post ischaemic presentation of moyamoya is an important goal.  A simple 
presumption of the earlier the better is complicated by the practical challenges of 
operating on small vascular calibre vessels, increased complication rates, lower 
cerebrovascular reactivity, difficulties with pain control made worse by age related 
limitations in communication, anaesthetic risk and comorbid associations (Soriano 
et al. 1993, Kim et al. 2004, Kim et al. 2005, Scott and Smith 2009, Jackson et al. 
2014).  Therefore there remains a need for a tool to help determine the time of 
surgery for the individual patient.  
 
3.6.5. Course and Outcome 
Stroke and TIA recurrence was highest in the MMD group. However, the MMS 
group was largely made up of children with NF1-MM.  The other syndromic MM 
groups were relatively small and some heterogenous eg. the All-chromosomal 
group.  The children in my study with Down syndrome had an aggressive course 
and poorer outcome when compared to the NF1-MM group.  This more aggressive 
natural history is reported (Erguven et al. 2005, Jea et al. 2005, Kainth et al. 2013) 
((See et al. 2015).   
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The PSOM summary of impression scores were poorest (high) in the All 
Chromosomal group.  This group included children with Down syndrome, Turner 
syndrome and other chromosomal abnormalities all of which have a phenotype 
which includes learning difficulties.  I did not conduct further analysis using the sub-
categories due to numbers.  However, the PSOM summary of impression scores 
may have been more reflective of the chromosomal comorbidity than poorer motor 
outcome. However, this remains to be explored.    
 
In summary 
In this descriptive study the non-moyamoya arteriopathy group presented with 
more recognizable features of stroke ie. focal motor weakness than did children 
with moyamoya arteriopathy regardless of age.  The presentation with seizures in 
the under two moyamoya group may be secondary to the diffuse hypoperfusion 
related ischaemic process seen in moyamoya, rather than the characteristic 
thrombo-embolic vaso-occlusive process of the non-moyamoya arteriopathies.  In 
addition neither the presentation (symptomatic or asymptomatic) of children with 
arteriopathy nor the laterality of arteriopathy were sensitive indicators of natural 
history or future stroke risk.   
The observed imaging signature of deep watershed infarction seen within the 
moyamoya arteriopathy group is in keeping with the main proposed hypoperfusion 
mechanism of injury and published literature. Current treatments in stroke are 
aimed at thrombotic vaso-occlusive mechanisms and are hence inadequate to fully 
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address the ongoing risk of ischaemic demise in this group. This highlights the 
need to explore tools that can identify children at risk of ischaemia at the tissue 
level in the context of chronic hypoperfusion as seen in our population. 
The children with TCA (unilateral non-progresive, non-moyamoya) all presented 
with an ishaemic event and none had a recurrence out of the expected 3 month 
period.  Notably, and in contrast the majority of the mostly unilateral (left sided) 
NF1-MM group were asymptomatic or had headache at the time of diagnosis.  A 
significant proportion of this group did not have an ischaemic event in the study 
period.   Therefore the NF1-MM group had a mixed and in some more indolent 
clinical course.   
 
3.6.6. Future Directions and Study Limitations 
1.  Population Ascertainment - Clinical and radiological comparisons between 
moyamoya and non-moyamoya arteriopathy groups are limited by the small 
numbers in the non-moyamoya arteriopathy categories as well as the 
heterogeneity of diagnosis in the Bilateral Non-MM group.  The patient 
ascertainment method for the children with Unilateral Non-MM may have resulted 
in the selection of a more severe phenotype as they were selected for the 
presence of a moderate to severe stenosis at onset of the disease.  A selection 
bias toward a more severe phenotype is possible but is less apparent in the 
Bilateral Non-MM group given the aetiologic and clinical heterogeneity.  Therefore 
meaningful interpretation of these findings is limited.  
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2.  Grading of Stenosis – the method used for classification of Grade of Stenosis 
may not have had sufficient discriminatory power at the moderate to severe end of 
the spectrum of vasculopathy.  Sultan et al (Sultan et al. 2015) devised a three 
point measure of steno-occlusive severity in children with moyamoya arteriopathy 
which on preliminary analysis may be  predictive of recurrence.  Specifically our 
grading system did not discriminate between severe stenosis and occlusion.  
Hence I plan to revise and include the suggested criteria for the Grading of 
Stenosis in moyamoya arteriopathy and use it in future analysis. 
 
3.  Studies –  
i) Understanding of the mechanisms that underpin differences within the MMD 
group and between the MMD and MMS groups would help inform the development 
of mechanism targeted therapies and guide management.  Strides have been 
made within this field with recent discoveries of novel gene mutations (Milewicz et 
al. 2010, Miskinyte et al. 2011, Munot et al. 2011, Guey et al. 2015) (Liu et al. 
2010, Liu et al. 2011)  
Therefore exploration into the genetic mechanisms of disease may identify 
common or unique pathophysiological mechanisms and genetic biomarkers of 
disease which may lead to the development of novel targeted management 
approaches.  
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ii) Longitudinal large cohort studies of non-Asian MMD and single syndromic 
MMD would inform our practice, and ability to clinically differentiate between the 
aetiologically different progressive and non-progressive arteriopathies.  This 
information will improve our ability to recognise the need for medical and surgical 
intervention and recommend it in a more timely manner.   
 
3.6.7. Conclusion 
I have hence demonstrated the similarities and differences between the various 
arteriopathy groups highlighting the challenge in managing children with 
arteriopathy for whom the better assessment of ischaemic risk would enable a 
more informed and individualised approach in the management of the child with 
arteriopathy.  The measurement of CVR using hypercapnic challenge BOLD MRI 
provides such an opportunity.  
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4. Interobserver Reliability and Reproducibility 
of hBOLD CVR Measures  
 
4.1. Abstract 
4.1.2. Background    
Qualitative hBOLD CVR with the use of carbon dioxide as a vasoactive stimulus 
(RespirAct) allows for the assessment of CVR in a non-invasive manner.   
However, application of this method is limited in the paediatric population, and 
particularly in the younger children.  There are no published reports on the 
repeatability and reliability of qualitative hBOLD CVR techniques (breath-hold and 
general anaesthetic) in children.  
 
4.1.3. Objective 
To examine the feasibility of conducting qualitative hBOLD CVR studies in children.  
I examined whether qualitative measures of hBOLD CVR using endogenous CO2 
in the awake (breath-hold) and sleep (general anaesthetic) state in children can be 
repeated reproducibly within a short time frame.  I also sought to assess the 
reproducibility of scoring by inspection of hBOLD CVR parametric maps by 
different raters. 
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4.1.4. Method 
Children with moyamoya were enrolled as described in Population Ascertainment 
Chapter 3.  Children had qualitative hypercapnic challenge with endogenous 
delivery of carbon dioxide (breath-hold and general anaesthetic) and quantitative 
hypercapnic challenge with exogenous delivery of carbon dioxide (RespirAct, re-
breathing mask) hBOLD CVR studies (see Chapter 2 for Methods).  
Interobserver agreement for the categorical scoring (1=normal CVR, 2=reduced 
CVR or steal<10%, 3=steal>10%) was compared using Kappa scores. All repeat 
studies conducted on the same day in the same MRI session were compared with 
Kappa for repeat categorical scores by the same observer. Coefficient of variation, 
intra-class correlation and the Bland-Altman method were used to assess 
reproducibility of continuous hemispheric pixel measurements.    
 
4.1.5. Results 
In the 22 of 37 children in whom categorical scoring was undertaken by both 
observers, inter-rater reliability was excellent (kappa=1.0 for the right hemisphere 
and 0.8 for the left).  Twenty nine of 37 children with moyamoya had repeat studies 
on the same day; 5 did not and 3 studies were excluded.  Qualitative measures of 
hBOLD CVR demonstrated overall good reliability for scores by inspection, 
especially if studies deemed to be methodologically ‘poor’ were excluded. There 
was good to excellent intraclass correlation and no evidence of bias using the 
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Bland-Altman method for 2 of the 3 hemispheric pixel measures.  Quantitative 
measures of hBOLD CVR were calculable for six children and ranged between 
0.23 and 0.5 in the right hemisphere, and 0.23 and 0.8 in the left.  
 
Conclusion 
In this chapter I demonstrate that qualitative measures of hBOLD CVR under 
general anaesthetic and using the breath-hold technique can be scored with good 
interobserver reliability and interpretable for use in clinical practice. Quantitative 
measures appear reproducible.  However, techniques to improve reliability and 
repeatability of patient breath-holding; standardization of the hBOLD CVR breath-
hold and general-anaesthetic protocols to include improved acquisition of 
respiratory data need to be developed to allow more widespread reliable 
application of these tools for assessment of ischaemic risk in childhood 
cerebrovascular disease. 
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4.2. Introduction 
Validation: interobserver reliability and reproducibility 
To be used clinically to follow disease progression and predict outcome, a measure 
must have good interobserver reliability and reproducibility. Interobserver reliability 
and reproducibility of measures of CVR using a variety of techniques has been 
investigated in adult studies, but the evidence in the paediatric literature remains 
scarce. Adult CVR studies using quantitative MRI techniques such as rebreathing 
with the RespirAct device are done in the awake state (Heyn et al. 2010).  In the 
paediatric population cerebrovascular disorders may be diagnosed in infancy when 
patient cooperation is not possible, necessitating an alternative means of 
assessing CVR reproducibly over time, such as either inspection and scoring or 
counting of the number of hemispheric pixels.    
 
Interrater reliability of categorical variables, such as scoring by inspection of 
hBOLD CVR parametric maps, and reproducibility of repeat scores, may be 
assessed using Kappa’s coefficient.  Interpretation of score for Kappa are as 
follows (Landis and Koch 1977):  
1. 0.01 indicates "poor" agreement  
2. 0.01 to 0.20 indicate "slight" agreement  
3. 0.21 to 0.40 indicate "fair" agreement  
4. 0.41 to 0.60 indicate "moderate" agreement  
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5. 0.61 to 0.80 indicate "substantial" agreement  
6. 0.81 to 1.00 indicate "almost perfect" agreement  
 
Reproducibility of continuous variables, such as quantitative hypercapnic challenge 
with exogenous delivery of carbon dioxide (RespirAct, re-breathing mask) hBOLD 
CVR studies, or hemispheric pixel measurements on breath hold or during general 
anaesthetic, may be assessed using coefficient of variation, providing there are no 
negative values, or by intraclass correlation.   Indices of reliability for ICC are as 
follows: 
 < 0.7 poor reliability 
 0.7 adequate reliability 
 0.8 good reliability 
 >0.9 excellent reliability 
 
Reproducibility of rebreathing hBOLD CVR Measures in children 
Computer controlled gas delivery using the rebreathing mask (RM) allows targeted 
manipulation of end tidal partial pressure of CO2 consisting of a sequential gas 
delivery breathing circuit in combination with an automated gas blender (RespirAct 
TM, Thornhill Research Inc., Toronto, Canada) (Slessarev et al. 2007).  The 
RespirAct device with a re-breathing mask has been validated in adults and 
children (Heyn et al. 2010, Han et al. 2011).  A recent study in children by 
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Kassner’s group demonstrated the reproducibility of quantitative CVR measures 
using the RespirAct device with a re-breathing mask  in ten healthy older children 
(age 16.1 ± 1.6 years) (Leung et al. 2015). The coefficient of variation was 
9.3+/5.9% for grey matter and 11.5+/-8.7% for white matter, while the within-day 
intraclass correlation was 0.857 (95% confidence intervals, CI 0.639, 0.943) and 
0.895 (95%CI 0.734, 0.958) for grey and white matter respectively. However, as 
previously mentioned, this method has limited applicability in the paediatric 
population and there are no equivalent data in the younger paediatric population 
for the more appropriate CVR modalities such as hBOLD CVR under general 
anaesthetic (GA) and breath-holding (BH).  
 
hBOLD CVR under general anaesthetic (GA) 
hBOLD CVR studies conducted under GA is a feasible, yet previously unreported, 
method for the assessment of CVR in the very young, and/or those unable to 
tolerate alternative awake methods.  It is relatively easy to measure carbon dioxide 
tension, either arterial or end-tidal, allowing quantitation of CVR, as well as 
inspection and scoring. 
  
Breath holding 
Breath-holding is a relatively well tolerated technique and has been used in adults 
as well as children.  There is no need for mask ventilation, making the experience 
within the scanner less claustrophobic and obviating the need for an anaesthetist.  
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Longer breath-holds result in more robust and repeatable BOLD responses 
(Magon et al. 2009), and certain manoeuvres, such as paced breathing between 
challenges and breath-holds after expiration, may improve repeatability (Scouten 
and Constable 2008, Thomason and Glover 2008).  In adult studies intraclass 
correlation for repeatability of CVR measurement for breath-holding ranges from 
not acceptable repeatability (ICC <0.4) to excellent repeatability (ICC=0.82) 
depending on the breath-hold challenge employed (Bright and Murphy 2013).  
Signal changes driven by BH range from 0.8% to 5.1% in a 1.5T MR system 
(Kastrup et al. 1998), with a similar or larger effect observed at 3T.  
 
If carbon dioxide measurements are not feasible during breath hold, CVR cannot 
be quantitated and scoring systems to capture the relative hemispheric differences 
on the CVR parametric maps in a manner quantifiable as categorical variables and 
hence as indirect measures of hBOLD CVR are required (see Chapter 2 Methods 
Scoring). A scoring system was devised by the raters (Ref Methods Section). 
Scores for each hemisphere were between 1 and 3 according to the following 
schema: 
1) Normal CVR = 1  
2) Reduced positive reactivity +/- steal >2%<10% = 2 
3) Steal > 10% with or without reduced positive reactivity = 3 
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4.3. Study Purpose and Hypothesis 
In this section I sought to determine whether qualitative studies of hBOLD CVR in 
children using the devised scoring system is reliable between observers.  I also 
hypothesized that indirect measures of hBOLD CVR conducted in children using 
breath hold or under general anaesthetic are reproducible. 
 
4.4. Methods 
Children with moyamoya and clinical hBOLD CVR studies were prospectively and 
retrospectively enrolled through the Children’s Stroke Programme Clinic and using 
the Stroke Registry Database (Ref Chapter 3 Population).  Children had qualitative 
(breath-hold and general anaesthetic) hBOLD CVR studies and a few had 
quantitative hBOLD CVR studies (Ref Chapter 2 Method Sections and Chapter 3 
Population Attainment Section).  
For interobserver reliability and reproducibility and assessment, hBOLD CVR 
studies of children with moyamoya arteriopathy were assessed for quality (good 
and poor).  Patient and method/technical factors were recorded.    
 
Interobserver reliability 
If one patient had more than one successfully completed study then the first one 
was chosen for inclusion in analyses of interobserver reliability. Two raters (ND 
and WL)  
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blinded to clinical information independently scored each hemisphere of the 
hBOLD CVR parametric map in the same - first axial slice - above the ventricles.  
Reproducibility 
By using semi-quantitative scoring of the paremtric maps, we tested the reliability 
of method of analysis of hBOLD CVR.  Blood flow measurements themselves, for 
example using ASL were not conducted.  This could have allowed for testing of the 
reliability and reproducibility of the test itself although difficulties with the 
implementation of ASL in the pediatric population were not adequately resolved 
during the course of this study. 
Repeat hBOLD CVR studies on the same day during the same MRI session were 
attempted in all children at all hBOLD CVR study time points.  Successfully 
completed repeat studies on the same day during the same MRI session (1A and 
1B) were included. Two methods of analysis of the scans were undertaken: 
(i) Hemispheric inspection scores were agreed together by the two scorers (WL 
and ND) and were compared between studies 1A and 1B. Analysis was repeated 
for those with ‘good’ quality studies only (Thomas et al. 2013). 
(ii) Positive and negative threshold hemispheric pixels of the hBOLD CVR 
parametric map in the first axial slice above the ventricles were counted as 
previously described (Method).  Hemispheric pixels for studies 1A and 1B were 
compared so as to provide an index of reproducibility of measures – the intraclass 
correlation.   
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4.5. Statistics 
The validation statistics used were: 
1. Kappa’s coefficient was used to assess: 
(i) interobserver reliability of scoring by inspection of hBOLD CVR 
parametric maps and  
(ii) reliability of repeat scores by one observer in studies 1A and 1B 
2. Coefficient of variation for the hemispheric pixel measurements was calculated 
as standard deviation divided by mean. 
3. Bland-Altman plots were used to assess the degree of agreement between 
hemispheric pixel measures (Bland and Altman 1986, Bartlett and Frost 2008).   
4. Intraclass correlation was used to assess reproducibility of hemispheric pixel 
measurements.   Absolute agreement analysis and the 2-way mixed effects model 
was chosen as the raters were fixed. Average measures intraclass correlation 
coefficient was reported (Shrout and Fleiss 1979).  Mixed effect repeated 
measures ANOVA were implemented, with time (1A, 1B) as the within-subject 
variable, and method (BH, GA) as the between-subject variable. 
Table 13 Overview of validation studies  
 Interobserver for the 
same study 
Repeatibility on the same day 
Scores  Pixels 
N included 22 28 29 
Time points 1A or 1B 1A & 1B 1A and 1B 
Statistics Kappa Kappa Coefficient variation, Bland-
Altman, Inter-class correlation 
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4.6. Results 
4.6.2. Repeatability and Reliability of hBOLD CVR Measures 
For the purpose of the interobserver reliability and reproducibility analyses the 
hBOLD CVR studies of children with moyamoya arteriopathy only (MMD or MMS) 
were considered (n=37). No repeat studies were done in five children, and a further 
three were excluded from repeated measure reproducibility as no scores were 
available for one or more of the hemisphere pixel analyses. Therefore 29/37 had a 
repeat study on the same day within the same session (1A, 1B; 29 repeat 
hemispheric pixel analysis, 28 repeat hemispheric inspection scores).  Of the 29 
(29/37) studies, one or both of 14/37 patient hBOLD CVR repeat (1A or 1B) studies 
had issues compromising quality (Table 14). Quality was significantly compromised 
in 10/14 of these studies and hence 10/29 studies were deemed poor quality and 
19/29 good quality.     
There was no statistically significant difference in age at diagnosis of MM, and age 
at the first hBOLD CVR study between the group who had repeat (1A, 1B) studies 
and those who did not. There was a statistically significant difference in age at 
diagnosis of MM and age at first hBOLD CVR study by General Anaesthetic and 
Breath-hold hBOLD hypercapnic challenge method (Table 14). 
Figure 28 Flowchart for validation studies 
 
  
37 patients with 
moyamoya 
Interobserver reliability for scoring 
(1,2,3) n=22 
Reproducibility for studies 1A and 
1B  
Scoring (1,2,3) 
n=28 
Hemisphere pixels n=29 
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Table 14 Demographics of Patients by hBOLD CVR Method 
 
No 
Repeat 
Studies 
Repeat 
Studies 
t-test 
Repeat Studies by Method 
 
p value 
General 
Anaesthetic 
Breath 
hold 
Rebreath 
Mask 
N 8 29  14 15 2  
Age at 
Diagnosis 
Mean (SD) 
 
7.27 
(4.39) 
 
9.65 
(3.65) 
 
.127† 7.74 
(4.07) 
 
11.42 
(2.05) 
 
 
12.13 
(0.88) 
 
0.004* 
Gender 
M (%) 
4 (50) 12 (41)  7 (50) 
 
5 (33) 
 
1(50) 0.371 
Mean Age 
at hBOLD 
CVR 
(SD) 
 
8.67 
(3.66) 
  
 11.24 
(4.34) 
 
.136† 9.02 
(4.84) 
 
13.3 
(2.55) 
 
 
12.46 
(.65) 
 
0.006* 
 
MM Stage 
1 
2 
3 
4 
5 
6 
 
 
0 
2 
5 
0 
0 
0 
 
 
2 
10 
11 
2 
1 
1 
  
1 
6 
5 
0 
1 
0 
 
 
1 
4 
6 
2 
0 
1 
 
 
0 
2 
0 
0 
0 
0 
 
 
 
 
 
    0.937 
Degree of 
Stenosis  
3/4 % 
 
0/88 
 
15/85 
 
15/85 
 
14/86 
 
  
0.314 
Stroke  
R/L/B  
 
4/1/0 
 
7/4/5 
  
4/2/2 
 
3/2/3 
 
0/0/1 
 
0.963 
MM Stage: angiographic MM stage 
* significant difference between age of diagnosis of MM and age at CVR between 
BH and GA groups  †trend toward significant difference in age of CVR between BH 
and GA group  
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Table 15 Factors Affecting Quality in hBOLD MRI Studies 
No of 
Patients 
 
Comment 
(one or both studies) 
Study 
Method 
(GA/BH) 
4 Patient factors – movement artefact 1/3 
1 Patient factors – prior medication* 1/0 
9 hBOLD MRI method technical factors** 5/4 
*  patient on Diamox 
** poor BOLD signal/Δ CO2 time course 
 
Table 16 Anaesthetic agents used for Studies under General Anaesthetic 
Number 
of 
patients 
 
Propofol Propofol 
and 
Sevoflurane 
Propofol, 
Sevofluorane 
(+ ) 
Thiopentone, 
Sevofluorane, 
Succinlycholine, 
Nitrous oxide, 
Lidocaine 
 17 5 
(1/5 
CG) 
7 2 (C) 
1 (A) 
1 (FG) 
 
1 
P = Propofol; S = Sevoflurane; C = Carbamazepine; A = Acetazolamide; G = 
Glycopyrolate; L = Lidocaine; SC = Succinylcholine; N = Nitrous oxide; TH = 
Thiopentone 
4.6.2.1. Inter-rater Reliability of Scores by Inspection 
Twenty-two patients (48 hemispheres) were independently scored by WL and ND 
blinded to clinical information.  Inter-rater hemispheric scoring of parametric maps 
was excellent; there was 100% agreement of right hemisphere scores (Kappa 
1.00, p=0.0005) and excellent agreement (Kappa 0.862, p=0.0005) for the left 
hemisphere (Table 17).  
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Table 17 Right and Left Hemisphere Interater Crosstabulation and Kappa 
 Right Hemisphere 
Rater 2 Score 
Total  Left Hemisphere 
Score 
Rater 2 
Total 
Rater 1 
Score 
1.00 2.00 3.00 Rater 1 
Score 
1.00 2.00 3.00 
1.00 2 0 0 2 1.00 5 0 0 5 
2.00 0 7 0 7 2.00 2 8 0 10 
3.00 0 0 13 13 3.00 0 0 7 7 
Total 2 7 13 22 Total 7 8 7 22 
Kappa 1.00; p=0.0005                             Kappa 0.862; p=0.005 
4.6.3. Reproducibility of Repeat Measures by Hypercapnic 
Challenge Method 
Of the 37 children with moyamoya and hBOLD CVR studies, 29 in total, 14 of 17 
GA (82%; Propofol and Sevoflurane being the main anaesthetic agents used - 
Table 16) and 15 of 18 BH (83%) hBOLD CVR studies had repeat parametric 
maps scored by  
(i) inspection by consensus of two observers 
(ii) counting of hemispheric pixels.   
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4.6.4. Reproducibility of Repeat Hemispheric Scoring by 
Inspection of Parametric Maps 
Assuming the study 1A score is the ‘true’ score, Cohen’s Kappa analysis was used 
to assess the reliability of repeat hemispheric scoring by inspection (n=28; 
including both ‘good’ and ‘poor’ quality studies) (Thomas et al. 2013).   Cohen’s 
Kappa analysis was repeated for the ‘good’ (n=19) studies only.   
 
4.6.4.1. Reliability of Hemispheric Repeat Scores by Study Quality  
4.6.4.1.0. Reliability of ‘All Good and Poor’ Quality Hemispheric Repeat  
Scores (n=28) 
Kappa was .557 and .523 for right and left hemispheric repeated measure scores 
respectively.  In the right and left hemisphere, hBOLD CVR parametric maps were 
scored as normal at both time points (1A and 1B) for 6/8 (75%) and 7/8 (86%) of 
the normal (scored as 1 at study 1A) studies and 14/20 (70%) and 12/20 (60%) of 
the abnormal (scored as ≥2 at study 1A) studies respectively. 
Out of 14 scores of 3, one child had a right hemispheric 1A score of 3, and 1B 
score of 1. The biggest difference in repeat measure scores was between scores 2 
and 3 for both hemispheres (Table 18). 
 
Table 18 Right and Left Hemispheric Scores Repeated Measures and Kappa (All 
repeat studies) 
 Score Right 1A Total  Score Left 1A Total 
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Score 
Right 
1B 
1.00 2.00 3.00 Score 
Left 
1B 
1.00 2.00 3.00 
1.00 6 0 1 7 1.00 7 2 0 9 
2.00 2 4 3 9 2.00 1 5 5 11 
3.00 0 2 10 12 3.00 0 1 7 8 
Total 8 6 14 28 Total 8 8 12 28 
Kappa .557, p=0.000                                  Kappa .523, p=0.0005 
 
 
 
 
 
4.6.4.1.1.  Reproducibility of Good Quality Hemispheric Repeat Scores (n=19) 
Kappa was 0.755 and 0.607 for right and left hemispheric repeated measure 
scores. In the right and left hemisphere hBOLD CVR parametric maps were scored 
as normal at both time points (1A and 1B) for 5/5 (100%) and 6/7 (86%) of the 
normal studies and 11/14 (79 %) and 8/12 (66%) of the abnormal (scored as ≥2) 
studies respectively. The biggest difference in repeat measure scores was 
between 2 and 3 for both hemispheres (Table 19). 
 
Table 19 Right and Left Hemispheric Scores Repeated Measures and Kappa of Good 
Quality Studies 
 Score Right 1A Total  Score Left 1A Total 
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Score 
Right 
1B 
1.00 2.00 3.00 Score 
Left 
1B 
1.00 2.00 3.00 
1.00 5 0 0 5 1.00 6 1 0 7 
2.00 1 3 2 6 2.00 0 4 3 7 
3.00 0 0 8 8 3.00 0 1 4 5 
Total 6 3 10 19 Total 6 6 7 19 
Kappa .755 p=.0005                                       Kappa .607 p=.0005 
 
 
 
4.6.4.2. Reproducibility of Hemispheric agreement of GA and BH studies of 
Good Quality only:  
Cohen’s Kappa was 0.813 and 0.321 for right and left good quality repeat scores of 
hBOLD CVR done under GA (Table 20) and 0.6 and 0.844 for right and left repeat 
scores of hBOLD CVR done using the BH technique (Table 21). 
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Table 20 Right and Left Hemisphere Kappa for Good Quality Studies of CVR under 
General Anaesthetic 
 Score Right 1A Total  Score Left 1A Total 
Score 
Right 
1B 
1.00 2.00 3.00 Score 
Left 
1B 
1.00 2.00 3.00 
1.00 5 0 0 5 1.00 4 1 0 5 
2.00 0 1 1 2 2.00 0 1 3 4 
3.00 0 0 2 2 - - - - - 
Total 5 1 3 9 Total 4 2 3 9 
Kappa 0.813 p=.001           Kappa 0.321 p=.107 
 
Table 21 Right and Left Hemispheric Kappa for Good Quality Studies of CVR by 
breath-holding 
 Score Right 1A Total  Score Left 1A Total 
Score 
Right 
1B 
1.00 2.00 3.00 Score 
Left 
1B 
1.00 2.00 3.00 
1.00 1 2 1 - 1.00 2 0 0 2 
2.00 0 0 6 4 2.00 0 3 0 3 
3.00 - - - 6 3.00 0 1 4 5 
Total 1 2 7 10 Total 2 4 4 10 
Kappa 0.6 p=.016                                        Kappa 0.844 p=0.0005 
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4.6.5. Reproducibility of Repeat Hemispheric Pixel Scoring 
4.6.5.1. Coefficient of variation for Reproducibility of Repeat Hemispheric Pixels 
The coefficient of variation was relatively high, especially for PTNP (Table 22) 
 
Table 22 Coefficient of variation for hemispheric pixel measurements made for 
studies 1A and 1B on the same day 
 n Mean (%) SD Median (%) Range 
Right PTPP 29 18 17 13 0-83 
Left PTPP 29 12 9 11 0-39 
Right PTNP 26 87 48 88 0-141 
Left PTNP 26 83 51 80 6-141 
Right NTNP 29 13 13 11 0-57 
Left NTNP 29 20 26 10 1-116 
 
4.6.5.2. Intraclass correlation coefficient for Reproducibility of Repeat 
Hemispheric Pixels 
Intraclass correlation coefficient analysis was used to analyse the reproducibility of 
repeat hBOLD-CVR hemispheric measures at one time point (1A and 1B) for each 
patient.  Repeat hemispheric hBOLD MRI pixel measures were reliable for PTPP 
(good reliability; ICC .783 and .803 for right and left hemispheres respectively), left 
PTNP (good reliability .858) and NTNP (excellent reliability; ICC .910 and .889 for 
right and left hemispheres respectively). Repeat measures were less reliable for 
right PTNP (ICC .649) (Table 23).   
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Table 23 Intraclass Correlation of Repeat hBOLD MRI Measures of Hemispheric 
Pixels 
 
CVR 
Pixels    
n=29 
 
Timepoint 
            
 
Intraclass  
 
 
Correlation 
  
95% Confidence Interval          
       
 
    Lower          Upper                              
1A 1B 
 
PTPP 
R  
L 
Mean (SD) 
 
.438 (.151) 
.563 (.146) 
Mean (SD) 
 
.435 (.130) 
.563 (.130) 
 
 
.783 
.803 
 
 
.534 
.577 
 
 
.899 
.908 
PTNP     
R  
L 
 
.159 (.222) 
.162 (.277) 
 
.180 (.384) 
.14 (.294) 
 
.649 
.858 
 
.245 
.697 
 
.836 
.933 
NTNP 
R 
L 
 
.482 (.192) 
.457 (.189) 
 
.478 (.191) 
.462 (.18) 
 
.910 
.889 
 
.807 
.762 
 
.958 
.948 
 
4.6.5.3. Hemispheric Pixels Repeat Measures by hBOLD MRI Method 
Six mixed effect repeated measures ANOVA were implemented, with time (1A, 1B) 
as the within-subject variable, and method (BH, GA) as the between-subject 
variable. Dependent variables for these analyses were right and left PTPP, right 
and left PTNP and right and left NTNP.  There was no significant time*method 
interaction for any of the dependent variables.  
The main effects of time and method were not significant for any of the dependent 
variables (all p values >.1).  There were no significant differences in the 
hemispheric pixels either at different time points or by when using different 
hypercapnic challenge methods (Table 24).  
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Table 24 Repeat Measures of Hemispheric Pixels by hBOLD CVR Method 
 
General Anaesthetic 
(n=14) Breath Hold (n=15) t-test 
Method 
Timepoint 1A 1B 1A 1B 1A 
1B 
n=29 Mean (SD) Mean (SD) Mean (SD) Mean (SD) P P 
R PTPP .455 (.163) .446 (.162) .423 (.143) .424 (.096) .581 .665 
L PTPP .550 (.155) .554 (.162) .575 (.141) .571 (.10) .652 .730 
R PTNP .151 (.235) .070 (.101) .167 (.218) .284 (.511) .854 .135† 
L PTNP .142 (.265) .067 (.123) .182 (.3) .208 (.385) .709 .202 
R NTNP .431 (.23) .418 (.221) .53 (.14) .534 (.144) .171† .105† 
L NTNP .451 (.240) .457 (.217) .462 (.134) .467 (.144) .881 .893 
 
4.6.5.4. Agreement between Right Repeat Hemispheric Pixels - Bland-Altman 
As hemispheric pixel measures were reciprocal, Bland-Altman analysis was 
conducted for right hemispheric pixel measures only, by taking the difference in 
repeat measure hemispheric pixels (1A, 1B) and the average hemispheric pixel 
scores and plotting the values against each other.  One sample t-test was 
conducted to compare mean repeat hemispheric pixel measures.  Upper and lower 
confidence intervals were calculated as follows:   
Upper interval:  Mean difference + (standard deviation x 1.96) 
Lower interval:  Mean difference – (standard deviation x 1.96)  
 
4.6.5.5. Right PTPP 
There was no significant difference between 1A and 1B for RPTPP (p=.880).  The 
mean difference was .0034 and standard deviation .120.  Upper and lower 
confidence intervals were .239 and -.232 respectively. Linear regression analysis 
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demonstrated that there was no proportional bias in measures (t=1.006, p=.323) 
(Fig 29A).   
 
4.6.5.6. Right PTNP 
Similarly, there was no significant difference between 1A and 1B for RPTNP 
(p=.727).  The mean difference was -.0211 and standard deviation .322.  Upper 
and lower confidence intervals were 0.60 and - 0.652 respectively.  Linear 
regression analysis demonstrated proportional bias in measures (t -3.55, p=.001). 
Visual inspection suggests good agreement for repeat hemispheric measures 
when the mean PTNP lies between 0.00 and 0.125. The agreement above this 
level reduces as the mean difference in PTNP increases (Fig 29B). 
 
4.6.5.7. Right NTNP 
There was no significant difference between 1A and 1B for RNTNP (p=.859).  The 
mean difference was .0037 and standard deviation .112.  Upper and lower 
confidence intervals were 0.223 and - 0.215 respectively.   Linear regression 
analysis demonstrated that there was no proportional bias in measures (t=.011, 
p=.991) (Fig 29C).   
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Figure 29 Bland-Altman plots for agreement between right hemispheric pixel 
measures.  The central horizontal line represents a mean difference of zero, and the 
lines above and below are the 95% confidence intervals 
 
 
 
 
 
A 
B 
C 
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4.6.5.8. hBOLD Cerebrovascular Reactivity 
Twenty seven children had a spot CO2 with their first hBOLD CVR study and 14 
children with a second hBOLD CVR study.  All children who successfully 
underwent GA had a spot CO2.  The mean spot CO2 for all the first available 
hBOLD CVR studies was 37.41, SD 5.116 mmHg.  The mean spot CO2 for all the 
second available hBOLD CVR studies was 36.07, SD 3.931 mmHg. These values 
are not significantly different.   
Six children (4 female, mean age first hBOLD CVR study 9.03, SD 4.657 years; 
mean age second hBOLD CVR study 9.06, SD 4.261 years) were identified with 
reliable serial CO2 measures, measurable CO2 change and BOLD MRI curves.  
Quantitative whole brain or hemispheric hBOLD CVR values were calculated for 
these using the following formula: 
% Δ BOLD MRI signal/∆PCO2 
Right sided hBOLD CVR1 in those who had right sided moyamoya (five of six: four 
bilateral and one right sided) ranged from 0.23 - 0.50 %/mmHg, mean 0.408 
%/mmHg.  Left sided hBOLD CVR1 on the unaffected hemisphere (one right sided 
only) ranged from 0.39 - 0.80 %/mmHg, mean 0.6 %/mmHg. 
Left sided hBOLD CVR1 in those who had left sided moyamoya (five of six, four 
bilateral and one left side only) ranged from 0.25 - 0.48 %/mmHg, mean 0.37 
%/mmHg.  hBOLD CVR 1 was not calculable pre-operatively on the unaffected 
hemisphere for the only patient with unilateral left sided moyamoya. 
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All second studies in this group were conducted following revascularization surgery 
so reproducibility data are not available.  hBOLD CVR 2 was higher than CVR 1 in 
those that had a second study.  Systematic evaluation of the effects of surgery on 
CVR are discussed in Chapter 7 (pre post). In the child with right sided MM hBOLD 
CVR was lower on the right than the left and improved following surgery.  In the 
child with left sided moyamoya hBOLD CVR was lower on the left compared to the 
right. 
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Table 25 Calculable hBOLD Cerebrovascular Reactivity in 6 patients studied under GA with CO2 and Patient Demographics 
Patient 
 (M/F) 
Idiopathic MM 
or Syndromic 
Diagnosis/ 
MM Laterality 
Age at 
CVR 1 
h BOLD Hemispheric 
Cerebrovascular Reactivity 
%/mmHg 
Number of 
Surgeries 
(Surgery timing) 
Stroke Comments 
Age at 
CVR 2 
W R L R 
Ave 
L 
Ave 
a, b, n a, b, n  
1  
Female 
Trisomy 21 
Bilateral 
         
1A 
1B 
 15.00 .26 
.36 
.31 
.41 
.23 
.41 
.39 .32 1(a) b 1B better study 
2A 
2B 
 16.56 .72 
.96 
1.18 
1.10 
.57 
.87 
1.14 .72    
2 
Female 
Turner Syn 
Left 
         
2A 
2B 
 6.61 .35 
.44 
.37 
.50 
.34 
.42 
.44 .38 1(b) n  
3 
Female 
Idiopathic 
Bilateral 
         
1A 
1B 
 7.50 .44 
.45 
.47 
.50 
.41 
.43 
.49 .42 2(b+a) b  
2A 
2B 
 8.13 .86 
- 
.89 
- 
.91 
- 
.89 
 
.91 
 
   
4 
Male 
Idiopathic 
Bilateral 
         
1A 
1B 
 7.17 
 
.23 
.39 
.23 
.23 
.20 
.33 
.23 .27 1(a) b Poor signal change.  
Diamox.  
1B better study 
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Patient 
 (M/F) 
Idiopathic MM 
or Syndromic 
Diagnosis/ 
MM Laterality 
Age at 
CVR 1 
h BOLD Hemispheric 
Cerebrovascular Reactivity 
%/mmHg 
Number of 
Surgeries 
(Surgery timing) 
Stroke Comments 
Age at 
CVR 2 
W R L R 
Ave 
L 
Ave 
a, b, n a, b, n  
5 
Female 
Idiopathic 
Right 
         
1A 
1B 
 5.75 .42 
.34 
.46 
.40 
.39 
.80 
.43 .6 1(a) n  
2A 
2B 
 6.26 .59 
.65 
.50 
.52 
.59 
.71 
.51 .65    
6 
Male 
Chromosomal 
Bilateral 
         
1A 
1B 
 14.67 .30 
.44 
.50 
.50 
.48 
.48 
.50 .48 N b  
1A=first hBOLD CVR study of the first hBOLD CVR session; 1B=second hBOLD CVR study of the first hBOLD CVR session; 2A=first hBOLD CVR 
study of the second hBOLD CVR session; 2B=second hBOLD CVR study of the second hBOLD CVR session; W=whole brain, R=right hemisphere, 
L=left hemisphere; Ave=average; Timing of Revascularisation Surgery in Relation to hBOLD CVR study:  a = after, b = before, n = no surgery; Timing of 
Stroke in Relation to hBOLD CVR study: a=after. b=before, n= no surgery. 
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4.6.5.8.0. hBOLD CVR Repeat Measures 
hBOLD CVR repeat measure means (1A and 1B, or when not available 2A and 2B) 
were correlated and compared using the paired t-test.  There was a trend toward 
significant association between right repeat CVR measures.  There was no 
statistically significant difference between the repeat measures.  There was a trend 
toward significance in difference in whole brain and left hemisphere repeat CVR 
measures.   
Table 26 hBOLD CVR Repeat Measure Comparison of Means 
Hemisphere h BOLD Cerebrovascular Reactivity %/mmHg 
Correlation p value Mean 
Difference 
SD Confidence  
Intervals 
paired t-test    
p value 
Whole Brain .172 .744 -.07 .09 -.164 - .024 .115
†
 
Right .778 .068
†
 -.033 .07 -.107 - .04 Ns 
Left .462 .357 -.137 .15 -.294 - .02 .076
†
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Figure 30  hBOLD CVR Values in Children with Moyamoya 
 
1A=first hBOLD CVR study of first hBOLD CVR session; 1B=second hBOLD CVR 
study of first hBOLD CVR session 
 
 
 
 
Patient 1
1A 1B
0.0
0.2
0.4
0.6
0.8
1.0
%

 M
R
I/

 P
C
O
2
Patient 2
1A 1B
0.0
0.2
0.4
0.6
0.8
1.0
Whole
Right
Left
%

 M
R
I/

 P
C
O
2
Patient 3
1A 1B
0.0
0.2
0.4
0.6
0.8
1.0
%

 M
R
I/

 P
C
O
2
Patient 4
1A 1B
0.0
0.2
0.4
0.6
0.8
1.0
Whole
Right
Left
%

 M
R
I/

 P
C
O
2
Patient 5
1A 1B
0.0
0.2
0.4
0.6
0.8
1.0
Timepoint hBOLD CVR
%

 M
R
I/

 P
C
O
2
Patient 6
1A 1B
0.0
0.2
0.4
0.6
0.8
1.0
Whole
Right
Left
Timepoint hBOLD CVR
%

 M
R
I/

 P
C
O
2
186 
 
 
Figure 31  GA BOLD-CO2 fit curve and Parametric Maps in Child with Left 
Moyamoya 
 
Whole brain T1 axial MRI at level above ventricle.  ∆BOLD signal/∆ CO2 curves for 
positive pixels (yellow) and negative pixels (purple).   
Left:   BOLD-fit curve and positive pixel parametric map.  Note reduced positive 
pixels (yellow) in the affected left hemisphere. 
Right:  BOLD-fit curve and negative pixel parametric map.  Note presence of 
bilateral negative (purple) pixels. 
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Composite CVR parametric map showing areas of positive and negative reactivity.  
Note reduced positive reactivity in left hemisphere and bilateral steal.   
4.7. Discussion 
4.7.1.  Patient Selection 
The controlled delivery technique has utility in the older child, yet clinical 
applicability remains minimal due to set-up costs, time, requirement for ethical 
approval and - despite the older age group – tolerability.  Furthermore the 
requirement for co-operation cannot be met by younger children, particularly those 
with challenging behaviors and developmental disorders.   
In this study, almost an equal number of children had a study under general 
anaesthetic as had a breath-hold study.  Only two children had studies using the 
rebreathing mask.  These two children were adolescents and have been reported 
in the published literature (Heyn et al. 2010, Han et al. 2011).  Hence this 
discussion will centre on the aforementioned general anaesthetic and breath-hold 
techniques. 
Breath-holding and GA hBOLD CVR techniques are usable in the very young child 
to adulthood.  Both methods use endogenous production of CO2 by breath-hold or 
ventilator simulation of apnea as the vasoactive stimulus.  Use of these techniques 
allows for the assessment of CVR in age groups previously only amenable to 
assessment using techniques such as PET, SPECT and TCD.  Children who had 
an hBOLD CVR study conducted under GA were significantly younger at diagnosis 
of MM and age of hBOLD CVR study and the youngest study was conducted at 
one year of age.   This is in contrast to the youngest patient reported in current 
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literature aged 10 (Han et al. 2011) and 16 years (Mandell et al. 2008, Leung et al. 
2015). 
 
4.7.2. Reliability of Repeat Qualitative Measures of hBOLD CVR by 
Method 
There are no published studies validating the use of ventilator induced hypercapnic 
challenge under GA in adults or children or validating the BH technique in children.  
There is one paediatric publication which discusses the feasibility and superior 
quality of GA studies in comparison to BH studies (Thomas et al. 2013). For a tool 
or technique to be valid it needs to measure what it sets out to measure.  Construct 
validity is an overarching term used to assess the validity of a measurement tool or 
technique, for example in our case BH or GA hBOLD CVR, to measure a construct, 
for example tissue level microvascular health.  It incorporates other forms of 
validity such as content validity, criterion validity, internal and external validity.  To 
this end establishing construct validity is a process that requires testing of the other 
forms of validity in order for it to be demonstrated.    
In our experience the use of these CVR methods has been informative and an 
important part of the decision making algorithm in this group of children.   
Kappa scores demonstrating reliability of repeat scores by inspection for GA and 
BH good and poor quality studies were ‘fair’ to ‘almost perfect’ in the group with 
repeat studies on the same day.  In studies conducted under GA, agreement 
between the right hemispheric repeat inspection scores was higher than for the left 
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hemispheric repeat inspection scores. The converse was true for the BH studies ie. 
Kappa scores were higher for the left hemispheric repeat measures than the right. 
Using Kappa scores as the comparator, repeat measures for GA studies were not 
more reliable than BH repeat measures.  However, as no one patient had two CVR 
studies using two different methods on the same day, and each hBOLD CVR by 
method group had different patients, direct comparison of reliability of method of 
analysis using test re-test analysis was not possible. 
The BH study is clearly limited to patients who can understand and comply with 
instructions.  As a more qualitative study, hBOLD CVR CVR studies are most 
useful for intra-subject analysis.  The specifics of breath-hold execution have 
implications for the magnitude and reliability of the CVR response.  A short breath-
hold of 3 seconds is adequate to produce a BOLD response. However a longer 
breath-hold results in increased magnitude of effect because of the number of 
voxels exhibiting the response, and also more robust and repeatable measures of 
BOLD CVR.  Good breath-hold practice guidelines for repeatable measures in 
healthy subjects include paced breathing between challenges and breath-holding 
after expiration (Bright and Murphy 2013).   
Post processing of BH studies has to account for the hemodynamic response delay 
(HRD), which is incorporated into the analysis and based on assumptions of 
potential delay in CO2 increase and not on actual measurements of ETCO2. This 
is another potential source of error in the generation of quantitative and qualitative 
hBOLD CVR measures.   
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However, the applicability of these enhanced BH techniques in the younger child 
are limited.  Hence our study reflects real world practice in this broad yet important 
age group. Of interest (Bright and Murphy 2013) set out to study the reproducibility 
of breath-hold CVR measures despite poor performance and demonstrated that 
with certain methods real world poor performance of BH can still result in 
reproducible results. 
GA studies have the advantage of being usable in the very young and the 
uncooperative. GA studies were scored as being of better quality than BH as in a 
previous smaller series from the same centre (Thomas et al. 2013). The aim when 
changing the ventilator settings is to cause PETCO2 change of 7-10 torr.  This was 
harder to achieve in our children on Diamox and Tegretol.  This is presumably 
because of the independent effects of Diamox on PaC02 which are useful in the 
management of some children with moyamoya as the increase in PaCO2 results in 
a shift of the patient to the right on the autoregulatory curve.  In some patients this 
may result in them reaching the peak of the vasodilatory capacity, resulting in an 
inability to further augment their CBF during hypercapnic stimulation.  
 
4.7.3. Qualitative hBOLD CVR and Anaesthetic Agents 
Cerebrovascular reactivity is affected by different anaesthetic agents. Propofol has 
cerebral vasoconstrictive properties and hence results in higher CVR in 
comparison to children anaesthetized using inhalational agents. The main 
anaesthetic agents used in our population were propofol and sevoflurane at 
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induction. Studies of the effects of various anaesthetics on middle cerebral artery 
blood flow and CVR have been conducted in healthy children using transcranial 
Doppler sonography (TCD). Although published literature on the effect of the 
combined agents on CVR is lacking and literature on their separate effects has to 
be interpreted with some caution because of the use of TCD to measure CVR, 
expected effects would be complementary and possibly allow for the truest 
measure of CVR in the individual. Propofol for neuroanaesthesia is well tolerated 
and CVR preserved in children as it is in adults.  Its pharmacokinetic properties are 
desirable as they allow for rapid metabolic clearance and hence fast predictable 
recovery post anaesthetic which is essential in this group of patients. 
(Vandesteene et al. 1988, Rowney et al. 2002).  This is contrast to the potentially 
undesirable cerebral vasodilatory effects of the volatile anaesthetic agents such as 
Sevoflurane (Matta et al. 1999, Fairgrieve et al. 2003, Karsli et al. 2003).  The 
vasodilatory effect of volatile anaesthetics may result in the maximal cerebral 
vasodilatory response to increments in PET CO2 being achieved at an earlier 
stage resulting in a plateau effect at PETCO2 above 45mmHg.  This in turn may 
result in less reliable assessment CVR, particularly at higher levels of PET CO2 
and in comparison to propofol (Rowney et al. 2002).  Furthermore there is a 
difference in magnitude of effect of specific volatile agents on CBF and hence 
CVR, with sevoflurane having the most potent effect when compared to isoflurane 
and halothane (Leon and Bissonnette 1991, Nishiyama et al. 1999).  However, 
propofol has been shown to decrease cerebral metabolism and cerebral blood 
flow.  This may have had an effect on absolute measures of CVR in our population.  
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Nitrous oxide in combination with propofol and sevoflurane was only used in one 
child.  Nitrous oxide in anaesthetic and subanaesthetic doses (Dashdoj et al 2013) 
is known to increase CBF and CMRO2.   When added to propofol or sevoflurane it 
does not affect CVR as measured by TCD in the normocapnic to hypercapnic 
range (Karsli et al. 2003, Wilson-Smith et al. 2003).  It however does have an effect 
on CVR in the hypocapnic range when added to sevoflurane despite mean arterial 
pressures and heart rate remaining stable (Fairgrieve et al. 2003, Karsli et al. 
2003).   
Gender differences in CVR are described in adults; limited early studies in children 
have not demonstrated that for the hypercapnic challenge (Kassner et al. 2010, 
Siriussawakul et al. 2011). 
 
4.7.4. Interobserver agreement of Scoring by 2 raters  
Assessments of the quality of hBOLD CVR studies (Thomas et al. 2013) were 
made post-processing - at the time of scoring. Patient and hBOLD method factors 
were noted such as (when available) ΔCO2, hBOLD signal/ΔCO2 curve, motion 
artefact and other specific patient factors such as medication taken at time of 
hBOLD CVR study.  Cohen’s Kappa is an inter-rater agreement analysis that 
controls for the agreement expected by chance alone.   
The inter-rater reliability of the expert raters measured by Kappa was excellent, a 
pre-requisite for using the technique clinically.  
193 
 
4.7.5. Repeat Measure Hemispheric Inspection Scores 
Kappa calculated for all available repeat measure scores were generally fair to 
moderate.  However, when calculated for studies assessed to be of good or 
reliable quality, Kappa scores were good to excellent.  However, the repeat scores 
were least reliably discriminatory between inspection score 2 and 3.  These scores 
were not sensitive enough to reliably discriminate between the abnormal studies 
where 2 represents reduced positive reactivity and 3 significant steal.   
 
Despite the limitations of the GA and BH technique, the good interobserver 
reliability and reproducibility of the studies scored simply as 1, 2 and 3 is 
reassuring and warrants further study into improving the use of these techniques. 
This has important implications for the translation and incorporation of the results 
of hBOLD CVR studies into clinical practice.   
 
4.7.6. Repeat Measure Hemispheric Pixels  
Intraclass correlation is usually used to look for differences in measures between 
two different techniques.  Like coefficient of variation, it can also be used to assess 
agreement between measures.  Intraclass correlation was good to excellent for 
repeat hemispheric pixel measures, although the correlation was less for PTNP 
and the coefficient of variation was unacceptably high for this measure for both left 
and right hemispheres.  Since high correlation may be explained by similar 
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variance, it does not necessarily imply a high level of agreement.  Hence Bland-
Altman analysis was used to investigate agreement between studies, any 
systematic difference between measurements and identify possible outliers.  There 
was good agreement between the repeat hemispheric pixel measures except for 
PTNP.  There was good to excellent level of reliability and agreement despite the 
inclusion of poor quality studies.  The methodological difference in calculation of 
PTNP are likely to be the explanation for the wide confidence intervals and 
systematic bias seen for this measure, which is in line with the unacceptable 
coefficient of variability and worse intraclass correlation and means that PTNP is 
not likely to be useful clinically.    
 
4.7.7. Quantitative Measures of hBOLD CVR 
Quantitative expression of CVR requires knowledge of the change in PETCO2 
which is not routinely measured in breath-hold studies, hence the limitation in 
applicability.  We were able to calculate CVR measures in a small group of children 
who had GA studies.  Direct CVR measures were not calculable for studies done 
by BH.  
There is limited published data on CVR values in children.  In a study comparing 
BOLD CVR to ASL CVR (Mandell et al. 2008) reported CVR measures in patients 
with arterial steno-occlusive disease.  hBOLD CVR values in the younger (< 30 
years) patients ranged from -.02 to .23 in the affected hemisphere of those with 
moyamoya, .37 in the unaffected hemisphere and .51 to 0.52 in a child with 
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subclavian steal syndrome.  In our group, hBOLD CVR measures in the affected 
hemisphere ranged from .23 to .50 and .37 to .80 in the unaffected hemisphere.   
 
Currently there are no qualitative CVR control data for healthy children, nor 
children with syndromic diagnosis commonly seen in moyamoya such as Sickle 
Cell Disease and NF1.  However our data are promising in as much as much as 
support the use of hypercapnic challenge methods that are more tolerable and 
hence available to the child or infant affected by moyamoya.   
 
4.8. Study Limitations and Future Directions 
Future directions could include: 
i) Test-retest method agreement analysis – this is standard practice in 
the comparative validation of different tools used to measure the same 
variable. BH and RM hBOLD CVR studies could be done in the same 
healthy patients with a brief 2-4 minute interval (Winter et al. 2010). 
ii) Anaesthetic agents for GA studies – guidelines to improve uniformity 
in anaesthetic use would enable more reliable interpretation of CVR and 
BOLD data 
iii) Breath-hold studies – use of forced expiration at the end of a breath-
hold would enable quantitative assessment of CVR in more children  In 
addition use of techniques known to improve reliability and repeatability 
such as paced breathing and end expiratory breath-holding, 
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measurement of end tidal CO2 and use of respiratory bellows or 
respiratory belt could help improve reliability of time course and 
quantitative CVR assessment, as the expired CO2 could be measured 
and used to quantify CVR, using the formula ∆ CO2/∆ BOLD MRI..   
iv) Real-time analysis – will reduce the time to reporting of results allowing 
for verification of data quality whilst the patient is in the scanner. 
v) Scoring by inspection – this technique could be further explored, 
perhaps with a more discriminatory scoring system. However, the simple 
scoring system has good interobserver reliability, perhaps because of 
the few options for the raters to choose from, and currently has the 
greatest potential for clinical use as it appears to be reliably scored and 
reproducible but is not very labour intensive.  
vi) Longitudinal qualitative and quantitative use of vailidated hBOLD CVR 
techniques in moyamoya arteriopathy and syndromic moyamoya 
arteriopathy studies. 
  
4.9. Conclusion 
Qualitiative CVR using breath-hold and general anaesthetic as the hypercapnic 
stimulus is feasible in paediatric practice, reliable and repeatable.  Raters can also 
be trained to score CVR inspection maps reliably. At present, counting of 
hemispheric pixels does not appear to be worth the additional time as the 
reproducibility is not as good. However, quantitation of the change in CO2 as well 
as the change in hBOLD during GA studies might allow reliable and reproducible 
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measurement of CVR for comparison with studies using rebreathing techniques in 
older children and adults and for use in longitudinal studies of children with 
cerebrovascular disease. 
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5. Population hBOLD CVR Measures 
5.1. Abstract 
5.1.1. Background   
Cerebrovascular reactivity (CVR) is an indicator of cerebrovascular reserve and a 
biomarker of cerebrovascular health and ischaemic risk. Adult studies of CVR 
using BOLD CVR are conducted in the awake state and require co-operation.  
However, diagnosis in moyamoya is often made in infancy and confers a lifelong 
risk of cerebral ischaemia, neurocognitive decline and stroke.  hBOLD CVR using 
breath-hold or general anaesthetic as the hypercapnic challenge have the potential 
for use as a biomarker of ischaemic risk in this group.  Yet reports of the use of 
these modalities remain scarce in the paediatric literature.    
5.1.2. Objective 
To describe the qualitative hypercapnic challenge BOLD (hBOLD CVR) measures 
of all the children enrolled in the study.  
5.1.3. Method 
Children with cerebral arteriopathy (moyamoya and non-moyamoya) were enrolled 
and had hBOLD CVR studies in addition to MRI/MRA brain and conventional 
angiography (See Population Ascertainment Chapter 3).  Children had qualitative 
hypercapnic challenge with endogenous delivery of carbon dioxide (breath-hold 
and general anaesthetic) and quantitative hypercapnic challenge with exogenous 
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delivery of carbon dioxide (RespirAct, re-breathing mask) hBOLD CVR studies 
(See Method Chapter 2).  
Measures of hBOLD CVR are presented in the moyamoya and non-moyamoya 
groups. 
5.1.4. Results 
Forty-seven children with arteriopathy had at least one hBOLD CVR study during 
the course of the study.  Thirty seven had moyamoya arteriopathy, ten non-
moyamoya arteriopathy (four Bilateral Non-moyamoya (Non-MM) arteriopathy and 
six Unilateral Non-moyamoya (Non-MM) arteriopathy.  The mean age of first 
hBOLD CVR study was 10.4 years.  The youngest child to have an hBOLD CVR 
study was one year of age.  This study was conducted under general anaesthetic.  
Mean hBOLD CVR inspection scores were higher in the moyamoya arteriopathy 
group compared to the non-moyamoya arteriopathy groups, suggesting more 
impaired hBOLD CVR and tissue level compromise.  Within the moyamoya 
arteriopathy group, qualitative measures of hBOLD CVR were suggestive of 
greatest impairment and tissue level compromise in the Tumour-MM and 
Chromosomal group. 
5.1.5. Conclusion 
To my knowledge this is the largest series to describe qualitative hBOLD CVR 
findings in a population of children with moyamoya and non-moyamoya 
arteriopathy.  I demonstrate that qualitative hBOLD CVR studies can be 
successfully conducted in children as young as one year and that those with more 
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severe cerebrovascular disease, i.e. moyamoya, have more compromise of the 
CVR. Furthermore there appear to be disease specific differences in generation of 
BOLD MRI signal and hence CVR.  This requires further exploration in future 
studies.  
 
5.2. Introduction 
Quantitative BOLD MRI may be used to assess changes in blood flow by 
harnessing the paramagnetic properties of deoxygenated haemoglobin.  
Cerebrovascular reactivity (CVR) is the measurement of vessel reactivity to 
vasoactive stimuli such as exogenous drugs (eg acetazolamide) or changing 
arterial CO2 tension, and is defined as the change in blood flow per unit change in 
PCO2.  It is an important marker for brain vascular reserve and the ability to 
augment and maintain CBF under conditions of stress. Cerebrovascular reactivity 
studies are the brain equivalent of a cardiac stress test. CVR in adults has been 
shown to predict ischaemic risk and impaired CVR is associated with conditions of 
cognitive decline such as Alzheimer’s disease (Silvestrini et al. 2000, Markus and 
Cullinane 2001, Gupta et al. 2012, Marshall et al. 2012, Reinhard et al. 2014).  
Hence impaired CVR is an indicator of tissue at risk of ischaemia.   
Breath-holding is a relatively well tolerated technique.  There is no need for mask 
ventilation, making the experience within the scanner less claustrophobic and 
obviating the need for an anaesthetist.  It however, requires co-operation from the 
child as it is conducted in the awake state.  
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In our group the youngest age of diagnosis of moyamoya was 6 months. hBOLD 
CVR studies conducted under GA is a previously unreported yet feasible method 
for the assessment of CVR in the very young, and/or those unable to tolerate 
alternative awake methods.   
A barrier to the widespread use of BH qualitative hBOLD CVR in adult clinical 
practice and research has been the lack of end tidal CO2 measures which are 
required for quantitation of CVR.  This was the case in my population.  Inferences 
and qualitative reports could be made from the inspection of individual hBOLD 
CVR parametric maps based on colour-coded direction and relative magnitude of 
flow.  Therefore, on a case by case basis, CVR was reported as demonstrating: 
normal (positive) reactivity (score 1), less than normal (positive) reactivity without 
steal or with steal up to 10% (score 2) and abnormal reactivity (negative with 
steal>10%) (score 3).  The scoring system was designed to capture this in a 
quantifiable manner and hence serve as indirect measures of hBOLD CVR in this 
study (Chapter 2 Methods Scoring).   
 
5.3. Study Purpose and Hypothesis 
In this chapter I describe qualitative and quantitative hBOLD CVR measures in a 
population of children with moyamoya and non-moyamoya arteriopathy, and 
explore potential reasons for observed differences.  
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5.4. Methods 
Children with arteriopathy and clinical hBOLD CVR studies were prospectively and 
retrospectively enrolled through the Children’s Stroke Programme Clinic and using 
the Stroke Registry Database (Chapter 3 Population).  Children had qualitative 
(breath-hold and general anaesthetic) hBOLD CVR studies and a few had 
quantitative hBOLD CVR studies (Chapter 2 Methods, Chapter 3 Population 
Attainment, Chapter 4 Validation).  
Positive and negative threshold hemispheric pixels of the hBOLD CVR parametric 
map in the first axial slice above the ventricles were counted as previously 
described (Chapter 2 Methods).   
hBOLD CVR hemispheric parametric maps in the same - first axial slice - above 
the ventricles were scored. As the pixel number was set to 100 in the slice above 
the ventricle, and the scoring was of raw (unsmoothed) data, it was possible to 
count individual pixels.  The scoring system was devised by two raters (See 
Chapter 2 Methods). Scores for each hemisphere were between 1 and 3 according 
to the following schema: 
 Normal CVR = 1  
 Reduced positive reactivity +/- steal >2%<10% = 2 
 Steal > 10% with or without reduced positive reactivity = 3 
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5.5. Statistics 
One way ANOVA and the T-test were used to compare means where the data 
were normally distributed, and Kruskal-Wallis and Mann-Whitney U test used to 
compare medians where the data were not normally distributed. Categorical data 
were analysed using Fisher’s exact test.  A significance level of p<.05 was 
accepted.  
 
5.6. Results 
One hundred and nine hBOLD CVR studies of 218 hemispheres were conducted in 
total. Forty-seven children with moyamoya (37) and non-moyamoya (10) 
arteriopathy had at least one hBOLD CVR study.   
 
5.6.1. Population 
The first GA or BH hBOLD CVR study of each patient was included for analysis.  
For 2 patients this resulted in inclusion of the second and fourth hBOLD CVR 
studies respectively, as earlier studies used rebreathing with quantitative CVR 
measurement and hence had not been analysed using pixel analysis. 
The mean age at time of first hBOLD CVR study was 10.4 (SD 4.5; range 1-17.7) 
years in the whole arteriopathy (n=47) group.  There was a statistically significant 
difference in age of first CVR between arteriopathy groups (Kruskal-Wallis; χ2(2) = 
6.5, p = 0.04). On post-hoc testing, there was a statistically significant difference in 
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age at first CVR between the Bilateral Non-MM arteriopathy group, Moyamoya 
(Mann-Witney U = 22, p=.02) and Unilateral Non-MM (U=1, p=.03) groups 
respectively.  There was no statistically significant difference age at first CVR 
between the Moyamoya and Unilateral-Non-MM arteriopathy groups (U=68, 
p>.05). 
 
5.6.2. Qualitative hBOLD CVR Measures by Arteriopathy 
Classification 
5.6.2.1. Hemispheric pixels  
Hemispheric pixels were available for analysis in 37/37 of the Moyamoya, 3/4 of 
the Bilateral Non-MM arteriopathy and 0/6 of the Unilateral Non-MM groups as 
these studies were conducted using the re-breathing mask (RespirAct).  There was 
no significant difference between the mean PTPP hemispheric pixels by 
arteriopathy.  Negative pixels (by positive and negative thresholds) were higher in 
the Moyamoya arteriopathy group.  Mann-Whitney U Test demonstrated a trend 
toward significant difference in right and left PTNP, and right NTNP respectively 
(U=22.5, p=.093; U=21.00, p=.082; U=28.00, p=.172) (Table 26). 
 
5.6.2.2. Asymmetry Indices 
Asymmetry indices (AI) were calculated for the arteriopathy groups and plotted 
(Chapter 2 Methods Asymmetry Index).  On inspection of the AI hemispheric plots, 
both Moyamoya and Bilateral Non-MM groups were predominantly right sided.  
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There was no statistically significant difference in mean AI (difference in 
hemispheric pixels/total pixels Ref Methods) for PTPP, PTNP or NTNP pixels 
between all three groups U=52, U=48, U=43 respectively, p>0.05 (Chapter 3 
Clinical and Radiographic Description of Arteriopathy Groups, Table 26 and Figure 
28). 
 
5.6.2.3. Hemispheric Scores by Inspection 
Mean hemispheric scores were higher in the Moyamoya arteriopathy group than 
the Bilateral Non-MM and Unilateral Non-MM groups.  There was a trend toward 
significant difference in mean scores between the arteriopathy groups (Kruskal-
Wallis; χ2(2) = 4.34, p=.10 and χ2(2) = 3.91, p=.16 for right and left hemispheric 
scores respectively).  On inspection the biggest difference in mean scores was 
between the Moyamoya and Bilateral Non-MM group scores (Table 27 and Figure 
32). 
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Figure 32 Asymmetry Indices by Arteriopathy 
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Figure 33 Mean Hemispheric Scores by Arteriopathy   
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Table 27  Qualitative hBOLD CVR Measures by Arteriopathy 
 Moyamoya 
arteriopathy 
 
 
n=37 (%) 
Bilateral non 
moyamoya 
arteriopathy 
 
n= 4 (%) 
Unilateral 
non-
moyamoya 
arteriopathy 
n=6 (%) 
Arteriopathy Laterality 
    Bilateral  
    Right 
    Left 
     
 
23 (62) 
6  (16) 
8  (22) 
 
4 (0) 
0 (0) 
0 (0) 
 
0 
2 (33) 
4 (66) 
CVR Method 18 GA 19 BH 3 GA 1 BH 6 RM 
CVR Parametric Maps 
   Steal (Yes/No) % 
   PTPP (mean, range) 
              Right 
              Left 
   PTNP 
              Right 
              Left    
   NTNP 
              Right 
              Left 
mean (range) 
 
 
.434 (.12 - .63) 
.571 (.38 - .90) 
 
.193 (.00 - 1.33) 
.159 (.00 – 1.32) 
 
.504 (.03 - .89) 
.450 (.03 - .73) 
mean (range) 
 
 
.43 (.2-.6) 
.58 (.4-.8) 
 
.013 (.01-.03) 
.012 (.00-.03) 
 
.38 (.29-.43) 
.44 (.37-.58) 
 
 
 
N/A 
Asymmetry Index 
             PTPP 
             PTNP 
             NTNP 
mean (range) 
-.134 (-.76 - .24) 
.033 (-.19 - .47) 
.054 (-.55 - .78) 
mean (range) 
-.15(-.6 - .19) 
.002(-.02- 03) 
-.06(-.14-.07) 
 
N/A 
CVR Hemispheric 
Inspection Scores (Total 
number of hemispheres 
= 92) 
1 
2 
3 
 
 
Total (R:L) 
 
17 (8:9) 
22 (10:12) 
35 (19:16) 
 
 
 
 
2 (1:1) 
4 (2:2) 
1 failed BH 
 
 
 
 
9 (4:5) 
0 
3 (2:1) 
Mean scores (SD) 2.3 (.81) 1.33 (.58) 1.8 (1.1) 
 
5.6.3. Qualitative hBOLD CVR Measures by Moyamoya Classification 
Moyamoya arteriopathy was classified as idiopathic (MMD) or syndromic (MMS).  
Syndromic categories were Neurofibromatosis Type 1 (NF1-MM), Sickle Cell 
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Disease (SCD-MM), Trisomy 21 (Trisomy 21-MM), All chromosomal (All 
Chromosomal-MM) and Tumours (Tumour-MM) (Table 28).   
 
5.6.3.1. Hemispheric Pixels and Aetiology 
Mean right and left hemispheric PTPP were lowest in the Tumour-MM and NF1-
MM groups respectively.  Mean right and left hemispheric PTNP were highest in 
the Tumour-MM and SCD-MM groups respectively.  Mean right hemisphere NTNP 
was highest in the Tumour-MM and mean left hemisphere NTNP was highest in 
the SCD-MM and NF1-MM groups respectively (Table 28 and Figure 34).   
Kruskal-Wallis analysis demonstrated that right and left PTPP were significantly 
affected by comorbidity (χ2(4) = 11.69, p = .020; χ2(4) = 13.35, p = .01).  Left 
NTNP had a trend toward being significantly affected by comorbidity χ2(4) = 8.0, p 
= .092.   Right and left PTNP and right NTNP were not significantly affected by 
comorbidity χ2(4) = 1.39, p = .846; χ2(4) = 4.29, p = .368; χ2(4) = 4.73, p = .316 
(Table 28 and Figure 34). 
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Table 28 Hemispheric Pixels by MM Arteriopathy Group 
hBOLD CVR 
       Pixels 
Idiopathic 
 
 
n=13 
Neurofibromato
sis 
Type 1 
 
n=9 
Sickle Cell 
Disease 
n=5 
All 
Chromosomal 
n=7 
Tumour 
 
n=2 
 
 
Age at  CVR 10.4 10.3 9.7 11.5 14.1  
Method 
   BH 
   GA 
   RM 
 
7 
6 
1 
 
5 
3 
1 
 
3 
2 
0 
 
1 
2 
0 
 
2 
0 
0 
 
Pixels 
 
PTPP    R 
             L 
PTNP   R 
             L 
NTNP  R 
             L 
mean (SD)    
 
.40 (.14) 
.60 (.14) 
.24 (.35) 
.21 (.35) 
.48 (.20) 
.43 (.19) 
mean (SD) 
 
.54 (.06) 
.45 (.06) 
.1 (.17) 
.11 (.2) 
.44 (.14) 
.55 (.11) 
mean (SD) 
 
.45 (.06) 
.54 (.05) 
.12 (.11) 
.21 (.18) 
.45 (.13) 
.55 (.13) 
. 
mean (SD) 
 
.37 (.13) 
.65 (.16) 
.19 (.18) 
.09 (.13) 
.61 (.19) 
.33 (.15) 
mean (SD) 
 
.35 (.07) 
.65 (.07) 
.32 (.38) 
.09 (.02) 
.64 (.22) 
.36 (.22) 
 
 
.02 
.01 
.846 
.368 
.316 
.092 
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hBOLD CVR 
       Pixels 
Idiopathic 
 
 
n=13 
Neurofibromato
sis 
Type 1 
 
n=9 
Sickle Cell 
Disease 
n=5 
All 
Chromosomal 
n=7 
Tumour 
 
n=2 
 
 
Asymmetry 
Index 
 
PTPP 
PTNP 
NTNP 
 
mean (SD) 
 
 
-.209 (.28) 
.02 (.09) 
.045 (.3) 
mean (SD) 
 
 
.084 (.11) 
.018 (.07) 
-.046 (.24) 
mean (SD) 
 
 
-.091 (.09) 
.10 (.12) 
.284 (.31) 
mean (SD) 
 
 
-.284 (.28) 
-.077 (.10) 
-.152 (.24) 
mean (SD) 
 
 
-.3 (.15) 
.22 (.36) 
.27 (.45) 
ᵡ
2
 (4) 
      
 
12.36* 
7.37** 
7.55** 
MM Laterality 
  Bilateral 
  Right 
  Left 
 
11 
2 
1 
 
2 
2 
5 
 
5 
0 
0 
 
4 
2 
1 
 
2 
- 
- 
 
Mean 
Hemispheric 
Pixel Scores  
R 
L 
Mean (SD) 
 
 
2.36 (.84) 
2.14 (.86) 
Mean (SD) 
 
  
1.89 (.93) 
2.44 (.73) 
Mean (SD) 
 
 
2.8 (.45) 
2.6 (.55) 
Mean (SD) 
 
 
2.43 (.79) 
1.86 (.9) 
Mean (SD) 
 
 
 2.0 (.0) 
1.5 (.71) 
 
* significant at p<0.05                                                                                                              
** trend toward significant at p</= .2 
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Figure 34  Mean Hemispheric Pixels by Moyamoya Arteriopathy Classification 
 
 
Error bars represent standard deviation 
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5.6.3.2. Hemispheric Pixels and  Asymmetry Indices  
Analysis was repeated using asymmetry index.  Kruskal-Wallis analysis 
demonstrated a statistically significant difference in PTPP and trend toward 
significance for PTNP and NTNP asymmetry index between the different 
comorbidities (χ2(4) = 10.5, p = 0.021; χ2(4) = 8, p = 0.09; χ2(4) = 7.75, p = 0.1) 
(Figure 35).  
Following visual inspection of the graphs independent group comparisons of CVR 
asymmetry index was conducted using the Mann-Whitney test. 
There was a statistically significant difference in PTPP AI between the NF1-MM 
and Idiopathic groups (U=21, p=0.007); PTPP and PTNP AI between the NF1-MM 
and chromosomal-MM groups (U=6, p=.007, U=11.5, p=.034); and a trend toward 
significant difference between the NF1-MM and chromosomal group-MM for NTNP 
(U=14, p=.064).   
There was a statistically significant difference in PTPP AI between the SCD-MM 
and NF1-MM group (U=7, p=.04), Tumour-MM and NF1-MM group (U=0, p=.036); 
a statistically significant difference in PTNP and NTNP AI between the SCD-MM 
and chromosomal-MM group (U=3, p=.02, U=4, p=.03) respectively; and a trend 
toward significant difference in PTNP AI between the SCD and NF1-MM group, 
PTNP and NTNP AI between the SCD-MM and Idiopathic group (U=19, p=.16, 
U=20, p=.19). 
NF1-MM AI demonstrated left hemispheric tissue level functional impairment 
(positive PTPP AI and negative NTNP AI). hBOLD CVR functional impairment was 
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right sided in the MMD, SCD-MM and Tumour-MM groups.  Laterality of functional 
impairment was mixed (right on assessment of PTPP AI and left of NTNP AI) in the 
All Chromosomal group.   
Figure 35 Comorbidity Pixel Asymmetry Index    Id Idiopathic NF-1 
Neurofibromatosis SCD Sickle cell disease Chr Chromosomal Tum Tumour 
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5.6.3.3. Hemispheric Pixels and Inspection Scores  
Using the Kruskal-Wallis test there was no significant difference in mean inspection 
scores by comorbidiity (χ2 (4) = 4.79, p=.32; χ2 (4) = 4.66, p=.337 for right and left 
hemispheres respectively; Figure 36). 
Figure 36  Mean Hemispheric Scores by Moyamoya Arteriopathy Classification 
 
 
5.6.4. Population by hBOLD CVR Method 
For this analysis the first hBOLD CVR (including RM where applicable) was 
included.  Of the 37 children, the first available hBOLD CVR studies were under 
GA in 18, using BH in 17 and RM in two.  Age at MM diagnosis was significantly 
lower in children who had a GA study when compared to children who had a BH or 
RM study (Kruskal-Wallis; χ2 (2) = 11.61, p = .003; Figure 36; Table 29). Similarly 
there was a trend toward a lower age at first hBOLD CVR in children with GA 
studies when compared to children with BH studies (Figure 36; Table 29).   The 
Moyamoya Arteriopathy 
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two children who had RM studies were older at diagnosis and at first hBOLD CVR 
study.  Mean right NTNP and right hemispheric inspection measures of hBOLD 
CVR had a trend toward being significantly higher in the BH group (Table 29 and 
Figure 39). 
 
Figure 37  Age at Moyamoya Diagnosis by hBOLD CVR Method 
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Table 29 Population by hBOLD CVR Method 
 
General 
Anaesthetic Breath hold 
Rebreath 
Mask 
t-test 
N 18 17 2  
Age at 
Diagnosis 
Mean 
(SD;range) 
7.0 
(4.3; .67-16.58) 
 
11.03 
(2.07; 8-15.58) 
 
 
12.13 
(.88; 11.5-
12.75) 
 
p=.003* 
 
Gender 
M (%) 8 (44) 7 (41) 
 
1(50) 
 
p=.96 
Age at hBOLD 
CVR 
Mean  
(range) 
8.5 
(1-17.67) 
 
12.8 
(8.08-17.08) 
 
 
 
12.46                      
(12-12.2) 
 
 
p=0.008* 
MM Stage 
1 
2 
3 
4 
5 
6 
 
n 
1 
7 
8 
0 
1 
0 
 
N 
1 
3 
8 
2 
0 
1 
 
n 
- 
2 
- 
- 
- 
- 
 
Stroke (%) 
R/L/B (%) 
12 (67) 
36/18/12 
8 (47) 
27/11/11 
1(50) 
0/0/100 
 
Mean 
Hemispheric 
Pixels 
    PTPP   R 
                L 
    PTNP   R 
                 L 
    NTNP   R 
                 L 
mean (SD) 
 
 
.43 (.151) 
.58 (.161) 
.15 (.167) 
.13 (.165) 
.46 (.224) 
.45 (.214) 
mean (SD) 
 
 
.44 (.09) 
.56 (.09) 
.18 (.17) 
.13 (.13) 
.56 (.121) 
.45 (.117) 
mean (SD) 
 
 
N/A 
 
 
 
p>.05 
p>.05 
p>.05 
p>.05 
p=.123* 
p>.05 
Asymmetry 
Index 
PTPP 
PTNP 
NTNP 
mean (SD) 
 
-.15 (.31) 
.016 (.132) 
.012 (.368) 
mean (SD) 
 
-.12 (.176) 
.05 (.129) 
.11 (.237 
mean (SD) 
 
N/A 
 
 
p>.05 
p>.05 
p>.05 
Mean 
Hemispheric 
Scores 
mean (SD) 
2.06 (.938) 
2.06 (.873) 
mean (SD) 
2.59 (.618) 
2.24 (.752) 
mean (SD) 
2 
3 
 
p=.057† 
p>.05 
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Figure 38  Age at First hBOLD CVR by hBOLD CVR Method 
 
 
 
Figure 39 Right and Left Hemisphere Inspection Scores by hBOLD CVR Method 
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5.7. Discussion 
5.7.1. Group Description 
There are a number of published studies validating quantitative MRI CVR 
assessments of cerebral blood flow using hypercapnia as a vasoactive stimulus in 
adults (Ito et al. 2008, Bright and Murphy 2013, Tancredi and Hoge 2013) (Mikulis 
et al. 2005). However reports in children are limited and mostly refer to the use of 
controlled delivery of CO2 (Kirton et al. 2008, Han et al. 2011) (Thomas et al. 2013, 
Leung et al. 2015). 
 
5.7.2. hBOLD CVR Measures 
i) Moyamoya, Bilateral Non-MM and Unilateral Non-MM arteriopathy 
Qualitative hBOLD CVR studies were successfully conducted in 47 children.  To 
my knowledge, this is the largest reported study of qualitative hBOLD CVR studies 
in children.  The non-moyamoya arteriopathy groups were small; hence 
comparison of findings is limited.  
However, negative pixels at the positive threshold were higher in those with 
moyamoya arteriopathy compared to those with Bilateral Non-MM.  Negative pixels 
are suggestive of steal and ischaemic risk.  This suggests more significantly 
impaired CVR and tissue level perfusion in the moyamoya arteriopathy group when 
compared to the Bilateral Non-MM group.   
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ii) Moyamoya Arteriopathy and Moyamoya Syndromic Arteriopathy 
Thirty-seven of the 47 children with arteriopathy who successfully had qualitative 
hBOLD CVR studies had moyamoya arteriopathy (14 Moyamoya Syndrome, 9 
NF1-MM, 5 SCD-MM, 7-All Chromosomal-MM and 2 Tumour-MM).  hBOLD CVR 
measures were most severe, i.e. low PTPP, high PTNP and NTNP, in the Tumour-
MM and SCD-MM groups.  NF1 hBOLD CVR measures were more severe, i.e. low 
PTPP, high PTNP and NTNP, on the left compared with the right side. 
 
Figure 40  Neurovascular Unit and Cerebral Autoregulation showing the interaction 
between the blood cells, the endothelium and the blood vessels (left) and the 
neurone, synapse and brain cells (right) involved in regulating the cerebral blood 
flow response to changing carbon dioxide and blood pressure 
 
221 
 
Neurovascular coupling and cerebral autoregulation are two vasoregulative 
mechanisms thought to be located at the level of the smooth muscle arteriole 
which functionally interact with each other (Figure 36).  Neurovascular coupling 
describes the relationship between neuronal firing and haemodynamic changes in 
the vasculature adjacent to the activation areas.  Synaptic activity stimulates the 
release of signaling molecules that initiate changes in vascular tone.  Hence, 
neurovascular coupling – also known as functional hyperemia - forms the basis of 
BOLD functional imaging.  It is a complex and incompletely understood process 
that involves multiple signaling pathways and chemical mediators (Koehler et al. 
2009, Attwell et al. 2010, Jackman and Iadecola 2015). Cerebral autoregulation 
maintains constant cerebral blood flow despite perfusion pressure changes in the 
cerebral circulation (Azevedo et al. 2007) (Jackman and Iadecola 2015).   Hence 
disruptions in this relationship may occur for any reason that affects the synaptic or 
vascular unit.  Abnormalities in CVR caused by abnormal cerebrovascular 
autoregulation may occur due to chronic vasodilation in conditions such as chronic 
anaemia (SCD), or distal to a chronically fixed stenosis, as in moyamoya.  In either 
situation there is a right sided shift on the cerebral autoregulatory curve with 
consequent attenuation of the vasodilatory response.  The neuronal or synaptic 
contribution to functional hyperemia and the BOLD response is less explored and 
understood.   
An example of how a specific disease may contribute to abnormality in functional 
hyperaemia is found with NF1.  Neurofibromin is the product of the NF1 oncogene 
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and is a Ras signalling pathway inhibitory protein, dysregulation of which leads to 
excessive SMC proliferation and vascular occlusion (Hamilton and Friedman 2000, 
Dasgupta and Gutmann 2003).  In addition, neurofibromin has been shown to 
modulate excitatory synaptic function (Costa and Silva 2002).   The NF1 mouse 
models suggest increased perfusion on SPECT and increased density of microglial 
cells accompanied by enlarged capillaries in juvenile NF1 mice, specifically in the 
amygdala.  Microglia survey the local microenvironment, and aid with the 
remodeling of neuronal circuits by making contact with synaptic spines (Tremblay 
and Majewska 2011, Siskova and Tremblay 2013, Welberg 2014, Apostolova et al. 
2015). Activated microglia have higher energy demands, resulting in an 
upregulation of local cerebral blood flow.  Neurofibromin has also been associated 
with brain tumorigenesis (Daginakatte et al. 2008).   In the juvenile NF1 mouse 
model, the observation of regional hyperperfusion seemed age dependent and the 
increased microglial density suggestive of disease-specific pathology.  Conversely 
regional cerebral hypoperfusion using Arterial Spin-labeled CBF was reported in 
children with NF1 by Yeom et al (2013), with similar findings in adult and childhood 
studies using FDG-PET (Balestri et al. 1994, Kaplan et al. 1997, Buchert et al. 
2008, Yeom et al. 2013).  These observations may explain difference between 
NF1-MM and non-NF1-MM, as well as differences within the group of children with 
NF1-MM.  These observations require replication and exploration in future studies 
(Apostolova et al. 2015).  
In my study, the lowest positive pixel and highest negative pixels measures – 
indicative of poor tissue level perfusion - were present in the Tumour-MM and 
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Chromosomal-MM group.  The Tumour-MM group was very small (n=2) therefore 
the ability to draw conclusions from findings is limited.  The tumour was resected in 
one.  Both patients had radiotherapy induced moyamoya vasculopathy.  Age at 
moyamoya diagnosis was the oldest in this group (14.1 years), and was four and 
ten years after tumour diagnosis and radiation.  Hypercapnic challenge BOLD CVR 
is increasingly used in the preoperative mapping of brain tumours prior to 
resection; the main use in this regard is for the assessment of neurovascular 
uncoupling potential in the region of the brain tumour or vascular malformation 
(Pillai and Mikulis 2015). Neurovascular uncoupling can occur in high and low 
grade tumours.  In high-grade glioma, tumour angiogenesis is associated with 
abnormal vasoactivity and permeability of the neovasculature. However the 
mechanism in low-grade tumours is not as well understood and may be associated 
with astrocytic dysfunction secondary to infiltration (Hou et al. 2006, Pillai and Zaca 
2011, Zaca et al. 2014).  The relative risk of stroke in childhood cancer survivors is 
10 fold higher than sibling controls, and is highest in adult survivors of blood-borne 
cancers and brain tumours (Bowers et al. 2005, Bowers et al. 2006, Oeffinger et al. 
2006).  Radiotherapy for brain tumours confers additional risk. It is thought to result 
in a weakening of the blood-brain barrier in the microvasculature and the initiation 
of an inflammatory cascade and prothrombotic factors.  There is a change in 
vascular integrity and function over time, leading to endothelial cell detachment 
and microthrombus formation on the subendothelium in the smallest vessels (Yuan 
et al. 2006, Wilson et al. 2009, Stewart et al. 2010).  The compromised vascular 
wall is prone to steno-occlusive or dilatory vasculopathy (Fajardo 2005).  In 
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addition secondary effects, such as the development of growth hormone deficiency 
at a young age (as in both of our children), is an independent additional stroke risk 
factor (de Haas et al. 2010, Green et al. 2012).  
There are no published studies of CVR in association with chromosomal disorders.  
Children with Down syndrome have a predisposition to vascular disease in multiple 
vascular beds (Kontras and Bodenbender 1966, Chi 1975, Fleisher et al. 1978). 
The literature on moyamoya in Trisomy 21 is mostly limited to case reports, with 
minimal discussion regarding the underlying pathophysiological mechanisms.  
Impaired vascular endothelial function is reported, which could have an impact on 
cerebrovascular compliance and reactivity (Cappelli-Bigazzi et al. 2004). However, 
this is only speculative. Therefore the reason that tissue level CVR measures in the 
chromosomal disorders group should be amongst the worst in the moyamoya 
arteriopathy group is unexplained.  Children with Down syndrome and moyamoya 
often present in infancy run a clinically severe course in terms of ischaemic events, 
and have a higher surgical complication rate (Dai et al. 2000, Jackson et al. 2014, 
See et al. 2015). Therefore clinical presentation and current understanding of the 
pathophysiological basis of tissue and vascular injury in Tumour-MM, and to a 
lesser extent Chromosomal-MM, is in keeping with the hBOLD CVR findings in my 
study, which are suggestive of higher ischaemic risk at the time of CVR than the 
other moyamoya arteriopathy groups.  However, these findings need to be further 
explored in a large longitudinal cohort.    
The SCD-MM group had high inspection scores, consistent with worse steal, when 
compared to the other moyamoya arteriopathy groups.  They did not have 
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correspondingly low positive pixels and high negative pixel ratios, perhaps because 
of an insensitive inspection scoring system, or an oversensitive hemispheric pixel 
counting system. Alternatively, there may be inherent limitations in using hBOLD 
CVR in children with SCD, who may exhaust their cerebrovascular reserve due to 
the chronic hyperdynamic state caused by the anaemia, and in some, chronically 
elevated pCO2 and low pO2 often seen in this population, in addition to the 
arteriopathy (Prengler et al. 2002, Prohovnik et al. 2009).  For children with SCD-
MM, the ability to generate BOLD MRI signal on any given stimulus may be 
reduced by a combination of this chronic hyperdynamic state and the increased 
pulmonary vascular resistance (Prengler et al. 2002, Prohovnik et al. 2009). 
The Idiopathic moyamoya group CVR measures were indicative of more right sided 
tissue level dysfunction. However their CVR measures were not the most severe in 
the moyamoya arteriopathy group.  This is interesting and suggestive of a different 
ischaemic risk profile for children with moyamoya, which may be more dependent 
on their comorbidity than the primary arteriopathy.   
Thus CVR of pre-ischaemic, normally perfused brains of children with syndromic 
arteriopathies may provide novel insights into the syndrome specific neuronal and 
vascular components of functional hyperaemia, and hence the pathological bases 
of difference in ischaemic risk between the moyamoya arteriopathy groups.  
 
iii) hBOLD CVR Measures by Method 
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The youngest age at CVR was 1 year.  This was done under GA which provides an 
approach to the assessment of tissue level ischaemic risk in the very young or 
uncooperative with moyamoya. Moyamoya severity by modified moyamoya stage 
was comparable between the GA and BH group.  The GA group had a higher 
proportion of children who had a stroke.  The observation that the right hemisphere 
scores were worse in the BH group compared to the GA group may be suggestive 
of poorer right hemisphere tissue level perfusion, and this may be related to the 
later age of diagnosis and hBOLD CVR in the BH group. 
 
5.7.3. Study Limitations and Future Directions 
5.7.4. Conclusion 
Increased understanding of qualitative hBOLD CVR measures in Idiopathic MM 
and the MM syndromes may help identify patients at increased risk of ischaemia 
prior to clinical presentation.  Inclusion of hBOLD CVR in longitudinal studies of all 
the moyamoya arteriopathy groups would provide relative, qualitative assessments 
of hBOLD CVR which could be adequate enough to guide the choice and timing of 
interventions such as revascularization surgery. 
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6. Comparison with Conventional Angiography 
and MM severity 
6.1. Abstract 
6.1.1. Background 
Quantitative measures of hBOLD CVR in adults are shown to correlate with the 
presence of moyamoya and angiographic indices of moyamoya severity. There are 
no such studies for qualitative CVR using breath-holding or general anaesthetic in 
childhood.  In addition there are a number of biological variables that are thought to 
influence BOLD MRI signal and hence may be important to take into account when 
interpreting hBOLD CVR measures. 
 
6.1.2. Objective 
To demonstrate whether hBOLD CVR measures using breath-hold and general 
anaesthetic are concordant with conventional angiography in children with 
moyamoya.  In addition, to determine whether hBOLD CVR hemispheric pixel 
measures were affected by biological indices, such as haematocrit, which are 
important variables in cerebral blood flow and consequent BOLD MRI signal. 
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6.1.3. Method 
Consecutive children diagnosed with moyamoya were enrolled.  All conventional 
angiograms were staged for severity using modified Suzuki criteria and graded 
according to the degree of stenosis (Ref Methods).  hBOLD CVR measures were 
compared to laterality and angiographic indicators of severity of moyamoya.  
hBOLD CVR measures were examined for correlation with biological variables. 
6.1.4. Results 
Thirty-seven children with moyamoya had qualitative hBOLD CVR assessments 
and 34 conventional angiography.  Abnormality of qualitative hBOLD CVR 
measures was concordant with conventional angiographic abnormality. There was 
a statistically significant difference in hemispheric measures by grade of stenosis, 
and haematocrit and a trend toward statistically significant difference in 
hemispheric pixels by heart rate.  There was no statistically significant association 
between hBOLD hemispheric measures and moyamoya severity using Modified 
Suzuki Staging.    
6.1.5. Conclusion 
Qualitative hBOLD CVR measures of impairment are concordant with abnormality 
as demonstrated on angiography and affected by the severity of disease as 
reflected by the severity of the stenosis.  Biological indices such as haematocrit 
may have an effect on the BOLD signal and hence be an important variable to 
control for in the interpretation of hBOLD CVR results, in certain disease conditions 
commonly associated with moyamoya such as Sickle Cell Disease. Association of 
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qualitative CVR measures with other variables such as Suzuki Stage, heart rate 
and blood pressure requires further exploration. 
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6.2. Introduction 
Conventional angiography is the standard tool for diagnosis of moyamoya and 
assessment of disease severity.  There is an increasing trend to rely on MR 
angiography in the pre-surgical work-up of children with moyamoya and non-
moyamoya arteriopathy.  However MRA is unable to adequately assess arterial 
collaterals and may overcall main artery stenosis, especially if time-of flight is used 
(Saeki et al. 2000). 
CVR is defined as change in BOLD MRI signal over change in the CO2 tension. 
There are a number of factors which affect CVR. BOLD MRI signal is dependent 
on CBF and other variables such as cerebral blood volume (CBV), cerebral 
metabolic rate of oxygen consumption, arterial partial pressure of oxygen (PaO2), 
and, to an unknown extent, hematocrit (Ogawa et al. 1993, Mandell et al. 2008). 
Another factor affecting CVR is blood pressure. Children and adolescents with 
untreated hypertension have diminished reactivity to hypercapnia, indicating 
abnormal vasodilatory reactivity (Settakis et al. 2003, Settakis et al. 2006, Wong et 
al. 2011). Furthermore, in studies using TCD to assess CVR, an inverse 
relationship between diastolic blood pressure indices and CVR has been 
demonstrated, suggesting that diastolic blood pressure may be a better predictor of 
cerebral end organ damage than systolic blood pressure (Settakis et al. 2003, 
Settakis et al. 2006, Wong et al. 2011). Therefore, I examined for the effect of 
these factors, namely hematocrit, diastolic and systolic blood pressure on hBOLD 
CVR measures. 
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Quantitative BOLD MRI CVR, using targeted control of end tidal CO2 delivery in 
children and adults, has demonstrated concordance of angiographic abnormalities 
with CVR deficits, and demonstrated deficits beyond the primary area of 
angiographic abnormality and in regions of brain which appeared normal on MRI 
(Heyn et al. 2010, Han et al. 2011).  Heyn also demonstrated a direct correlation 
between quantitative BOLD MRI CVR and measures of moyamoya severity, 
including the Suzuki score.                               
These studies–conducted mostly in adults, and using targeted controlled delivery 
of CO2–show that hBOLD CVR can provide additional functional information of the 
haemodynamic effect of steno-occlusive arteriopathy at the tissue level and 
complements both conventional angiography and more traditional structural and 
vascular MR imaging.   
The studies described in this chapter were designed to establish the regional 
concordance of angiographic findings, to correlate indices of angiographic severity 
with qualitative hBOLD CVR, and to assess variables that may account for some 
difference in hBOLD signal in a group of children with moyamoya arteriopathy. 
Insights into any of these factors could improve our ability to assess ischaemic risk 
and direct management in this group of children. 
 
6.3. Study Hypothesis 
1)  The region of abnormality on qualitative hBOLD CVR corresponds with the 
region of abnormality as demonstrated by conventional angiography. 
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2)  Qualitative hBOLD CVR measures are associated with the severity of 
moyamoya as assessed by Modified Suzuki staging and grade of stenosis. 
3)  Qualitative hBOLD CVR measures are associated with biological indices such 
as haemoglobin, haematocrit, platelets, blood pressure and heart rate. 
 
6.4. Methods 
Children diagnosed with moyamoya arteriopathy (Idiopathic and Syndromic) were 
consecutively enrolled in the study and had a 6 vessel cerebral conventional 
angiogram, a brain MRI and a 3D TOF MRA.  Conventional angiograms were 
staged using Modified Suzuki criteria and graded by the degree of stenosis by ND 
and DA (Chapter 2 Methods). In addition, 3D TOF MRA images were reviewed by 
ND and DA. Axial T2 FLAIR MRIs were also reviewed and the presence of Ivy 
noted. Qualitative hBOLD CVR studies were conducted in all (Chapter 2 Methods).   
Haematologic and cardiovascular indices collected closest to the hBOLD CVR 
studies were recorded and used for the purpose of analysis.  These included a 
complete blood count (haemaglobin, white cell count, platelets and haematocrit), 
blood pressure and heart rate. 
 
6.5. Statistical Analysis 
One way ANOVA and the independent t-test were used to compare group means 
of parametric data.   Kruskal-Wallis and the Mann-Whitney U test were used to 
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compare non-parametric. Categorical data were analysed with Fisher’s exact test. 
Statistical difference was deemed significant at a level of p<= 0.05.   
Binomial regression analysis was used to assess the ability of hemispheric pixels 
to predict moyamoya laterality. 
 
6.6. Results 
6.6.1. Group Description 
Moyamoya arteriopathy diagnosis and clinical characteristics are as described in 
Chapter 3.  Thirty-seven children (mean age at diagnosis 9.3 +/- 3.88 years) had 
quantitative hemispheric hBOLD CVR studies and conventional angiography.  The 
majority had bilateral moyamoya disease (Table 30). 
Table 30 Arteriopathy Severity Measures and Biological Indices of Children with 
Moyamoya Arteriopathy   
 Moyamoya Arteriopathy  n=37 
Mean Age at Diagnosis (SD) 9.13 (3.88) 
Mean Age at CVR 
(SD) 
10.68 (4.29) 
Gender M(%) 16 (43) 
Moyamoya Laterality 
(B/R/L) 
 
23/6/8 
Suzuki Scores (Frequency) 
1 
2 
3 
4 
5 
6 
 
2 
12 
16 
2 
1 
1 
Grade of Stenosis  
 Frequency 
Grade 3/4 
4/30 
Stroke  
Yes/No 
B/R/L 
 
21/16 
5/11/5 
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Mean Biological Indices (SD)  
Hb 
Hct 
Platelets 
 
Systolic  BP 
Diastolic BP 
 
126.46 (18.89) 
.377 (.054) 
311.73 (86.8) 
 
112.76 (16.96) 
66.08 (12.54 
M=male, B=bilateral, R=right, L=left, Hb=haemoglobin, Hct=haematocrit 
 
6.6.2. Hemispheric Pixels and Moyamoya Laterality Whole Group 
(n=37) 
6.6.2.1. Positive threshold positive pixels (PTPP) 
There was a significant difference in right hemispheric PTPP between children with 
right moyamoya and left moyamoya, between children with right moyamoya and 
bilateral moyamoya, and between those with left moyamoya and bilateral 
moyamoya.  Children with left moyamoya had higher right hemispheric PTPP than 
children with right or bilateral moyamoya (one way ANOVA; Table 31, Figure 41).    
There was a significant difference in left hemispheric PTPP between children with 
left moyamoya and right moyamoya, between children with left moyamoya and 
bilateral moyamoya, and between those with left moyamoya and bilateral 
moyamoya.  Apparently paradoxically, children with right moyamoya had higher 
numbers of left hemispheric PTPP than children with left or bilateral moyamoya 
(one way ANOVA; Table 31, Figure 41). 
Children with right moyamoya had the lowest number of right hemispheric PTPP 
when compared to children with left and bilateral moyamoya.  Children with left 
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moyamoya had the highest number of right hemispheric positive threshold positive 
pixels when compared to children with right and bilateral moyamoya. 
 
6.6.2.2. Positive threshold negative pixels (PTNP) 
There was no significant difference in PTNP in either hemisphere by moyamoya 
laterality (one way ANOVA; Table 31, Figure 41). 
 
6.6.2.3. Negative threshold negative pixels (NTNP) 
There was a significant difference in right hemispheric NTNP between children with 
right MM and left MM, and right MM and bilateral MM (one way ANOVA; Table 31, 
Figure 41).  There was a significant difference in left hemispheric NTNP between 
children with right MM and left MM and children with right MM and bilateral MM 
(one way ANOVA; Table 31, Figure 41).   Children with right MM had the highest 
number of NTNP in the right hemisphere.  Similarly children with left MM had the 
highest number of NTNP in the left hemisphere. 
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Table 31 Hemispheric Pixels and Moyamoya Laterality 
 
hBOLD 
CVR 
Pixels    
 
Moyamoya   
Laterality     
n=37 
 
Right 
(n=6) 
Left 
(n=7) 
Bilateral 
(n=24) 
 
 
 
PTPP 
R  
L 
mean, 
median 
 
.31;.31*^ 
.69;.70**^^   
SD  (range) 
 
 
.15 (.13-.48) 
.15 (.52-.88) 
mean, 
median 
 
.55;.54*
†
  
.45;.46**
††
  
SD  (range) 
 
  
.06(.49-.62) 
.05 (.38-.53) 
mean, 
median 
 
.43;.44^
†
  
.58;.56^^ 
††
 
 SD  (range) 
 
 
.11 (.23-.63) 
.12 (.40-.90) 
p value 
 
 
.001*;.05^;.04
†
 
.003**;.13^^;.06
††
 
PTNP     
R  
L 
 
.18;.17 
.06;.03 
 
.12 (.01-.36) 
.08 (.00-.19) 
 
.14;.02 
.12;.03 
 
.19 (.00-.46) 
.19 (.01-.53) 
 
.21;.1 
.2;.11 
 
.3 (.00-1.33) 
.28 (.00-1.32) 
 
 
NTNP 
R 
L 
 
.72;.74^* 
.29;.26
†**
 
 
.12 (.57-.85) 
.13 (.15-.43) 
 
.45;.51^ 
.55;.5
†
 
 
.15 (.18-.62) 
.11 (.43-.73) 
 
.47;.45* 
.46;.5
**
 
 
.17 (.03-.89) 
.17 (.03-.69) 
 
.02^;.005* 
.01
†
;.05
**
 
One way ANOVA  
Significant difference in means at the p<0.01 level between * right and bilateral hemispheres,**right and left  
^ p<=.05
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Figure 41   Box-and-whisker plots showing hemispheric pixels and Moyamoya 
Laterality with medians, upper and lower quartiles (the edges of the boxes) and 
maximum and minimum excluding outliers (the ends of the whiskers) 
 
 
Bivariate correlation was run for right MM and right hemispheric pixel measures, 
right MM and left hemispheric pixel measures.   The same was repeated for left 
MM, and bilateral MM (Table 31).  There was a significant negative correlation 
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between right PTPP and right MM, and significant positive correlation between 
right NTNP and right MM (p=.006 and p=.001 respectively).  The direction of 
significant right MM correlation with left hemispheric measures was reversed.  
There was a significant negative correlation between left PTPP and left MM and a 
trend toward significant positive correlation between left NTNP and left MM 
(p=0.000 and p=.067 respectively). There was no statistically significant correlation 
between bilateral MM and hemispheric pixel measures. This indicates that hBOLD 
CVR, using hemispheric pixel measures, is concordant with moyamoya laterality. 
Table 32 Moyamoya laterality correlation with Hemispheric Pixels 
Moyamoya 
Laterality 
 Right Hemispheric 
Measures 
N=37 
Left Hemispheric Measures 
N=37 
  PTPP PTNP NTNP PTPP PTNP NTNP 
Right Pearson 
correlation 
-.44 -.016 .518 .392 -.18 -.433 
 P value .006* .925 .001* .016* .286 .007* 
Left Pearson 
correlation 
.590 -.197 -.145 -.584 -.203 .304 
 P value .000* .243 .393 .000* .228 .067** 
Bilateral Pearson 
correlation 
.028 -.091 .282 -.053 -.210 -.108 
 P value .870 .591 .091** .757 .213 .525 
* significant at p<0.05 level  ** trend toward significant at p<0.1 level 
Binomial regression analysis was used to assess the ability of hemispheric pixels 
to predict moyamoya laterality: 
6.6.2.4. Right Moyamoya 
Using binomial regression analysis, right PTPP and NTNP were significantly 
predictive of right moyamoya laterality (p=.002) and p=.053 respectively).  The 
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model was able to predict MML 89.2% of the time compared to the null hypothesis 
prediction of 16.2%.  Left NTNP was significantly predictive of right MM.  
Remaining left hemispheric pixel measures were not predictive of right MM 
laterality.   
 
6.6.2.5. Left Moyamoya 
Left PTPP and NTNP were significantly predictive of left MM (p=.017 and p=.031 
respectively).  There was a trend toward left PTNP being predictive of left MM 
(p=.157).  Left hemispheric pixels were able to predict left MM 81.1 % of the time 
compared to the null hypothesis prediction of 21.6%.   There was a trend toward 
right NTNP being negatively predictive of left MM (p=0.057).  The remaining right 
hemispheric pixel measures were not predictive of left MM.  Right hemispheric 
pixel measures were predictive of left MM 78.4% of the time compared to the null 
hypothesis prediction of 21.6%.   
 
6.6.2.6. Bilateral Moyamoya 
The right hemispheric measures were not predictive of bilateral MM.  Right 
hemispheric pixel measures were predictive of bilateral MM 70.2% of the time 
compared to the null hypothesis prediction of 35.1%.   Left hemispheric measures 
were not significantly predictive of bilateral MM laterality.  Left hemispheric 
measures were predictive of bilateral MM 64.9% of the time compared to the null 
hypothesis prediction of 35.1%.   
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Table 33 B coefficient and Odds Ratios 
Hemispheric 
Pixels 
Right MM Left MM 
 B  Sig Exp(B) Lower Upper B Sig Exp(B) Lowe
r 
Upper 
Right           
PTPP -8.85 .002 .000 .000 .037 -11.08 .017 .000 .000 .134 
PTNP -2.6 .403 .075 .000 32.49 -5.07 .157 .006 .000 7.072 
NTNP 4.2 .053 66.888 .949 4715.7 9.89 .031 19775.4 2.48 >>>* 
Left           
PTPP 1.368 .295 3.928 .303 50.885 2.808 .205 16.57 .215 1274.5 
PTNP -2.074 .688 .126 .000 3085.4
5 
-1.486 .541 .226 .002 26.53 
NTNP -5.725 .027 .003 .000 .521 -4.694 .057 .009 .000 1.16 
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6.6.3. Hemispheric Inspection Scores and Moyamoya Laterality  
Thirty-seven children had at least one pair of hemispheric inspection scores.  
Frequency of distribution of scores by moyamoya laterality was explored by cross-
tabulation (Tables 33-35). In the right hemisphere inspection, scores were 
abnormal for 20/24 (83%) of the bilateral moyamoya, 4/7 (43%) of the left-sided 
moyamoya, and 5/6 (83%) of right sided moyamoya groups.  In the left hemisphere 
inspection, scores were abnormal in 19/24 (79%) of the bilateral moyamoya, in 7/7 
(100%) of the left-sided moyamoya, and 2/6 (33%) of the right sided moyamoya 
groups. In children with unilateral moyamoya, none had a normal hemispheric 
score for the affected hemisphere. There was a significant difference in frequency 
of right and left hemispheric scores when right and left moyamoya groups were 
compared (Mann-Whitney U=7.5, p=.05 and U=5.5, p=0.02).  There was a 
difference in right and left hemispheric scores when right and bilateral, and left and 
bilateral moyamoya groups were compared but this was not significant (Mann-
Whitney U=46, p=.191, U=38.5, p=.082 and U=52, p=.139 and U=54, p=.167). 
Right mean hemispheric scores by laterality were significantly different between 
children with right (mean 2.83+/-.408) and left (1.71+/-.951) moyamoya (p=.036).  
There was a difference in mean hemispheric scores between children with left 
(1.71+/-.951) and bilateral (2.33+/-.761) moyamoya but this was not significant 
(p=.199).  There was no significant difference between mean scores for children 
with bilateral and right moyamoya. 
Left mean hemispheric scores by laterality were significantly different between 
children with right (1.50+/-.837) and left (2.71+/-.488) moyamoya (p=.018). There 
243 
was a difference in mean hemispheric scores between children with right (1.50+/-
.837) and bilateral (2.21+/-.779) moyamoya but this was not significant (p=.135).  
There was no significant difference between mean scores for children with bilateral 
and left moyamoya. 
Table 34 Cross-tabulation of Right Hemispheric Scores and Moyamoya Laterality 
 Moyamoya Laterality  
Right 
Hemispheric 
Scores 
Bilateral Left Right Total 
1 4 4 0 8 
2 8 1 1 10 
3 12 2 5 19 
Total 24 7 6 37 
 
 
Table 35 Cross-tabulation of Left Hemispheric Scores and Moyamoya Laterality 
 Moyamoya Laterality  
Left 
Hemispheric 
Scores 
Bilateral Left Right Total 
1 5 0 4 9 
2 9 2 1 12 
3 10 5 1 16 
Total 24 7 6 37 
 
 
Table 36 Mean Hemispheric Scores by Moyamoya Laterality 
Mean 
Hemispheric Scores 
Moyamoya Laterality 
 Right Left Bilateral 
Right (SD) 2.83* (.408) 1.71*† (.951) 2.33† (.761) 
Left (SD) 1.50*† (.837) 2.71* (.488) 2.21† (.779) 
One way ANOVA *significant difference in mean hemispheric scores between right 
and left moyamoya groups p=<0.5 
† trend toward significant difference in hemispheric mean scores between left and 
bilateral, and right and bilateral moyamoya groups.  
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6.6.4. Hemispheric Pixels and Stroke  
6.6.4.1. Hemispheric Pixels, Stroke and No Stroke 
Of the thirty-seven children, 21 had had at least one stroke at the time of their 
hBOLD CVR study.  There was a trend toward significance in difference between 
stroke and no stroke groups in PTNP with higher numbers in the stroke group (t-
test; Table 37 middle row, Figure 42).  There was no statistical difference in pixels 
between stroke and no stroke groups for positive and negative pixels generated at 
positive and negative thresholds respectively (t-test; Table 37, Figure 42).  
 
Table 37 Comparison of Hemispheric Pixels between Stroke and No Stroke Groups  
 
hBOLD 
CVR 
Pixels    
 
Stroke 
(n=21) 
 
No Stroke 
(n=16) 
 
t-test 
 
PTPP 
R  
L 
Mean 
 
.42 
.59 
 
SD 
 
.12 
.13 
 
Mean 
 
.46 
.54 
SD 
 
.13 
.13 
p value 
 
.378 
.273 
PTNP     
R  
L 
 
.25 
.22 
 
.31 
.29 
 
.12 
.09 
 
.14 
.14 
 
0.147
†
 
0.107
†
 
NTNP 
R 
L 
 
.50 
.47 
 
.16 
.16 
 
.51 
.43 
 
 
.21 
.18 
 
0.830 
0.504 
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Figure 42 Comparison of Hemispheric Pixels for Stroke and No Stroke Groups. The 
error bars represent standard deviations 
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6.6.4.2. Hemispheric Pixels and Stroke Laterality 
Of the children who had a stroke (21/37[56%]), 11 (52%) were right sided, 5 (24%) 
were left sided and 5 (24%) bilateral.  On inspection in the children with unilateral 
moyamoya, PTPP were lower in the stroke hemisphere than the non-stroke 
hemisphere.  Similarly NTNP were higher in the stroke hemisphere than the non-
stroke hemisphere.  In those with bilateral moyamoya, PTPP were lower in the 
right hemisphere, and NTNP higher in the right.  Using the paired t-test, the within 
group difference between right PTPP in those with right stroke were significantly 
lower than left PTPP, and there was a trend toward right PTPP being significantly 
lower than left PTPP in those with bilateral stroke, and a trend toward right NTNP 
being significantly higher than left NTNP in those with right stroke. There was no 
statistically significant difference in hemispheric pixels between groups, by stroke 
laterality (one way ANOVA, p>0.5) (Table 38). 
Table 38 Hemispheric Pixels and Stroke Laterality 
hBOLD 
Pixels 
Stroke Laterality     
Right (n=11) Left (n=5) Bilateral (n=5) 
 
 
PTPP 
R  
L 
mean, 
median 
 
.40;.43 
.62;.57 
SD  (range) 
 
 
.13 (.2 -.63)  
.15 (.4 -.90) 
mean, 
median 
 
 .45; .49 
.55; .51 
SD  (range) 
 
  
.13 (.26-.60) 
.13 (.40-.74) 
mean, 
median 
 
 .42; .41 
.58; .59 
 SD  (range) 
 
 
.11 (.27-.55) 
.11 (.46-.74) 
p value .026* .455 .180
†
 
PTNP     
R  
L 
 
.25; 27 
.17; 12 
 
.18 (.00-58) 
.15 (.00-45) 
 
.17; .05 
.18; .08 
 
.22 (.0-.51) 
.21 (.0-.46) 
 
.32; .06 
.35; .11 
 
.57 (.03-1.33) 
.55 (.03-1.32) 
p value .194
†
 .808 .498 
NTNP 
R 
L 
 
.57; 54 
.43; 46 
 
.19 (.32-89) 
.18 (.11-64) 
 
.47; .47 
.53; .53 
 
.07 (.40-.59) 
.07 (.41-.6) 
 
.45; .45 
.56; .55 
 
.10 (.31-.57) 
.10 (.44-.69) 
p value .256 .430 .315 
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6.6.5. Hemispheric Pixels in Surgery and No Pre-surgery groups 
Ten of the 37 (27%) children had undergone previous revascularization surgery at 
the time of their first hBOLD CVR.  Further analysis was conducted on the children 
who had not had revascularization surgery prior to their first hBOLD CVR study 
(n=27).  There was no statistically significant difference in hemispheric PTPP, 
NTNP and right PTNP between those with and without prior revascularization 
surgery.  There was a trend toward significant difference in left hemispheric PTNP 
between groups. There was no significant difference in mean scores between 
groups (Table 39). 
Table 39 Hemispheric Pixels in Surgical and Surgically Naïve Children 
hBOLD 
CVR 
Pixels    
 
Surgery 
(n=10) 
 
No Surgery 
(n=27) 
 
t-test 
 
PTPP 
R  
L 
Mean 
 
.44 
.57 
SD 
 
.151 
.147 
Mean 
 
.43 
.57 
SD 
 
.117 
.127 
p value 
 
.884 
.893 
PPPTNP     
R  
L 
 
.28 
.24 
 
.403 
.407 
 
.17 
.13 
 
.170 
.143 
 
.295 
.198
†
 
NTNP 
R 
L 
 
.45 
.45 
 
.221 
.210 
 
.52 
.45 
 
.165 
.155 
 
.267 
.977 
 
Table 40 Mean Hemispheric Scores by Surgical and Surgically Naive Children 
Mean 
Hemispheric Scores 
Surgery No 
Surgery 
t-test 
Right  (SD) 2.3 (.823) 2.3 (.823) .990 
Left  (SD) 2.4 (.843) 2.1 (.801) .343 
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6.6.5.1. Hemispheric Pixels and Moyamoya Laterality (no pre-surgery, n=27) 
There were similar significant differences in hBOLD CVR measures by moyamoya 
laterality in the no pre-surgery group. 
 
Table 41 hBOLD CVR Pixels and Moyamoya Laterality in No Pre-surgery Group   
hBOL
D 
CVR 
Pixels  
 
Moyamoya Laterality  
Right (n=5) Left (n=5) Bilateral (n=17)  
 
 
PTPP 
R  
L 
mean, 
median 
 
.33;.39* 
.67;.62** 
SD  (range) 
 
 
.16 (.12-.48) 
.16 (.52-.88) 
mean, 
median 
 
.53;.53 
.47;.47 
SD  (range) 
 
 
.04 (.49-.59) 
.04 (.41-.53) 
mean, 
median 
 
.43;.46 
.57;.55 
SD  (range) 
 
.09 (.23-.60) 
.11 (.40-.90) 
p value 
 
 
.014* 
.043** 
PTNP     
R  
L 
 
.19;.17 
.07;.04 
 
.13 (.01-.36) 
.08 (.00-.19) 
 
.17;.02 
.15;.02 
 
.22 (.00-.46) 
.23 (.01-.53) 
 
.16;.07 
.13;.11 
 
.17 (.00-.58) 
.13 (.00-.46) 
 
0.7 
0.5 
NTNP 
R 
L 
 
.7;.68^ 
.31;.33
†
 
 
.13 (.57-.85) 
.13 (.15-.43) 
 
.48;.5 
.53;.5 
 
.1 (.37-.62) 
.08 (.44-.63) 
 
.52;.47
^^ 
.48;.53
††
 
 
.15 (.31-.89) 
.15 (.11-.69) 
 
.062;.059 
.044
†
;.058 
 
*Significant difference in right PTPP in right MM compared with left MM  
** Significant difference in left PTPP in left MM compared with right MM  
† 
Significant difference in left NTNP between right and left MM laterality 
 
 
 
6.6.6. Hemispheric Pixels in Stroke and No Stroke Groups (without 
pre-surgery) 
Fifteen of 27 children had had a stroke at the time of their first hBOLD CVR.  There 
was no statistically significant difference in hemispheric pixels or scores between 
the stroke and no stroke groups.  In the stroke group, right PTPP were significantly 
lower than left PTPP and there was a trend toward significantly higher PTNP and 
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NTNP in those with right stroke.  Left NTNP were also significantly higher than right 
NTNP in the left stroke group.   
 
Table 42 Hemispheric Pixels between Stroke and No Stroke Groups with No Pre-
surgery 
hBOLD 
CVR 
Pixels    
Stroke (n=15) No Stroke (n=12) t-test 
 
PTPP 
R  
L 
Mean 
 
.417 
.594 
SD 
 
.114 
.132 
mean 
 
.452 
.546 
SD 
 
.121 
.121 
p value 
 
.446 
.344 
PTNP     
R  
L 
 
.187 
.144 
 
.187 
.140 
 
.140 
.107 
 
.150 
.151 
 
.491 
.511 
NTNP 
R 
L 
 
.505 
.444 
 
.189 
.177 
 
.549 
.456 
 
.134 
.132 
 
.495 
.845 
 
 
Table 43 Mean Hemispheric Scores between Stroke and No Stroke Groups with No 
Pre-surgery 
Mean Hemispheric Scores Stroke No Stroke t-test 
Right  (SD) 2.33  (.724) 2.25 (.965) .8 
Left    (SD) 2.00  (.845) 2.25 (.754) .431 
 
 
Table 44 Hemispheric Pixels by Stroke Laterality in No Pre-Surgery Group 
 
hBOLD 
Pixels    
 
Stroke Laterality     
Right 
(n=9) 
Left 
(n=4) 
Bilateral 
(n=2) 
 
PTPP 
R  
L 
Mean 
 
.37 
.64 
SD   
 
.117 
.140 
mean 
  
.51 
.5 
SD   
  
.081 
.081 
mean 
  
.44 
.56 
 
 SD   
 
.089 
.089 
. 
p value .013* .99 .513 
PTNP     
R  
L 
 
.266 
.146 
 
.192 
.125 
 
.08 
.14 
 
.13 
.216 
 
.04 
.14 
 
.019 
.108 
p value .071
†
 .253 .459 
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NTNP 
R 
L 
 
.577 
.373 
 
.213 
.186 
 
.434 
.551 
 
.033 
.478 
 
.32 
.55 
 
.013 
.2 
p value .143
†
 .054* .367 
 
Figure 43 Box-and-whisker plots showing Hemispheric Pixels between Stroke and 
No Stroke Groups with No Pre-surgery with medians, upper and lower quartiles (the 
edges of the boxes) and maximum and minimum excluding outliers (the ends of the 
whiskers) 
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6.6.7. Hemispheric Pixels and Radiographic Indices of Moyamoya 
Severity 
6.6.7.1. Hemispheric Pixels and Scores by Modified Suzuki Stage 
Conventional angiograms were available for review in 92% (34/37) children (Tables 
44 and 45).  Of these, most 55% (12/22) children with bilateral disease had Suzuki 
Stage 3 disease and 27% (6/22) had Suzuki Stage 2 disease.  The rest (18%; 
4/22) were spread between the remaining scores.  Of the children with right sided 
moyamoya 2/22 had Suzuki Stage 2 disease and 1/22 Stage 1, 2 and 4 disease 
respectively.  All children with left sided moyamoya had Suzuki Stage 1-3 disease. 
None had Stage 4, 5 or 6.  There was no statistically significant difference in mean 
hemispheric pixels (Table 47) or scores (Table 48) by Modified Suzuki stage in the 
whole group (n=37), or in the No Pre-surgery Group (n=27) (Table 49).  Linear 
regression analysis was run for Modified Suzuki Stage and hemispheric pixels.  
There was no statistically significant effect on hemispheric pixels by Modified 
Suzuki Stage (Table 50).   
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Table 45 Moyamoya Laterality by Modified Suzuki Stage in Whole Group (ConA) 
Moyamoya 
Laterality 
Modified Suzuki Stage (ConA) Total 
1 2 3 4 5 6 
Bilateral 1 6 12 1 1 1 22 
Left 0 5 2 0 0 0 7 
Right 1 1 2 1 0 0 5 
Total 2 12 16 2 1 1 34 
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Table 46 Moyamoya Laterality by Modified Suzuki Stage in No Presurgery Group 
Moyamoya 
Laterality 
Modified Suzuki Stage (ConA) Total 
1 2 3 4 5  
Bilateral 1 5 7 0 1 1 15 
Left 0 3 2 0 0 0 5 
Right 1 1 1 1 0 0 4 
Total 2 9 10 1 1 1 24 
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Table 47 Hemispheric Pixels by Modified Suzuki Stage in Whole Group 
 Modified Suzuki Stage 
 1 
n=2 
2 
n=12 
3 
n=16 
4 
n=2 
5 
n=1 
6 
n=1 
PTPP 
Right 
Left 
Mean (SD) 
.3 (.146) 
.7 (.146) 
 
 
.48 (.101) 
.52 (.103) 
 
.41 (.138) 
.60 (.147) 
 
.5 (.071) 
.49 (.045) 
 
.6 
.4 
 
.3 
.7 
PTNP 
Right 
Left 
 
.24 (.164) 
.087 (.066) 
 
.2 (.38) 
.2 (.371) 
 
.18 (.165) 
.16 (.166) 
 
.06 (.088) 
.06 (.078) 
 
.01 
.00 
 
.58. 
.11 
NTNP 
Right 
     Left 
 
.63 (.248) 
.37 (.248) 
 
.44 (.128) 
.51 (.131) 
 
.51 (.219) 
.42 (.197) 
 
.57 (.002) 
.44 (.004) 
 
.41 
.59 
 
.80 
.21 
 
 
Table 48 Mean Hemispheric Scores by Suzuki Stage in Whole Group (n=37) 
Mean 
Hemispheric 
Scores 
Modified Suzuki Stage 
n=34 
 1 
n=2 
2 
n=12 
3 
n=16 
4 
n=2 
5 
n=1 
6 
n=1 
Right 
(SD) 
3.00 
 
2.00 
(.853) 
2.38 
(.806) 
2.5 
(.707) 
1 2 
Left 
(SD) 
1.50 
(.707) 
2.58 
(.669) 
2.00 
(.816) 
2.00 
(1.41) 
2 1 
  One way ANOVA p>0.5 
 
 Table 49 Mean Hemispheric Scores by Modified Suzuki Stage in No Presurgery   
Group (n=27) 
Mean 
Hemispheric 
Scores 
Modified Suzuki Stage 
n=24 
 1 
n=2 
2 
n=9 
3 
n=10 
4 
n=1 
5 
n=1 
6 
n=1 
Right 
(SD) 
3.00 
(0.00) 
2.11 
(.928) 
2.30 
(.823) 
2 1 2 
Left 
(SD) 
1.50 
(.707) 
2.44 
(.726) 
2.00 
(.816) 
1 2 1 
One way ANOVA p>0.5
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Figure 44 Scatterplot of Suzuki Stage and Hemispheric Pixels in No 
Presurgery Group 
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Table 50 Prediction of Hemispheric Pixels by Modified Suzuki Stage 
 R R
2 
Adj R
2
 F B SE 
for B 
Beta T P 
PTPP_R_ratio 
Modified 
moyamoya 
stage 
0.01 0.0001 -0.031 0.003 0.001 0.023 0.010 0.056 0.956 
PTPP_L_ratio 
Modified 
moyamoya 
stage 
0.004 0.0001 -0.031 0.000 -0.001 0.024 -0.004 -0.024 0.983 
PTNP_R_ratio 
Modified 
moyamoya 
stage 
0.027 0.001 -0.030 0.002 0.007 0.047 0.027 0.156 0.877 
PTNP_L_ratio 
Modified 
moyamoya 
stage 
0.104 0.011 -0.020 0.352 -0.026 0.044 -0.104 -0.593 0.557 
NTNP_R_ratio 
Modified 
moyamoya 
stage 
0.173 0.030 0.000 0.992 0.032 0.033 0.173 0.996 0.327 
NTNP_L_ratio 
Modified 
moyamoya 
stage 
0.166 0.028 -0.003 0.905 -0.029 0.030 -0.166 -0.951 0.348 
 
 
6.6.8. Hemispheric Pixels by Grade of Stenosis 
In the thirty four children with quantitative hBOLD CVR measures and conventional 
cerebral angiograms, grading of stenosis was done on visual inspection of all 
conventional angiograms.  Vessels were scored according to the degree of artery 
narrowing or occlusion in the affected hemisphere(s) and expressed as a 
percentage (Chapter 2 Methods for details):   
Grade 1 = 0-25%; Grade 2 = 26-50%; Grade 3 = 51-75%; Grade 4 = 76-100% 
occlusion 
All vessels of the COW were scored and the worst score used for the purpose of 
analysis.  Four children had Grade 3 and 30 children had Grade 4 narrowing or 
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occlusion (n=34).  Two of the four children with Grade 3 stenosis had 
Chromosomal (Trisomy 21)-MM.   
 
Table 51 Mean Hemispheric Pixels by Grade of Stenosis 
 
 
 
 
 
 
Mann-Whitney U *  Significant at p<0.05 level;  
 
  
Pixels Grade 3 
n=4 
Grade 4 
n=30 
p value 
PTPP Mean SD Mean SD  
Right .377 .176 ..443 .124. 0.348 
Left .626 ..178 .563 .131 0.398 
PTNP      
Right .616 .481 .136 .161 0.007* 
Left .504 .585 .109 .123 0.082 
NTNP      
Right .544 .199 .492 .187 0.608 
Left .456 .2 .451 .173 0.956 
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Figure 45  Hemispheric Pixels by Grade of Stenosis (Code: 0=Grade 3; 1=Grade 4) 
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6.6.9. Hemispheric Pixels by IVY sign 
Thirty six children had quantitative hBOLD CVR studies and MRIs reported for IVY.  
There was no statistically significant difference between the presence or absence 
of Ivy in hemispheric pixels (Table 52; Figure 46), nor the presence or absence of 
steal, as defined as reduction of pixels as an indicator of reduced CBF despite a 
vasodilatory stimulus, and total CVR score (Table 53; Figure 47). 
 
Table 52 Hemispheric Pixels by Presence of Ivy 
 
 
 
 
 
 
 
 
 
 
 
Table 53 Measures of hBOLD CVR Abnormality by Presence of Ivy 
 
 
 
 
 
 
 
Hemispheric 
Pixels 
No Ivy 
n=9 
Ivy 
n=27 
PTPP Mean SD Mean SD 
Right .449 .119 .426 .129 
Left .553 .113 .58 .138 
PTNP     
Right .161 .186 .21 .275 
Left .126 .14 .176 .273 
NTNP     
Right .515 .166 .505 .192 
Left .443 .163 .446 .173 
Measures of hBOLD 
Abnormality Using 
Inspection Scores 
No Ivy 
n=9 
Ivy 
n=27 
 Mean (Median) SD (IQR) Mean SD (IQR) 
Total CVR Score 4.67 (5.00) 1.323 (3.00) 4.44 (4.00)  1.31 (3.00) 
 
Yes (%) No (%) Yes (%) No (%) 
Steal 
6 (67) 3 (33) 17 (63) 10 (37) 
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Figure 46  Hemispheric Pixels by Presence or Absence of the Ivy sign (prominent 
leptomeningeal collaterals result in vivid contrast enhancement) 
 
 
 
 
 
Ivy Code: 0=No Ivy; 1=Ivy 
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Figure 47 Total hBOLD Score by Presence or Absence of Ivy (prominent 
leptomeningeal collaterals result in vivid contrast enhancement) 
 
 Ivy Code: 0=No Ivy; 1=Ivy 
 
 
6.6.10. Hemispheric Pixels and Biological Indices 
Spearman’s non-parametric correlation was used to examine the association 
between potential biological indices of disease and hemispheric pixels in the no 
pre-surgery group (Table 54). 
The mean interval between testing of haematologic indices, cardiovascular indices 
and  hBOLD CVR was 1.2 (SD 5.16) and 1.7 (SD 5.88) months respectively.  
Group hematologic means were normal for age.  Assuming the 50th centile for 
group height, the group mean systolic and diastolic BP was in the 50 – 90th centile 
using the National Heart, Blood and Lung Institute Tables and Guide 
(www.nhlbi.nih.gov). There was a significant inverse association between 
haematocrit and left hemispheric PTNP, and a trend toward a significant inverse 
262 
association between heart rate and PTNP.  There was no statistically significant 
association between haemoglobin, platelets blood pressure and hemispheric pixels 
(Table 54). 
 
Table 54 Laboratory Data and Pixels In No Presurgery Group 
 
hBOLD 
CVR 
Pixels    
n=27 
 
Laboratory Data  
Correlation coefficient (p value) 
 
Hb 
 
Hct 
 
Plts 
BP 
Systolic      Diastolic 
 
HR 
PTPP 
R  
L 
  
-.025 (.9)  
.039 (.85) 
 
  
-.033 
(.87) 
.03 (0.87) 
  
 .06 (.77) 
-.07 (.72) 
 
-.23 (.25) 
.26 (.2) 
. 
 
-.12 (.58) 
.17 (.42) 
 
 
-.15 (.48) 
.14 (.49) 
PTNP     
R  
L 
 
-.22 (.26) 
-.37 (.06) 
 
-.25 (.21) 
-.42 (.03)* 
 
 
.08 (.69) 
.15 (.47) 
 
.21(.28) 
.09 (.64) 
 
.17 (.41) 
.1 (.63) 
 
-.38 (.06)^ 
-.32 (.11) 
^ 
NTNP 
R 
L 
 
-.21 (.30) 
-.23 (.26) 
 
 
.23 (.26) 
-.23 (.25) 
 
-.11 (.61) 
.12 (.55) 
 
.11 (.59) 
-.07 (.72) 
 
-.02 (.93) 
.06 (.77) 
 
-.16 (.45)  
.15 (.47) 
* Significant association between left sided negative pixels (PT) and haematocrit 
^Trend toward significant association between right and left negative pixels (PT) 
and heart rate  
 
 
Figure 48  Hemispheric Pixels and Haemoglobin 
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Figure 49  Hemispheric Pixels and Haematocrit 
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Figure 50  Hemispheric Pixels and Platelets 
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Figure 51  Hemispheric Pixels and Systolic Blood Pressure 
 
 
 
266 
 
 
 
 
Figure 52 Hemispheric Pixels and Diastolic Blood Pressure 
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Figure 53   Hemispheric Pixels and Heart Rate 
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Figure 54  Pre and Post Bone Marrow Transplant Parenchymal, Vascular and CVR 
Images in Child with Sickle Cell Disease 
 
 
Top Row:  Pre-bone marrow transplant axial DWI image showing area of acute 
infarction. Conventional Angiogram and MR angiogram showing bilateral 
moyamoya arteriopathy. CVR parametric map demonstrating bilateral poor 
reactivity and steal.   
Bottom Row:  Post-bone marrow transplant axial FLAIR image showing area of 
encephalomalacia.  MR angiogram showing bilateral moyamoya arteriopathy.   
CVR parametric map demonstrating bilateral good reactivity and no significant 
steal.  
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6.7. Discussion 
6.7.1. Concordance of Quantitative CVR measures and 
angiographic moyamoya laterality 
Our study found concordance between regional abnormality of hBOLD CVR with 
the region of abnormality as depicted on conventional angiography.   
In a normal brain hemispheric PTPP would be equally distributed between 
hemispheres.  As all hemispheric pixels were calculated as a proportion of 200 
total hemispheric pixels ie. right hemispheric pixels/200 and left hemispheric 
pixels/200, the right and left hemispheric pixel ratio should be 0.5:05 ie. one would 
expect 100 PTPP on the right and left hemisphere.   
Examination of hBOLD CVR hemispheric pixels in the unilateral moyamoya group 
demonstrated a relationship between hBOLD CVR hemispheric pixel measures 
and moyamoya laterality, where positive pixels were lower in the diseased 
hemisphere and higher in the normal hemisphere, and negative pixels were higher 
in the diseased hemisphere and lower in the normal hemisphere.  Mean PTPP 
were less than 0.5 in the affected hemisphere, and mean NTNP were greater than 
0.5 in the affected hemisphere. This suggests that in unilateral moyamoya, 
hemispheric measures of hBOLD CVR may be used to predict moyamoya laterality 
and is indicative of tissue level microvascular dysfunction – the main aim of the 
tool.  (Table 55). 
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Table 55 Example of Ratio of Hemispheric Pixels by Moyamoya Laterality 
 Summary of Impressions 
Laterality of Arteriopathy by Conventional Angiography 
 No arteriopathy Right Left Bilateral 
PTPP 
Right:Left 
 
0.5:0.5 
 
.25:.75 
 
.25:.75 .5:.5 
PTNP 
Right:Left 
   
0:0 
 
>0:0 0:>0 >0:>0 
NTNP 
Right:Left 
0:0 
 
.75:.25 .75:.25 .5:.5 
 
Negative pixels are an indicator of abnormal paradoxical reactivity. In the normal 
brain, no negative pixels would be expected.  The presence of negative pixels 
could therefore be used as a marker of disease severity. However, to account for 
circumstances where negative pixels may be apparent but not due to pathology, 
we set a threshold whereby negative pixels >2% of 200 positive pixels were 
considered abnormal (Chapter 2 methods). 
We also found that the magnitude of difference between diseased and normal 
hemispheric pixel measures was higher in those with right sided moyamoya than 
left sided moyamoya. 
Examination of hemispheric pixels by moyamoya laterality in the bilateral 
moyamoya group demonstrated a reduced proportion of right hemisphere positive 
pixels when compared to the left.  However, hemispheric negative pixels measures 
were equally distributed between hemispheres.   
In summary, since hemispheric positive pixels would be expected to be 0.5 
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respectively in a normal brain, deviation from this toward 0 would be indicative of 
disease in unilateral moyamoya, or the more diseased hemisphere in bilateral 
moyamoya; and deviation from 0.5 toward 1 would suggest a healthy or healthier 
hemisphere.  Negative pixels could also be used an indicator of disease severity 
but may not be as sensitive an indicator of laterality. 
 
6.7.2. Concordance of CVR measures and angiographic regional of 
abnormality 
In the group of children with left sided MM on conventional angiography (n=7), 
three out of the seven had right and left hBOLD CVR abnormality.  In those with 
right sided MM (n=6) two out of six had left and right hBOLD CVR abnormality.  
This is in keeping with study findings by Han et al (Han et al. 2011), and Heyn et al. 
(Heyn et al. 2010) where abnormality in quantitative measures of hBOLD CVR 
were demonstrated beyond the region of angiographic abnormality and in 
otherwise normal looking brain.  This suggests that despite their more qualitative 
nature BH and GA studies of hBOLD CVR are useful for demonstrating existing or 
at risk regions of perfusion compromise beyond what can be seen on conventional 
angiography and MRI.   
 
6.7.3. Laterality of Function 
Our measures of CVR abnormality were consistently more abnormal on the right 
hemisphere than the left hemisphere.  This was not simply explained by laterality 
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since in the bilateral moyamoya group, right hemisphere CVR measures were also 
worse than left CVR measures. These findings may relate to functional and 
anatomical asymmetries, which are described in humans and animals and seem to 
be advantageous for human and animal life (Duboc et al. 2015). Examples of this 
include cerebral lateralization of the autonomic nervous system and cardiovascular 
function (Hilz et al. 2001, Foster et al. 2008, Foster et al. 2013). BOLD fMRI 
studies have been used to investigate functional lateralization as a function of 
handedness and have shown that right-handed individuals have larger BOLD 
responses to hand movements in the dominant motor cortex compared with the 
non-dominant one (Bertolino et al. 2004, Haaland et al. 2004, Gut et al. 2007, Zeng 
et al. 2007).  Whether this difference is due to neuronal responsiveness or vascular 
reactivity between the dominant and non-dominant hemispheres remains unclear.  
In a study of healthy right handed adult males, Driver et al recently demonstrated 
that there is hemispheric asymmetry in cerebrovascular reactivity, with CVR being 
higher and better on the left side.  The higher CVR was associated with an 
increased density of large veins, something we were not able to control for in our 
study. Specifically the asymmetry in CVR was seen in the precentral gyrus but not 
evident when the whole hemisphere was compared. Whether this is as a result of 
lifelong use of the right hand, or that hemispheric dominance is innate and present 
from birth is not fully understood (Driver et al. 2015, Duboc et al. 2015).   
Our study suggests preferential preservation of left hemispheric CVR.  This may be 
an age related phenomenon as CVR asymmetries have not been identified in the 
literature based on the mostly adult studies (despite the functional and anatomical 
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differences noted in other eg. cognitive functions), or this finding may be due to   
the left hemisphere having more vascular reserve and resilience at the level of the 
capillary bed and neurovascular unit. In summary, whether there is preferential 
preservation of left hemispheric CVR requires further study and replication.   
 
6.7.4. Hemispheric Pixels and Stroke  
Although there was no statistically significant difference in quantitative CVR pixel 
measures between the stroke and no stroke group there was a significant 
difference between the stroke and non-stroke hemisphere within the stroke group.  
PTPP were lower in the stroke hemisphere in those with right and left stroke, and 
significantly so in those with right stroke.  There was a trend for the right PTPP to 
be significantly lower on the right side in those with bilateral disease.  
Neurovascular activity as reflected by CVR is shown to be reduced to absent in the 
peri-infarct and infarcted regions.  In contrast CVR appears to remain unaffected in 
healthy tissue both in patients with a history of stroke and healthy controls 
(Geranmayeh et al. 2015).  Our method used to calculate the pixels i.e.  adjusting 
the threshold to allow generation of 200 pixels in an axial slice, would negate the 
potential net effect of a large region of no reactivity on the hemispheric measures.  
Therefore, post processing lowering of the threshold to facilitate the generation of 
200 pixels in some patients (eg large stroke) may have resulted in spurious or false 
positive findings and not be a reflection of active disease.   
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6.7.5. Hemispheric Pixels in Surgically Naïve Group 
Group qualitative CVR measures were the same regardless of whether the patients 
had revascularization surgery or not.  However, the difference in CVR measures in 
the stroke group, within the stroke and non-stroke hemisphere, was more 
pronounced in the surgically naïve group.  Therefore, it is possible that there was a 
difference in CVR between the surgical groups which was not detected because of 
the difference in group size and the magnitude of CVR change. 
The relationship between moyamoya laterality and hemispheric pixel measures 
was statistically significant in the children who had no history of prior 
revascularization surgery. 
It is possible, however, that successful revascularization surgery does not always 
result in improved CVR.  Direct or indirect bypass surgery improves the delivery of 
blood to the tissue.  Improved perfusion distal to the stenosis should result in 
reduced vasodilation within the capillary bed, and therefore improved 
cerebrovascular responsiveness and reactivity.  However, it is plausible that under 
certain circumstances, such chronic dilatation, hypertension, chronic anaemia and 
older age, this correction in cerebrovascular responsiveness may not occur.  
Therefore, perfusion studies alone may show improvement post revascularization 
surgery, but no improvement in CVR.  In addition post-operative hyperperfusion, 
oedema and shifts in the post-operative watershed as demonstrated on SPECT 
has also been demonstrated in children with moyamoya, all of which could account 
for a lack of improvement in post-operative CVR. (Ogasawara et al. 2005, Ohue et 
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al. 2008, Fujimura et al. 2009, Hayashi et al. 2010) Longitudinal studies with larger 
cohorts are needed to further explore these theories.   
 
6.7.6. Hemispheric Pixels and Angiographic Indices of Disease 
Severity 
6.7.6.1. Modified Suzuki Stage 
Donahue et al (Donahue et al. 2013) and Heyn et al. (Heyn et al. 2010) 
demonstrated an association between severity of moyamoya disease using 
Modified Suzuki staging, arterial circulation time (ACT) and hBOLD CVR.  This was 
not replicated in the current study, and we did not quantitatively assess ACT. The 
majority of children in our study had Suzuki stage 2 or 3 disease.  Modified Suzuki 
staging alone is likely not a good enough indicator of disease severity, or predictor 
of stroke risk.  It is a description of the appearance of collaterals, ranging from no 
collaterals (Stage 1) to disappearance of collaterals (Stage 6).  Stage 3 
angiographic disease denotes the classic moyamoya or ‘puff of smoke 
appearance’ and is the most common stage reported in children presenting with 
moyamoya.  It is difficult to differentiate between Stage 2 (initiation of collaterals), 4 
and 5 (minimisation and reduction).  Accurate staging requires serial conventional 
angiographic studies, which is a problem given the growing reluctance to perform 
conventional angiography in young children coupled with the limitations of MR 
angiography ie undercalling collaterals, and overcalling medium to large vessel 
stenois.  In addition, current staging does not account for laterality of moyamoya; 
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therefore, using this method, unilateral Stage 6 moyamoya is deemed as severe as 
bilateral Stage 6 moyamoya.   
Ischaemic injury in chronic hypoperfusion as seen in moyamoya occurs more 
gradually and over time.  This is in contrast to the abrupt ischaemic injury caused 
in vaso-occlusive thromboembolic stroke.  The rate of collateralization in response 
to parent artery stenosis is likely to be more important at a tissue level than the 
presence of collateralization. This is difficult to capture with the standard use of 
conventional angiography.  Therefore the use of the traditional conventional 
angiography to infer disease severity and tissue level impairment is likely limited 
and the use of a non-invasive MR technique using conventional sequences could 
be of significant benefit in this population. 
 
6.7.6.2. Grading of Stenosis  
The majority (30/34 with conventional angiograms) of our children had Grade 4 
(severe 75 – 100%) stenosis or occlusion. Four had Grade 3 (50 – 74% stenosis).  
Children with less severe stenosis had lower right PTPP and significantly higher 
right PTNP.  Of the four children who had Grade 3 stenosis, two had Trisomy 21-
MM and three had stroke (2 right sided, 1 bilateral).  The children with 
chromosomal disorders, including Trisomy 21, had some of the lowest CVR 
measures (See Chapter 5).  Hence the worse CVR measures of the less severe 
group are likely to be related to the underlying disease syndrome rather than a 
reflection of the Grade of stenosis itself.  
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The relationship between arteriopathy and tissue level impairment is unlikely to be 
linear.  A study by Liu and Zhou in adults with ICA and MCA stenosis suggests that 
degree of stenosis may not be as good a predictor of stroke as CVR (Liu and Zhou 
2014). The degree of stenosis is not necessarily correlated with the degree of 
regional blood flow, perfusion nor the risk of stroke. Adult studies of patients with 
carotid artery diseases report a relatively low risk of stroke in patients with severe 
stenosis (ie.90%) (Kasner et al. 2006) (Inzitari et al. 2000) The presence or 
absence of collaterals may influence this but not necessarily infer hemodynamic 
compromise at the tissue level. Collaterals may reflect either aggressive, unstable 
disease or alternatively protective compensatory mechanisms (Liebeskind et al. 
2011). The integrity of the neurovascular unit may hence be maintained despite the 
presence of severe parent artery disease in the presence of adequate and timely 
collateralization.  Detection of impending failure of this unit and stroke risk is 
possible with the use of qualitative hBOLD CVR. Deviation of hemispheric pixel 
CVR measures away from 0.5, the presence or increase of negative pixels, and 
relatively lower positive or higher negative CVR on a parametric map are all 
utilizable methods of qualitative CVR assessment in the childhood moyamoya 
population. Descriptions of longitudinal hBOLD CVR results which appear to 
predict ischaemic events are provided in the following chapter.  However, this study 
was not powered to demonstrate whether abnormality in quantitative CVR was 
predictive of stroke.    
 
6.7.6.3. Ivy Sign 
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In adults with moymoya disease, one study using single photon emission CT 
(SPECT) showed leptomeningeal high signal intensity (ivy sign) seen on fluid-
attenuated inversion recovery images had a significant negative relationship with 
resting CBF and CVR, and a significantly positive relationship with ischaemic 
symptoms (Mori et al. 2009). In addition, the ivy sign has been shown to decrease 
post-operatively with corresponding increase in SPECT and MR perfusion 
changes.  Ivy may be present in the absence of moyamoya vessels/collaterals and 
hence may be particularly useful sign when using conventional MRI imaging for the 
diagnosis and management of moyamoya disease (Fujiwara et al. 2005).  
However, there was no association between the presence of ivy and any hBOLD 
CVR measures of tissue level impairment.   
 
6.7.7. hBOLD CVR Measures and Biological Indices of Disease 
MRI BOLD signal is dependent on CBF and to unknown extent haematocrit 
(Ogawa et al. 1993, Hoge et al. 1999, Petersen et al. 2006), which is known to be 
correlated with CBF. Cerebral blood flow may also be related to haemoglobin, 
associated with oxygen content, and platelets, in relation to thrombosis.  However, 
there are no published quantitative studies of hBOLD CVR examining the 
relationship between CVR and these biological measures.  In addition systemic 
blood pressure is known to be an indicator of cerebrovascular disease and 
associated with compromise of CVR Ref (Settakis et al. 2003, Settakis et al. 2006, 
Wong et al. 2011). Hence I sought to examine the relationship between 
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haemoglobin, haematocrit, platelets and blood pressure with hBOLD CVR 
measures.   
A statistically significant relationship between biological indices of disease and 
hBOLD CVR measures was only found for haematocrit and left PTNP, and a trend 
toward significance for heart rate and PTNP.  The results are limited by the chosen 
methodology for measurement of pixels as a maximum number of 200 pixels is 
predetermined for each patient PTPP and NTNP are unlikely to be sensitive 
enough to demonstrate small to moderate effect of the biological parameters on 
hemispheric measures of qualitative CVR.  As PTNP values were generated 
differently ie. number of negative pixels/200 positive pixels, this is likely to be more 
sensitive for across group analysis.  Despite this the observed suggestion of 
association with heart rate is in keeping with heart rate being a marker of 
cardiovascular and cerebral autonomic function and therefore may be a real finding 
(Settakis et al. 2003, Wong et al. 2011, Mitra et al. 2014, Mitra et al. 2014). 
 
6.8. Study Limitations and Future Directions 
A number of the limitations of my study have already been mentioned.  Further 
limitations and future directions are as follows: 
1) Population size - The small numbers with Modified Suzuki Stage 1, 4, 5 and 6 
meant that I was underpowered to make any conclusions about the association 
between Modified Suzuki Staging and hBOLD CVR as a measure of tissue level 
impairment. Similarly I did not have enough children with grade 1, 2 or 3 stenosis 
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to test whether grade of stenosis is associated with tissue level impairment as 
measured by hBOLD CVR.  Our grading system did not distinguish between a 75% 
stenosis and a totally occluded vessel, which may have different upstream effects 
on CVR.    
2) Longitudinal studies – analysis of hBOLD CVR studies in a longitudinal cohort 
would allow for the generation of quantitative CVR measure normal ranges, and 
quantification of ischaemic risk much like is done in stroke risk assessment in SCD.   
3) Indicators of disease severity and biological indices - Modified Suzuki staging is 
limited as a sole marker of disease severity.   Review of conventional angiograms 
to calculate ACT and modification of the scoring system to account for laterality of 
Suzuki stage; severity of parent artery stenosis; involvement of posterior circulation 
disease and regional distribution of ivy and non-moyamoya collaterals would be 
more representative of disease severity.  This supplemented with the development 
of a more comprehensive scoring system which included clinical information would 
provide a better means for comparison with measures of CVR and improve our 
understanding of the ability of CVR to inform of ischaemic risk in this population. 
Improved methodology in the collection of biological data, specifically BP would 
allow for a more robust assessment of association with CVR.   
4) Laterality of function – resting state fMRI, CVR, EEG and PET studies 
conducted at the same time at different ages could help elucidate whether, and if 
so, to what extent there is lateralization of CVR in childhood and any impact on 
stroke risk in the developing brain.  
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5) It may be possible to investigate changes in cerebral blood flow with age in 
normal children in relation to cognition and behaviour 
 
 
6.9. Conclusion 
1) Abnormalities of qualitative measures of hBOLD CVR ie. hemispheric pixels and 
scores are concordant with laterality of angiographic abnormality.  
2) Qualitative measures of hBOLD CVR demonstrate functional impairment of the 
cerebral vasculature beyond the region of angiographic abnormality.  
3) Measures of hBOLD CVR are correlated with angiographic measures of 
moyamoya severity as determined by Grade of Stenosis.   
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7. Pre and post-surgical hypercapnic BOLD 
CVR    
7.1. Abstract 
7.1.1. Background 
Moyamoya causes recurrent ischaemic events and progressive neurological 
decline.  Revascularization surgery may prevent this decline. However indicators 
for selection of patients and optimal timing of surgery are not established. 
Abnormalities of hypercapnic challenge blood oxygen level dependent (hBOLD) 
CVR cerebrovascular reactivity (CVR) are predictive of brain-at-risk for ischaemia 
in steno-occlusive cerebral arteriopathy. 
 
7.1.2. Objective 
To determine whether qualitative hBOLD CVR identifies children at risk of cerebral 
ischaemic events and demonstrates changes associated with revascularization 
surgery in moyamoya. 
 
7.1.3. Method 
Children with moyamoya disease (MMD) or moyamoya syndrome (MMS) were 
assessed with MRI/MRA, conventional angiography and hBOLD CVR.  Those who 
underwent revascularization surgery also had post-operative studies.  Children with 
284 
serial hBOLD CVR studies but not recommended for surgery were included as a 
control group.   
 
7.1.4. Results 
Thirteen children (5 male, mean age diagnosis 9.1, SD 3.27 years, bilateral 
moyamoya in 6) underwent hBOLD CVR pre- and post-revascularization surgery 
(26 hemispheric studies). Of the surgical group five children had MMD and 8 MMS 
(5 with NF1).  Seven children (2 male, mean age diagnosis 7.96, SD 4.02 years, 
bilateral moyamoya in 5) did not have intervening surgery and were a non-surgical 
control group with follow-up.  Two of the non-surgical controls had MMD and 5 
MMS (2 NF1, 2 SCD and 1 Trisomy 21).    
Four children were asymptomatic at the time of diagnosis.  Symptomatic children 
presented with headache (2), seizures (2), TIA’s or stroke (3) and paroxysmal 
episodes (1). Pre-surgical hBOLD CVR was abnormal in hemispheres affected by 
moyamoya in all children.  Three children developed de novo TIA/stroke prior to 
surgery.  In all children follow-up CVR (1-6 months post-surgery) improved on the 
side of surgery following surgery.   Four of seven children with worsened CVR 
measures (3 post-operatively, 1 serial measures) proceeded to become clinically 
symptomatic, and required further revascularization surgery in all 4.   
7.1.5. Conclusions 
The study results suggest that CVR has potential as a role for evaluating ischaemic 
risk in childhood moyamoya. It demonstrates clinically meaningful CVR 
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improvement post-revascularization surgery in the majority, and worsening 
appears to be predictive of clinical deterioration and ischaemic risk.    
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7.2. Introduction 
Diagnosis in MM is typically made after symptomatic presentation.  However, due 
to disease specific surveillance protocols (Adams et al. 1998), there is an increase 
in diagnoses in asymptomatic patients.  The presence of moyamoya angiopathy is 
associated with an increased risk of ischaemic or haemorrhagic injury to the brain, 
however understanding of the natural history of MM is limited by small sample 
studies and a lack of systematic follow-up imaging (Ezura et al. 1995, Kuroda and 
Houkin 2008).  The course of disease is variable yet predictors of progression or 
severity of disease lacking.  Symptomatic progression may be rapid - leading to 
disability or death - or slow.  In addition the steno-occlusive arteriopathy appears to 
progress in asymptomatic and unilateral cases (Ezura et al. 1995, Kuroda et al. 
2005, Lin et al. 2011).  
There is no cure for MM.  Current standard treatment strategies do not halt the 
primary vascular progression.   Hence treatments are aimed at improving cerebral 
blood flow distal to the stenosis.  Medical options include the use of anti-platelet 
agents such as Aspirin, vascular vasodilators such as Acetazolamide and 
Carbamazepine and simple measures such as good hydration.  However 
revascularization surgery is the definitive approach improving blood flow distal to 
the stenosis by direct or indirect revascularization procedures.  Current standard 
indications for revascularization surgery include clinical presentation with 
ischaemic symptoms, and/or progression in moyamoya angiopathy and/or 
progression in ischaemic parenchymal lesions.  Studies of perfusion and 
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cerebrovascular reserve or reactivity to date have been used to corroborate clinical 
and standard radiological findings.  However the current literature is limited to 
describing it’s use to guide surgical decision making in the absence of traditional 
indicators in childhood moyamoya rather than in examining any association with 
status at follow-up. 
In this chapter I sought to explore how hBOLD CVR changes in response to 
revascularization surgery and over time, and by so doing explore the utility of 
qualitative hBOLD CVR in informing decisions regarding surgery in children with 
moyamoya. 
 
7.3. Study Hypothesis 
1)  Abnormality in hBOLD CVR corresponds with the vascular territories supplied 
by the narrowed vessels as demonstrated on CA. 
2) Regional abnormality in hBOLD CVR improves following revascularization 
surgery in the corresponding vascular territory. 
3)  Change in hBOLD CVR predicts change in clinical outcome. 
 
7.4. Method 
Indicators for revascularization surgery included the following parameters: 
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i) Severity of clinical presentation ie. presence and frequency of TIAs; 
history of acute AIS, frequent accompaniment of other clinical 
presentations such as headache and/or paroxysmal symptoms 
ii) Severity of radiographic presentation ie. presence and extent of 
ischaemic injury, presence of IVY and severity of moyamoya according 
to the Modified Suzuki Stage. 
iii) Severity of abnormality on hBOLD CVR 
Inclusion criteria 
i)   Diagnosis of MMD/MMS 
ii)  Revascularization surgery or serial hBOLD CVR studies 
iii) Pre and post-operative: 
MRI/MRA   
conventional angiography 
hBOLD CVR 
Exclusion criteria 
i) Children < 28 days >18 years 
 
7.5. Parenchymal and Vascular Imaging 
Over the study period 1.5T or 3T MRI (Achieva, Philips, Best, Netherlands) brain, 
3D TOF MR angiography and 6 vessel conventional angiography were done in 
study participants before and after revascularization surgery.  In addition 
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superselective angiography was conducted in patients after revascularization 
surgery.  MRI/MRA and conventional angiograms were read by study investigator 
(ND) and study radiologist (DA). 
Grading of arterial stenosis by the study investigator (ND) and study 
neuroradiologist (DA) was by visual inspection of the conventional angiograms and 
MRAs closest to the time of the hBOLD CVR studies.  ND and DA were blinded to 
clinical information.  Stenosis was graded as a percentage of the normal arterial 
diameter such that:   
1= <25%; 2 = 25-49%; 3= 50-74%; 4=75-100% occlusion  
If more than one vessel was involved all were graded and the worst vessel chosen 
for the purpose of analysis.  Staging of the conventional angiograms and MRAs 
was done using Modified Suzuki criteria and the presence or absence of the ivy 
sign noted pre and post operatively (Chapter 2 Methods). 
 
7.6. Pre and post hBOLD CVR Analysis 
hBOLD CVR studies conducted before and after revascularization surgery were 
processed and analysed by ND and WL.  hBOLD CVR parametric maps were 
scored by inspection and hemispheric pixels measured by WL and ND blinded to 
clinical information. (Chapter 2 Methods) 
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7.7. Statistical Analysis 
Independent samples t-test to compare means for parametric data and one sample 
paired t-test to compare means for parametric data from the same sample analysis 
were used. Wilcoxon’s-matched pair test was used for non-parametric categorical 
paired analysis. The Mann-Whitney test was used for non-parametric assessment 
of association and Fisher’s exact test for comparison of categorical data.  A p value 
of <0.05 was deemed statistically significant.  
 
7.8. Results 
7.8.1. Group Description 
Of the 37 children with moyamoya, 13 (5 male, mean age diagnosis 9.1, SD 3.27 
years) had pre and post-operative hBOLD CVR studies as described above.  
Seven children (2 male, mean age diagnosis 7.96, SD 4.02 years) with a minimum 
of two hBOLD CVR studies at different time points and without intervening surgery 
were included as non-surgical controls with follow-up.  There was no statistically 
significant difference in age of moyamoya diagnosis, moyamoya arteriopathy 
diagnosis and moyamoya laterality between the revascularization group (n=13), 
the no intervening surgery group (n=24), and the non-surgical controls with follow-
up (n=7). (Ref Figs 52a and 52b, and Table 56). 
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Figure 52a Pie charts of Comorbidity Frequencies and Moyamoya Laterality 
in Intervening Surgery Group compared with No Intervening Surgery Group 
                 n=24                                     n=13 
 
 
 
 
 
              n=7 
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Figure 52b Pie Charts of No Intervening Surgery/Serial CVR Group 
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Table 56 Group Demographics of Non-surgical and Surgical Patients 
 
No Intervening 
Surgery 
 
 
 
(a) 
 
t-test 
Revascularization  
Surgery 
 
 
(b) 
 
p value 
No Surgery-Serial 
hBOLD CVR 
Controls 
 
N 24  13  7 
Mean Age at 
Diagnosis (SD) 
9.1 
(4.25) 
 
 
.984 9.1  
(3.27) 
 
 
.496 
 
 
7.96 
(4.02) 
Gender M (%) 11 (46) - 5 (38) - 2 (29) 
Mean Age at  
hBOLD CVR 1 
(SD) 
11.1 
(4.6) 
 
.46 10 
(3.73) 
 
.961 
 
10 
(5.13) 
Mean Age at  
hBOLD CVR 2 
(SD) 
12.5 
(4.6) 
 
.61 11.5 
(3.87) 
 
.504 
 
12.5 
(4.61) 
Time between 
CVR1 and CVR2 - 
 
 
- 
1.47 
(1.19) 
 
.203 
   
2.35 
(1.72) 
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Moyamoya 
Laterality 
(B/R/L) 
17/4/3 
 
 
.499 6/2/5 
 
 
.588 
 
 
5/1/1 
Comorbidity Code 
Idiopathic 
NF1 
SCD 
Chromosomal 
Tumour 
 
8 
4 
5 
4 
3 
 
 
 
.169 
 
5 
5 
0 
3 
0 
 
 
 
.351 
 
2 
2 
2 
1 
0 
MM Stage 
1 
2 
3 
4 
5 
6 
 
2 
8 
10 
0 
0 
1 
 
 
 
 
 
- 
0 
4 
6 
2 
1 
0 
 
 
 
 
 
- 
 
1 
3 
3 
0 
0 
0 
 
Degree of 
Stenosis 
1/2/3/4 0/0/1/20 
 
- 
0/0/3/10 
 
- 
 
 
0/0/0/7 
Stroke (%) 
B/R/L  
14 (58) 
2/8/4 
 
- 
7 (54) 
3/3/1 
 
- 
4 (57) 
1/3/0 
B=bilateral, R=right, L=left
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7.8.2. Moyamoya Arteriopathy Diagnosis and Clinical Description 
in Surgical Group 
Of the 13 children, five had Idiopathic-MM (two familial), five NF1-MM and three 
Chromosomal-MM (2 Trisomy 21 and one Turner’s syndrome). Seven had 
bilateral, two right and four left sided moyamoya.   
Four children were asymptomatic at the time of diagnosis and recommendation for 
surgery: 3 with NF1-MM and 1 Chromosomal-MM (Turner Syndrome).  Diagnosis 
in these four was made following brain imaging indicated by their respective 
syndromic diagnosis.  Of the remaining nine children, two presented with acute 
AIS; three with TIAs (two with headache and one with additional seizures); one 
with seizures and headache; and two with headache only. One child presented 
with paroxysmal sensory symptoms.  Two of the four children who were 
asymptomatic at the time of diagnosis and recommendation for surgery had new 
overt ischaemic symptoms (1 AIS, 1 TIA) prior to surgery (Table 57). 
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Table 57 Moyamoya Classification and Clinical Description of Patients with Revascularization Surgery 
Patient 
(M/F) 
MM 
Disease or 
Syndromic 
Diagnosis 
Moyamoya 
Laterality 
Age at 
Moyamoya 
Diagnosis 
(years) 
Moyamoya 
Presentation 
hBOLD 
CVR 1 
Age 
(years) 
hBOLD 
CVR 1 
Method 
Age at  
Surgery 
(years) 
hBOLD  
CVR 2 
Age 
(years) 
 
hBOLD 
CVR2 
Method 
1 (F) 
 
Trisomy 21 Bilateral 10.17 Bil AIS  10.33 GA 10.58* 11.67 GA 
2 (F) 
 
Trisomy 21 Bilateral 14.25 R MCA AIS 15 GA 15.42 16.5 GA 
3 (M) 
 
NF1 Left 11.17 Asymptomatic 11.42 BH 11.83 12.33 BH 
4 (M) 
 
NF1 Left 11.50 Headache 12 RM 12 12.58 BH 
5 (F) 
 
NF1 Right 10.83 Headache 16.33 BH 16.42 16.92 BH 
6 (F) 
 
NF1 Left 5.17 Asymptomatic 5.58 GA 6.08 6.25 GA 
7 (F) 
 
Turners 
Syn 
 
Left 3.83 Asymptomatic 4.08 GA 4.17 6.58 GA 
8 (F) 
 
Idiopathic Bilateral 6.00 L TIAs 7.5 GA 7.5* 8.08 GA 
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Patient 
(M/F) 
MM 
Disease or 
Syndromic 
Diagnosis 
Moyamoya 
Laterality 
Age at 
Moyamoya 
Diagnosis 
(years) 
Moyamoya 
Presentation 
hBOLD 
CVR 1 
Age 
(years) 
hBOLD 
CVR 1 
Method 
Age at  
Surgery 
(years) 
hBOLD  
CVR 2 
Age 
(years) 
 
hBOLD 
CVR2 
Method 
9 (M) 
 
Idiopathic Bilateral 10.67 Headache 
Seizures 
Bil TIAs 
10.75 BH 10.83 13.75 BH 
10 (M) 
 
Idiopathic Bilateral 6.58 Seizures 
Headache 
7.17 GA 7.25 7.67 GA 
11 (F)  Idiopathic Right 5.67 Paroxysmal 
sensory 
episodes 
5.75 GA 5.75 7.17 GA 
12 (F) 
 
Idiopathic Bilateral 12.75 R TIAs 
Headache 
12.92 RM 13.08 14.17 RM 
13 (M) 
 
NF1 Left 9.92 Asymptomatic 10.67 BH 13.33 15.25 BH 
* Prior right and left (respective) revascularization procedures 
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7.8.3. Moyamoya Arteriopathy Diagnosis and Clinical Description 
in No Intervening Surgery Group 
Of 37 children, seven had moyamoya and repeat hBOLD CVR studies without 
intervening revascularization surgery or stroke.  Two children had Idiopathic-MM; 
two NF1-MM; two SCD-MM and one Chromosomal-MM (Trisomy 21).  Of these 
four presented with AIS; one headache and found to have a remote AIS on MRI; 
and two were asymptomatic at diagnosis.  Diagnosis in the latter two was made 
following syndromic disease targeted screening protocols. 
Two children had revascularization surgery prior to their serial studies and one 
after.   One child had a bone marrow transplant between studies.  The two children 
with SCD were also on a chronic blood transfusion programme (Table 58). 
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Table 58 Non-surgical ‘Controls’ with follow-up:  Demographics of Patients with no Revascularization Surgery 
between hBOLD CVR Studies 
Patient 
(M/F) 
MM 
Disease/ 
Syndromic 
Diagnosis 
Moyamoya 
Laterality 
Age at 
Moyamoya 
Diagnosis 
(years) 
Moyamoya 
Presentation 
hBOLD  
CVR 1 
Age 
(years) 
hBOLD 
CVR 
Method 
hBOLD  
CVR 2 
Age 
(years) 
 
hBOLD 
CVR 
Method 
Intervention 
(Age,years) 
1 (F) Idiopathic Bilateral 9.5 Bilateral AIS 15 BH 16.83 BH R EDAS 
(10.92) 
L EDAS 
(11.00) 
2 (M) NF1 Left 6.33 L AIS 
(movement 
disorder) 
7.25 GA 8.08 GA L pial (6.42) 
3 (M) Sickle Cell 
Disease 
Bilateral .83 R AIS 1.00 BH 6.17 GA BMT (4.6) 
4 (F) Idiopathic Bilateral 12.67 HA 
Remote R AIS  
16.08 BH 17.33 BH  
5 (F) 
 
NF1 Right 8.58 Asymptomatic 9.00 BH 9.92 BH  
6 (F) 
 
Sickle Cell 
Disease 
Bilateral 11.83 Asymptomatic 12.5 BH 16.83 BH  
7 (F) 
 
Trisomy 21 Bilateral 6.00 R MCA AIS 9.58 GA 12.08 GA BEMS 
(13.25) 
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Table 59 Clinical and Radiological Details of Children with Revascularization Procedures 
No  Age 
(yrs) 
Sex Op Surgery Co-
morbidity/ 
Surgical 
Indication 
Conventional angiography Magnetic resonance  Cerebro-
vascular 
Reactivity Vessels Grade 
Stenosis 
 
Suzuki 
Stage 
Anatomic 
adequacy 
Collaterals 
Moya 
moya 
Parenchyma IVY 
1 
 
 F 1 R EDAS Trisomy 21 
R TIAs 
 
L dICA 
L M1/A1 
R dICA 
R M1/A1 
4 3 Adeq colls 
Slow perf 
RMCA 
2 Bil R>L 
encephalomal
acia ; laminar 
scarring 
Y Impaired R 
reactivity 
and steal 
     L vascular 
progression 
U U 2 Adeq 6 Bil R>L 
encephalomal
acia  ; laminar 
scarring 
N Improved R 
steal 
L impaired 
reactivity 
and steal 
2 
 
15 F 1 
 
Bilateral 
pial syn 
Trisomy 21 
High F VIII 
MTHFR het:  
R MCA AIS 
R dICA 
L dICA 
L M1/A1 
3 
 
 
2 
 
 
Bil ant circ 
deficits 
 
 
2 
 
 
Bilateral 
watershed 
 
Y-
bil 
 
 
Bilateral 
impairment 
and steal 
     Asymptomati
c 
+RM1 
+RA1 
4 4 Good 
(STA>MMA) 
1  Bilateral 
watershed 
Y- 
less 
Some 
improvement
,but still 
bilateral 
impairment 
w  steal 
3 
 
11 M 1 L pial syn NF1 
Occ 
headaches  
R TIA 
L 
dICA/A1 
3 
 
3 
 
Good ant. (R 
to L) 
L temporal 
lobe deficit 
 
2/4 
 
 
 
Normal 
 
 
 
Y 
 
 
 
Impaired L 
reactivity 
with some 
steal 
 
 
     Improved 
headache 
No TIA 
 
 
U 4 4 Good (STA, 
MMA) 
2/4 Normal Y Improved 
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No  Age Sex Op Surgery Co-
morbidity/ 
Surgical 
Indication 
Conventional angiography Magnetic resonance Cerebro-
vascular 
Reactivity 
Vessels Grade 
Stenosis 
 
Suzuki 
Stage 
Anatomic 
adequacy 
Collaterals 
Moya 
moya 
Parenchyma IVY 
4 
 
11 M 1 L pial syn NF1 L M1 occ 4+ 
 
2 
 
Adeq 
 
2 
 
L watershed 
 
N 
 
L steal 
Impaired  R 
reactivity 
 
       4+ 3 Better but 
slow  (min 
from STA) 
2 L watershed N Improved L 
steal. 
Some 
persistent R 
impairment 
5 
 
16 F 1 R pial 
syn 
NF1 
Headache 
R dICA 
R M1/A1 
4 
4 
4 
4 
Good 
 
4 
 
R watershed 
 
Y 
 
Bilateral 
steal WM 
 
     Improved 
headache 
U 4+ 4 Good (STA, 
MMA) 
4 R watershed Y Bilateral 
improved 
reactivity, 
less steal 
6 
 
6 F 1 L pial syn NF1 
Asymptomati
c until 6 days 
b4 planned 
sx 
R A1 
L dICA 
occ 
 
3 
4+ 
5 
 
Good patchy 
frontal deficit 
 
6 
 
 
 
Hamartomas 
 
 
 
Y 
 
 
 
Impaired L 
anterior 
reactivity 
 
 
     Post-op TIAs 
resolved. 
U 4 
4+ 
5 Improved 
(MMA, STA 
non-contrib) 
Patchy 
frontal deficit 
 
6 Hamartomas Y Improved 
overall +/- 
new steal L 
frontal 
7 
 
4 F 1 L pial syn Turner’s 
Asymptomati
c 
L 
dICA/M1 
4 
 
2 
 
Adequate 
but slow 
 
2 
 
L watershed 
 
Y 
 
Bilateral 
impaired 
reactivity 
 L>R c  with 
steal 
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 No  Age Sex Op Surgery Co-
morbidity/ 
Clinical 
presentati
on/Sx 
Indication 
Conventional angiography Magnetic resonance Cerebro-
vascular 
Reactivity 
Vessels Grade 
Stenosis 
 
Suzuki 
Stage 
Anatomic 
adequacy 
Collaterals 
Moya-
moya 
Parenchyma IVY 
      U 4+ 2 Adequate 
but slow 
(STA/MMA) 
2 L watershed Y Improved – 
no steal 
8 
 
6 F 1 R pial 
syn 
Factor IX def 
L TIAs 
R dICA 
RM1/A1  
L dICA 
L M1/A1 
4 3 Adeq 
(Post/STA/M
MA) 
3 R watershed N Marked 
bilateral 
steal – 
mostly 
anterior 
(L>R) 
   2 L pial 
and inter-
hemisph 
syn 
R TIAs and 
AIS 
U 4 3 Adeq 6 R MCA AIS 
Bilateral 
watershed 
N Improved 
Small areas 
of persistent 
bilateral 
steal 
9 
 
6 M 1 L ECIC NF1 
L focal 
seizures 
Migraine 
R dICA 
R M1/A1 
R opth  
L dICA 
L M1/A1  
L opth 
4+ 3 Inadeq R 
vasc 
6 Bil w’shed L>R 
Bil volume loss 
L>R 
Acute R MCA 
AIS 
Y R motor strip 
suggestive 
of steal. 
Failed BH  
   2 R EDAS  +RP1 
+LP1 
4+ 4 Improved but 
patchy 
frontal 
perfusion 
deficit 
4 Bil w’shed L>R 
Bil volume loss 
L>R 
Old R MCA 
AIS 
N Bilateral 
impairment 
with steal 
No direct 
comparison 
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 No  Age Sex Op Surgery Co-
morbidity/ 
Clinical 
presentation
/Sx 
Indication 
Conventional angiography Magnetic resonance Cerebro-
vascular 
Reactivity 
Vessels Grade 
Stenosis 
Suzuki 
stage 
Anatomic  
Adequacy  
Collaterals 
Moya 
moya 
Parenchyma IVY 
10 
 
5 M 1 
 
Bilateral 
pial syn 
Familial; 
Seizures 
Headache 
TIA 
LMCA AIS 
L dICA 
occ 
R dICA 
R M1/A1 
 
4+ 3 
 
 
 
Good (R to 
L: L post to 
ant) 
5 
 
 
 
L MCA atrophy 
 
 
Y Bilateral 
impaired 
reactivity 
with steal - 
frontal 
sparing 
 
     Asymptomati
c 
Not done    6 R MCA AIS 
 
Y Improved; 
decreased 
steal 
11 
 
5 F 1 R pial 
syn 
 
Β-
Thalassaemi
a 
Trait: 
Headache 
Paroxysmal  
episodes 
R dICA 
R M1/A1 
   1 Normal Y Impaired 
reactivity 
and  R  steal 
   2 R occ 
pial syn 
Reduced 
paroxysmal 
episodes 
Persistent 
HA 
U    1 Normal Y Improved R 
ant steal 
Persistent R 
post steal 
12 
 
13 F 1 L pial syn Familial: 
TIAs++ 
(R>L) 
Headache 
R M1/A1 
RP1 
L M1/A1 
3 2 Good L hem 
perf from 
RICA colls, 
and LVA 
colls to ant 
circ 
 
 
 
2 L watershed Y Impaired L 
reactivity 
304 
 No  Age Sex Op Surgery Co-morbidity/ 
Clinical 
presentation/ 
Sx Indication 
Conventional angiography Magnetic resonance Cerebro-
vascular 
Reactivity Vessels Grade 
Stenosis 
Suzuki  
Stage 
Anatomic  
Adequacy  
Collaterals 
Moya 
moya 
Parenchyma IVY 
   2 R pial 
syn 
Initially 
improved TIAs.  
Subsequent 
increase L TIAs 
+RdICA 
 
4 3 Good 
(STA, 
MMA) 
2 L watershed 
R MCA, ACA 
AIS 
 Regional 
improvement 
L reactivity 
with new 
regional 
impairment  
L ACA 
territory and  
R 
hemisphere 
with steal 
13 
 
 M 1 L EDAS NF1 L dICA  
L M1occ 
LA1 
 
4+ 
 
3 
Inadeq L 
watershed 
2 
 
Hamartomas 
 
Y Bilateral 
steal 
      ND    2 Hamartomas  Improvement 
but 
persistent 
scattered 
steal 
M=male; F=female; L=left; R=right; Bil=bilateral; syn=synangiosis, dICA=distal internal carotid artery; M1=proximal middle cerebral artery; 
A1=proximal anterior cerebral artery; occ=occlusion; STA=superficial temporal artery; MMA=middle meningeal artery; Y=yes; N=no; ant=anterior; 
PCA=posterior cerebral artery; ↓=decreased; Adeq=adequate; BH=breath hold; EDAS= Encephaloduroarteriosynangiosis; 
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7.8.4. Conventional Angiographic Findings  
All (n=20) children had a conventional angiogram at at least one time point.   Pre 
and post-operative four vessel angiography and post-operative (where applicable) 
superselective angiography were conducted to assess the extent of involvement of 
the vessels.  Vessels were staged and graded as described in Methods (Chapter 2 
Methods).  In addition details of anterior circulation contribution to the watershed 
was noted.  Arterial transit times were noted to be slow or normal as determined by 
an experienced interventional radiologist on the basis of time taken from arterial to 
capillary phase on conventional angiography. 
Grossly, adequate anatomic self-collateralisation and perfusion albeit slow, from 
lenticulostriate, thalamostriate and/or pial collaterals was seen in all children.  
Cross-filling from the contralateral unaffected (in unilateral MM) or less affected (in 
bilateral MM) anterior circulation to the ipsilateral affected hemisphere, and cross-
filling from the posterior to anterior circulation was seen with shifting of the 
watershed zones toward the ipsilateral (affected) or bilateral (more affected) 
hemisphere ie. unaffected ACA/MCA to affected ACA/MCA;unaffected PCA to affected 
MCA/PCA was seen in all.  Regression of the cross-filling and shifted watershed 
was seen post-operatively in all with intervening surgery.  Subsequent review of 
conventional angiography in 2 patients demonstrated patchy areas of avascularity 
despite good ipsilateral and contralateral self-collateralisation in other vascular 
regions (Table 59). 
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CVR abnormality was concordant with moyamoya laterality in all.  Six children had 
unilateral moyamoya.  Bilateral CVR abnormality was observed on the parametric 
maps in four of the six children (Fig 55 and 56). 
 
Figure 55  hBOLD CVR Parametric Map (breath-hold) for Patient 13 with 
Unilateral Left Sided Moyamoya.  Note the bilateral presence of steal (purple 
pixels).   
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Figure 56  hBOLD Parametric Map (re-breathe mask) for Patient 4 with 
Unilateral Left Sided Moyamoya.  Note the bilateral reduced reactivity (left 
more than right). Red denotes higher blood flow than yellow, blue or no 
colour 
 
 
7.8.5. Revascularization Surgery and hBOLD CVR Studies  
The mean age at revascularization surgery was 10.33 SD (3.87) years.  Indications 
for revascularization surgery were as described above (Chapter 6 Methods)  
 308 
Thirteen children had, twenty-six hBOLD CVR studies (one pre-operative and one 
post-operative for each patient; 52 hemispheres):  7 GA-GA, 4 BH-BH, 1 RM-BH, 1 
RM-RM.  
In the revascularization surgery group the mean time between the first included 
hBOLD CVR study and revascularization surgery was 0.35 years (4.2 months), SD 
.689 years.  The mean time between revascularization surgery and the second 
(follow-up) hBOLD CVR study was 1.08 years (13 months), SD 0.815 years. 
In the non-surgical control with follow-up group the mean time between the first 
and second hBOLD CVR study was 2.35 years, 1.72 SD.   
Six of 37 children had additional CO2 measurements, three of these (3/13) pre and 
post-operatively. Hence, quantitative hBOLD CVR was calculated pre and post-
operatively for this sub-group. 
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Figure 57  Pre and Post-operative hBOLD Parametric Maps in 3 Children 
 
 
 
 
 
 
1-3 a: Pre-operative CVR parametric maps 
demonstrating a) bilateral steal, left more than right, and 
reduced positive reactivity left more than right b) bilateral 
steal and c) right hemispheric steal 
1-3 b:  post-operative CVR parametric maps 
demonstrating reduced steal in all.  
  
11                                          
  
1 
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7.8.6. Serial hBOLD CVR Hemispheric Scores 
Nineteen children had CVR inspection scores at two time-points (12/13 pre and 
post-operative; 7/7 no intervening surgery).  Therefore 76 hemispheric scores were 
available for analysis.   
 
7.8.6.1. Hemispheric Scores Operated, Operation Naïve and Control 
Hemispheres            
7.8.6.1.1. Surgical Group                                                                        
The mean (SD) of the pre- and post-operative scores of the operated hemisphere 
were 2.5 (0.555) and 2.4 (0.756).  The mean (SD) pre- and post-operative score of 
the operation-naive hemisphere was 1.75 (0.858) and 1.9 (0.966) respectively.  
There was no statistically significant difference between pre and post-operative 
scores in the operated or operation naïve hemisphere.  Pre-operative scores were 
higher in the operated hemisphere but this was not statistically significant. There 
was no statististically significant difference in scores by presence of unilateral or 
bilateral moyamoya (Table 60). 
 
7.8.6.1.2. Control Group                                                                         
The mean (SD) right hemispheric T1 and T2 scores were 2.6 (0.787) and 2.1 (0.9) 
respectively.  The mean (SD) of the left hemispheric T1 and T2 scores were 2.6 
(0.45) and 2.4 (0.748) respectively.  There was a trend toward significant difference 
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in right hemispheric T1 and T2 scores (p=0.149).  There was no significant 
difference between left hemispheric T1 and T2 scores, right and left T1 scores, or 
right and left T2 scores (Table 60 and Fig 60). 
 
Figure 58  hBOLD CVR Parametric Map for Non-Surgical Control Patient 7.  
Patient became symptomatic and proceeded to have revascularization 
surgery. 
 
Note bilateral reduced reactivity and scattered steal.  Patient became 
symptomatic and proceeded to have revascularization surgery.  
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Figure 59  Pre and Post-operative Hemispheric Scores in Operated (n=7) and 
Operation- Naïve (n=6) Hemispheres 
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Figure 60 Timepoint 1 and 2 Hemispheric Scores (Right n=4; Left n=7) for 
Non-Surgical patients with Follow-up Control Group 
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7.8.6.2. Hemispheric Score Change and Clinical Description  
Qualitative hBOLD CVR scores were divided into three categories better, same or 
worse depending on whether the scores respectively decreased, remained the 
same or increased respectively between the first and second study.  
  
7.8.6.2.1. Operated Hemisphere Score Change and Clinical Description 
In the operated hemisphere (n=14) scores remained the same pre and post-
operatively for 8 hemispheres, were better (lower) in 4 hemispheres and worse 
(higher) in 2 hemispheres.  The two children who had worse scores (score change 
2 to 3) had NF1 (one right, one left moyamoya; Patients 5 and 6 respectively Table 
56).  Clinically Patient 5 improved following surgery, while Patient 6 had TIAs in the 
early post-operative period which resolved within 3 months, and persistent 
headache.   (Table 60) 
 
7.8.6.2.2. Operation Naive Hemisphere Score Change and Clinical 
Description 
In the operation naïve hemisphere (n=10) scores remained the same pre and post-
operatively in 5 hemispheres, were better (lower) in 2 and worse (higher) in 3.  Of 
the children whose scores deteriorated one (Patient 12) had bilateral Idiopathic-
MM, one (Patient 4) left NF1-MM and one (Patient 1) bilateral Chromosomal-MM 
(Trisomy 21).  Score change was 1 to 3 in the first and 2 to 3 for the latter two 
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children.  Patient 12 (Idiopathic, bilateral MM) had new onset left TIAs on the 
operation-naïve hemisphere. Patient 1 (Trisomy 21, bilateral MM) had de novo 
right TIAs and subsequently had left pial synangiosis. Patient 4 (NF1, unilateral 
MM) clinically improved following surgery. Pre and post-operative hypercapnic 
challenge method was different in this patient (RM first study, BH second study) 
(Table 60, 61 and 62; Fig 61). 
 
7.8.6.2.3. Non-Surgical Control Group with Follow-up Hemisphere Score 
Change and Clinical Description 
In the control (n=7) right hemisphere scores remained the same between T1 and 
T2 for 4 hemispheres, were better (lower) in 3 hemispheres and lower (worse) in 0 
hemispheres.  In the control (n=7) left hemisphere scores remained the same 
between T1 and T2 for 3 hemispheres, were better (lower) in 2 hemispheres and 
higher (worse) in 2 hemispheres.  
The two patients who had worsening of scores had bilateral MM (one idiopathic, 
one SCD).  Patient 1 had prior revascularization surgery with symptomatic 
improvement.  Worsening in CVR scores was followed by clinical deterioration and 
increase in ischaemic symptoms.  She subsequently had a further 
revascularization procedure.   Patient 30 remained clinically stable on a regular 
transfusion programme.   (Table 60, 62 and 63. Fig 61)  
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Table 60 Pre and Post Revascularization Hemispheric Scores and hBOLD MRI Timepoint 1 and Timepoint 2 
Hemispheric Scores 
 
CVR 
Scores 
Surgery No Surgery 
  Operated  
Hemispheres 
N=14 
 
Pre     Post 
p 
 
 
Operation 
Naïve 
N=10 
 
Pre     Post 
p Right hBOLD 
CVR 
N=7 
   
T1        T 2 
p Left hBOLD 
CVR 
N=7 
 
T1        T2 
p 
Mean 
 
2.5 
 
2.4 
 
0.829 1.75 
 
1.9 
 
.784 2.6 
 
2.1 
 
0.149† 2.6 
 
2.4 
 
0.713 
             
Score 
Change 
(%) 
B 
S 
W 
  
 
4 (29) 
8 (57) 
2 (14) 
   
 
2 (20) 
5 (50) 
3 (30) 
   
 
3 (43) 
4 (57) 
0 (0) 
  
 
 
 
 
2 (29) 
3 (43) 
2 (29) 
 
Wilcoxon matched-pair test p>0.5 
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Table 61 Deterioration in Score and Clinical Change in Operated Group 
Patient MM 
Diagnosis 
MM 
Laterality 
Op Hem Score 
Change Op 
Hemisphere 
Score 
Change 
Op Naïve 
Hemisphere 
Hypercapnic 
Method 
Pre-post-op 
Clinical Course Pre-
post op 
Progress 
5  NF1 Right Right 2 to 3 1 to 1 BH-BH Improved HA Stable 
6 NF1 Left Left 2 to 3 1 to 1 GA-GA AIS pre-op  
TIA post-op 
Persistent patchy 
frontal deficit on 
ConA and HA. LD 
1  Trisomy 21 Bilateral Right 2 to 1 1 to 3 GA-GA R TIAs post-op L pial 
4 NF1 Left Left 3 to 3 2 to 3 RM-BH Improved HA Stable 
12 Idiopathic Bilateral Left 3 to 3 2 to 3 RM-RM L TIAs post-op R pial 
Op Hem=operated hemisphere, Pre-post op=clinical course, HA=headache, LD=learning difficulties, L pial=left pial synangiosis, 
R pial=right pial synangiosis 
 
 
 
Table 62 Deterioration in Score and Clinical Change in Non-Surgical Controls with Follow-up 
Patient MM 
Diagnosis 
MM 
Laterality 
Score Change 
Right 
Hemisphere 
T1 T2  
Score 
Change Left 
Hemisphere 
T1 T2 
Hypercapnic 
Method 
T1 T2 
Progress 
1  Idiopathic Bilateral 3 to 3 2 to 3 BH-BH Clinical improvement following prior bilateral 
hemisphere revascularization surgery. Subsequent 
deterioration in clinical symptoms predated by 
deterioration in CVR. 
Omental free-flap procedure 2010 
6 SCD Bilateral 3 to 3 2.5 to 3 BH-BH Stable 
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Table 63 Change in Scores in Revascularization Surgery Group and Non-Surgical Controls with Follow-up by 
Moyamoya Laterality 
 hBOLD CVR Change  
Moyamoya 
Laterality 
Revascularization Surgery Controls 
 Operated 
N=14 
Operation-Naïve 
N=10 
T1 
N=7 
T2 
N=7 
 Better Same Worse Better Same Worse Better Same Worse Better Same Worse 
Bilateral  2 5 1 1 1 2 2 3 0 1 2 2 
Right 0 1 1 0 2 0 1 0 0 1 0 0 
Left 2 2 0 2 0 2 0 1 0 0 1 0 
             
Fisher’s exact p= 0.556; 0.360; 1.0; 1.0 
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Figure 61 Hemispheric Score Change in Operative and Operation Naive 
Hemispheres in patients who were clinically better (blue bars), unchanged 
(green bars) or worse (light brown bars) 
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7.8.6.3. Pre and post-operative Hemispheric Score Change by Moyamoya 
Laterality 
Cross-tabulation of change in hBOLD CVR scores by moyamoya laterality was 
performed.  Using Fishers’ exact test there was no statistically significant 
association between the hBOLD CVR change score and moyamoya laterality.  
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7.8.6.4. Moyamoya Laterality and Clinical Change in Surgical and Non 
Surgical Controls with Follow-up Group 
To assess the association between clinical change and moyamoya laterality, 
clinical change between time of decision to proceed with surgery and post-surgical 
evaluation in the surgical group and clinical assessment closest to time point 1 and 
time point 2, clinical change was scored as follows and Fisher’s exact test used for 
analysis: 
1 = remained asymptomatic or improvement in symptoms 
2 = no change/persistence of previous symptoms 
3= worsening of previous or new/different symptoms 
In the surgical group 3 children, all of whom had bilateral MM, had worsening of 
existent or new symptoms.  The rest (n=9) of the children had improvement in 
symptoms or remained asymptomatic.  Fisher’s exact 3.08, p=.209 Spearman’s 
correlation .548, p=.065 (Table 64 and 65). 
Table 64 Clinical Change by Moyamoya Laterality in Surgical Group 
 Clinical Change Score  
Moyamoya 
Laterality 
Asymptomatic 
or Improved 
New or Worse Total 
Right  2 0 2 
Left  4 0 4 
Bilateral 3 3 6 
Total 9 3 12 
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All children in the no intervening surgery group had initial improvement in 
symptoms or remained asymptomatic.  However, five (5/7) had a prior intervention 
(ie revacularization surgery) or non-surgical intervention (blood transfusion or bone 
marrow transplant) between hBOLD CVR studies. There was no clinically 
significant difference in clinical change score between the surgical and no 
intervening surgery group (Fisher’s exact 1.53. p=1.00; Tables 64 and 65) 
 
Table 65 Clinical Change by Moyamoya Laterality in Control Group 
 Clinical Change Score  
Moyamoya 
Laterality 
Asymptomatic 
or Improved 
Same or 
Persistent 
Total 
Right  1 0 1 
Left  1 0 1 
Bilateral 4 1 5 
Total 6 1 7 
 
 
I sought to further explore whether comorbidity was associated with clinical change 
score. Using Fisher’s exact test there was no significant association between 
comorbidity or moyamoya laterality and clinical change scores (p > 0.5 for all 
categories). 
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Table 66 Change in Scores in Revascularization Surgery Group and Non-Surgical Controls with Follow-up by 
Comorbidity 
MM Disease 
or Syndromic 
Diagnosis 
Revascularization Surgery Controls 
  Clinical Symptoms Clinical Symptoms 
Operated Operation-Naive T1 T2 
 Better Same Worse Better Same Worse Better Same Worse Better Same Worse 
Idiopathic 1 4 0 1 1 1 0 2 0 0 1 1 
NF1 1 2 2 2 2 1 1 1 0 1 1 0 
SCD       1 1 0 0 1 1 
Chromosomal 2 2 0 0 0 2 1 0 0 1 0 0 
 
Fisher’s exact test; p=.494; .771; .771; 1 
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7.8.7. Serial hBOLD CVR Hemispheric Pixels 
Ten of thirty-seven children (twenty hemispheres) had pre and post-operative 
hemispheric pixels available or suitable for analysis.  On inspection mean PTPP 
was lower in the ‘to be’ operated (ipsilateral) hemisphere (.418 +/- .13) than the 
‘not to be’ operated (contralateral) hemisphere (.613 +/- .18), and the operated 
(ipsilateral) hemisphere (.463 +/- .16) than the operation-naïve (contralateral) 
hemisphere (.57 +/- .13).  There was a correction toward a mean PTPP ratio of 0.5 
in the operated and operation naïve hemispheres.  Using the paired t-test there 
was a trend toward these differences being significant in all but the NTNP post 
operated and post operation-naive hemispheric pairings.   
There was a trend toward significant difference in pre and post-operative NTNP 
pixel means in the operated hemisphere. There was no statistically significant 
difference in pre and post-operative hemispheric pixels within the surgical and non-
surgical group for all other hemispheric pixel studies (all p>0.05).    There was no 
statistically significant difference in mean pre and post-operative pixels in the 
surgical or no intervening surgery group by moyamoya laterality (Table 67 and Figs 
62–65). 
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Table 67 Pre and Post-operative Mean Hemispheric Pixels and Non-Surgical Controls with Follow-up 
 
† trend toward significant difference  
 
CVR 
Pixels 
Surgery No Surgery 
Operated 
 
N=12 
Pre     Post 
t-test 
p value 
 
 
Operation Naïve 
N=8 
Pre     Post 
t-test 
p value 
Right hBOLD 
CVR 
N=7 
1                  2 
t-test 
p 
valuet 
Left hBOLD 
CVR 
N=7 
1               2 
t-test 
p value 
 
 
 
PTPP 
mean 
(SD ) 
 
.418 
(.13) 
mean 
(SD) 
 
.463 
(.16) 
 
 
 
.51 
mean 
(SD) 
 
.613 
(.18) 
mean 
(SD) 
 
.57 
(.13) 
 
 
 
.64 
mean 
(SD) 
 
.47 
(.073) 
mean 
(SD) 
 
.51 
(.057) 
 
 
 
.34 
mean 
(SD) 
 
.53 
(.073) 
mean 
(SD) 
 
.48 
(.056) 
 
 
 
.32 
 
PTNP 
 
 
.16 
(.18 ) 
 
.24 
(.37) 
 
.37 
 
.17 
(.22) 
 
.10 
(.17) 
 
.57 
 
.16 
(.128) 
 
.1 
(.095) 
 
.4 
 
.16 
(.117) 
 
.13 
(.107) 
 
.64 
 
NTNP 
 
 
.57 
(.17) 
 
.39 
(.18) 
 
.077
†
 
 
.38 
(.17) 
 
.39 
(.28) 
 
.91 
 
.424 
(.136) 
 
.373 
(.139) 
 
.21 
 
.56 
(.105) 
 
.6 
(.132) 
 
.34 
 326 
Figure 62  Pre and Post-operative Hemispheric Pixels in Operated (n=12) and 
Operation Naive (n=8) Hemispheres 
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Figure 63  Pre and Post-operative Hemispheric Pixels in Bilateral MM 
Operated (n=6) and Operation Naive (n=2) Hemispheres 
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Figure 64  Pre and Post-operative Pixels in Unilateral MM Operated (n=6) and 
Operation Naive (n=6) Hemispheres  
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Figure 65  Prepost Controls (n=7) - Change in Hemispheric Pixels Over Time 
Without Intervening Surgery 
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Clinical change scores were compared with hemispheric pixel change scores in 
the operated and operation naïve in the surgical group, and the right and left 
hemispheres in the no intervening surgery group.  Using Fisher’s exact test and 
Spearman’s correlation there was a statistically significant association between 
operated hemisphere PTNP and clinical change score Fisher’s exact 4.967, 
p=0.05.   There was no other statistically significant association between the pre 
and post-operative CVR and clinical change scores (all p>0.5). 
There was no significant difference in CVR score change or clinical score change 
in the operated and operation naïve hemispheres in the surgical group when 
divided by age of moyamoya diagnosis (less than compared to equal and more 
than 9 years; all p>0.05). 
 
7.8.8. Quantitative hBOLD CVR Pre and Post Revascularization 
Surgery 
Three of six children with calculable quantitative CVR had measures pre and post-
surgery.  Two (2/3) of the children had Idiopathic-MM (one bilateral, one 
unilateral), (1/3) Chromosomal-MM (Trisomy 21, unilateral).  Pre-operative CVR in 
the ‘to be’ operated hemisphere ranged from .32 to .49.  Patient 2 had bilateral 
hemispheric surgery at the same time point.  Post-operative CVR in the operated 
hemisphere increased and ranged from .51 to 1.14.  Notably pre-operative 
operation-naïve hemisphere CVR was .42 and .6 and post-operative CVR .65 to 
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.91.  Hence there was post-operative improvement in CVR in the operation and 
operation-naive hemisphere.  There was a trend toward the pre and post 
quantitative CVRs being significantly different. (Ref Tables 68- 70; Fig 66) 
 
Table 68 Quantitative hBOLD CVR Pre and Post Revascularization Surgery 
Patient MM  
Class 
MM 
Lat  
(B/R/L) 
Surg 
Hem 
(B/R/L) 
Operated 
Hemispheric 
hBOLD CVR 
n=4 
p Not Operated 
Hemispheric 
hBOLD CVR 
n=2 
Pre Post Pre Post 
2 Tri 
21 
B B .39 
.32 
1.14 
.72 
   
8 Id B R .49 .89  .42 .91 
11 Id R R .43 .51  .6 .65 
      .059   
  
Table 69 hBOLD CVR1 (baseline CVR) Values by Moyamoya Laterality 
 hBOLD CVR1  %/mmHg  
mean 
CVR Brain 
Region 
 
All Moyamoya Laterality 
 
n=3  
Bilateral  
n=2 
Right 
n=1 
Whole 0.363 0.38 0.38 
Right 0.401 0.44 0.43 
Left 0.418 0.373 0.6 
 
Table 70 hBOLD CVR2 (Follow-up CVR) Values by Moyamoya Laterality 
 hBOLD CVR2  %/mmHg 
mean  
CVR Brain 
Region 
 
Moyamoya Laterality 
All 
n=3 
Bilateral  
n=2 
Right 
n=1 
Whole .735 .85 .62 
Right .762 1.015 .51 
Left .732 .815 .65 
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Figure 66 Pre and post-operative Hemispheric hBOLD CVR 
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Figure 67  Pre and post-operative conventional angiogram 
 
 
 
15 old girl with bilateral moyamoya.  1A:  Right lateral ICA injection 
demonstrating reasonably good hemispheric perfusion prior to 
revascularization surgery 
1B:  Left lateral ICA injection demonstrating poor frontal and parieto-occipital 
perfusion prior to revascularization surgery 
2A:  Right lateral ICA injection demonstrating progressive occlusion and 
deterioration in right hemisphere perfusion 
2B:  Right lateral ECA injection demonstrating limited effect of synangiosis  
2C:  Left lateral ICA injection demonstrating progressive poor frontal and 
parieto-occipital perfusion 
2D:  Left lateral ECA injection demonstrating synangiosis within frontal and 
parietal regions 
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Figure 68  Pre and post-operative hBOLD CVR parametric maps 
 
 
 
 
 
 
  
Top row:  Pre-operative hBOLD CVR Parametric maps demonstrating bilateral 
reduced positive (yellow) reactivity (left more than right) and minimal bilateral 
steal.   
 
Bottom row:  Post-operative hBOLD CVR parametric maps demonstrating 
improved positive reactivity in left hemisphere and worsened positive reactivity 
(ie less yellow) and increased negative reactivity (purple) in right hemisphere 
in keeping with changes seen on conventional angiography and scoring. 
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7.9. Discussion 
Standard indications for surgery include symptomatic presentation (stroke, TIA or 
seizures) progressive radiological findings ie vascular and or parenchymal.  
Ischaemic stroke – in particular bilateral – results in significant neurological injury, 
morbidity and mortality.  In this study I sought to explore how hBOLD CVR 
changes in response to revascularisation surgery and over time. 
 
7.9.1. Group Description and Clinical Presentation                                                       
The majority of children in this sub-population (n=20, surgical and control) had 
bilateral MM (6 Idiopathic-MM; 3 Trisomy 21; 2 SCD).  The majority (5/7) of 
children with left MM had NF1-MM.  Of the intervening surgery group, only two 
(Chromosomal-MM/ Trisomy 21) presented with AIS, three (Idiopathic-MM) TIAs.  
Almost half (6/13) had headache only or were asymptomatic at diagnosis (5 NF1-
MM, 1 Turners Syndrome).  One had seizures and headache, the other 
paroxysmal symptoms (both Idiopathic-MM).  The majority in the control group had 
a history of ischaemic symptoms. Two out of the seven (1 with NF1-MM, 1 SCD-
MM) were asymptomatic.  All children in our group had adequate collateralisation 
on conventional angiography.  Hence this is not a reliable sole discriminator of 
adequacy of tissue perfusion and indication for surgery.   
Published Japanese and US indications for revascularization surgery include 
presentation with ischaemic symptoms; progressive vasculopathy; decreased 
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regional cerebral blood flow, vascular response and perfusion reserve, retrieved 
from cerebral circulation and metabolism studies (Roach et al. 2008, Research 
Committee on the et al. 2012, Smith and Scott 2012).  These would be similar 
worldwide and applied according to regional resources.  However, PET, SPECT 
and Tc-99m HMPO are all associated with a risk of radiation exposure, are 
technically challenging, have poor spatial resolution high capital costs (Lee et al. 
2009);(Frush et al. 2003).  Measures from conventional or digital subtraction 
angiography such as arterial circulation time (ACT) may be used to calculate 
haemodynamic status.  However, there is a growing reluctance to perform ConA in 
children due to safety concerns compounded by an increase in early diagnosis of 
MM in asymptomatic children in whom the risk of an invasive angiographic 
procedure may be even less acceptable.  Despite attempts to demonstrate parity 
in findings between these two angiographic modalities standard MRI and MRA 
ability to inform on haemodynamic status is confined to demonstration of 
parenchymal ischaemic injury, presence of the ivy sign, signal attenuation on TOF 
MRA and presence of collaterals (Saeki et al. 2000).  MRA has been shown 
overcall degree of parent artery stenosis and under call collateralization again 
limiting it’s utility in determining haemodynamic status. Based on their study of 
radiographic and clinical progression in children with asymptomatic MM and a 
demonstration of radiographic and clinical progression in their group comprised of 
children with SCD-MM and NF1-MM Lin et al recommended revascularization 
surgery in the majority even If asymptomatic (Lin et al. 2011). However, young 
 337 
children (under 3 years) with a symptomatic presentation of moyamoya under 
have poor cognitive outcomes (Matsushima et al. 1990); and a more clinically 
fulminant course (Imaizumi et al. 1998, Kim et al. 2004) (Jackson et al. 2014). 
Furthermore specific indications to guide the timing and type (unilateral or 
bilateral) surgery in asymptomatic or incidentally diagnosed moyamoya are not 
well established. This is coupled with the absence of longitudinal outcome data in 
the young asymptomatic group. Therefore the potential risks of surgery in the 
young requires careful consideration (Soriano et al. 1993, Jackson et al. 2014).  
 
7.9.2. Pre and post-operative concordance of CVR Abnormality 
and Angiography 
As noted in the previous chapter (Chapter 5) hBOLD CVR abnormality was 
concordant with laterality of moyamoya pre-operatively and (from this study) post-
operatively.   
Pre-operative hBOLD CVR results are suggestive of disruption of CVR and 
consequent perfusion in the affected and un- or less severely affected 
hemisphere.   The dynamic response and shifting of the un- or less affected 
watershed to support the abnormal or less affected hemisphere may itself be a 
stressor on the unaffected side.  It is not known whether this shift in watershed to 
support the affected hemisphere may result in functional compromise on the 
unaffected side over time.  The finding of abnormality of qualitative CVR, evident 
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beyond the ipsilateral diseased vascular territory into the non-infarcted, 
contralateral healthy appearing vascular territory and parenchymal tissue in 
unilateral moyamoya would suggest contralateral tissue level compromise. These 
regional abnormalities in hBOLD CVR were evident despite apparent adequate 
pre-operative self-collateralisation and are in keeping with the findings of Han et al. 
2011. 
Post-operatively there was a correction in region of hBOLD CVR abnormality 
toward the ipsilateral diseased hemisphere, such that the contralateral 
hemispheric abnormalities appeared to improve, again most clearly seen in those 
with unilateral disease, although numbers were small and the data must be 
interpreted with caution.  This change is likely to be captured by measurement of 
angiographic arterial circulation time (ACT) not done in our group (Donahue et al. 
2013). 
 
7.9.3. Pre and post-operative hBOLD CVR scores and clinical 
change 
7.9.3.1. Surgical Group 
7.9.3.1.1. Operated hemisphere 
Mean hemispheric scores in the pre-operative operated hemisphere were higher 
than in the operation naïve and healthy (in unilateral MM) or less diseased (in 
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bilateral MM) hemisphere. This would suggest concordance of tissue level 
microvascular dysfunction with clinical presentation.  
The majority (8/14) of hemispheric scores on the surgical hemisphere remained 
the same post-operatively.  Four of fourteen improved and two were worse.  Of the 
two with worse post-operative scores one clinically improved and the other had 
progressive ischaemic symptoms which resolved in the early post-operative 
period.  The latter child had persistent areas of avascularity on conventional 
angiography post-operatively, despite the improvement in some clinical 
symptomatology.    
 
7.9.3.1.2. Operation naïve hemisphere 
Five out of 10 hemispheric scores remained the same in the operation naïve 
hemisphere, two improved and three worsened.  Two of the three children with 
worsened scores had bilateral MM and progressive ischaemic symptoms referable 
to the operation naïve hemisphere.  Both children subsequently had 
revascularization surgery of the operation naïve hemisphere.  One of the three 
children with worse scores had unilateral NF1-MM and clinically improved post-
operatively.  hBOLD CVR method was different between studies and score 
change was from 2-3.   
Therefore post-operative worsening of scores occurred in five children (two in the 
operated hemisphere, three in the operation naïve hemisphere) and was predictive 
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of worsening ischaemic symptoms in 3/5 (60%).  The two with worsening of scores 
but improvement in clinical symptoms probably reflect the previously noted limits 
of the scoring system to discriminate between degree of abnormality of hBOLD 
CVR ie between 2 and 3, and the additional difficulty in scoring different method 
serial hBOLD.  Therefore in the majority the worsening of scores was indicative of 
tissue level functional cerebrovascular impairment despite operation in the 
operative hemisphere (unilateral MM) and contralateral operation naïve 
hemisphere (bilateral MM).  This would support consideration of bilateral 
revascularization surgery in children with bilateral MM at the same surgery or 
closer time-points.  
Just over half of the scores remained the same post-operatively in the operated 
and operation-naïve hemispheres despite the majority of children clinically 
improving post-operatively.  This is somewhat unexpected for the operative 
hemisphere.  This may be a limitation of the scoring system, method or real.  If 
real this would suggest that the functional CVR at the tissue level did not 
significantly improve post-operatively.  In all cases post-operative super-selective 
angiography demonstrated improved collateralization from the external circulation 
and hence improved perfusion.  This should result in increased BOLD signal within 
the region of interest (the operative hemisphere) and reduced capillary bed 
vasodilatation given the improved distal perfusion, with consequent secondary 
improvement in cerebrovascular reactivity.  Bowen et al (1998) demonstrated 
improved bloodflow on Xenon-CT CBF studies following revascularizaton surgery.  
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However, it is also possible that despite improvements in perfusion, vasodilatory 
capacity may not be regained in certain conditions where the post-stenotic 
dilatation has become more fixed, less compliant and and able to recover it’s 
original diameter. This may occur when the fixed proximal steno-occlusive disease 
co-exists with for example, chronic anaemia or chronic hypertension.  In addition 
recent studies of post-operative neurological decline have demonstrated that 
changes in cerebral haemodynamics are not always favourable.  Post-operative 
cerebral hyperperfusion, oedema and shifting watershed have all been implicated 
– all of which would negatively affect CVR. (Hayashi et al. 2010) This requires 
further exploration in future studies.   
 
7.9.3.2. Control Group 
Most of the control group were pre-treated in as much as they had 
revascularization surgery (2/7), a BMT (1/7) and blood transfusion (2/7).  Hence, 
the group was controlled for intervening surgery only. 
Scores worsened in two (bilateral MM: one idiopathic, one SCD) of the 14 second 
time point control hBOLD CVRs.  Of these two, one (idiopathic MM) had 
progressive worsening of CVR and ischaemic symptoms, and subsequently had 
further revascularization surgery.  The other remained clinically stable on a regular 
blood transfusion programme.  Blood transfusion occurred two days before the 
first hBOLD CVR study and one day before the second.  Haematological 
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parameters on the respective transfusion days were Hb 94, HbS 26%, Hct .280, 
Platelets 411 and Hb 100, HbS 21.4%, Hct .308 and Platelets 409.   Hence, 
worsening qualitative hBOLD CVR measures were indicative of clinical 
deterioration in children with bilateral disease one of whom was receiving ongoing 
treatment and the other had prior revascularization surgery and went on to have 
further revascularization surgery. 
The mean interval between revascularization surgery and the second CVR study 
was 1.08 years (13 months), SD .815 years and 2.35 years SD 1.72 for the no-
intervention group. This is a retrospective analysis and there was no protocol 
mandating a post-operative CVR at a specific timepoint. It is difficult to justify 
multiple CVR studies in children and there is no consensus on timing of post-
operative investigations. SPECT and proton magnetic resonance spectroscopy 
studies have demonstrated that the efficacy of revascularization surgery as shown 
by it’s effect on metabolism gradually appears within 3-6 months Uno et al. (Uno et 
al. 1996).  Hence, in this study adequate time for the efficacy of revascularization 
surgery to be apparent elapsed by the second CVR.  Arguably however, a more 
protracted interval may be confounded by the development of true new symptoms 
which is likely to have been the case in the two with worse CVRs who had 
concordant clinical deterioration. 
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7.9.4. Pre and post-operative hemispheric pixels and clinical 
change 
Mean hemispheric PTPP were lower in the ‘to be operated’ hemisphere than the 
contralateral hemisphere suggesting impaired CVR on the ‘to be operated’ 
hemisphere. Observed correction toward mean hemispheric pixel ratio of 0.5:05 in 
the operation and operation-naïve hemispheres is in keeping with the biological 
expectation of improved perfusion and CVR on the operated hemisphere post 
revascularization surgery and the concordant hBOLD qualitative CVR 
improvement and was observed in the surgical group.  There was a statistically 
significant association in clinical change scores for PTNP in the operated 
hemisphere of the surgical group.  This association was not seen in the remaining 
hemispheric pixel change scores.   
 
7.9.5. Pre and post-operative Quantitative hBOLD CVR change  
Changes in quantitative CVR pre and post-operatively were quite striking.  Pre-
operative measures were lower pre-operatively and higher post-operatively.  This 
is similar to the findings in the study by (Mikulis et al. 2005).  This was However, in 
a small sub-group of children and needs to be replicated in other studies.   
 
7.9.6. Clinical potential 
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This is the first reported study of children with moyamoya with consecutive 
qualitative CVR studies pre and post-operatively.  This is also the first study to our 
knowledge which reports pre and post-operative quantitative measures of CVR.  
Han et al. (Han et al. 2011) reported on post-operative CVR change in three 
children using the targeted-controlled delivery of CO2 method.  This study 
demonstrates that sequential and pre- and post- operative quantitative CVR 
studies are feasible in children and that region of abnormality as demonstrated on 
conventional angiography is concordant with region of abnormality on CVR.  
Furthermore in some cases the region of abnormality and suggestion of 
haemodynamic compromise at the tissue level extends beyond the region of 
abnormality as demonstrated on standard ConA, MRI or MRA.  In Han et al’s 
study (Han et al. 2011) two children had improvement in CVR and clinical 
symptoms post-operatively.  One child with sequential studies had worsening of 
CVR and development of ischaemic symptoms over time.  This is in keeping with 
the findings in our study.   
This may reflect the limitation of the devised scoring systems as well as the need 
for caution when interpreting different modality qualitative CVRs.   
Although there was a difference in qualitative and quantitative CVR measures 
between the ‘to be operated’ and operation naïve hemispheres, and pre and post-
operatively, this was not statistically significant. This may be because of our 
sample size, the method devised to generate quantitative measures or the 
absence of a significant difference.   This needs to be explored in future studies.  
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Revascularization surgery is not without risk of complication.  Complications 
include stroke, transient neurological deterioration and death.  In more recent 
literature transient neurological deterioration has been linked to post-operative 
focal hyperperfusion perhaps related to exhaustion of the cerebrovascular reserve, 
in part thought to be caused by a mismatch between OEF and CBV which both 
seem to be increased in pre and post-operative PET and SPECT studies.  
Postoperative cerebral hyperperfusion is defined as a major increase in ipsilateral 
cerebral blood flow (CBF) well above the metabolic demands of brain tissue 
(Sundt et al. 1981, Piepgras et al. 1988).  It is well characterized in adult patients 
after carotid endarterectomy and more recently so  in adult moyamoya (Furuya et 
al. 2004, Ogasawara et al. 2005, Kim et al. 2008, Kaku et al. 2012) 
Haemodynamically the risk appears to be represented by an increased OEF in the 
face of increased CBV which may be suggestive of maximized vasodilation 
reflecting exhausted autoregulatory reserve and hence higher risk of stroke.  This 
is in comparison to the presence of increased OEF and normal CBV (Ogasawara 
et al. 2005) which may reflect preserved vasodilatory and hence autoregulatory 
capacity and hence a lower risk of stroke (Derdeyn et al. 2002).  A combination of 
information derived from qualitative and quantitative CVR measures including 
absence of steal, low quantitative CVR measures and TIAs may be indicative of 
exhausted autoregulatory reserve and higher risk of stroke.  However, to my 
knowledge, to date hBOLD CVR measures have not been used to assess 
operative risk and as hBOLD CVR does not provide a direct measure of CBV, and 
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quantitative ranges of CVR values are yet to be determined, this remains an area 
for further study and exploration.  
 
7.10. Study Limitations and Future Directions  
1) Development and validation of quantitative and qualitative CVR indicators 
for surgery.  
2)  Development of CVR measures of surgical risk to allow for improved 
selection for surgery and post-surgical risk management. 
3)     Longitudinal serial measurements of hBOLD CVR in a larger cohort of 
asymptomatic and symptomatic children with moyamoya. 
 
7.11. Conclusions 
1) In this relatively small sample, qualitative hBOLD CVR abnormality appears 
to be concordant with region of abnormality as demonstrated on conventional 
angiogram, and appears to extend beyond the primary region of arteriopathy into 
unaffected vascular beds in the contralateral hemisphere. 
2)   If confirmed in a larger sample of children, progression in hBOLD CVR 
abnormality with corresponding clinical deterioration may be able to be used to 
inform decision timing of surgery in symptomatic and asymptomatic moyamoya. 
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3)  Regional abnormality in hBOLD CVR may improve following revascularization 
surgery in the corresponding vascular territory.   
4)  Lack of improvement of hBOLD CVR post revascularization surgery, despite 
clinical improvement, may reflect methodological limitations, exhausted 
autoregulatory capacity, or patchy tissue level functional compromise. 
 
 
 
8. CVR and Neuropsychological Outcomes 
8.1. Abstract 
8.1.1. Background:    
Moyamoya (MM) is a progressive cerebral vasculopathy associated with increased 
risk of arterial ischaemic stroke (AIS) and cognitive decline.  Hypercapnic blood 
oxygen level dependent (hBOLD) CVR allows assessment of cerebrovascular 
reactivity (CVR) and reserve (CRes).  There are few data on CVR and cognitive 
function. 
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8.1.2. Hypothesis:   
We hypothesized that in childhood MM abnormalities of left, right and total CVR 
are associated with reduced verbal IQ (VIQ), performance IQ (PIQ) and 
processing speed (PS) respectively and that executive function would be abnormal 
in children with abnormal CVR.  
8.1.3. Methods:   
Children with MM, with or without AIS prospectively completed hBOLD CVR and 
Wechsler scales of intelligence. Parents and teachers completed the BRIEF. CVR 
studies were scored per hemisphere and grouped by presence of steal. Scores of 
intellectual and executive function were analysed for each group.   
8.1.4. Results:   
27 children with moyamoya completed an hBOLD CVR study and age-appropriate 
Wechsler Intelligence Scales (mean age 10.2 years, range 4.1-16.3 years; SD 3.9 
years; 14 male, 13 female).  In eleven children with no history of overt stroke of 
revascularization surgery abnormality of left CVR was associated with lower verbal 
IQ and bilateral steal was associated with lower intelligence scores in all domains 
apart from processing speed.  Interestingly, indices of executive function were 
better (lower) in children with steal, although this result did not meet statistical 
significance.  
8.1.5. Conclusion:   
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Abnormalities of CVR are associated with cognitive impairment in paediatric 
MM. Impairment of CVR may represent increased ischaemic risk as demonstrated 
by abnormality of CVR.  However, the weighting of neurocognitive demise 
secondary to the chronic hypoperfusion of MM and neurocognitive demise 
secondary to disease specific factors in MMS and their relative manifestation in 
measures of CVR is yet unexplained. Further studies are required to explore the 
utility of hBOLD CVR as a biomarker for tissue level microvascular dysfunction In 
MMD and MMS so as to be able to determine risk of neurocognitive injury and 
ischaemia in children with MM.  
 
8.2. Introduction 
Untreated moyamoya disease and moyamoya syndrome may be associated with 
cognitive difficulties (Williams et al. 2012) and even decline (Imaizumi et al. 1999, 
Hogan et al. 2005) although this is not a universal finding (Lee et al. 2011). 
Intelligence quotient may be within the normal range in moyamoya disease in 
Asian children (Lee et al. 2011) but studies in North America have not found this 
(Williams et al. 2012). Traditional measures of cognitive ability such as IQ scores 
provide limited measures of cognitive function.  A few studies have reported on 
more sensitive measures of brain injury and disease (Bowen et al. 1998, Williams 
et al. 2012).  
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The underlying disease in moyamoya syndrome may have an independent effect 
on cognitive outcome, e.g in Sickle Cell Disease or Neurofibromatosis Type I, 
even when children with severe learning difficulties, e.g with Down syndrome, are 
excluded. However, although one study found a difference in cognitive 
performance between children with Sickle Cell Disease and those with Idiopathic 
moyamoya (Hogan et al. 2005), another did not (Williams et al. 2012).  The 
duration of symptoms probably plays a role, although this does not necessarily 
reflect the duration of vascular disease.  Most studies have included children with 
stroke (Imaizumi et al. 1999, Hogan et al. 2005, Williams et al. 2012) and there are 
few data on the effect of isolated vasculopathy, e.g. bilateral vs unilateral, or 
Suzuki stage and these are typically limited to Japanese populations (Suzuki and 
Takaku 1969, Maki et al. 1976).  
Bowen (Bowen et al. 1998) reported an improvement in overall cognitive ability 
following surgery, although this may not be seen in those with a ‘poor intelligence 
quotient/severe learning disability’ noted early on (Matsushima et al. 1997).  In 
addition, Matsushima et al. (Matsushima et al. 1990) reported poorer cognitive 
outcomes in children presenting under the age of two years compared with those 
presenting after two years and treated before nine years of age.  
Despite high individual variability, the left and right cerebral hemispheres display 
anatomical, molecular and functional left-right asymmetries that correlate with their 
functional specialization in particular cognitive processes. However, determination 
of the laterality of these cognitive functions in childhood is complex.  Historical 
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descriptions of patients with lesioned hemispheres in the nineteenth century 
informed us of the neuroanatomical correlates of cognitive functions (Duboc et al. 
2015).  Language is probably the most studied of these functions. In 1967 
Lenneberg suggested a critical period during which hemispheric dominance of 
language is established (2-12 year) (Lenneberg 1967).  More recent neuroimaging 
studies would suggestive early bilateral representation of language with left sided 
dominance occurring between early childhood and adolescence with synaptic 
growth spurts and developmental peaks (Thatcher et al. 1997). In comparison 
studies about the lataralizaton of right hemispheric function in childhood are few 
and therefore based on adult literature and experience (Holland et al. 2001, 
Ressel et al. 2008, Everts et al. 2009, Everts et al. 2010).  Cognitive functions 
such visuo-spatial perception, attention and performance IQ are more typically 
associated with the right hemisphere, whereas functions such as processing 
speed and executive function rely on recruitment of bilateral both cortical and sub-
cortical networks.   
In this study and based on the classic views on the lateralization of cognitive 
function, I sought to explore whether chronic hypoperfusion and abnormality in 
cerebrovascular reactivity, as seen in moyamoya, has ischaemic consequences 
measurable as neurocognitive outcome.   
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8.3. Study Hypothesis 
I hypothesised that measures of hBOLD CVR can be used to predict 
neurocognitive outcome in childhood MM, specifically: 
      i)  abnormal left hemispheric CVR is associated with reduced verbal IQ 
       ii)  abnormal right hemispheric CVR is associated with reduced performance 
IQ 
       iii) abnormal CVR in either or both hemispheres is associated with reduction in 
processing speed 
      iv)  abnormal CVR in either or both hemispheres is associated with 
abnormality in indices of executive function 
 
8.4. Method 
8.4.1. Inclusion criteria 
Children with a diagnosis of MMD or MMS and a neuropsychological assessment 
as follows were included in the study: 
Children aged between 6 and 16 years of age with cognitive assessments 
performed using the Wechsler Intelligence Scale for Children third edition (WISC-
III) or the WISC fourth edition (WISC-IV).   Children who were 16 years or older at 
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the time of assessment completed the Wechsler Adult Intelligence Scale, third 
edition (WAIS-III). 
Participants who were 4 to 5 years old completed the Wechsler Preschool and 
Primary Scale of Intelligence, third edition (WPPSI-III), which provides index 
scores for overall intellectual ability (Full-scale IQ), verbal ability (Verbal IQ), and 
non-verbal ability (Performance IQ), with a mean score of 100 and an SD of 15. 
Average scores, as specified by test developers, range from 90 to 110, compared 
with a ‘normal’ test score range which reflects statistical consideration of one SD 
from the mean (e.g. 85–115). We did not include additional measures of memory, 
attention, or language, or formally test executive function because of time 
constraints in these patients attending for clinical purposes. 
Executive function was assessed using the Behavior Rating Inventory of Executive 
Function, a standardized questionnaire completed by parents and teachers, which 
evaluates multiple aspects of executive function including emotional control, ability 
to transition between different activities, initiation, inhibitory control, working 
memory, planning, organization, and behavior self-monitoring (Gioia et al. 2000).  
The school-age version was used for participants aged 6 to 18 years, and the 
preschool version was used for participants aged 4 to 5 years. Both versions 
provide index scores for emotional–behavioral symptoms (Behavior Regulation ⁄ 
Inhibitory Self-Control Index [BRIS]) and cognitive symptoms (Metacognitive Index 
[MET]) of executive dysfunction, as well as an overall index of executive 
impairment (Global Executive Composite [GEC]). The normative sample has a 
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mean of 50 and an SD of 10. High scores are related to poorer functioning, with 
scores of 65 or greater considered significantly elevated and indicative of 
impairment (Williams et al. 2012). 
 
8.4.2. Exclusion criteria 
i) Children under the age of 4 years and over 18 years at the time of testing 
ii) Children with a history of whole brain radiation therapy 
iii) Children with a severe learning disability in the context of a genetic 
comorbidity such as Downs Syndrome were excluded from the analyses based on 
intelligence, as the underlying condition would have been a confounder and the 
focus was on the effect of moyamoya, but where possible parent and/or teacher 
reports of executive function were obtained.   
 
8.5. Results 
8.5.1. Group description  
8.5.1.1. Intellectual Testing 
27 children with moyamoya completed an hBOLD CVR study and age-appropriate 
Wechsler Intelligence Scales (mean age 10.2 years, range 4.1-16.3 years; SD 3.9 
years; 14 male, 13 female).  26 had full scale intelligence quotient (FSIQ) and 
verbal IQ (VIQ), 27 performance IQ (PIQ), 21 Wechsler memory scales (WMS), 
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and 22 Processing speed (PS).   Two children had a diagnosis of Trisomy 21 and 
significant learning difficulties hence their intellectual assessments were not 
usable.  Reports of executive function were obtained from parents and teachers 
using the Behavior Rating Index of Executive Function (BRIEF). 
The mean age of intellectual assessment of the whole group (n=27) was 10.44 
years, range 4.08-16.33, SD 3.86 years. 
The hBOLD CVR study closest to the time of intellectual assessment was chosen 
for analysis.  The mean time between hBOLD CVR and IQ assessment was 8.7 
months (range 15 days – 4 years; SD 12 months).   
 
8.5.1.2. Clinical Description 
The mean age at moyamoya diagnosis of the whole group with intellectual 
assessments (n=27) was 8.75 years, range 0.83-15.58 years, SD 3.57 years. 
Twelve children had a clinically overt stroke.  The mean age of overt stroke was 
7.6 years, range 0.75 – 14.2, SD 4.2years. Of the children with overt stroke two 
(overt strokes) occurred after the intellectual assessment so they were included in 
the no stroke group.  Therefore 17 children with moyamoya and no antecedent 
history of overt stroke had an intellectual assessment.  
The mean age of intellectual assessment in the group with overt stroke (n=10) was 
11.1 years SD 3.69 years. The mean age of intellectual assessment in the group 
without an overt stroke (n=17) was 10.03 years SD 4 years.  There was no 
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statistically significant difference in age of intellectual assessment between the 
overt stroke and no overt stroke groups independent of arteriopathy (disease or 
syndrome) diagnosis.   
The mean interval between intellectual assessment and hBOLD CVR for the 
stroke and no stroke groups was 12.1 months, SD 11.8 months and 7.2 months, 
SD 12.1 months respectively (Table 71). 
 
Table 71 Clinical Description of Patient's with Intellectual Assessments 
 All patients 
 
 
n = 27  
Moyamoya 
disease 
 
n = 11 
Moyamoya 
syndrome 
 
n = 16 
Arteriopathy Laterality 
        Bilateral  
        Right 
        Left 
 
 
16 
4 
7 
 
 
8 
2 
1 
 
 
8 
2 
6 
Mean age at diagnosis  
  years (SD) 
 
 
8.75 (3.57) 
 
8.46 (3.18) 
 
8.88 (3.78)^ 
Mean age at intellectual 
assessment  
  years (SD)  
    
 
10.44 (3.87) 
 
 
10.13 (3.78) 
 
 
10.65 (4.03)^ 
Stroke (%)  
  Mean age at stroke  
   years (SD) 
 
10 (37)  
 
7.15 (4.14) 
 
7 (64) 
 
7.55 (3.9) 
 
5 (31) 
 
7.58 (4.99)^ 
 
Radiographic Findings 
(Y:N) 
    Not ischaemic 
    Cortical 
    Watershed 
       (Deep white matter) 
       (Cortical) 
 
 
7 
1 
8 
(8) 
(1) 
 
 
2 
0 
3 
(3) 
(0) 
 
 
5 
1 
5 
(5) 
(1) 
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    Cortical ischaemic and     
    Watershed 
    Other 
     
10 
 
1 
5 
 
1* 
5 
 
0 
^Mann-Whitney U, p>0.05 * left hemiatrophy 
8.5.2. Steal, Intellectual and Executive Function in Whole Group 
To test my hypothesis and examine for an association between CVR abnormality  
as demonstrated by the presence of steal, hypothesised to represent more severe 
haemodynamic compromise, and intellectual outcome BOLD CVR scores were 
recategorized into 2 groups: significant steal (CVR score 3 in either hemisphere) 
and no significant steal (CVR score of less than 3 in both hemispheres).  Eighteen 
of twenty seven children had significant steal: 9 male, 9 bilateral, 4 right and 5 left 
sided steal. Of the 9 without steal 5 were male, 6 had bilateral, 1 right and 2 left 
sided moyamoya.   
 
8.5.2.1. Effect of Steal on full scale, verbal and performance IQ, and on 
working memory index and processing speed index 
Although mean scores were mostly higher and within normal range in those with 
steal, two sided t-test revealed that the mean scores for FSIQ, VCI, PRI, WMS and 
PSI did not differ between children with steal and no significant steal (Table 72, Fig 
69). 
 
 
Table 72 Weschler Intelligence Scale Intelligence Scores (WISC) by Presence of 
Significant Steal 
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Steal 
 Yes           No 
mean        mean 
(SD)         (SD) 
n=17            n=8 
Mean 
difference 
(CI) 
 
p value 
 
FSIQ 90.1 
(20.09) 
83.4 
(19.72) 
-6.63 
(-25.47- 12.2) 
ns 
VCI 93.9 
(13.4) 
85.1 
(16.6) 
-8.8 
(-22.37- 4.78) 
ns
 
PRIQ 91.12 
(23.6) 
84.9 
(21.9) 
-6.24 
(-26.72- 14.23) 
ns 
WMS 88.5 
(21.32) 
84.4 
(22.5) 
-4.14 
(-28.27- 20) 
ns 
PS 91 
(17.02) 
83.8 
(10.9) 
-7.2 
(-24.56- 10.16) 
ns 
t-test  
Figure 69 Weschler Intelligence Scale Intelligence Scores (WISC) by 
Presence of Significant Steal 
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8.5.2.2. Effect of Steal on Parent and Teacher BRIEF scores of executive 
function 
 
Available mean scores of executive function were lower for patients with steal than 
those without steal in both Parent and Teacher reports for two of the three 
composite scores (GEC and BRI). There was a trend toward significant difference 
in composite scores for MET with higher scores being in the no steal group.   
Parent and Teacher mean scores for monitoring and Teacher mean scores for 
initiation were significantly lower in those with steal than those without steal.  
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There was a trend toward difference by steal for working memory and shift (Table 
73 and Fig 70 and 71). 
 
 
 
Table 73  Linear regression for effect of unilateral and bilateral steal vs no steal on 
scores of intelligence 
 
 Parent Teacher 
 Steal 
Yes           No 
mean        mean 
(SD)         (SD) 
n=16         n=8 
 
mean 
difference 
(CI) 
 
p 
value 
Steal 
Yes            No 
mean          
mean 
(SD)          (SD) 
n=16           n=7 
 
mean 
difference 
(CI) 
 
p 
value 
Inh 54.8 
(9.75) 
64.6 
(8.82) 
9.8 
(1.32-18.31) 
.026* 53.4 
(10.65) 
62.6 
(18.06) 
9.2 
(-3.24-21.66) 
ns 
 
Shift 55.8 
(12.28) 
68 
(13.72) 
12.25 
(.79-23.71) 
.057† 57.9 
(12.25) 
71.6 
(18.81) 
13.7 
(.096-27.3) 
.05* 
EmC 56.3 
(14.1) 
61.8 
(10.38) 
5.5 
(-6.2-17.2) 
ns 54.4 
(11.31) 
70.4 
(16.1) 
16 
(3.86-28.13) 
.012* 
Initi 57.6 
(14) 
66 
(8) 
8.36 
(-3.7-20.41) 
.16 60.2 
(10.71) 
72 
(10.2) 
11.79 
(.527-23.05) 
.035* 
WMT 60.8 
(12) 
71.4 
(13.14) 
10.56 
(-.54-21.66) 
.06† 59.2 
(12.46) 
71.9 
(17.91) 
12.67 
(-.742-26.08) 
.063† 
Plan 61.1 
(11.71) 
71.7 
(9.41) 
10.66 
(.19-21.14) 
.046* 59.7 
(10.71) 
65 
(8.23) 
5.31 
(-4.17-14.79) 
ns 
Org 55.9 
(9.54) 
55.6 
(5.68) 
-.36 
(-.86-7.89) 
ns 55.3 
(12.69) 
75 
(29.15) 
19.71 
(.473-39) 
.045* 
Mon 57.5 
(9.5) 
68.6 
(10.11) 
11.07 
(1.68-20.47) 
.023* 56.9 
(11.65) 
68.5 
(11.1) 
11.57 
(-.20-23.35) 
.054* 
BRI 56.7 
(11.67) 
67.4 
(9.75) 
10.71 
(.634-20.78) 
.038* 55.7 
(9.9) 
70 
(19) 
14.27 
(1.54-27) 
.03* 
MET 60.8 
(12.42) 
71.9 
(10.12) 
11.06 
(-.19-22.3) 
.054† 60.6 
(10.94) 
71.1 
(13.51) 
10.54 
(-.7-21.78) 
.064† 
GEC 59.6 
(11.4) 
71 
(7.81) 
11.44 
(1.55-21.33) 
.026* 58.94 
(11.15) 
71.4 
(16.23) 
12.49 
(.421-24.56) 
.043* 
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Flex 
n=1 
44 43   83 47 
 
  
t-test    * significant at the p</=0.05 level  
†
trend toward significance at the p<0.1 level 
 
Figure 70  Mean Parent Scores of Scales of Executive Function by Steal 
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Figure 71  Mean Teacher Scores of Scales of Executive Function by Steal 
 
 
 
 
 
8.5.2.3. Effect of Laterality of Steal on full scale, verbal and performance IQ, 
and on working memory index and processing speed index and on Parent 
and Teacher BRIEF scores of executive function 
To examine whether hemispheric abnormality of CVR was associated with specific 
neurocognitive deficits, scores of intellectual and executive function I used linear 
regression analysis with laterality of steal as the CVR measure and predictor.   
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8.5.2.3.1. Right, Left and Bilateral Steal and Neurocognitive Function 
Laterality of steal was not significantly predictive of Wechsler indices of 
intelligence scores.  There was a trend toward right sided steal being inversely 
associated with VCI, i.e. the greater the steal, the lower the VCI. Similarly, WMI 
was lower when left sided steal was higher (Table 74 and Fig 72). 
For indices of executive function, bilateral steal was significantly inversely 
associated with Parent and Teacher BRI, Parent MET and Parent GEC.  There 
was a trend towards bilateral steal predicting Teacher MET and Teacher GEC.  
Right sided steal was significantly inversely associated with Teacher GEC and 
there was a trend toward a significant relationship with Teacher BRI (Tables 75 
and 76; Fig 73). 
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Table 74 Linear regression for effect of right, left or bilateral steal vs no steal 
on IQ measures 
 
 R R
2 
Adj R
2
 F B SE for 
B 
Beta T p 
Full scale IQ 
Compared with 
no steal 
R Steal 
L steal 
Bilateral steal 
 
0.343 
 
0.117 
 
-0.022 
 
0.843 
 
 
 
11.321 
13.971 
-1.286 
 
 
 
12.529 
11.705 
10.685 
 
 
 
0.222 
0.298 
-0.031 
 
 
 
0.904 
1.194 
-0.120 
 
0.487 
 
0.378 
0.247 
0.905 
VCI Verbal IQ 
Compared with 
no steal 
R Steal 
L steal 
Bilateral steal 
 
0.468 
 
0.219 
 
0.095 
 
1.775 
 
 
 
17.107 
11.857 
1.867 
 
 
 
8.744 
8.168 
7.457 
 
 
 
0.452 
0.341 
0.060 
 
 
 
1.956 
1.452 
0.249 
 
0.186 
 
0.065** 
0.163 
0.806 
PRI 
Performance 
IQ 
Compared with 
no steal 
R Steal 
L steal 
Bilateral steal 
 
0.295 
 
0.087 
 
-0.044 
 
0.666 
 
 
 
9.375 
15.325 
-1.000 
 
 
 
14.251 
13.275 
11.644 
 
 
 
0.154 
0.274 
-0.021 
 
 
 
0.657 
1.154 
-0.086 
 
0.582 
 
0.518 
0.261 
0.932 
WMI 
Compared with 
no steal 
R Steal 
L steal 
Bilateral steal 
 
0.538 
 
0.289 
 
0.137 
 
1.898 
 
 
 
-8.400 
23.100 
-3.114 
 
 
 
16.379 
13.133 
11.463 
 
 
 
-0.129 
0.469 
-0.074 
 
 
 
-0.513 
1.759 
-0.272 
 
0.176 
 
0.616 
0.100** 
0.790 
PSI 
Compared with 
no steal 
R Steal 
L steal 
Bilateral steal 
 
0.252 
 
0.063 
 
-0.124 
 
0.339 
 
 
 
5.200 
11.200 
5.771 
 
 
 
12.148 
11.159 
9.740 
 
 
 
0.124 
0.299 
0.182 
 
 
 
0.428 
1.004 
0.593 
 
0.798 
 
0.675 
0.331 
0.562 
**Trend toward significance at level of p</=0.1 
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Table 75 Linear regression for effect of of right, left or bilateral steal vs no 
steal on Parent BRIEF measures of executive function 
 R R
2 
Adj R
2
 F B SE for 
B 
Beta T P 
Parent BRIS 
Compared with 
no steal 
R steal 
L steal 
Bilateral steal 
 
0.479 
 
0.229 
 
0.107 
 
1.881 
 
 
 
 
 
 
 
-7.375 
-8.375 
-13.804 
 
 
 
7.678 
6.465 
5.869 
 
 
 
-0.212 
-0.294 
-0.541 
 
 
 
-0.961 
-1.295 
-2.352 
 
0.167 
 
0.349 
0.211 
0.030* 
Parent Metacog 
Compared with 
no steal 
R steal 
L steal 
Bilateral steal 
 
 
0.643 
 
 
0.413 
 
 
0.315 
 
 
4.224 
 
 
 
 
-0.857 
-6.657 
-18.571 
 
 
 
 
7.221 
6.127 
5.593 
 
 
 
 
-0.024 
-0.226 
-0.700 
 
 
 
 
-0.119 
-1.086 
-3.320 
 
 
0.020 
 
0.907 
0.292 
0.004* 
Parent GECT 
Compared with 
no steal 
R steal 
L steal 
Bilateral steal 
 
0.612 
 
0.375 
 
0.276 
 
3.799 
 
 
 
-5.000 
-8.200 
-17.429 
 
 
 
6.176 
5.769 
5.267 
 
 
 
-0.167 
-0.299 
-0.708 
 
 
 
-0.810 
-1.421 
-3.309 
 
0.027 
 
0.428 
0.171 
0.004* 
 
  
 366 
Table 76 Linear regression for effect of right, left or bilateral steal vs no steal 
on Teacher BRIEF measures of executive function 
 R R2 Adj 
R2 
F B SE 
for B 
Beta T p 
Teacher 
BRIS 
Compared with 
no steal 
R Steal 
L steal 
Bilateral steal 
 
0.511 
 
0.261 
 
0.137 
 
 
2.115 
 
 
 
-19.333 
-9.400 
-15.571 
 
 
 
9.405 
7.980 
7.285 
 
 
 
-0.463 
-0.275 
-0.506 
 
 
 
-2.056 
-1.178 
-2.137 
 
0.134 
 
0.055** 
0.254 
0.047* 
Teacher 
Metacog 
Compared with 
no steal 
R Steal 
L steal 
Bilateral steal 
 
 
0.445 
 
 
0.198 
 
 
0.064 
 
 
1.482 
 
 
 
 
-14.810 
-6.943 
-11.286 
 
 
 
 
8.368 
7.101 
6.482 
 
 
 
 
-0.415 
-0.238 
-0.429 
 
 
 
 
-1.770 
-1.741 
-0.978 
 
 
0.253 
 
0.094* 
0.341 
0.099** 
Teacher 
GECT 
Compared with 
no steal 
R Steal 
L steal 
Bilateral steal 
 
 
0.523 
 
 
0.274 
 
 
0.159 
 
 
2.385 
 
 
 
 
-19.429 
-6.229 
-13.000 
 
 
 
 
7.947 
7.424 
6.777 
 
 
 
 
-0.545 
-0.190 
-0.442 
 
 
 
 
-2.445 
-0.839 
-1.918 
 
 
0.101 
 
0.024* 
0.412 
0.070** 
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Figure 72  Boxplots show full scale, verbal and performance Intelligence Quotient 
(IQ) Scores, Working Memory index and Processing Speed Index by Steal Laterality 
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Figure 73 Boxplots showing (a) Parent and (b) Teacher Scores of Executive 
Function (BRISC, Metacognition and GECT) by Steal Laterality  
(a) Parent 
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(b) Teacher 
 
 
 
8.5.2.3.2. Unilateral and Bilateral Steal and Neurocognitive Function 
Groups were further collapsed into unilateral (n=3 right, n=5 left) steal and bilateral 
(n=10) steal.  In univariable regression VCI, Parent and Teacher BRIS were 
significantly lower in those with unilateral steal when compared to those with no 
steal; Parent MET and GEC were significantly lower in those with bilateral steal 
when compared to those with no steal.  Teacher MET and GEC scores were lower 
in those with bilateral steal when compared to no steal (Tables 77-79). 
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Table 77 Linear regression for effect of unilateral and bilateral steal vs no steal on 
scores of intelligence 
 
IQ (n) R R2 Adj 
R2 
F B SE 
for B 
Beta T  P 
FSIQ (23) 
Compared 
with no steal 
Unilateral 
steal 
Bilateral steal 
 
.340 
 
.116 
 
.027 
 
1.308 
 
 
 
 
12.79 
-1.29 
 
 
 
 
9.83 
10.43 
 
 
 
 
.323 
-.031 
 
 
 
 
1.30 
-.123 
 
.293 
 
 
.208 
.903 
VCI (23) 
Compared 
with no steal 
Unilateral 
steal 
Bilateral steal 
 
.454 
 
.206 
 
.127 
 
2.595 
 
 
 
 
14.19 
1.86 
 
 
 
 
6.91 
7.33 
 
 
 
 
.483 
.060 
 
 
 
 
2.054 
.253 
 
.10 
 
 
.053* 
.803 
PRI (25) 
Compared 
with no steal 
Unilateral 
steal 
Bilateral steal 
 
.284 
 
.081 
 
-.003 
 
.964 
 
 
 
 
12.68 
-1.0 
 
 
 
 
11.09 
11.42 
 
 
 
 
.273 
-.021 
 
 
 
 
1.143 
-.088 
 
.397 
 
 
.265 
.931 
WMI (18) 
Compared 
with no steal 
Unilateral 
steal 
Bilateral steal 
 
.337 
 
.114 
 
-.004 
 
.964 
 
 
 
 
12.6 
-3.114 
 
 
 
 
12.787 
12.365 
 
 
 
 
.290 
-.074 
 
 
 
 
.985 
-.252 
 
.404 
 
 
.340 
.805 
PSI (19) 
Compared 
with no steal 
Unilateral 
steal 
Bilateral steal 
 
.223 
 
 
.05 
 
-.069 
 
.417 
 
 
 
 
8.63 
5.77 
 
 
 
 
9.50 
9.50 
 
 
 
 
.273 
.182 
 
 
 
 
.908 
.607 
 
.666 
 
 
.377 
.552 
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Table 78 Linear regression for effect of unilateral or bilateral steal vs no steal on 
Parent BRIEF measures of executive function 
 
 R R2 Adj R2 F B SE 
for B 
Beta T  P 
Parent 
BRIS 
Compared 
with no steal 
Unilateral 
steal 
Bilateral 
steal 
 
 
0.478 
 
 
 
 
 
0.228 
 
 
.151 
 
 
2.961 
 
 
 
 
 
-8.0 
-13.80 
 
 
 
 
 
5.723 
5.529 
 
 
 
 
 
-0.541 
-0.325 
 
 
 
 
 
-2.412 
-1.447 
 
 
.075 
 
 
0.026* 
0.163
†
 
Parent 
Metacog 
Compared 
with no steal 
Unilateral 
steal 
Bilateral 
steal 
 
 
0.628 
 
 
0.394 
 
 
.331 
 
 
6.186 
 
 
 
 
 
-4.482 
-18.571 
 
 
 
 
 
5.35 
5.53 
 
 
 
 
 
-0.174 
-0.700 
 
 
 
 
 
-0.837 
-3.358 
 
 
.009 
 
 
0.413 
0.003** 
Parent 
GECT 
Compared 
with no steal 
Unilateral 
steal 
Bilateral 
steal 
 
 
 
0.606 
 
 
 
0.367 
 
 
 
0.304 
 
 
 
5.804 
 
 
 
 
 
-6.778 
-17.429 
 
 
 
 
 
4.869 
5.165 
 
 
 
 
 
-0.292 
-0.708 
 
 
 
 
 
-1.392 
-3.374 
 
 
 
.01 
 
0.179
†
 
0.003** 
* significant at p<.05 level ** p<.01 
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Table 79 Linear regression for effect of unilateral or bilateral steal vs no steal 
on Teacher BRIEF measures of executive function 
 R R2 Adj 
R2 
F B SE 
for B 
Beta T P 
Teacher 
BRIS 
Compared with  
no steal 
Unilateral steal 
Bilateral steal 
 
 
.469 
 
 
.220 
 
 
.138 
 
 
2.676 
 
 
 
 
-13.125 
-15.571 
 
 
 
 
7.053 
7.284 
 
 
 
 
-0.44 
-0.506 
 
 
 
 
-1.861 
-2.138 
 
 
.095 
 
.046* 
.078
†
 
Teacher 
Metacog 
Compared with  
no steal 
Unilateral steal 
Bilateral steal 
 
 
0.404 
 
 
0.163 
 
 
0.075 
 
 
1.849 
 
 
 
 
-9.893 
-11.286 
 
 
 
 
6.241 
6.446 
 
 
 
 
-0.429 
-0.389 
 
 
 
 
-1.585 
-1.751 
 
 
0.185 
 
0.129 
0.096
†
 
Teacher 
GECT 
Compared with  
no steal 
Unilateral steal 
Bilateral steal 
 
 
0.426 
 
 
0.181 
 
 
0.100 
 
 
2.217 
 
 
 
 
-12.095 
-13.000 
 
 
 
 
6.661 
7.012 
 
 
 
 
-0.437 
-0.442 
 
 
 
 
-1.830 
-1.854 
 
 
0.135 
 
0.082
†
 
0.079
†
 
*significant at p<.5 level;    †trend toward significance at p<0.1 level 
 
In summary examination for an association between CVR abnmormality as 
measured by steal in the whole group (n=27) is suggestive of a negative 
association between right and left steal and VCI; left steal and WMI; and right and 
bilateral steal with indices of executive function. 
 
 373 
8.5.3. Intellectual and Executive Function by Stroke, Comorbidity 
and Moyamoya Laterality 
I sought to examine for potential confounders of the analysis for association 
between CVR abnormality and neurocognitive function.  Namely, I sought to 
examine whether differences in neurocognitive outcome were explained by a 
history of 1) stroke 2) comorbidity or 3) moyamoya laterality.  Due to the numbers 
in my study I used exploratory group descriptive analysis to determine this. 
 
8.5.3.1. Effect of stroke on full scale, verbal and performance IQ, and on 
working memory index and processing speed index and Parent and Teacher 
BRIEF scores of executive function 
At the time of intellectual assessment ten children had a stroke, seventeen no 
stroke.  Children with bilateral stroke had lower scores of intelligence than children 
with right sided or no stroke (Fig 71).  However, using Kruskal-Wallis there was no 
statistically significant difference in FSIQ, VCI, PIQ, WMS and PS between the 
clinically overt stroke and no stroke groups (Table 80 and 82; Fig 75 and 76). 
There was no statistically significant difference in measures of executive function 
by Parent or Teacher BRIEF by stroke (Table 81, 82, 83; Fig 77 and 78). 
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Figure 74 Presence of Stroke and Stroke Laterality 
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Table 80 Mean Scores of Intelligence in children with moyamoya with and without 
stroke 
 
 
Stroke 
 Yes           No 
mean        mean 
(SD)         (SD) 
n=10          n=15 
 
Mean difference 
(CI) 
 
 
t-test 
p 
value 
 
FSIQ 85.78 
(17.22) 
89.5 
(21.76) 
-3.72 
(-21.63 – 14.18) 
ns 
VCI 90.89 
(11.48) 
91.5 
(16.82) 
-.611 
(-13.95 – 12.73) 
 
Ns
 
PRIQ 86.1 
(20.9) 
91.13 
(24.48) 
-5.033 
(-24.58 – 14.51) 
 
ns 
WMS 86.43 
(19.51) 
88 
(22.9) 
-1.57 
(-23.82 – 20.68) 
 
ns 
PSI 88.14 
(17.92) 
89.67 
(15.06) 
-1.52 
(-17.71 – 14.66) 
 
ns 
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Table 81 Mean Scores of Executive Function by Parent and Teacher BRIEF scores in children with moyamoya 
with and without stroke 
 Parent Teacher 
 Stroke 
Yes           No 
mean       mean 
(SD)         (SD) 
 
mean 
difference 
(CI) 
t-test 
p 
value 
         Stroke 
Yes            No 
mean        mean 
(SD)          (SD) 
 
mean  
difference 
(CI) 
t-test 
p value 
Int 57.27 
(12.93) 
58.77 
(8.15) 
-1.5 
(-10.5 – 7.5) 
ns 55.64 
(15.74) 
56.67 
(12.02) 
-1.03 
(-13.12–11.05) 
ns  
Shift 58.09 
(12.97) 
61.31 
(14.82) 
-3.22 
(-15.12 – 8.69) 
ns 62.91 
(16.67) 
61.25 
(15.05) 
1.66 
(-12.09 – 15.41) 
ns 
EmC 56.45 
(13.81) 
59.46 
(12.7) 
-3.01 
(-14.24 – 8.22) 
ns 59.0 
(16.47) 
59.58 
(13.52) 
-.58 
(-13.60 – 12.44) 
ns 
Initi 57.3 
(12.82) 
63.27 
(12.65) 
-5.97 
(-17.61 – 5.67) 
ns 65.0 
(12.82) 
62.5 
(10.97 
2.5 
(-8.71 – 13.71) 
ns 
WMT 63.27 
(13.82) 
65.23 
(12.98) 
-1.96 
(-13.32 – 9.4) 
ns 65.27 
(18.27) 
61.0 
(12.04) 
4.27 
(-9.03 – 17.57) 
ns 
Plan 62.9 
(13.61) 
65.38 
(10.95) 
-2.49 
(-13.12 – 8.15) 
ns 62.27 
(10.51) 
60.42 
(10.18) 
1.86 
(-7.12 – 10.83) 
ns 
Org 54.3 
(8.04) 
57.18 
(8.67) 
-2.88 
(-10.54 – 4.78) 
ns 61.4 
(25.84) 
61.0 
(14.77) 
.40 
(-19.37 – 20.17) 
ns 
Mon 59.2 
(11.29) 
63 
(10.66) 
-3.8 
(-13.83 – 6.23) 
ns 60.9 
(15.09) 
59.9 
(9.91) 
1.00 
(-10.99 – 12.99) 
ns 
BRI 58.64 
(12.73) 
62 
(11.62) 
-3.36 
(-13.92 – 7.19) 
ns 60.09 
(16.85) 
60.45 
(12.97) 
-.36 
(-13.74 – 13.01) 
ns 
MIT 62.7 
(14.52) 
65.67 
(11.33) 
-2.97 
(-14.46 – 8.53) 
ns 64.36 
(15.39) 
63.55 
(9.64) 
.82 
(-10.60 – 12.24) 
ns 
GEC 61 
(12.56) 
64.62 
(11.02) 
-3.62 
(-13.85 – 6.62) 
ns 63.27 
(15.98) 
62.25 
(12.23) 
1.02 
(-11.25 – 13.3) 
ns 
Flex 
n=1 
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Table 82  Mean Scores of Intelligence and Parent and Teacher BRIEF by Presence 
of Stroke and Stroke Laterality 
 No 
stroke 
Right 
Stroke 
Bilateral 
stroke 
Chi 
squared 
df p 
Value 
IQ       
Number 12 4 2    
FSIQ 87.75  
(20.68) 
90.00 
(17.8) 
68.00 
(16.97) 
1.914 
 
2 ns 
VIQ 89.33 
(16) 
98.25 
(13.57) 
82.0 
(7.07) 
1.493 2 ns 
PIQ 91.75 
(23.79) 
87.75 
(23.43) 
67.00 
(15.56) 
1.920 2 ns 
WMI 89.92 
(22.84) 
90.25 
(14.22) 
66.50 
(14.85) 
2.482 2 ns 
PSI 88.25 
(12.9) 
90.25 
(18.72) 
78.00 
(22.63) 
.763 2 ns 
BRIEF 
Parent 
      
Number 14 7 1    
BRI 63.5 
(11.39) 
56.43 
(12.71) 
52.50 
(12.02) 
3.120 2 ns 
MET 65.43 
(10.70) 
63.14 
(17.27) 
57.00 
n=1 
1.245 2 ns 
GEC 65.57 
(10.58) 
60.14 
(14.19) 
52.00 
n=1 
2.704 2 ns 
BRIEF  
Teacher 
      
Number 13 6 3    
BRI 60.54 
(12.98) 
 
61.33 
(22.02) 
57.00 
(4.36) 
.438 2 ns 
MET 61.85 
(9.73) 
64.83 
(19.61) 
71.33 
(2.89) 
2.23 2 ns 
GEC 61.29 
(11.65) 
64.17 
(21.6) 
62.74 
(3.22) 
1.247 2 ns 
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Figure 75  Box plots showing Mean Scores of Intellectual Function (full scale 
verbal and performance IQ, working memory index, processing speed index) 
by Stroke 
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Figure 76  Box plots showing Mean Scores of Intellectual Function (full scale 
verbal and performance IQ, working memory index, processing speed index) 
by Stroke Laterality 
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Table 83 Mean Parent and Teacher BRIEF Scores of Executive Function by 
Stroke 
 
 Parent 
 
Teacher 
 Stroke 
Yes           No 
mean       mean 
(SD)         (SD) 
 
mean 
difference 
(CI) 
t-test 
p 
value 
Stroke 
Yes            No 
mean        mean 
(SD)          (SD) 
 
mean  
difference 
(CI) 
t-test 
p 
value 
Int 57.27 
(12.93) 
58.77 
(8.15) 
-1.5 
(-10.5 – 7.5) 
ns 55.64 
(15.74) 
56.67 
(12.02) 
-1.03 
(-13.12–11.05) 
ns  
Shift 58.09 
(12.97) 
61.31 
(14.82) 
-3.22 
(-15.12 – 
8.69) 
ns 62.91 
(16.67) 
61.25 
(15.05) 
1.66 
(-12.09 – 
15.41) 
ns 
EmC 56.45 
(13.81) 
59.46 
(12.7) 
-3.01 
(-14.24 – 
8.22) 
ns 59.0 
(16.47) 
59.58 
(13.52) 
-.58 
(-13.60 – 
12.44) 
ns 
Initi 57.3 
(12.82) 
63.27 
(12.65) 
-5.97 
(-17.61 – 
5.67) 
ns 65.0 
(12.82) 
62.5 
(10.97 
2.5 
(-8.71 – 13.71) 
ns 
WMT 63.27 
(13.82) 
65.23 
(12.98) 
-1.96 
(-13.32 – 9.4) 
ns 65.27 
(18.27) 
61.0 
(12.04) 
4.27 
(-9.03 – 17.57) 
ns 
Plan 62.9 
(13.61) 
65.38 
(10.95) 
-2.49 
(-13.12 – 
8.15) 
ns 62.27 
(10.51) 
60.42 
(10.18) 
1.86 
(-7.12 – 10.83) 
ns 
Org 54.3 
(8.04) 
57.18 
(8.67) 
-2.88 
(-10.54 – 
4.78) 
ns 61.4 
(25.84) 
61.0 
(14.77) 
.40 
(-19.37 – 
20.17) 
ns 
Mon 59.2 
(11.29) 
63 
(10.66) 
-3.8 
(-13.83 – 
6.23) 
ns 60.9 
(15.09) 
59.9 
(9.91) 
1.00 
(-10.99 – 
12.99) 
ns 
BRI 58.64 
(12.73) 
62 
(11.62) 
-3.36 
(-13.92 – 
7.19) 
ns 60.09 
(16.85) 
60.45 
(12.97) 
-.36 
(-13.74 – 
13.01) 
ns 
MIT 62.7 
(14.52) 
65.67 
(11.33) 
-2.97 
(-14.46 – 
8.53) 
ns 64.36 
(15.39) 
63.55 
(9.64) 
.82 
(-10.60 – 
12.24) 
ns 
GEC 61 
(12.56) 
64.62 
(11.02) 
-3.62 
(-13.85 – 
6.62) 
ns 63.27 
(15.98) 
62.25 
(12.23) 
1.02 
(-11.25 – 13.3) 
ns 
Flex 
n=1 
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Figure 77  Boxplots showing Mean Parent and Teacher BRIEF (BRISC, 
metacognition and GEC) Scores in Stroke and No Stroke Groups 
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Figure 78  Boxplots showing Mean Parent and Teacher BRIEF (BRISC, 
metacognition and GEC)  Scores of Executive Function by Stroke Laterality 
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8.5.3.2. Effect of comorbidity on full scale, verbal and performance IQ, and 
on working memory index and processing speed index and Parent and 
Teacher BRIEF scores of executive function 
Eleven children had MMD and 16 MMS (Table 83 and Fig 76).  The comorbidity 
diagnoses of the MMS group were Neurofibromatosis Type 1 ([NF1] n=9), Sickle 
Cell Disease ([SCD] n=4) and Chromosomal disorders (n=3).  Of the children with 
chromosomal disorders two had Trisomy 21 and one Turner’s syndrome.  There 
was no statistically significant differences in age of either moyamoya diagnosis, or 
intellectual assessment between the MMD and MMS groups by comorbidity (Table 
84). 
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Table 84 Frequency, Age of Moyamoya Diagnosis and Age of Intellectual 
Assessment by Moyamoya Diagnosis 
Moyamoya 
Classification 
N Percent Mean Age 
Diagnosis (SD; 
range) years 
Mean Age of 
Assessment 
(SD; range) years 
Idiopathic 
11 37.0 
 
8.46 (3.18; 2.9-
12.75) 
 
10.13 (3.78; 4.08-
16.17) 
Neurofibromatosis 
Type 1 9 33.3 
 
9.23 (3.18; 5.17-
14.42) 
 
11.13 (4.58; 5.33-
16.33) 
Sickle Cell Disease 
 4 14.8 
 
7.69 (4.86; .83-
11.83) 
 
8.88 (2.94; 5.92-
12.42) 
All chromosomal 
3 11.1 
 
9.42 (5.25; 3.83-
14.25) 
 
11.56 (4.03; 7-
14.67) 
 
Total 27 100.0 
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Figure 79  Frequency of Moyamoya Diagnosis by Comorbidity 
 
 
 
8.5.3.2.1. Comorbidity and Intelligence Scores 
Mean scores of intelligence were within the normal range for children with 
Idiopathic-MM and children with NF1-MM.  Children with SCD-MM had below 
normal scores of intelligence in all domains.  However, there was no statistically 
significant difference in mean scores between groups (Table 84).  Only one child 
in the Chromosomal-MM group had usable scores of intelligence as two of the 
children with Chromosomal-MM had severe learning difficulties (Fig 80). 
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Table 85 Mean Scores of Intelligence by Comorbidity 
 
Moyamoya 
Classification 
 
n (male) 
 
MM 
Laterality 
 
B/R/L 
Clinical 
Stroke 
 
Yes 
 
FSIQ 
mean 
(SD) 
 
VIQ 
mean 
(SD) 
 
PRIQ 
mean 
(SD) 
 
WM 
mean 
SD 
 
PS 
mean 
(SD) 
Idiopathic 
n=11 (6) 
 
 
8/2/1 
 
7 
 
87.88 
(19.05) 
 
92.88 
(12.11) 
 
90.75 
(26.26) 
 
87.75 
(18.45) 
 
87.75 
(16.63) 
NF1 
n=9 (6) 
 
 
2/2/5 
 
1 
 
91.71 
(21.94) 
 
94.43 
(14.77) 
 
93.43 
(22.04) 
 
 
94 
(25.59) 
 
90.71 
(15.01) 
Sickle Cell 
Disease 
n=4 (2) 
 
 
4/0/0 
 
2 
 
69.5 
(4.95) 
 
81 
(19.8) 
 
71 
(1.41) 
 
66.5 
(2.12) 
 
78 
(7.07) 
Chromosomal 
n=3 (0) 
 
 
2/0/1 
 
2* 
 
 
66 
 
63 
 
64 
 
80 
 
83 
P value 
One way 
ANOVA 
Kruskal Wallis 
   
 
.307 
.185 
 
 
.114^ 
.186 
 
 
.399 
.365 
 
 
.460 
.345 
 
 
.750 
.579 
^trend toward significance at p<0.1 level 
   *Two with severe learning disability.   
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Figure 80 Boxplots showing Mean Intelligence Scores (full scale, verbal and 
performance), Working Memory Index and Processing Speed Index by 
Comorbidity 
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8.5.3.2.2. Comorbidity and Executive Function 
Children with Chromosomal-MM had abnormal and severely abnormal Parent and 
Teacher BRI, MET and GEC scores, which were significantly higher for the 
Teacher scores (Table 86, Fig 81). 
 
Table 86 Parent and Teacher Mean Summary Scores of Executive Function 
Moyamoya 
Classification 
 
 
MM 
Laterality 
 
 
B/R/L 
Clinical 
Stroke 
 
 
Yes 
Parent BRIEF 
 
BRI            MET         GEC 
mean         mean         
mean 
(SD)           (SD)          
(SD) 
Teacher BRIEF 
 
BRI           MET        GEC 
mean        mean        
mean 
(SD)          (SD)         (SD) 
Idiopathic 
n=11 (6) 
 
 
8/2/1 
 
7 
 
57.75 
(11.34) 
 
61.75 
(13.48) 
 
60.25 
(12.2) 
 
55.88 
(10.83) 
 
60.63 
(13.61) 
 
60.13 
(13.95) 
NF1 
n=9 (6) 
 
2/2/5 
 
1 
 
61.5 
(14.65) 
 
57.33 
(10.76) 
 
60.0 
(12.82) 
 
60.17 
(12.11) 
 
58.0 
(6.42) 
 
59.67 
(5.82) 
Sickle Cell 
Disease 
n=4 (2) 
 
4/0/0 
 
2 
 
51.0 
(6.25) 
 
73 
(14.18) 
 
63.0 
(9.64) 
 
58.0 
(8.72) 
 
67.33 
(4.93) 
 
63.67 
(6.81) 
Chromosomal 
n=3 (0) 
 
 
2/0/1 
 
2 
 
78.5 
(4.95) 
 
78 
(5.66) 
 
80 
(5.66) 
 
93.5 
(14.85) 
 
87.5 
(12.02) 
 
92.5 
(14.85) 
p value    
.118 
 
 
.223 
 
 
.289 
 
 
.002** 
 
 
.022* 
. 
 
.007* 
. 
 
One way ANOVA significant at the p<.05 level*; significant at p<.01 level** 
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Figure 81  Boxplots showing Parent and Teacher Mean Summary Scores of 
Executive Function (BRISC, Metacognition and GEC) by Comorbidity 
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8.5.3.2.3. Ischaemic Risk Profile by Comorbidity 
Using history of clinic stroke, TIA or steal on CVR as indicators of ischaemic risk, 
children with Idiopathic-MM had high proportions of stroke prevalence, TIA and 
prevalence of steal.  There was apparent discordance between clinical indicators 
of ischaemic risk (stroke and TIA) and steal in the syndromic moyamoya group.  
This was most evident in the Chromosomal-MM in whom there was a high 
proportion of stroke, but low proportion of children with steal (Table 87). 
Table 87  Ischaemic Profile by Comorbidity 
 Idiopathic 
n=11 
NF1 
n=9 
SCD 
n=4 
Chromosomal 
n=3 
Steal 
    Yes 
    No 
n (%) 
9 (82) 
2 (18) 
n (%) 
5 (56) 
4 (44) 
n (%) 
3 (75) 
1 (25) 
n (%) 
1 (33) 
2 (67) 
Stroke 
    Yes 
    No 
 
8 (73) 
3 (27) 
 
2 (22) 
7 (78) 
 
2 (50) 
2 (50) 
 
2 (67) 
1 (33) 
TIA 
    Yes 
    No 
 
5 (83) 
6 (17) 
 
1 (11) 
8 (89) 
 
0 
4 (100) 
 
0 
4 (100) 
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8.5.3.3. Effect of moyamoya laterality on full scale, verbal and performance 
IQ, and on working memory index and processing speed index and Parent 
and Teacher BRIEF scores of executive function 
Moyamoya was bilateral in 16 and unilateral in 11 (7 left, 4 right).  Available scores 
of intelligence were analysed by moyamoya laterality.  Mean scores of intelligence 
were highest and within normal range in all children with right sided moyamoya 
and overall lowest in children with bilateral moyamoya, specifically mean FSIQ, 
WMI and PSI were lowest in children with bilateral moyamoya.  Mean VCI scores 
were lowest in children with left moyamoya.  Apparently paradoxically, mean PRIQ 
was highest in children with right moyamoya but there were only 2 children in this 
group and there were no statistically significant differences in scores on the 
Wechsler scales or the BRIEF by moyamoya laterality (Table 88). Kruskal-Wallis 
revealed a trend toward significance by moyamoya laterality for FSIQ (χ2 = 4.652 
(2), p=.096) but not for other mean scores of intelligence or Parent and Teacher 
BRIEF scores of executive function (p values > 0.05) (Table 88 and Fig 82). 
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Figure 82  Pie chart Showing Moyamoya Laterality in Group  
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Table 88 Mean Scores of Intelligence and Summary Parent and Teacher 
Scores of Executive Function by Moyamoya Laterality 
  
Moyamoya Laterality 
Right                    Left                           Bilateral 
χ2 
 (df) 
p 
value 
 mean    
(SD) 
Mean 
(SD) 
mean 
(SD) 
  
IQ 
n 
 
2 
 
6 
 
10 
  
FSIQ 98.5 
(17.68) 
85 
(24.19) 
84.2 
(18.57) 
4.65 
(2) 
.096 
VIQ 97.5 
(14.85) 
88.17 
(19.09) 
90.5 
(13.52) 
3.50 
(2) 
.173 
PRIQ 100.5 
(21.92) 
86.17 
(24.02) 
86.8 
(24.6) 
4.32 
(2) 
.115 
WMI 100 
(19.8) 
89.67 
(26.64) 
83.5 
(18.59) 
.917 
(2) 
ns 
PSI 95.5 
(6.36) 
87.83 
(15.97) 
85.5 
(15.41) 
2.79 
(2) 
ns 
BRIEF 
Parent 
N 
 
 
2 
 
 
5 
 
 
12 
  
BRI 69 
(9.9) 
58.8 
(15.69) 
59.08 
(12.77) 
1.45 
(2) 
ns 
MET 61.5 
(10.6) 
61.4 
(14) 
65.25 
(14.35) 
.253 
(2) 
ns 
GEC 65.5 
(10.61) 
60.2 
(15.3) 
63.25 
(12.34) 
.037 
(2) 
ns 
BRIEF  
Teacher 
N 
 
 
2 
 
 
5 
 
 
12 
  
BRI 52.5 
(10.61) 
64.2 
(17.23) 
61.9 
(15.88) 
1.25 
(2) 
ns 
MET 60 
(7.07) 
64.4 
(13.41) 
64 
(14.58) 
.082 
(2) 
ns 
GEC 58 
(9.9) 
66.4 
(15.14) 
63.9 
(15.34) 
2.11 
(2) 
ns 
 
In exploratory Wilcoxon post hoc analysis FSIQ, PRIPIQ were statistically different 
by right and bilateral moyamoya laterality (p=.020 and.046) and there was a trend 
toward significant difference in VCI and PSI (p=.103 and .112).  There was no 
statistically significant difference in mean scores of WMI by right and left 
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moyamoya laterality.  There was no statistically significant difference between 
scores of intelligence by left and bilateral moyamoya laterality.  
In univariable linear regression, right moyamoya laterality was significantly 
predictive of FSIQ and PRI but not of Parent or Teacher indices of executive 
function  (Table 90 and 91). 
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Figure 83  Boxplots showing effect of moyamoya laterality on full scale, verbal and 
performance IQ Scores and on Working Memory Index and Processing Speed Index 
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Table 89 Linear regression for effect of moyamoya laterality on Parent BRIEF 
measures of executive function  
 R R
2 Adj 
R2 
F B SE 
for B 
Beta T p 
Parent BRIS 
Compared with 
bilateral moyamoya 
R MM 
L MM 
 
0.226 
 
0.051 
 
-0.044 
 
0.541 
 
 
 
9.500 
0.214 
 
 
 
9.269 
5.676 
 
 
 
0.228 
0.008 
 
 
 
1.025 
0.038 
 
0.591 
 
0.318 
0.970 
Parent Metacog 
Compared with 
bilateral moyamoya 
R MM 
L MM 
 
0.104 
 
0.011 
 
-0.093 
 
0.103 
 
 
 
-3.808 
-2.022 
 
 
 
10.044 
6.200 
 
 
 
-0.089 
-0.076 
 
 
 
-0.379 
-0.326 
 
0.902 
 
0.709 
0.748 
Parent GEC 
Compared with 
bilateral moyamoya 
R MM 
L MM 
 
0.044 
 
0.002 
 
-0.098 
 
0.020 
 
 
 
-0.051 
-1.099 
 
 
 
7.773 
5.689 
 
 
 
-0.002 
-0.045 
 
 
 
-0.007 
-0.193 
 
0.981 
 
0.995 
0.849 
 
Table 90 Linear regression for effect of moyamoya laterality on Teacher 
BRIEF measures of executive function 
 R R
2 Adj 
R2 
F B SE 
for B 
Beta T p 
Teacher BRIS 
Compared with  
bilat moyamoya 
R MM 
L MM 
 
.21 
 
.044 
 
-.057 
 
.436 
 
 
 
-7.5 
4.2 
 
 
 
11.36 
7.79 
 
 
 
-.15 
.123 
 
 
 
-.66 
.539 
 
.652 
 
.517 
.596 
Teacher 
Metacog 
Compared with 
bilatl moyamoya 
R MM 
L MM 
 
. 
 
102 
 
 
 
.010 
 
 
 
-.094 
 
 
 
.1 
 
 
 
 
-4.33 
.067 
 
 
 
 
9.87 
6.77 
 
 
 
 
.102 
.002 
 
 
 
 
-.439 
.010 
 
 
 
 
.666 
.992 
Teacher GECT 
Compared with bilat 
moyamoya 
R MM 
L MM 
 
0.284 
 
0.081 
 
-0.011 
 
0.877 
 
 
 
-10.067 
3.000 
 
 
 
8.793 
7.179 
 
 
 
-
0.251 
0.092 
 
 
 
-
1.145 
0.418 
 
0.431 
 
0.266 
0.680 
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Figure 84  Boxplots showing Mean Summary Parent and Teacher Scores 
(BRISC, Metacognition and GEC) of Executive Function by Moyamoya 
Laterality 
 
 
 
In summary stroke and comorbidity appeared to be associated with 
neurocognitive outcome in the children with MM.  Moyamoya laterality did not 
seem to have a significant effect on neurocognitive outcome.  
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I therefore sought to further explore whether there was an association between 
CVR abnormality and neurocognitive outcome in a group of children without a 
history of stroke, and examine within this group the effect of comorbidity and 
moyamoya laterality. I also excluded the children with a prior history of surgery. 
 
8.5.4. hBOLD CVR and Intellectual Outcome in Children with No 
History of Stroke or Surgery Prior to Assessment 
8.5.4.1. Group Description 
Ten children did not have a history of stroke or revascularisation surgery prior to 
their hBOLD CVR and intellectual study.  One child without stroke had surgery five 
days (inadequate time to alter haemodynamic status) before their intellectual 
assessment, and after their hBOLD CVR study so was included in the group 
(n=11, 4 male, 7 female, mean age diagnosis 9.43 years, range 5.17 – 15.58 
years).   Mean interval from intellectual assessment to hBOLD CVR study was 
0.18 years SD 0.27 years.  Six of these children had NF1-MM, 3 Idiopathic-MM 
and two SCD-MM (Table 92). 
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Table 91 Group Description of Children with No Stroke and No Surgery Prior 
to Intellectual Assessment 
 No Stroke 
No Presurgery 
n = 11 
MM Classification 
    Idiopathic 
    Neurofibromatosis Type 1 
    Sickle Cell Disease 
 
3 
6 
2 
Arteriopathy Laterality 
    Bilateral  
    Right 
    Left 
 
6 
3 
2 
 
Steal 
    None 
    Right 
    Left 
    Bilateral 
               
5 
2 
1 
3 
 
 
Age at Diagnosis 
 
 
Age at Intellectual 
Assessment 
 
 
Time between hBOLD CVR 
and Intellectual Assessment 
               
years (SD, range) 
9.4 (3.45; 5.17-
15.6)) 
 
10.36 (3.88; 5.33-
16.33) 
 
 
.18 (.27; .00 - .83) 
Mean age at intellectual 
assessment (SD) years 
10.55 (4.03, 5.33- 
16.33) 
Radiographic Findings (Y:N) 
Not ischaemic 
Cortical 
Watershed 
(Deep white matter) 
(Cortical) 
Cortical ischaemic and 
Watershed 
Other^ 
 
 
5 
0 
5 
(5) 
(0) 
 
1 
4 
^NF1 lesions 
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8.5.4.2. Effect of Steal on Full Scale, Verbal and Performance IQ, and on 
Working Memory Index and Processing Speed Index  
There was no statistically significant difference between scores of intellectual 
function by laterality of steal.  There was no statistically significant difference in 
scores of intellectual function between children by steal or laterality of steal (Table 
93 and Fig 85). 
 
Table 92  Intelligence Scores by Laterality of Steal in No Stroke No Surgery Group 
 
 
 
No Steal 
n=3 
Bilateral 
Steal 
n=3 
Right  
Steal 
n=1 
Left 
Steal 
n=1 
FSIQ 89.33 
(30.07) 
82.33 
(14.84) 
110 105 
VCI 90.67 
(22.68) 
83.00 
(14.42) 
105 87 
PRIQ 100.33 
(29.77) 
85.67 
(16.01) 
113 122 
WMS 88.33 
(30.93) 
80.67 
(11.02) 
N/A 111 
PSI 80.67 
(13.05) 
95.33 
(10.79) 
N/A 100 
All p>0.05 
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Figure 85  Boxplots showing Scores of Intelligence (Full scale, Verbal and 
Performance), Working Memory Index and Processing Speed Index by 
Laterality of Steal 
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8.5.4.3. Effect of Steal on Indices of Executive Function as Measured using 
the BRI, Metacognition, and General Cognitive Index from the Parent and the 
Teacher BRIEF questionnaires 
There was no statistically significant difference in scores of executive function 
between children with no steal, bilateral steal and unilateral steal (Table 94 and 
Fig 86). 
 
Table 93  Indices of Executive Function by Laterality of Steal in No Stroke No 
Surgery Group 
 
 
 
No 
Steal 
n=3 
Bilateral 
Steal 
n=2 
Right 
Steal 
n=1 
Left 
Steal 
n=1 
Parent     
BRI 70 
(5) 
50.5 
(16.26) 
N/A 70 
MET 67.33 
(9.5) 
46 
(11.31) 
N/A 70 
GEC 70 
(4) 
47.5 
(14.85) 
59 71 
Teacher     
BRI 67 
(6.08) 
52 
(11.31) 
N/A 48 
MET 63.33 
(9.61) 
59 
(8.49) 
N/A 52 
GEC 65.33 
(5.03) 
57.5 
(10.61) 
44 51 
All p > 0.05 
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Figure 86  Boxplots showing Parent and Teacher Mean Scores of Executive 
Function (BRISC, Metacognition and GECF) by Laterality of Steal 
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8.5.4.4. Laterality of Steal by Comorbidity 
Within the group, three patients had Idiopathic-MM, six NF1-MM and two SCD-
MM.  Four of the five patients with no steal had NF1-MM. (Table 95, 96 and Fig 
87) 
 
Table 94 Laterality of Steal by Comorbidity 
 Steal Laterality Total 
Comorbidity No 
Steal 
Bilateral 
Steal 
Right 
Steal 
Left 
Steal 
Idiopathic 1 0 1 1 3 
Neurofibromatosis 
Type 1 
4 2 0 0 6 
Sickle Cell 
Disease 
0 1 1 0 2 
Total 5 3 2 1 11 
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Table 95  Scores of Intellectual and Executive Function by Comorbidity 
  
 
FSIQ 
 
 
VCI 
 
 
PRI 
 
 
WMI 
 
 
PSI 
Parent Teacher 
BRI MET GEC BRI MET GEC 
Idiopathic 
n=2 
103.5 
(2.12) 
93.0 
8.49 
120.5
0 
(2.12) 
104 
(9.9) 
92.5 
(10.6
1) 
67.5 
(3.54) 
73.5 
(4.95) 
72.5 
(2.12) 
55.5 
(10.6
1) 
62 
(14.1
4) 
60.5 
(13.4
4) 
NF1 
n=4 
86.75 
(23.5
6) 
88.75 
(18.0
4) 
92.25 
(21.6
1) 
85.5 
(24.5
7) 
90 
(16.7
9) 
61.5 
(15.9
3) 
50.25 
(12.1
2) 
57.75 
(14.7
1) 
60.5 
(12.4
8) 
59 
(6.93) 
60.25 
(7.32) 
SCD 
n=2  
69.50 
(1.41) 
81.0 
(19.8) 
71 
(1.41) 
66.5 
(2.12) 
78 
(7.07) 
65 
(n=1) 
77 
(n=1) 
 
74 
(n=1) 
63 
(n=1) 
72 
(n=1) 
70 
(n=1) 
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Figure 87 Steal Laterality by Comorbidity 
 
 
 
8.5.4.5. Hemispheric pixels and Intellectual Outcome 
Using Pearson’s bivariate correlation there was no statistically significant 
correlation between scores of intellectual outcome and hemispheric pixels.   
Using Pearson’s bivariate correlation there was a statistically significant correlation 
between BRIEF Teacher Initiate scores and right and left PTNP (p=.049 and 
p=.046) and a trend toward correlation between BRIEF Teacher Initiate scores and 
left NTNP (p=0.054) and BRIEF Parent Initiate scores and right and left PTPP 
(p=0.095 and p=0.096 respectively). There was no statistically significant 
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correlation between the remaining executive scores of function and hemispheric 
pixels (Table 97 and 98). 
 
Table 96 Hemispheric Pixels and Scores of Intellectual Function in No Stroke 
No Pre Surgery Group 
 Pearson Correlation 
 FSIQ VCI PRIPIQ WMI PSI 
PTPP      
Right -.394 -.268 -.461** -.367 -.098 
Left .398 .271 .466** .357 .110 
PTNP      
Right .317 -.008 .460** .457 .551** 
Left .268 -.039 .416 .453 .571** 
NTNP      
Right -.062 -.048 -.187 -.286 -.036 
Left -.280 -.284 -.381 -.098 .176 
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Table 97  Parent and Teacher BRIEF Scores of Executive Function 
  
Pearson Correlation 
BRIEF Parent 
 
 Inhibit
T 
ShiftT EmC
onT 
InitT WM
T 
PlanT Org 
MatT 
Mon
T 
BRIS MET GECT 
PTPP            
Right -.395 .110 .010 -
0.629*
* 
 -.275 -
.649*
* 
-
.405 
-.214 -
.617*
* 
-.240 
Left .398 -.104 -.004 .628** .162 .277 .643*
* 
.398 .218 .611*
* 
.245 
 409 
PTN
P 
           
Right .064 -.146 .149 .123 -
.064 
-.083 .199 -
.211 
.027 -.039 -0.035 
Left -.015 -.141 .131 .084 -
.065 
-.101 .169 -
.246 
-.016 -.079 -.064 
NTN
P 
           
Right .014 -.429 -.010 -.255 -
.439 
-.386 -.121 -
.473 
-.142 -.410 -.329 
Left -.252 -.021 .108 -.235 -
.168 
-.294 -.028 -
.491 
-.111 -.397 -.219 
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BRIEF Teacher 
 
 Inhibit
T 
ShiftT EmCo
nT 
InitT WM
T 
PlanT Org 
Mat
T 
MonT BRIS MET GECT 
PTPP            
Right .231 .478 .583 .271 .384 .255 -
.120 
.265 .392 -.009 .524** 
Left -.237 -.454 -.568** -.299 -
.374 
-.264 .143 -.206 -.369 .012 -.516** 
PTN
P 
           
 411 
Right -.390 -.370 -.504** -
.710* 
-
.336 
-.255 -
.325 
-.330 -
.590*
* 
-
.536*
* 
-.454 
Left -.339 -.327 -.461 -
.716* 
-
.262 
-.205 -
.318 
-.316 -
.603*
* 
-
.539*
* 
-.373 
NTN
P 
           
Right -.249 -
.499*
* 
-.335 -.190 -
.505
** 
-
.582*
* 
-
.428 
-.479 -.203 -.422 -.613** 
Left .150 -.054 .043 -.699 -
.070 
-.503 -
.406 
-.235 -.139 -
.722* 
-.074 
*p<0.05; ** p<0.2 
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8.5.4.6. Hemispheric pixels, Comorbidity and Intellectual Outcome 
Using Pearson’s bivariate correlation there was no statistically significant 
correlation between hemispheric pixels and scores of intelligence by NF1-MM.  
There was a statistically significant negative correlation between right and left 
PTNP and BRIEF Parent MET, Parent GEC and Teacher BRI. There was a trend 
toward significant negative correlation between right and left PTNP and BRIEF 
Parent BRI and Teacher GEC (Table 99).   
Numbers in the Idiopathic-MM and SCD-MM group were too small (2 and 2 
respectively) for individual correlation.   
Table 98 Bivariate Pearson Correlation of Hemispheric Pixels and Scores of 
Executive Function in NF1 moyamoya 
 Pearson Correlation 
BRIEF 
 Parent Teacher 
 BRI MET GEC BRI MET GEC 
PTPP       
Right 
 
-.079 
 
-.274 
 
-.206 
 
.054 
 
-.902** 
 
-.653 
 
Left .079 282 .210 -.054 .907** .656 
PTNP       
Right 
 
-.826** 
 
-.935* 
 
-.939* -.962* 
 
-.354 
 
-.807** 
 
Left 
 
-.834** 
 
-.932* 
 
-.941* 
 
-.966* 
 
.731 
 
-.812** 
 
NTNP       
Right .107 .261 .216 .097 -.740 615 
Left 
 
-.113 
 
-.271 
 
.224 
 
100 
 
.326 
 
-.624 
 
*p<0.05; **p<0.2 
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8.5.4.7. hBOLD CVR scores and Intellectual Outcome                                  
Childrens’ hBOLD CVR scores were recategorized as normal to mildly abnormal 
hBOLD CVR score (total score 2-3) or moderate to severely abnormal hBOLD 
CVR score (total score 4-6) (Table 100).   
 
Table 99 Frequency of Recategorized hBOLD CVR Scores 
CVR Scores Frequency Percent 
Normal to mild  
(2-3) 
5 45.5 
Moderate to 
severe (4-6) 
6 54.5 
Total 11 100.0 
 
 
In the group with normal to mild abnormality of hBOLD CVR by score, median 
scores of intellectual function were above the average for the group (90) for FSIQ, 
VCI, PIQ and WMI and below the average for the group (90) for PSI.  In the group 
with moderate to severe abnormality of hBOLD CVR by score, median scores of 
intellectual function were below the average for the group for FSIQ, VCI, PIQ and 
WMI and above the average for the group for PSI.  However, none of these 
differences were statistically significant (Table 101 and Fig 87 and 88). 
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Median scores of Parent and Teacher executive function were higher in the normal 
to mild abnormality hBOLD CVR by recategorized score group than in the 
moderate to severe hBOLD CVR by recategorized score group. There was a trend 
toward significance in difference between the BRIEF Teacher BRI and GEC 
scores. 
 
Table 100 Scores of Intellectual and Executive Function by Recategorized 
hBOLD       CVR Scores 
 hBOLD CVR Abnormality by Score  
 Normal  
to mild   
Moderate  
to Severe 
p 
value 
 mean;   median 
(SD; range) 
 
mean; median 
(SD; range) 
 
 
IQ 
N 
 
5 
 
6 
 
FSIQ 89.3; 102 
(30.07; 55-111) 
85; 86 
(15.86; 66-105) 
ns 
VCI 90.67; 99 
(22.68; 65-108) 
86.2; 87 
(11.45; 67-95) 
ns 
PIQ 100.3; 116 
(29.77; 66-119) 
90.2; 85 
(21.89; 70-122) 
ns 
WMI 88.3; 97 
(30.93; 54-114) 
83.6; 86 
(18.47; 65-111) 
ns 
PSI 80.67; 85 
(13.05; 66-91) 
91.80; 100 
(13.14; 73-103) 
 
ns 
BRIEF 
Parent 
N 
 
 
4 
 
 
4 
 
BRI 66.25; 67.5 
(8.53; 55-75) 
56; 57.5 
(13.29; 39-70) 
.191† 
MET 65.75; 64 
(8.38; 58-77) 
60; 62 
(17.74; 38-78) 
ns 
GEC 67.5; 68 
(5.97; 60-74) 
59; 64 
(15.81; 37-71) 
ns 
 415 
BRIEF  
Teacher 
N 
 
 
3 
 
 
6 
 
BRI 67; 64 
(6.08; 63-74) 
52.8; 48 
(8.67; 44-64) 
.070† 
MET 63.33; 65 
(9.61; 53-72) 
58; 56 
(6.12; 52-65) 
 
ns 
GEC 65.3; 66  
(5; 60 – 70) 
 
57; 53 
(7.84; 50-66) 
.092† 
†trend toward significance at p<0.1 level 
 
 
Figure 88 Boxplots showing Scores of Intellectual Function (full scale, verbal 
and performance IQ, working memory index, processing speed index) by 
Recategorized hBOLD CVR Scores 
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Figure 89  Boxplots showing Parent and Teacher Summary Scores (BRISC, 
Metacognition and GEC) of Executive Function by Recategorized hBOLD 
CVR Scores 
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8.5.4.8. Age at Diagnosis and Hemispheric Pixels 
There was no statistically significant relationship between age of moyamoya 
diagnosis and hemispheric pixels.  
 
8.5.4.9. Age at Diagnosis and Scores of Intellectual Function  
There was no statistically significant relationship between age of moyamoya 
diagnosis and scores of intellectual function.   
 
8.5.4.10. Age at Diagnosis and Scores of Executive Function by Parent and 
Teacher BRIEF questionnaire 
There was a statistically significant correlation between age of moyamoya 
diagnosis and BRIEF Teacher BRIS score n=8, r= -.733, p=.038.  There was a 
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trend toward significant correlation between age of moyamoya diagnosis and 
BRIEF Teacher Emotional Control n=8, r= -.641, p=.063 and BRIEF Teacher 
Initiation Control n=8, r= -.695, p=.056.  There were no further statistically 
significant correlations between age of diagnosis and scores of executive function.  
 
8.5.4.11. Age at Diagnosis – less than two years and less than 9 years     
Only two children in our group were diagnosed under the age of two years.  Five 
children were less than nine years of age, i.e. definitely prepubertal.  Scores of 
intellectual function were higher in the children diagnosed under the age of nine 
years.  However, there was no statistically significant difference in scores of 
intellectual function between children less than nine years of age and children who 
were age nine or above at the time of moyamoya diagnosis.   
There was a statistically significant difference in scores of executive function by 
Teacher BRIEF for scores of Shift control, Emotional control, Initiation and 
Behavioural regulation Index (p=.04; .042 and .037 respectively).  There was a 
trend toward significance difference in Teacher BRIEF scores of Monitor control, 
and Parent BRIEF scores of Behaviour regulation Index (Tables 102 and 103). 
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Table 101  Intelligence Scores by Age at MM Diagnosis 
 Age at Diagnosis of Moyamoya (years) 
 
     Less than 9               Greater than 9 
 
p 
value 
 mean 
(SD) 
mean 
(SD) 
 
IQ N  
5 
 
6 
 
FSIQ 94 
(11.31) 
84.17 
(22.7) 
Ns 
VIQ 93 
(8.46) 
86.17 
(17.02) 
Ns 
PIQ 102 
(24.04) 
91.33 
(25) 
Ns 
WMI 91.5 
(7.78) 
83.33 
(25.14) 
Ns 
PSI 92.5 
(10.61) 
86 
(14.75) 
Ns 
 
 
Table 102  Indices of Executive Function by Age at MM Diagnosis 
 Parent Teacher 
 Age at MM  
Diagnosis (years) 
<9                  >9 
mean           mean 
(SD)             (SD) 
t-test 
p 
value 
Age at MM 
Diagnosis (years) 
<9               >9 
mean          mean 
(SD)            (SD) 
t-test 
p 
value 
Inh 64 
(6.68) 
53.5 
(11.56) 
.102 52.5 
(3.87) 
54.25 
(13) 
.582 
Shift 63.5 
(9.75) 
55.25 
(11.62) 
.495 69.25 
(3.59) 
49.75 
(6.29) 
.04 
EmC 68 
(7.26) 
53.25 
(12.66) 
.119 72.5 
(9.68) 
48.5 
(5.69) 
.042 
Initi 58.5 
(9.75) 
66.5 
(19) 
.482 64.25 
(3.59) 
57.75 
(3.3) 
.037 
WMT 62 
(9.63) 
61.25 
(16.58) 
.890 62.75 
(8.66) 
54.25 
(7.18) 
.490 
Plan 67 
(10.92) 
62.75 
(17.04) 
.761 65 
(11.02) 
55.25 
(4.03) 
.357 
Org 57.5 
(1.29) 
55 
(14.07) 
.736 58.75 
(12.58) 
56.75 
(20.44) 
.873 
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Mon 63.5 
(12.18) 
56 
(12.06) 
.415 62 
(3.83) 
52.5 
(8.58) 
.090 
BRI 68 
(5.72) 
54.25 
(12.69) 
.095 66.25 
(6.08) 
51 
(8.87) 
.038 
MIT 64 
(10.23) 
61.75 
(17.29) 
.830 63.75 
(7.89) 
56.25 
(5.44) 
.169 
GEC 67 
(6.83) 
59.5 
(15.8) 
.473 65.25 
(4.11) 
55 
(7.44) 
.358 
Flex 
n=1 
      
 
8.6. Discussion 
8.6.1. Group Description 
The 27 children within this group had MMD and MMS.  It also included children 
with and without a history of stroke and revascularization surgery.  Almost 40% of 
the children had MMD and another 30% children had NF1-MM.  The remaining two 
groups had either SCD-MM or Chromosomal-MM (2 Trisomy 21 and 1 Turner’s 
syndrome).  Only a third of the children had a stroke prior to their hBOLD CVR and 
intellectual assessment. The majority of the strokes occurred within the right 
hemisphere despite the majority of the children having bilateral moyamoya.  
Despite only a third of children having a history of overt stroke, 74% had 
radiographic evidence of ischaemic injury, which was mostly within the watershed 
territories.    
To date, most studies of intellectual outcome in children with moyamoya have been 
in those who have had a stroke (Matsushima et al. 1997, Bowen et al. 1998, 
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Imaizumi et al. 1998, Hogan et al. 2005, Lee et al. 2011, Williams et al. 2012).  The 
lower scores of intelligence in children with bilateral stroke in our group is 
concordant with findings in other studies (Hogan et al. 2005). However, data on 
children who have not had a stroke is limited (Hogan et al. 2005, Williams et al. 
2012).  
  
8.6.2. CVR Abnormality and Intellectual Outcome 
8.6.2.1. Whole Group 
The presence of steal is suggestive of poor tissue microvascular health and 
represents tissue at risk of ischaemia. Hence the findings of the relationship 
between steal and intellectual outcome in our study were surprising.  The presence 
of steal was associated with higher intelligence and better scores of indices of 
executive function.  Right steal was associated with higher VCI and left steal higher 
scores of WMI.  Children with bilateral steal had highest scores of executive 
function.  Hemispheric steal was present on the side affected with moyamoya in all.  
There was the suggestion of association between laterality of moyamoya and 
intellectual outcome (specifically left sided MM with reduced VCI and bilateral MM 
PSI and WMI).  Conversely children with right MM had high PIQ and FSIQ scores.  
However, numbers with unilateral MM and unilateral steal were small making it 
difficult to infer significant meaning from the results.  Calviere et al demonstrated 
an association between cognitive dysfunction and cerebral haemodynamic 
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impairment using dynamic susceptibility contrast-enhanced MR perfusion imaging 
in adults with MMD.  Specifically impaired executive function was associated with 
significantly lower frontal regional CVR.  (Calviere et al. 2010)  Analysis in this 
study looked for association between cognitive outcome and hemispheric 
measures of tissue level microvascular compromise.  This approach was probably 
too simplistic, and further regional association analysis would be valuable. 
The whole group was composed of children with stroke and no stroke; children with 
a history of revascularizaiton surgery and no surgery.  It is possible to have no 
steal following a stroke or revascularization surgery as these two categories of 
children may have already experienced a significant amount of ischaemic demise 
(given the presentation and/or need for surgery) with effect on intellectual function.  
Therefore further analysis was conducted in a group with no history of stroke or 
revascularization surgery.    
 
8.6.2.2. No Stroke, No Surgery Group  
High hemispheric negative pixel measures were positively associated with PSI and 
positive pixel measures with PRI.  However, there was no clear pattern observed 
therefore interpretation of these findings is difficult.   
However, a more expected relationship between intellectual function and 
abnormality of CVR with higher intellectual scores demonstrated in the no steal 
and normal to mild CVR abnormalities score group.  However, the finding of higher 
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(poorer) indices of executive function in children with bilateral steal, and normal to 
mild CVR abnormality group when compared to those with no steal, or moderate to 
severe CVR abnormality was surprising and in contrast to the findings of the 
Calviere et al study (Calviere et al. 2010) Another possibility is that the 
maintenance or preservation of executive function despite apparent tissue level 
microvascular dysfunction as manifest by steal, may be as a result of increased 
CMRO2.  In this situation the metabolic demand is increased in the face of reduced 
cerebrovascular reserve and increased OEF resulting in – unexpected – steal  
However, further studies are required to explore this. The no steal and normal to 
mild group was however, dominated by children with NF1-MM.  Interpretation of 
these findings is limited by the small numbers.  The children with NF1 had high IQ 
scores.  However, children with NF1 are recognized as having difficulties with 
executive function.  This would suggest that comorbidity may be more predictive of 
neurocognitive outcome than the presence of MM itself.  This has, however, not 
been clearly demonstrated in my study nor other reported studies (Williams et al. 
2012) often limited by numbers.  
 
8.6.3. CVR Measures, Comorbidity and Intellectual Outcome 
In this study children with NF1-MM had the highest scores of intelligence across all 
domains when compared to children with Idiopathic-MM, SCD-MM and 
Chromosomal-MM.  They were also the group with the lowest occurrence of stroke.  
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Executive function was poor across all the moyamoya groups and profoundly so in 
the group with Chromosomal-MM.  This is concordant with the noted severely low 
scores of intelligence.  However, in the NF1-MM group the high scores of executive 
function are discordant with the high levels of intelligence in this sample, but in 
keeping with the relative abnormalities in executive function noted in published 
literature.  There may be a number of comorbidity specific factors that influence the 
MRI BOLD signal and hence the interpretation of CVR in the syndromic group.  
These are discussed below for the main comorbidities represented in this study, 
namely NF1-MM, SCD-MM and Chromosomal-MM.  
 
 
 
8.6.3.1. Neurofibromatosis Type 1 
Areas of increased T2 weighted signal intensity also known as foci of abnormal 
signal intenisity (FASIs) are typically seen in NF1.   Research to date is conflicting 
regarding a link between the presence and location of T2 hyperitensities and 
neuropsychological function in children with NF1.  T2 hyperintensities are 
frequently located in frontal subcortical networks through basal ganglia and 
thalamus (Chapman et al. 1996) (Joy et al. 1995). Frontal networks are one of the 
most richly connected brain structures with a protracted development with age, so 
they are subject to a higher risk of impairment in case of general dysfunction 
 425 
(Perecman 1987). Hence the frontal sub-cortical vulnerability hypothesis.  The 
BOLD signal in NF1 is likely a result of a combination of general and syndrome 
specific factors.  Neurofibromin has a role in modifying synaptic plasiticity and 
excitation. Imaging can be used as a biomarker for synaptic activity eg.PET, 
SPECT and BOLD MRI.  Microglia are key in this process and their activation 
results in upregulation of local blood flow and with a concomitant increase in 
energy demands (Tremblay and Majewska 2011, Siskova and Tremblay 2013, 
Welberg 2014, Apostolova et al. 2015).  In NF1 microglial activation has been 
associated with brain tumorigenesis (Daginakatte et al. 2008).  Juvenile NF1n31 
mice show hyperperfusion bilaterally in the amygdala, which normalizes when 
reaching adulthood (Apostolova et al. 2015). This behavior resembles the typical 
time course of cognitive deficits in NF1. However, further studies are required to 
test for causal relationship.  It could be hypothesised that impairment of of 
cognitive function in NFI is associated with increased synaptic activity, energy 
demands, and cerebral blood flow.  This combination of factors are likely to have 
implictions for the interpretation of CVR in NF1-MM.   
 
8.6.3.2. Sickle Cell Disease 
Children with SCD generally obtain lower IQ scores compared with sibling controls 
(Watkins et al. 1998).  Furthermore, additional factors may contribute to the 
cognitive burden seen in SCD such as covert stroke (Watkins et al. 1998, Noll et al. 
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2001, Gold et al. 2008) and hypoxaemia (Kirkham and Hogan 2004).  Hogan et al 
demonstrated significantly lower VIQ and PIQ in children with SCA when compared 
to healthy controls and a furtherther statistically significant reduction in PIQ 
associated with MMS.  In a study of 54 children with SCD by Steen et al, 30 with 
normal MRI had significant deficits in Wechsler Full-Scale IQ, Verbal IQ and 
Performance IQ compared to age- and gender-matched African-American controls 
(Steen et al. 2005).  Despite a focus on frontal lobe MRI findings and deficits in 
attention, tests of executive functioning have been shown to be more sensitive 
indicators of cognitive difficulties within this group, which if not spectifically 
examined for can be missed (Hariman et al. 1991, DeBaun et al. 1998, Watkins et 
al. 1998, Brown et al. 2000).  In Brown’s study of neurocognitive function in 63 
children and adolescents with SCD, almost half of the children (n=30) had no 
cerebrovascular accident (i.e. stroke or silent infarct).  Despite the normal 
appearing MRI, one third of these children were in receipt of special education.  
Although the high proportion of educational needs in this group may reflect study 
participant referral bias, the observation remains unexplained (Brown et al. 2000).  
Hence, the neuropathological basis of the observed abnormalities in executive 
function in SCD remains unexplained in the absence of silent infarcts.  Despite the 
children in my study not having a history of stroke or revascularization surgery, 
both (n=2) had white matter silent infarcts on MRI therefore my cohort does not 
provide a group of children with SCD and no deep white matter infarcts for further 
study and comparative analysis.   
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8.6.3.3. Chromosomal Disorders 
The association between certain chromosomal disorders and neurocognitive 
difficulties is well recognized.  Down syndrome is the most common identified 
genetic syndrome associated with learning difficulties, and accounts for 
approximately 15% of the significantly learning impaired population (Lai and 
Williams 1989, Pinter et al. 2001).  Genetically mediated cortical developmental, 
neurophysiological and perfusion related abnormalities are reported in children with 
Trisomy 21 with a possible important role for microglia noted to be increased in 
number in fetal Trisomy 21 (Golden and Hyman 1994, Puri et al. 1994, Engidawork 
and Lubec 2003). In particular fronto-parietal-temporal abnormalities of perfusion, 
both hypo and hyper, right more than left, are reported in studies using PET and 
SPECT techniques (Nakayasu et al. 1991, Maruyama et al. 1995, Gokcora et al. 
1999, Aydin et al. 2007). 
In addition neuronal and neurotransmitter level abnormalities are shown to be 
associated with learning and memory deficits deficits in children with Trisomy 21 
(Lubec et al. 2001, Begni et al. 2003, Hill et al. 2003). Hence, it is clear that there 
are a number of factors which may contribute both to the MRI BOLD signal seen in 
these children, as well as the neurocognitive profile a substantial proportion of 
which may be realted to having Trisomy 21 rather than moyamoya.  Further studies 
are required to explore this.  
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8.7. Study Limitations and Future Directions  
My study was limited by the small numbers and number of variables to be 
considered within each group.  Longitudinal analysis in a similar but larger cohort 
would be informative.  Furthermore and specifically: 
1) We were unable to replicate the association reported by Matsushima et al of 
age of onset of MM before 2 years of age and cognitive outcome in my study 
because of the small numbers (Matsushima et al. 1990). Exploration of outcome by 
presentation before and after 9 years at age of diagnosis was suggestive of lower 
scores of intellectual outcome in the younger group.   Further studies of 
neurocognitive outcome and hBOLD CVR could help elucidate developmental 
changes in CVR and their impact on outcome in the younger child with MM.  
2)   The absence of a non-moyamoya syndromic control group is a limitation of 
this study.  Further hBOLD CVR studies in healthy children with comorbid 
diagnosis such as NF1 and SCD paired with measures of intellectual outcome 
would provide a useful comparison for future studies.  
 
8.8. Conclusions 
1) Paradoxically the presence of steal was associated with higher intelligence and 
better scores of indices of executive function. 
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2) Bilateral steal was associated with lower intelligence scores in all domains apart 
from processing speed. 
3) Abnormal left hemispheric CVR was associated with reduced verbal IQ 
4) Abnormal right hemispheric CVR was associated with lower intelligence scores 
in all domains apart from verbal IQ.   
5) Comorbidity is likely to contribute significantly to the neurocognitive profile of 
children with MMS.  Elements of the contributory factors may be measurable using 
hBOLD MRI and CVR.  However, this is yet to be demonstrated and requires 
further study.   
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9. Cortical Thickness and hBOLD CVR  
9.1. Abstract 
9.1.1. Background 
The mechanism of chronic neuronal injury in moyamoya is principally one of 
chronic hypoperfusion distal to the steno-occlusive moyamoya arteriopathy.  
Cortical thickness is a measure of neuronal number and density.  Repeated and 
chronic periods of hypoperfusion may not cause immediate necrotic cell death, but 
may lead to apoptosis, cell involution and neuronal dropout, with consequent 
thinning of the cortical rim. An association between abnormality of hBOLD CVR 
measures and cortical thickness has been shown in adults.   
9.1.2. Objective 
To determine whether abnormalities in quantitative measures of hBOLD CVR are 
associated with reduced cortical thickness in children with moyamoya.  
9.1.3. Method 
Children with moyamoya, no history of stroke and normal appearing cortical rim on 
FLAIR sequences were included in the study.  Automated measures of cortical 
thickness were obtained using Freesurfer and high resolution 3D T1 anatomic 
sequences.   Association between qualitative hBOLD CVR measures, cortical 
thickness, and predictors of cortical thickness were explored for all.    
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9.1.4. Results 
Twelve children (7 male, 5 female; mean age 9.04 +/- 4.29 years) were included in 
the study.  Ten had unilateral MM.  In the majority, hemispheric cortical thickness 
was lower in the hemisphere affected by moyamoya and with impaired quantitative 
and qualitative CVRs.  In addition cortical thickness improved over time in those 
who had revascularization surgery and declined over time in those who did not.  
However, these findings did not reach statistical significance.  
9.1.5. Conclusions 
Cortical thickness may be a useful biomarker of severity of chronic hypoperfusion 
injury in moyamoya, particularly in those with an apparently low ischaemic burden.  
Recovery of cortical thickness following surgery lends further support to current 
management strategies.  However, the mechanisms underpinning the apparent 
cortical thinning and cortical reconstitution, and interpretation of these findings 
remains challenging and requires further study.  
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9.2. Introduction   
Brain development and neuroanatomical organization in the human fetus is a 
complex but well ordered process.  In the early preterm period, thalamocortical 
afferents accumulate within the superficial subplate of the ventricular zone and 
grow into the cortical plate with the simultaneous development of synapses. 
Neuronal migration from the ventricular zone to the cortical plate is essentially 
complete by 26 weeks gestation (Sidman and Rakic 1973, Kostovic et al. 2002). In 
the late preterm period, the resolution of the subplate and growth of cortico-cortical 
fibres into the cortical plate occur simultaneously with gyration. In neonates, the 
long cortico-cortical pathways stop growing, and the main histogenetic events are 
an elaboration of intracortical circuitry and synaptogenesis (Kostovic and Jovanov-
Milosevic 2006). 
In a study of 45 children between 5-9 years, Sowell et al (2004) demonstrated a 
mean cortical thickness of 1.5 – 5.5 mm over the lateral and medial surface of the 
brain. Grey matter thinning and brain growth was observed to occur in the same 
regions (i.e., frontal and parieto-occipital regions) and at the same time (Sowell et 
al. 2004). This is thought to be secondary to a relative reduction in neuronal bodies 
and cortical gray matter density attributable to, in part, increased proliferation of 
myelin into the periphery of the cortical neuropil (Sowell et al. 2001, Sowell et al. 
2003). Regional (left) cortical grey matter thinning in childhood is associated with 
increases in vocabulary. Changes in cortical thickness in childhood may be 
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associated with cognitive development.  Reduction in cortical thickness in 
childhood is not necessarily pathological. Although age related processes such as 
reduction in size or number of neuronal cell bodies or their synaptic processes may 
play a part, this does does not entirely account for the changes (Sowell et al. 2003, 
Richards et al. 2009). 
Lesion volume and lesion location have been shown to be predictive of outcome in 
paediatric stroke (Ganesan et al. 1999). Involvement of cortical tissue is thought to 
be of particular importance, with significant impact on outcome, while the prognosis 
of children with subcortical infarction is thought to be good (Dusser et al. 1986, 
Abram et al. 1996). However, in children with moyamoya, neurocognitive decline is 
recognised in the absence of infarction and is thought to be secondary to chronic 
hypoperfusion.  Pre-infarctive MRI changes are not well recognized, but 
possibilities include the presence of the IVY sign and atrophy on MRI, although 
there are few longitudinal data.  Therefore, biomarkers of this chronic injury are still 
lacking.  hBOLD CVR and measures of cortical thickness are potential candidate 
biomarkers for use in this population. 
In adults, cortical thickness measures have been used to investigate a range of 
neurological disorders including Alzheimer’s disease, schizophrenia and autism 
(Hadjikhani et al. 2006, Du et al. 2007, Goghari et al. 2007). In childhood SCD 
global measures of cortical thickness and sub-cortical volumes have been shown 
to be diminished when compared to age-matched healthy controls (Kirk et al. 2009, 
Kawadler et al. 2013). 
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In moyamoya, cerebral perfusion pressure drops distal to the moderate-severe 
stenosis or occlusion as the autoregulatory response of the smooth muscle 
arterioles fails with uncoupling of the autoregulatory curve. In addition, the normal 
vasodilatory response to increased PCO2 in the unaffected vascular bed(s) results 
in the diversion of blood away from the affected vascular beds, i.e. the ‘steal’ 
phenomenon. which has been associated with increased ischaemic risk in adults 
(Reinhard et al. 2014). Hypoperfusion occurs maximally at the distal vascular 
watershed territories (Fig).  Experimental animal models have demonstrated 
disruption of neuronal structure and hence increased neuronal loss as a 
consequence of chronic hypoperfusion (Sekhon et al. 1994, Hai et al. 2009).    
Fierstra et al (Fierstra et al. 2010) demonstrated a relationship between steal, as 
seen on hBOLD CVR, and cortical thinning in a mostly adult population with MM 
(age range 12 – 75; mean 42).   In addition, the same group demonstrated 
improvements in cortical thickness following successful revascularization surgery in 
the revascularized hemisphere with concomitant reversal in steal physiology as 
demonstrated by hBOLD CVR (Fierstra et al. 2011). Postulated mechanisms 
underpinning the change before and after surgery include loss and gain of 
neuronal tissue, changes in cortical blood volume or changes in extracellular fluid 
volume (Duning et al. 2005). 
Selective neuronal loss has been observed in the penumbra of acute ischaemic 
stroke, and the chronic hypoperfusion state of moyamoya may represent a chronic 
penumbra-like state, which results in progressive tissue loss. Therefore it is 
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possible that within a region of steal physiology, the penumbra-like state may result 
in a higher rate of cell death and attrition, a decrease in synaptic density and 
dendritic arborisation, reduction in the number or volumes of glial cells and myelin 
loss within the cortex (Horner et al. 1996, Kurumatani et al. 1998, Tomimoto et al. 
2003). 
To my knowledge to date there are no published studies of cortical thickness and 
any relation to CVR in children with MM. 
 
9.3. Hypothesis:   
I hypothesized that cortical thickness 
 is significantly attenuated in the hemisphere with intracranial arteriopathy 
and  
 is associated with abnormality in CVR as demonstrated by steal in the 
respective hemisphere.  
 
9.4. Method 
9.4.1. Inclusion Criteria: 
 Clinically acquired T1 3D TEF scans (needed for anatomical overlay during 
Functional MRI Study) and functional hBOLD CVR study 
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9.4.2. Exclusion Criteria: 
 MRI evidence of ischaemic injury on fluid attenuated inversion recovery 
imaging (FLAIR)  
 
9.4.3. Image Pre-processing 
BOLD images were imported into the functional image-processing package, AFNI.  
We applied standard pre-processing steps, including time-shift correction, volume 
re-registration, and signal de-trending.  
 
9.4.3.1. Time-shift correction: 
Data was time-shifted to correct for difference in acquisition time from one slice to 
the next.  For this, the signal time series in every voxel was interpolated to a 
common grid of time (0, 1*TR, 2*TR, 3*TR and so on).  The AFNI 3dTshift was 
used in this step. 
9.4.3.2. Volume re-registration: 
We used the AFNI 3dvolreg program to perform a least square function to minimize 
the difference between each acquired volume and the first one.  
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9.4.3.3. Signal drift 
System noise and head motion can contribute to low frequency BOLD signal drift 
over time. In this study, we de-trended our BOLD data with a 3rd order polynomial 
function. 
 
9.4.4. Breath-hold reference waveform 
Subsequent to pre-processing steps, the data was regressed against a reference 
waveform.  The reference waveform represents the breath hold or hyperventilation 
stimulus. 
In some cases, when breath hold instructions were not followed properly by the 
patient, it was more appropriate to use the BOLD signal from a healthy part of the 
brain.  As the posterior circulation is usually affected late, if at all, in MM, we used 
the cerebellum for the reference waveform.  
 
 
 
9.4.4.1. Regression 
BOLD signal in each voxel of the brain was first scaled as a percentage before 
being regressed against the reference waveform.  The slope of this regression was 
 438 
the cerebrovascular reactivity measure expressed as a percent BOLD signal 
change. 
 
9.4.4.2. Regression motion correction 
Regression motion correction was used in some patients with significant motion. 
 
9.4.5. Cortical Thickness 
The high resolution T1-weighted images from the acquired anatomic volume data 
were used to calculate the cortical thickness using Freesurfer 
(http://freesurfer.net/). This is a method for automated surface reconstruction and 
accurate cortical thickness measurement (Sailer et al. 2003). An inflated 3-
dimensional brain surface image is reconstructed by the software, which allows 
interpretation of functional MRI data across the entire cortical surface after 
accounting for cortical folding (Dale et al. 1999, Fischl et al. 1999, Salat et al. 
2004).  This program constructs models of the boundary between white matter and 
cortical gray matter as well as the pial surface.  Once those surfaces are 
reconstructed, the cortical thickness can be measured. 
9.4.5.1. ROI analysis 
We used Freesurfer to visualize the inflated pial surface onto which the BOLD CVR 
map was projected.  A region of interest (ROI) was then manually drawn on the 
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affected hemisphere.  This ROI was restricted to the most affected area, where 
hBOLD CVR was negative, i.e. representative of steal physiology (score 3), or just 
positive reactivity was diminished (score 2) compared with normal (score 1).  
Cortical thickness measurements were confined to the ROI, and the results were 
generated by the software.  This ROI was reflected on the other side to use as a 
control ROI.  For each patient, the mean CVR and cortical thickness within those 
ROIs could be calculated.   
 
9.5. Statistical Analysis 
The paired t-test was used to calculate the difference between group means, and 
the independent samples t-test was used to compare the mean hemispheric 
cortical thickness in the unilateral group by steal.  The independent samples t-test 
was also used to evaluate significant differences in cortical thickness before and 
after surgical revascularization.   
 
9.5.1. Group Description 
Images of all patients with moyamoya and who had an hBOLD CVR study were 
reviewed to identify those with no MRI evidence of ischaemic injury on Axial T2 
FLAIR sequences.  Fifteen out of 37 children were identified.  High resolution T1 
3D anatomic images were available in 12 (7 boys, 5 girls, mean age at moyamoya 
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diagnosis 7.93 +/- 3.47 years, mean age at first CVR 9.05 years +/- 4.29 years).   
The mean age at first included CVR for girls and boys was 8.95 +/- 2.07 and 9.11 
+/- 1.67 years respectively.   
Three had Idiopathic-MM, seven NF1-MM and two Chromosomal-MM (1 Turner 
syndrome).  The children with NF1 had foci of abnormal signal intensity (FASIs) on 
MRI. Clinical descriptions are presented in Table 104. 
Eight (8/12) children had revascularization surgery.  Four of these had hBOLD 
CVR and 3D anatomic sequences prior to surgery, and four after surgery.  Nine 
(9/12) had two time-point studies available for analysis.   
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Table 103  Clinical Characteristics of Group 
Patient 
(M/F) 
Moyamoya 
Disease or 
Syndromic 
Diagnosis 
Moyamoya 
Laterality 
Age at 
Moyamoya 
Diagnosis 
(years) 
Moyamoya 
Presentation 
hBOLD 
CVR 1 
Age 
(years) 
Age at  
Surgery 
(years) 
hBOLD 
CVR 2 
Age 
(years) 
1 (M)  NF1 Left 11.17 Asymptomatic 11.42 11.83 12.33 
2 (M) 
 
NF1 Left 11.50 Headache 12 12 12.58 
3 (F) 
 
NF1 Right 10.83 Headache 16.33 16.42 16.92 
4 (F) 
 
Turners Syn Left 3.83 Asymptomatic 4.08 4.17 6.58 
5 (F) Idiopathic Right 5.67 Paroxysmal 
sensory 
episodes 
5.75 5.75 7.17 
6 (M) Idiopathic Left 2.92 Seizures 2.83 n/a n/a 
7 (M) 
 
NF1 Left 6.33 L AIS 
(movement 
disorder) 
7.25 6.42 8.08 
8 (F) 
 
NF1 Right 8.58 Asymptomatic 9.00 n/a 9.92 
9 (M) 
 
NF1 Left 14.42 Headache 15 n/a n/a 
10 (F) Chromosomal Right 8.00 Headache 9.08 n/a 11.75 
11 (M)  Idiopathic Bilateral 6.75 Headache 8.67 6.92 10.08 
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12 (M) 
 
NF1 Bilateral 5.17 TIA 5.42 5.42 n/a 
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9.5.2. Cortical Thickness and Steal 
Of the 12 children, 7 (58%) had steal.  The laterality of steal was cross-tabulated 
with moyamoya laterality (Table 105).  Neither of the two with bilateral MM had 
steal, although both had impaired qualitative measures of CVR (Pt 11: reduced 
right positive pixels; Pt 12: bilateral negative pixels). Steal was otherwise confined 
to the ipsilateral hemisphere with moyamoya (2/4 with right MM, 3/6 with left MM), 
was bilateral (1/4 with right MM, 1/6 with left MM) or not present (1/4 right MM, 2/6 
with left MM).  The 5/12 with no steal had reduced positive reactivity in the 
ipsilateral hemisphere with MM, and bilateral increased negative pixels in one of 
the patients with bilateral MM (as above). 
 
Table 104  Steal Laterality by Moyamoya Laterality 
Steal 
Laterality 
Moyamoya Laterality Total 
Bilateral Right Left 
Bilateral 0 1 1 2 
Right 0 2 0 2 
Left 0 0 3 3 
None 2 1 2 5 
Total 2 4 6 12 
 
Mean cortical thickness was compared by presence of steal/reduced positive 
reactivity and no steal in the children with unilateral MM without a history of prior 
revascularization surgery (n=7). Using the paired t-test there was no statistically 
significant difference between the two groups.   The biggest difference in cortical 
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thickness between steal/reduced reactivity and no steal hemispheres was seen in 
the oldest child in the group (patient 3; age 16 years) (Table 106).    
In binary logistic regression there was a trend toward left hemispheric steal being 
predictive of left cortical thickness B (-6.66), p=.098, confidence interval .00-3.41.  
Right cortical thickness was not predictive of left or right cortical thickness.  
 
Table 105  Cortical Thickness in Hemispheres with Steal and No Steal or 
Reduced Positive Reactivity 
Patient Number 
(n=7) 
Age Cortical Thickness (mm) 
Thickness 
Difference 
No Steal 
 
Steal/Reduced 
Reactivity 
1 11 2.6995 2.684 .02 
3 16 2.5656 2.3776 .19 
4 4 2.4912 2.4436 .05 
6 3 2.762 2.662 .10 
8 9 3.0702 3.08 -.01 
9 13 2.886 2.9426 -.06 
10 8 3.0512 3.0483 .00 
Mean +/- SD 9  2.79 +/- .225 2.75 +/- .283 .04 
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9.5.3. Cortical Thickness and Quantitative CVR 
Quantitative CVR was calculable in six of the seven children with unilateral MM 
and no history of revascularization surgery.  Hemispheric CVR was lower in the 
hemisphere affected by MM.  Although there was no statisitically significant 
difference in CVR between the hemispheres, cortical thickness was lower in the 
hemisphere with lower CVR in four of the six children.  The two children (Patient 8 
and 9) with discordant cortical thickness and hemispheric CVR had NF1.  Serial 
measures of cortical thickness in Patient 8 demonstrated a subsequent drop in 
right (affected) hemisphere cortical thickness, whereas left hemispheric cortical 
thickness remained the same.  No serial measures were available for Patient 9. 
Linear regression analysis was conducted to examine whether hemispheric CVR 
was predictive of hemispheric cortical thickness.  Using a one-sided t-test there 
was a trend toward correlation between left hemispheric cortical thickness and 
CVR (r=.581, p=.113) and no significant correlation between right hemispheric 
cortical thickness and CVR (r=.151, p=.388).  Hemsipheric CVR was not predictive 
of cortical thickness (Table 107, Figs 90 and 91). 
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Table 106  Hemispheric Cortical Thickness and Quantitative CVR 
Patient 
Number 
(n=6) 
Moyamoya 
Laterality 
Cortical Thickness 
Right               Left 
Hemispheric CVR 
Right             Left 
1 Left 2.6995 2.684 .5555 .1466 
3 Right 2.3776 2.5656 .0056 .6802 
4 Left 2.4912 2.4436 2.5346 .4163 
6 Left 2.762 2.662 .518 .3617 
8 Right 3.08 3.0702 -.4996 .7976 
9 Left 2.886 2.9426 2.367 2.0577 
Mean +/- 
SD 
 2.79 +/- .225 2.75 +/- .283 .913 +/- 
1.253 
.743 +/- 
.685 
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Figure 90 CVR Parametric Maps (top images) and Cortical Thickness (lower 
images) for Patient 3 right moyamoya (ROI outlined) 
 
               Left Hemisphere                                                 Right Hemisphere 
Top row:  CVR maps showing steal within the outlined ROI in the affected 
right hemisphere, and reduced reactivity in the unaffected left 
hemisphere. 
Bottom row:  Cortical thickness maps showing reduced (more red) 
cortical thickness in ROI compared to the unaffected (comparatively less 
red) ROI in the unaffected hemisphere.  
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Figure 91  CVR Parametric Maps (top images) and Cortical Thickness (lower 
images) for Patient 4, left moyamoya (ROI outlined).   
 
 
 
 
                           Left Hemisphere                                                  Right 
Hemisphere 
Top row:  CVR maps showing left, more than right hemispheric impaired CVR 
Bottom row:  Cortical thickness maps showing reduced (more red) cortical 
thickness in affected left hemisphere.  
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Table 107 Cortical Thickness over time and following Surgery 
 Operative 
Hemisphere 
Pre Surgery/First 
Study 
Post Surgery/Second 
Study 
Post Surgery/Third 
Study 
Post Surgery 
 
  Mean Cortical 
Thickness (mm) 
Mean Cortical 
Thickness (mm) 
Mean Cortical 
Thickness (mm) 
Mean Cortical 
Thickness (mm) 
Patient Operative 
Hemisphere 
No 
Steal 
Steal or 
reduced 
reactivity 
No Steal Steal or 
reduced 
reactivity 
No 
Steal 
Steal or 
reduced 
reactivity 
  
1  Left 2.6995 2.684 2.6089 2.5864     
2  Left   2.6578 2.6971     
3  Right 2.5656 2.3776 2.58 2.41     
4 Left 2.4912 2.4436 2.9563 2.78     
5  Right   3.0839 3.1884 3.099 3.2054 3.3376 3.2176 
6  NS 2.762 2.662       
7  Left   2.9525 2.6723     
8  NS 3.0702 3.08 2.9786 3.0718     
9  NS 2.886 2.9426       
10  NS 3.0512 3.0483 3.0208 2.9856 2.9093 2.8526   
11  Bilateral   2.7054 2.7161 2.6969 2.6270   
12 Bilateral 2.3225 2.4492       
NS=no surgery
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9.5.4. Change in Cortical Thickness over Time  
Children were divided into three groups depending on whether they had 
revascularization surgery prior to their first included hBOLD CVR study or not 
(Table 108).  The three groups were configured as follows: 
1)  No surgery at any time-point:  No surgery (n=3) 
2)  No surgery prior to first hBOLD CVR study and surgery after first hBOLD CVR 
study: Pre and post surgery. (n=5) 
3)  Surgery prior to first hBOLD CVR study:  Post surgery (n=4) 
Seven children had serial studies (five studies over two time-points, two studies 
over three time-points).  The mean interval between the first and second (T1 and 
T2) hBOLD CVR was 16.7 months +/- 9.78, range 7 – 31 months.  The mean 
interval between the second and third (T2 and T3) hBOLD CVR was 10 months +/- 
4.24, range 7 – 13 months.   
The mean age at first CVR in the No Surgery group was 11.03 years +/- 3.44, 
second CVR 10.83 years +/- 1.3 and third 12.83 years.   The mean age at first 
CVR in the Pre and post Surgery group was 8.02 years +/- 5.7 and second CVR 
11.94 years +/- 5.18.   The mean age at first CVR in the Post Surgery group was 
8.42 years +/- 2.67, second CVR 9.48 years +/- 2.4 and third CVR 7.75 years.   
The group mean cortical thickness was calculated according to the presence or 
absence of steal or reduced postitive reactivity on initial qualitative hBOLD CVR 
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assessment.  Mean cortical thickness was highest in the No Surgery group at T1 
and lowest in the Pre and post Surgery group at T1 (Table 108).  Mean cortical 
thickness increased between the first and last available studies in the Pre and post 
Surgery group (T1 and T2) and the Post Surgery group (T1 and T3) (Fig 91).  
Mean cortical thickness declined over time (T1 and T3) in the No Surgery group.   
It is interesting to note the greater mean difference over time in cortical thickness in 
the hemisphere affected by steal in the No Surgery group, and the Pre and post 
Surgery group (Table 109; Fig 91).  Consequently apparent cortical thinning 
occurred at a faster annual rate in the No Surgery group, and increases in cortical 
thickness occurred at a slower rate in the Pre and post Surgery group.  The 
increases in cortical thickness occurred at a slower rate in the no steal, not 
surgically treated hemisphere in the surgical group.   
Two of the three children over 11 years had serial studies.  Both had 
revascularization surgery between their first and second study.  Cortical thickness 
decreased over time in one child (11.42 years old) and increased (16.3 years) in 
the other (Fig 92). 
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Table 108  Mean Cortical Thickness by Steal over Time 
Mean 
Cortical 
Thickness 
by 
Patient 
Group 
(mm
3
) 
 
No Steal 
 
        
   T1       T2        T3 
 
Mean 
Difference  
Cortical 
Thickness/T
ime (years) 
 
Steal/Reduced Positive 
Reactivity 
 
   T1         T2           T3 
 
Mean 
Difference 
Cortical 
Thickness 
No 
Surgery  
(n=3) 
3.002 3.046 2.909 -0.093/1.5= 
-0.062/year 
3.024 2.982 2.853 -0.171/1.5= 
-0.114/year 
Pre and 
post 
Surgery        
(n=5) 
2.568 2.715  0.147/1.3= 
.113/year 
2.523 2.592  .069/1.3= 
.053/year 
Post 
Surgery 
(n=4) 
2.876 2.900 3.218 0.342/3.67= 
.093/year 
2.792 2.717 3.338 0.546/3.67= 
0.149/year 
T1= first time-point hBOLD CVR; T2=second time-point hBOLD CVR; T3=third 
time-point hBOLD CVR 
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Figure 92  Group Measures of Cortical Thickness by Presence of Steal 
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Figure 93  Changes in Cortical Thickness in Children who had Serial Measures by 
Steal 
 
            No steal 
            Steal 
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Figure 94  CVR Parametric Maps (top images) and Cortical Thickness (lower 
images) for Patient 7 Following Surgery (ROI outlined) 
 
 
 
 
  
               Left Hemisphere                                        Right Hemisphere 
Top row:  CVR parametric maps showing area of steal in left hemisphere 
(circled ROI) 
Bottom row:  Reduced (more red) cortical thickness in left hemisphere 
(circled ROI) 
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9.6. Discussion 
Changes in cortical volume in childhood do not conform to the more linear model 
ascribed to adults, where over time there is an expectation of decline.  Published 
data of changes in cortical volume in childhood suggest an age related increase in 
cortical volume leading to a peak just before adolescence with subsequent decline 
over time.   This in itself is not simple as there are regional and gender specific 
differences in the observed changes (Lenroot et al. 2007, Sowell et al. 2007, Shaw 
et al. 2008). In Lenroot et al’s longitudinal study of 829 scans from 387 subjects, 
ages 3 to 27 years, mapping brain development during childhood, total cerebral 
volume was noted to peak at 10.5 years in females and 14.5 years in males, with 
total grey matter peaks of 8.5 years in females and 10.5 years in males.   
Trajectories followed an inverted U shape with onset of gradual decline occurring 
earlier in females (Lenroot et al. 2007). 
Kirk et al (Kirk et al. 2009) demonstrated a significant association between areas of 
cortical thinning and watershed (ACA/PCA) regions in older (over 12 years) 
children with SCD, no stroke and no cerebral vasculopathy, providing a link 
between cerebral hypoperfusion and cortical thickness in children.   
 
9.6.1. Group Description 
The majority of the children in this study were asymptomatic or had headache.  
Hence this group is representative of children with a low ischaemic symptom 
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burden.  The majority had revascularization surgery at some time-point.  Only three 
did not.  The mean cortical thickness in our group was within normal described 
ranges in childhood (Sowell et al. 2004). 
The two children over 11 years of age with serial studies of cortical thickness had 
different post-operative trajectories of cortical thickness.   The younger child had 
continued thinning of the cortex despite surgery in contrast to the older (16 year 
old) that had an increase in cortical thickness post-operatively.  The latter is more 
in keeping with the findings in the study by Fierstra et al, in which successful 
revascularization surgery and reversal of steal resulted in restoration of cortical 
thickness (Fierstra et al. 2011).  
 
9.6.2. Cortical Thickness and Steal 
The lack of a significant difference in group mean cortical thickness by 
steal/reduced reactivity in this study may be as a result of a number of confounding 
factors.  Aside from the small numbers, the gender and age differences within the 
group limit the ability to make meaningful group comparisions.  However, in all but 
two (Patient 8 and 9), the cortical thickness was lower on the side of the 
moyamoya vessels with impaired CVR. Cortical thickness on the side wih impaired 
CVR in Patient 8 dropped in the subsequent study eleven months later.  The 
observation of reduced cortical thickness in the three (3/7) with left moyamoya may 
be more significant than immediately apparent, given the occurrence of the 
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difference in the typically thicker left hemisphere (Jones et al. 2000, Luders et al. 
2006). Furthermore, my study (Chapters 4 and 5) demonstrated the presence of 
abnormalities of CVR in the contralateral, unaffected hemisphere, in some children 
with unilateral moyamoya.  Therefore it is possible that the contralateral cortex is 
also thinned, albeit not to the same extent as the primarily affected hemisphere.  
This could reduce the magnitude of difference in cortical thickness between 
hemispheres.  This, however, requires exploration in further studies and 
comparison of findings with age and sex matched healthy controls.  
The presence of steal also appeared to have a negative effect on the rate of 
increase in cortical thickness in the ipsilateral hemisphere of the no surgery and 
pre and post-surgical group, with a faster rate of cortical thinning in the group not 
treated with surgery, and slower rate of increase in the operated/steal hemisphere 
of the pre post-surgery group.  This is not seen in the group with surgery at first 
hBOLD CVR and hence with the longest time post revascularization.  In this group 
the annual rate of increase in cortical thickness was lower in the non-operative/no 
steal hemisphere.  This may be suggestive of the benefits of surgery persisting and 
increasing relative to the operation naïve hemisphere over time.   
 
9.6.3. Cortical Thickness and Quantitative CVR 
Despite small numbers, there was a trend toward correlation between left 
hemispheric quantitative CVR and cortical thickness.    
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9.6.4. Change in Cortical Thickness over Time 
The mean age of CVR and cortical thickness calculation in the no surgery group 
was higher than both surgical groups and around 11 years of age.  However, the 
two (2/3) with serial studies within this group were average age 8 years.  Hence, 
older age with expectant decline in cortical thickness would not be an adequate 
explanation for the decline in cortical thickness in this untreated group.   
The greatest increase in cortical thickness was noted in the Post Surgery group, 
who represent those already revascularized at first included hBOLD CVR and 
therefore with the longest period of revascularization. These preliminary 
observations would suggest longer duration of successful revascularization surgery 
result in greater reconstitution of cortical thickness.   
 
9.6.4.1. Interpretation of Findings and Proposed Mechanisms of Change in 
Cortical Thickness 
Although we were unable to examine for the association between 
neurodevelopmental outcome and cortical thickness in our study, it has been 
shown that adverse neurocognitive outcomes may just as well be associated with 
larger cortical thickness measures as smaller measures, for example in the 
development of vocabulary (Sowell et al. 2004). Specifically grey matter cortical 
thinning occurs in normal children with a bilateral posterior and right lateral frontal 
predominance at a rate of 0.1-0.33 mm/year.  In addition bilateral perisylvian and 
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left inferior frontal increases in cortical thickness are both developmentally 
appropriate and occur at a rate of 0.05-0.2 mm/year (Sowell et al. 2001, Sowell et 
al. 2003, Sowell et al. 2004). The rate of cortical thinning was lower (.062/year) in 
the no steal hemisphere of the no surgery group in my study compared to the 
reported norms. Other rates of thinning and thickening in this study were in keeping 
with reported norms.   
The results of this study have to be interpreted in the context of a chronic injury in a 
developing brain.  Impaired CVR, and in particular the presence of steal 
physiology, is likely to result in chronic and/or intermittent episodes of hypoxic-
ischaemic injury.  Cell death may not be the result of this injury, hence the absence 
of diffusion restriction and normal looking FLAIR sequence on MRI.  However, 
injury in the form of apoptosis or involution of cells may result in selective neuronal 
loss and consequent cortical thinning (Yamauchi et al. 2005, Saur et al. 2006, 
Guadagno et al. 2008). This has been observed in the penumbra of acute 
ischaemic stroke.  In addition, intermittent hypoxemia are also likely to result in 
neuroinflammation, degeneration and diminution of the induction of long-term 
potentiation, all of which are mechanisms likely to play a role in cortical thinning 
(Payne et al. 2004, Pena and Ramirez 2005). 
 
The mechanisms underlying the apparent recovery of the cortex post 
revascularization are not clear, and could potentially be explained by loss or gain 
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or neuroglial tissue, reversal of cortical myelin loss or post-operative increase in 
cortical blood volume (Horner et al. 1996, Kurumatani et al. 1998, Derdeyn et al. 
2002, Tomimoto et al. 2003). This requires further exploration.  
 
9.7. Study Limitations and Future Directions  
The main limiting factor to this study was the limited numbers.  Given the 
aforementioned important variables and determinants of cortical thickness future 
studies should be powered to at least account for differnces in gender and age.    
Matching a larger group to healthy age and gender controls would be ideal.   
Larger numbers would also allow for further exploration of the association between 
cortical thickness and neurocognitive outcome.   
 
9.8. Conclusions 
To my knowledge this is the first study to investigate the association of impaired 
vascular reactivity in childhood moyamoya and cortical thickness, and the change 
in cortical thickness measures over time, with and without intervening surgery.  
Improvements in cortical thickness following revascularization surgery lends 
support to revascularization surgery being an appropriate intervention for this 
group of children even when they appear to be mildly affected.  Correlation with 
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neurocognitive outcomes in a larger cohort would help explore the implications of 
increased post-operative cortical thickness.  
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Transient Cerebral Arteriopathy as a model 
for Chronic Non-progressive Arterial Stenosis 
and hCVR  
9.9. Abstract 
9.9.1. Background  
In adults, cerebral arterial stenosis is frequently treated by endovascular or surgical 
revascularization to restore perfusion and reduce ongoing and recurrent ischaemia. 
Hypercapnic-challenge blood oxygen level-dependent MRI cerebrovascular 
reactivity (hBOLD CVR) measures the regional perfusion response to altered CO2.  
hBOLD CVR correlates with the risk of ischaemia, informing revascularization 
strategies. Among children with arterial ischaemic stroke (AIS), transient cerebral 
arteriopathy (TCA) is a frequent and non-progressive unilateral intracranial 
arteriopathy with basal ganglia infarction and chronic cerebral artery stenosis.  
Therefore TCA provides a model for studying cortical perfusion distal to the 
stenotic artery in a chronic non-progressive arteriopathy. Altered hBOLD CVR 
perfusion and secondary cognitive decline are unstudied in TCA but, if impaired 
during chronic stenosis, may suggest a role for reperfusion strategies.    
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9.9.2. Objective  
To describe, in children with TCA, whether chronic non-progressive intracranial 
stenosis is associated with impaired cortical hBOLD CVR or cognitive decline.      
9.9.3. Methods 
Children with a prior diagnosis of unilateral TCA having 1) significant (>50% 
diameter) residual stenosis of the distal internal carotid (dICA), proximal anterior 
(pACA) or middle cerebral artery (pMCA) and 2) AIS within basal ganglia sparing 
overlying cortex were enrolled in this thesis study. We quantified infarct volumes, 
the degree of arterial stenosis, hBOLD CVR in the cortex, and intellectual function. 
9.9.4. Results 
hBOLD CVR studies were conducted in six children.  One child had a normal initial 
MRI and TOF MRA and was removed from further analysis.  The five remaining 
children had hBOLD CVR studies at a mean age of 8.96 years (3.33 – 14.58 years) 
post-stroke. Impaired CVR was limited to the infarct zone and adjacent white 
matter.  Overlying cortex demonstrated normal CVR on inspection of parametric 
maps. Neuropsychological assessment demonstrated intellectual deficits in four 
children, all referable to the initial sub-cortical infarct. 
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9.9.5. Conclusion  
In children with TCA and sub-cortical infarction, ipsilateral cortical CVR and cortical 
intellectual function referable to the ipsilateral cortex are preserved despite 
persistent arterial stenosis. These findings suggest that reperfusion strategies in 
TCA are unlikely to be of benefit. 
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9.10. Introduction 
Arteriopathy occurs in 63% of children with AIS. These arteriopathies are usually 
intracranial, characteristically involving the circle of Willis arteries, in particular the 
distal internal carotid (dICA), proximal middle cerebral (MCA) and anterior cerebral 
(ACA) arteries. Childhood arteriopathies are associated with recurrent stroke in up 
to 66% (Fullerton et al. 2007). The most frequent intracranial arteriopathies are 
moyamoya in 22% of these patients, which is bilateral and progressive, and TCA in 
25% of these patients which is unilateral and, in the chronic phase, non-
progressive (Amlie-Lefond et al. 2009).  
Moyamoya is characterized by bilateral involvement, progressive arterial stenosis, 
chronic hypoperfusion and ongoing recurrent strokes.  Both recurrent strokes and 
chronic hypoperfusion are well-recognized and each is posited to contribute to the 
observed chronic progressive cognitive decline (Ishii et al. 1984, Ikezaki et al. 
1994, Hogan et al. 2005).  
In contrast, TCA is characterized by unilateral arteriopathy involving the circle of 
Willis arteries (dICA, pMCA, pACA) with infarction in the territory of perforator 
arteries arising from these arteries (Chabrier et al. 1998, Sebire 2006).  TCA is the 
most frequent cause for chronic non-progressive intracranial arteriopathy 
associated with childhood stroke (Braun et al. 2009).  Stenosis can increase in the 
initial 3-6 months post-stroke, however beyond 6 months the course is static or 
resolving.  Therefore TCA is a useful model for studying whether static arterial 
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stenosis is associated with chronic perfusion deficits in ipsilateral cortex and if so, 
whether these deficits are associated with cognitive decline referable to the 
uninfarcted ipsilateral cortex. This in turn can elucidate whether reperfusion 
strategies are indicated in children with TCA. 
As a biomarker of neurological injury neuropsychological evaluation can be used to 
measure cognitive deficits referable to either cortical or sub-cortical injury.  Deficits 
in verbal and visual reasoning are typically associated with cortical injury, and 
deficits in information processing and working memory with sub-cortical injury.  
In this chapter I explored whether the chronic stenosis seen in TCA results in 
impaired hBOLD CVR in the region beyond the stenosis and/or cognitive decline. 
 
9.11. Hypothesis 
The hypotheses were that: 
1. In children with TCA, despite persistent moderate-severe stenosis, CVR 
abnormalities as an indicator of perfusion abnormalities would be limited to the 
infarct location and spare the overlying cortex.   
2. Intellectual deficits would be limited to those referable to the sub-cortical 
stroke lesion (including information processing and working memory) and spare 
those  referable to the cortex in the distal perfusion zone of brain supplied by the 
stenosed artery (such as verbal and visual reasoning). 
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9.12. Method 
9.12.1. Patient Population  
Clinical and radiographic data of all children enrolled in our institutional Stroke 
Registry with TCA diagnosed per published criteria (Chabrier et al. 1998) between 
1990-2007 were screened.  Children with persistent moderate to severe stenosis 
on conventional angiography (defined below) of pMCA, pACA and/or dICA, plus 
infarcts limited to sub-cortical structures with spared cortex at the time of their 
follow-up imaging were selected and consent sought.  
Formal neuropsychological assessments and follow-up clinical information were 
obtained as part of routine standardized follow-up in our Stroke Clinic. In addition 
all children underwent neuropsychological assessments at school entry and these 
data were utilized for the current study (Westmacott et al. 2009).   
 
9.12.2. Patient Definition 
9.12.2.1. Inclusion criteria were:  
i) acute AIS limited to sub-cortical structures (basal ganglia and adjacent white 
matter) 
ii) conventional angiography performed within three months of the initial stroke, 
demonstrating unilateral stenosis or occlusion involving dICA, pMCA or pACA. 
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iii) MRI/MRA >6 months from index stroke demonstrating non-progressive vascular 
disease  
iv) MRI/MRA >12 months from index stroke demonstrating stable moderate to 
severe stenosis (defined below) in dICA, pMCA or pACA. 
v) MRIs showing no recurrent AIS after 6 months post-initial stroke 
vi) able to co-operate with awake research MRI and breathe with a face mask in 
place for minimum 20 minutes  
 
9.12.3. Magnetic Resonance Imaging Including BOLD CVR 
MR imaging was performed on a 3.0T MRI system using an 8-channel head coil 
(Philips Healthcare, Best, the Netherlands). Anatomical imaging included standard 
FLAIR, DWI, 3D time-of-flight (TOF), and a high-resolution T1-weighted sequence.  
BOLD-CVR data were acquired using a T2*-weighted single-shot EPI gradient 
echo sequence (TR/TE=2000/30 ms, FA=90°, FOV=220×220 mm2, matrix=64×64, 
slices=25, slice thickness=5 mm, dynamics=270). During BOLD-CVR imaging, 
precise and independent manipulation of subject partial pressures of end-tidal CO2 
(PETCO2) and O2 (PETO2) was achieved by introducing a CO2 breathing challenge 
via a rebreathing mask and computer-controlled gas sequencer (RespirAct; 
Thornhill Research Inc., Toronto, Canada) (Slessarev et al. 2007). The challenge 
involved alternating 60 second blocks of targeted normocapnia (PETCO2=40 
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mmHg) and hypercapnia (PETCO2=45 mmHg) while PETO2 was maintained at 100 
mmHg.  
 
9.12.4. Grading of stenosis 
Grading of arterial stenosis was performed by the study neuroradiologist (DA), 
through visual inspection of initial and follow-up 3D TOF MRAs and conventional 
angiograms.  Stenosis was graded as a percentage of the normal arterial diameter.   
If more than one vessel was involved all were graded and the vessel with maximal 
stenosis was chosen for the purpose of study analysis: 
1 = 0-25%; 2 = 26-49%; 3=50-74%; 4=75-100%.   
 
9.12.5. BOLD CVR analysis 
MRI and end-tidal data were analysed offline using FSL v4.1.1 (FMRIB Software 
Library; FMRIB Analysis Group, Oxford, UK) (Smith et al. 2004). BOLD-CVR 
images were first corrected for motion then filtered to remove signal drift. The 
PETCO2 waveform for each subject was temporally aligned with the BOLD-CVR 
data to adjust for sampling delays. The linear correlation between the BOLD-CVR 
values of each voxel and the subject's PETCO2 waveform was calculated and then 
normalized to generate a CVR map expressed as a percent signal change per 
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mmHg of PETCO2. Each map was co-registered to the associated high-resolution 
anatomical images to allow for qualitative clinical assessment. 
 
9.12.6. Measurement of Lesion Volumes 
The ischaemic regions of interest were outlined using semi-automated planimetry 
on axial FLAIR research MRIs employing Analyze 8.0 software (Analyze Direct, 
KS). Total brain volume (all supra-tentorial brain parenchyma excluding the 
brainstem, cerebellum, ventricles and CSF) was also measured and infarct 
volumes were expressed as a proportion of total brain volume to account for the 
variable brain size across childhood.   
 
9.12.7. Neuropsychological Assessments 
All children had a full neuropsychological assessment conducted at 3-9 years 
following their clinical stroke. Assessment included appropriate standardized 
Wechsler Intelligence Scales for Children (WISC-IV).for overall intellectual ability 
(Full-scale IQ), language, and verbal ability (Verbal Comprehension Index), visual–
spatial ability (Perceptual Reasoning ⁄Organization Index), auditory attention and 
mental manipulation (Working Memory ⁄ Freedom from Distractibility Index), and 
visual–motor speed (Processing Speed Index).  Participants’ scores were 
compared with the normative sample of the test, where each index score has a 
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mean of 100 and a standard deviation of 15.  An abnormal score was defined as 
equal to or less than 85. 
 
9.13. Results 
9.13.1. Patient Population 
Forty-five children diagnosed with TCA at our institution between 1990 and 2007 
were screened for inclusion. We excluded 10 children with infarcts involving 
overlying cortex and 24 children with normal artery calibre or only mild residual 
arterial stenosis. Among the remaining 11 children, two patients refused 
participation and three could not be contacted.  The remaining six children with 
sub-cortical infarcts and moderately severe arterial stenosis comprised our study 
sample (Table 109). At the time of the study CVRs, review of the initial MRI and 
TOF MRA revealed a normal MRI and no abnormality on MRA in one child.  
Therefore this child was removed from further analysis. One child (Patient 4) had a 
recurrent stroke 2 months following the initial stroke while the remainder had no 
symptomatic or silent recurrent strokes after the initial stroke.  All were managed 
with anticoagulant or aspirin therapy during the course of the follow-up.  
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9.13.2. Parenchymal and vascular findings 
hBOLD CVRs were conducted in 2011 at a group mean age of 8.96 years (3.33 – 
14.58 years) following initial stroke diagnosis. Parenchymal MRI demonstrated 
unilateral infarcts limited to the basal ganglia and adjacent sub-cortical structures 
(Table 110; Fig 95).  MRA showed moderate to severe arterial stenosis. Infarcts 
were all confined to the vascular territory of the stenotic cerebral artery.  Infarct 
volumes were mean 4436 mm3 (range 802 – 8107), and mean 0.4% (range 0.06-
0.7%) of total brain volume.  There appeared to be a relationship between the 
degree of arterial occlusion and infarct volume as the patient with the smallest 
degree of occlusion had the smallest volume infarct (Patient 5; 25-50% occlusion; 
0.06%) and the patients with the largest degree of arterial occlusion had the largest 
infarct volumes (Patients 1 and 2; 100% occlusion; 0.7%). 
Compared to the MRAs performed in the initial 3 months post-stroke, the research 
MRAs showed stable, moderate to severe, unilateral stenosis involving pMCA 
alone (Patients 1 and 4); pMCA and dICA (Patient 3); pMCA, ACA and dICA 
(Patient 2) and pACA alone (Patient 5).  
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   Table 109 Patient Clinical and Imaging Characteristics 
Patient 
No 
(Age) 
Age 
at 
Time 
of 
Strok
e 
(year
s) 
Time 
to 
CVR 
(year
s) 
Parenchymal  
Lesions 
Vessel/ 
%Occlusi
on 
Vascular 
Stenosis 
CVR  
Impaired 
reactivity 
stroke area 
(Yes/No) 
CVR 
impaired in 
deep WM  
(Yes/No) 
CVR 
Impaired 
cortex 
Y/N 
(Yes/No) 
1). 15, M 0.5 14 Right caudate, 
putamen, 
corona radiata 
M1/100 Right M1 Yes No No 
2).  7, M 
 
4.0 3 Right deep WM, 
caudate, putamen 
M1/100 Right M1, 
A1, dICA 
Yes No No 
3).  17, F 
 
7.9 10  Left  corona radiata M1/100 Left M1, 
dICA 
Yes No No 
4). 10, M 
 
3.2 7 Left deep WM, Left 
putamen 
M2/51-75 Left distal 
M1/M2 
junction  
Yes No No 
5). 9,   M 
 
1.9 7 Left internal 
capsule 
A1/25-50 Left  M1, A1, 
dICA  
Yes No No 
M=male; F=female; WM= white matter; M1=proximal middle cerebral artery; A1=proximal anterior cerebral artery; M2= second branch of middle 
cerebral artery; dICA= distal internal carotid artery; Vessel = worst vessel affected; occlusion = percentage occlusion at time of diagnosis 
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Figure 95  MR Angiography, CVR Parametric Maps and Axial FLAIR Images of 
Patients (1-5) with Transient Cerebral Arteriopathy 
 
 
MRA: yellow circled area demonstrating area of stenosis on  
CVR parametric maps demonstrating intact positive reactivity in stroke and   non-stroke 
hemispheres except in the area of infarction 
MRI: arrows showing region of ischaemic injury 
 
9.13.3. BOLD CVR Results 
hBOLD CVR studies were done at a mean age of 11.6 years (range 7-15 years) 
and at a mean of 7.7 years from the acute stroke (range 3.3-14.5 years).  The fit of 
the BOLD-CVR data with the PetCO2 waveform was excellent in four of the five 
patients. (Fig 96) In the fifth child (Patient 2) CVR study was sub-optimal due to 
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excessive patient motion and a small (poor) magnitude of CO2 change (Fig 97). 
Within the infarct territory CVR in all children during hypercapnic challenge 
demonstrated either no increase or paradoxical decrease in BOLD signal. Within 
the intact cortex overlying the deep infarct, the CVR was normal and symmetric to 
the non-lesioned hemisphere in the four children with adequate studies. (Fig 94) 
 
Figure 96  BOLD fit Curves in Patient 3 Showing Good Fit 
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Figure 97  BOLD fit Curves in Youngest Patient (Patient 2) Showing Poor Fit 
 
 
 
9.13.4. Neuropsychological Outcomes   
Neuropsychological assessments were conducted in all children at mean age 6.9 
years (3.2-14.3 years) at intervals ranging from 3 to 9 years post stroke.  The mean 
interval between the neuropsychological assessments and hBOLD CVR was 3.1 
years (range 0.2-5.7 years).  Group mean intelligence scores were normal in all 
domains (Table 110). However, scores in sub-domains fell into the abnormal range 
in three of the six patients. Three children (Patients 2, 3 and 4) demonstrated lower 
scores in their processing speed and working memory (predominantly sub-cortical 
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functions) compared with higher scores in verbal-reasoning (predominantly cortical 
function) (Table 111). Patient 1 had the lowest scores in all domains (all abnormal): 
FSIQ (74), VCI (75), PRI (76) and PSI (80) and also had the largest volume stroke.  
In the five patients, the calculated mean neuropsychological scores in each domain 
were highest in Patients 4 (FSIQ 95) and 5 (FSIQ 107) who had the two smallest 
lesion volumes compared to lower scores in Patients 1, 2 and 3 (FSIQ 74, 87 and 
89 respectively) who had the largest lesion volumes (Table 111).    
 
   
Table 110 Volume of Infarct and Neuropsychological Findings 
 
Patient 
Number, 
age, sex 
Age at 
time of 
stroke 
(years) 
Age at 
time of 
NP 
(years) 
Parenchymal 
lesions 
(%Occlusion) 
Volume of 
Infarct 
(mm3)/ 
%Total 
Brain 
Weschler Scales of 
Intelligence Scores 
 
 
FSIQ    VCI     PRI    WI       
PSI 
       
1). 15, M 
 
0.5 9.8 Right caudate, 
putamen, 
corona radiata 
(100) 
8109/0.7 74 75 76 86 80 
2).  7, M 
 
4.0 7.3 Right deep 
WM, caudate, 
putamen 
(100) 
7910/0.7 87 95 91 91 83 
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3). 17, F 
 
7.9 13.5 Left corona 
radiata 
(100) 
2822/0.2 89 91 100 88 88 
4). 10, M 
 
3.2 7.3 Left deep WM, 
left putamen 
(50-75) 
2537/0.2 
 
 
95 109 82 98 87 
5). 9,   M 
 
1.9 9.2 Left internal 
capsule 
(25-50) 
802/0.06 107 104 114 103 110 
Group Findings 
Patient 
Number 
Age at 
Study 
(mean; 
range) 
years 
Age at 
Stroke 
(mean; 
range) 
years 
Age at 
NP  
(mean; 
range) 
years 
Infarct 
volume 
(mean; 
range) 
mm3 
   
FSIQ      VCI           PRI         WMI         
PSI 
(mean;range) 
n=5 9.4; 
7.3-
13.5 
3.5; 
0.5-
7.9 
6.9; 
3.2-
14.3 
4436; 
802-
8109 
90.4;   
74-
107 
95; 
75-
109 
93; 
76-
114 
93; 
86-
103 
90; 
80-
110 
FSIQ=full scale intelligence quotient; VCI=verbal comprehension index; PRI=perceptual reasoning 
index; WI=working memory; PSI=processing speed index 
 
9.14. Discussion  
We studied five children with TCA to determine the association between persistent 
moderate to severe arterial stenosis, distal CVR, and neuropsychological outcome. 
We found CVR abnormalities and intellectual deficits limited only to the zone of the 
sub-cortical infarct and not in the overlying cortex. Together with the lack of late 
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recurrent visible infarcts on the follow-up MRIs, our findings support the absence of 
significant ongoing ischaemia or chronic hypoperfusion in the cortex supplied by a 
stenotic artery, at least in the developing brain. To our knowledge, these are the 
first data looking at cerebrovascular reactivity in a non-progressive arteriopathy in 
childhood although there are some studies of perfusion using arterial spin labelling 
(Chen et al. 2009). 
 
9.14.1. TCA and CVR 
TCA is common in childhood stroke. In its chronic phase (beyond 3-6 months post-
stroke), TCA provides an excellent model of non-progressive arteriopathy. Among 
79 children with TCA longitudinal vascular imaging demonstrated that beyond 6 
months, arterial stenosis stabilized in 32% and improved in the remainder (Sebire 
et al. 2004, Braun et al. 2009) In a single center study we were able to enrol a 
group with childhood TCA, stable significant stenosis and infarcts limited to sub-
cortical structures.  This enabled us to explore whether tissue level microvascular 
dysfunction and under-perfusion of the non-infarcted cortex distal to the stenotic 
artery was present (using CVR) and clinically significant (neuropsychological 
testing).   
The results of hBOLD CVR we observed showed that CVR abnormalities were 
limited to the region of the previous stroke and were not present in the cortex. 
hBOLD CVR measures cerebrovascular reactivity in response to changes in CO2.  
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Prior studies in adults with cerebrovascular disease have demonstrated that 
hBOLD CVR is a valid indicator of tissue at risk of ischemia (Mikulis et al. 2005).  
Cortical thinning in non-infarcted brain distal and secondary to chronic stenosis is 
seen in the presence of paradoxical ‘steal’ reactivity (Fierstra et al. 2010) 
supporting subtle ongoing tissue damage. Normal cerebral vasculature responds 
with vasodilation to the CO2 stimulis. However, in regions with pre-existing poor 
perfusion, the vasculature is already maximally vasodilated, and therefore such 
regions show either failure of augmentation or a paradoxical reaction consisting of 
decreased perfusion. Alternative methods of hBOLD CVR are available for use in 
younger children including general anaesthetic (with anaesthetic manipulation of 
CO2) and awake breath holding (Thomason et al. 2005). In our study five of the six 
children had technically excellent CVRs consistent with prior reports on the 
reproducibility and reliability of this technique in children (Han et al. 2011). The only 
child with a sub-optimal study was the youngest child studied (Patient 2, age 7 
years). This child did not tolerate the prolonged positioning of the re-breathing 
mask. The limitations of this method of hypercapnic challenge have been 
discussed in previous chapters (Chapter 2 and 5). 
In the study subjects, there was an absence of CVR response within the previously 
infarcted tissue. Within the cortex overlying the deep infarct CVR was normal and 
symmetric when compared to the non-lesioned hemisphere in the five technically 
adequate studies. This indicates normal perfusion of the cerebral cortex even 
under a stressed condition of hypercapnia. Based on this finding suggestive of 
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intact tissue level microvascular function, we would suggest that the risk of 
ischaemic demise beyond the chronic moderate to severe stenosis is minimal. The 
theoretical concern for neuronal loss, which cannot be visualized on parenchymal 
MRI, appeared not to be supported by our findings.  
These findings contrast those in moyamoya.  BOLD CVR studies in moyamoya 
have demonstrated cortical perfusion deficits consistent with, and resulting from, 
the vascular steno-occlusive disease (Tzika et al. 1997) (Mikulis et al. 2005, Han et 
al. 2011)  Abnormalities in CVR concordant with moyamoya have been 
demonstrated in prior chapters in this thesis. Thus in moyamoya ongoing ischemia 
exists and is deleterious to brain tissue.  Early PET studies in children with 
moyamoya demonstrated disrupted cerebral haemodynamics with loss of vascular 
reserve in brain tissue and ‘misery perfusion’ even in the absence of cerebral 
infarcts (Ohtaki et al. 1998) (Kuwabara et al. 1997) (Kuwabara et al. 1997).  Silent 
or overt cerebral infarcts may develop, and these appear to be reduced by 
revacularization surgery (Kuwabara et al. 1997) (Scott et al. 2004) (Ng et al. 2012).  
 
9.14.2. Neuropsychological Tests 
Neuropsychological test results were employed in this study to assess for the 
presence of clinical deficits referable to the cortex distal to arterial stenosis. 
Processing speed typically recruits both cortical and sub-cortical networks whereas 
verbal reasoning is classically considered a cortically based cognitive function. The 
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results summarized in Table 110, demonstrated age appropriate cognitive deficits 
that were accounted for by the location and size of the initial sub-cortical infarct. 
Patient 5, with the smallest sub-cortical stroke had a normal IQ. Patient 1, the 
youngest at stroke (6 months age) had abnormal scores across all domains and 
the worst scores of the group.  This non- lateralized pattern of deficits is consistent 
with research showing that brain injury prior to age four or five years results in 
widespread cognitive deficits (Vargha-Khadem et al. 1992, Anderson et al. 2000, 
Anderson and Catroppa 2007, Westmacott et al. 2009).  
Among these subjects, the group mean score for FSIQ was normal (90; range 74-
107) indicating relative sparing of intellectual ability. Although the small numbers 
did not allow for statistical analysis our observations are in keeping with the 
previously published findings of specific cognitive vulnerability in FSIQ, WMI and 
PSI for unilateral focal ischaemic lesions acquired in early childhood (Westmacott 
et al. 2009) and white matter and basal ganglia injury association with slowed 
perceptual reasoning (O'Dougherty et al. 1985, Caine and Watson 2000, Maneru et 
al. 2001, Banwell and Anderson 2005, Raman et al. 2006). Deficits are expected to 
be associated with weaker overall intellectual ability (Westmacott et al. 2009).  The 
combined findings of normal CVR within the cortex overlying the stroke and relative 
sparing of FSIQ are reassuring and suggest the risk of tissue ischaemia and 
neuronal dropout (Saver 2008) are low in this group.   
This study does not support a need for revascularization surgery, endovascular 
stenting or other delayed reperfusion techniques in children with unilateral non-
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progressive arteriopathy. The dangers associated with catheter-related 
interventions have been highlighted in a recent communications from the NIH, 
National Institute of Neurological Disorders and Stroke (NINDS) ((NIH) and (CDC) 
2011). Persistent arterial stenosis still presents a risk for recurrent thrombotic 
stroke (albeit rare beyond the initial 6 to 12 months post-stroke), for which medical 
antithrombotic treatment is indicated and apparently effective.  
 
9.15. Study Limitations and Future Directions 
This is a study of a small number of children, thus the results may only be 
presented in a descriptive manner. Confidence in the findings remains relatively 
limited by this small number. However, the children formed a homogenous group 
that were suitable for the purpose of the study.   
In addition, the time interval between the most recent neuropsychological testing 
and CVR testing was disparate in most children and additional neuropsychological 
deficits could have emerged in the interval to CVR. However, since both studies 
were performed on average several years from stroke, there should have been 
time for evidence of neuropsychological deficits in the cortical tissue to emerge. 
Future larger cross-sectional BOLD CVR studies or longitudinal studies of serial 
BOLD CVRs paired with repeated neuropsychological assessments would enable 
more robust statistical findings regarding cortical CVR and neuropsychological 
deficits in cortical or sub-cortical patterns.   
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9.16. Conclusion  
This study demonstrates in children with moderately severe non-progressive 
stenosing arteriopathy, that distal perfusion appears to be adequate, in contrast to 
the ongoing perfusion deficits that characterize the progressive childhood 
arteriopathies.   
This study of TCA as a model of chronic non-progressive arteriopathies adds 
important new information to our understanding of the consequences on 
intellectual function, post-stenotic occlusion and CVR. This study demonstrates 
normal CVR responses outside of the infarct zone and intellectual deficits referable 
to the age and location of stroke. The risk of recurrent stroke, neuronal dropout and 
cognitive decline in this non-progressive arteriopathy group is therefor likely to be 
low and the need for revascularization minimal.  
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10. Discussion 
Moyamoya disease is a lifelong, progressive condition which results in ischaemic 
demise as evidenced by neurocognitive decline, transient ischaemic attacks and 
death in childhood and adulthood.  There is no treatment that halts the progression 
of the vasculopathy, therefore medical and surgical strategies to improve cerebral 
blood flow distal to the steno-occusive disease are the mainstay of treatment.   The 
ability to identify tissue level poor perfusion and quantify ischaemic risk would 
potentially allow for primary preventative strategies to be employed to prevent 
stroke and ischaemic demise.  The aim of this thesis was to validate the use of 
qualitiative methods of hypercapnic challenge BOLD cerebrovascular reactivity and 
assess their utility in the evaluation of ischaemic risk in children with moyamoya 
arteriopathy.   
 
10.1. Moyamoya Disease and Syndrome:  challenges in 
management 
In Chapters 1-3 of this thesis I highlighted the differences in natural history and 
outcome of children with progressive and non-progressive arteriopathies.  A unique 
challenge in the management of children with moyamoya is the increasingly early 
age of diagnosis due to improved access and use of MRI imaging and disease 
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specific screening protocols.  This has resulted in asymptomatic diagnosis of 
moyamoya in children of all age groups. Detailed reports of natural history in 
moyamoya are mostly derived from Asian (principally Japanese) populations.  
There remains a substantial gap in our understanding of the natural history of 
moyamoya in Caucasian and non-Sickle Afro-Caribbean moyamoya disease.  
Furthermore our understanding of the natural history of the syndromic moyamoyas 
is confined to case reports.  However, this study has demonstrated variability in 
natural history between the moyamoya disease and syndrome groups, as well as 
within the moyamoya disease and within the moyamoya syndromic groups.  Of 
note the children with NF1 had a more indolent clinical course and mostly left sided 
arteriopathy.  Smith et al suggest that given the radiologic and clinical progression 
seen in asymptomatic children with moyamoya, revascularization surgery should 
be considered in all (Lin et al. 2011).  However, operative technical constraints, 
higher complication rate and anaesthetic risk in the very young countered by the 
risk of cognitive decline and stroke over time highlights the need for a clinically 
usable biomarker of ischaemic risk to inform the decision to proceed to surgery, 
operative procedure choice – including whether to operate on one or both 
hemispheres - and optimal timing of surgery. 
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10.2. Qualitative hBOLD CVR:  feasibility and 
reproducibility of measures and interobserver reliability 
Having described the clinical need and risk profile of the population studies in 
Chapters 1-3, I sought to demonstrate that it was feasible to conduct qualitative 
hBOLD CVR studies in all age groups, including the very young in Chapter 5.  I 
also sought to ascertain whether the methodology was reliable and repeatable in 
Chapter 4 and to demonstrate good interobserver reliability in scoring of the 
studies if they were to be clinically useful.   
i) Feasibility - to my knowledge to date, this is the largest group of children 
who have had clinically qualitative hBOLD CVR studies.  The limited utility of 
quantitative controlled CO2 delivery techniques for the measurement of CVR in 
childhood has been discussed.  Our experience of qualitative hBOLD CVR is in 
keeping with that of adult centers using breath-hold studies for clinical practice and 
research (Pillai and Mikulis 2015). The ability to regionally assess and compare 
CVR in our patients - sequentially if necessary - is hence served by this tool.  
ii) Reproducibility - Reproducibility of measures was mostly good for the 
hemispheric pixels apart from the negative pixels generated at the threshold set to 
generate 200 positive pixels.  The poor reproducibility indices for these (PTNP) 
pixels would suggest that they are not reliably useful for application in clinical 
practice.  Repeat measures demonstrated good reliability of the methods of 
analysis for both GA and BH studies which was improved by selection of good 
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quality studies for analysis.  In practice the technically better study is often 
apparent, and can be judged by the child’s ability to perform the breath-hold task 
successfully or the adequacy of CO2 change achieved by ventilator manipulation 
under GA. It may be possible to improve repeatability by measuring CO2 before 
and after the breath-hold in the younger children, either with an end-tidal CO2 or a 
transcutaneous method as described in a number of adult studies ((Bright and 
Murphy 2013, Pillai and Mikulis 2015). 
The noting of technical and/or patient factors which may compromise the quality of 
the studies is important to ensure accurate interpretation of qualitative hBOLD CVR 
using these techniques.   
iii)     Scoring - we developed objective and subjective methods of CVR scoring 
as described in Chapter 2.  The pre-setting of a total number of target pixels 
however, did not allow for a full assessment of individual magnitude of CVR 
response.  The presence of true negative reactivity should be a more robust 
indicator of impaired CVR and tissue at risk of ischaemic damage.  Analysis of the 
presence and extent of negative reactivity or steal is hence essential in both our 
subjective and objective scoring methods for the determination of normal and 
abnormal CVR, allowing us to make some intra and inter patient comparisons of 
CVR response.   
There was excellent agreement between the two neurologist’s independently 
obtained scores.  This method is simpler and less time consuming than the pixel 
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method and may be an adequate scoring tool. The scoring tool was good at 
discriminating between normal and abnormal studies, but less good at 
discriminating between the two abnormal scores (two and three).  Hence, further 
revisioin of these scores is required.   
Therefore, in Chapters 1 -5 of the thesis I demonstrated the clinical need for a tool 
to measure ischaemic risk, proposed that qualitative hBOLD CVR would be a 
suitable tool, and demonstrated that it is feasible to use in children with good 
reproductibilty of measures and interobserver reliability in scoring.   
 
10.3. Qualitative hBOLD CVR and clinical application: 
i) hBOLD CVR and angiographic measures –  
Chapter 6 demonstrated that in this study hBOLD CVR abnormality was 
concordant with laterality of moyamoya.  An interesting observation was the 
bilateral CVR abnormality seen in patients with unilateral moyamoya.  This has 
been described in adult studies of CVR in moyamoya (Heyn et al 2010).  The 
observation of a relationship between heart rate, hematocrit and CVR is also 
reported in adult studies of CVR. However, I did not demonstrate an association 
between CVR abnormality and severity of moyamoya as measured by Modified 
Suzukii Staging but discussed the limitations of the staging applied and plan to 
revise this in future studies.   
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ii) hBOLD CVR pre and post surgery -  
In Chapter 7 abnormality in CVR in asymptomatic children prior to surgery 
appeared to be premonitory of clinical deterioration.  Post-surgical change in CVR 
was variable but appeared to be predictive of clinical course in the study.  Children 
with bilateral moyamoya sometimes appeared to have deterioration of hBOLD CVR 
measures in the operation naïve hemisphere with clinical deterioration and 
symptoms referrable to that hemisphere potentially requiring further 
revasculariation surgery.  Hence, the reported findings would suggest that 
qualitative hBOLD CVR might usefully be employed in the presurgical work-up and 
follow-up of children with moyamoya.   
iii) hBOLD CVR and cognitive testing –  
The results in Chapter 8 were significantly confounded by the small study numbers 
and the different moyamoya arteriopathy groups.  As in other published studies 
children with bilateral stroke had poorer neurocognitive outcomes than children 
with unilateral stroke.  In addition this study demonstrated that moyamoya 
arteriopathy alone, in the absence of stroke, was associated with specific cognitive 
difficulties for example, left moyamoya and reduced VIQ.  Hence there is a 
suggestion that the effects seen may be explained by chronic hypoperfusion, 
resulting in sub-clinical ischaemia and neuronal damage, and in some children 
possibly representing children at increased risk of acute AIS.  The relationship 
between abnormal CVR and indices of executive function was unexpected (ie poor 
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indices of executive function associated with good CVR).  Whether this can be 
explained by the effect of disease specific pathology eg NF1 and chromosomal 
disorders on CVR and cognitive outcome was not fully elucidated by this study and 
requires further exploration.   
iv) hBOLD CVR and cortical thickness –  
In adults with moyamoya and significant steal, and without cortical infarction 
cortical thinning is demonstrated on the side of the arterial disease, lending support 
to the suggestion that chronic hypoperfusion in the context of moyamoya may have 
significant effects detectable on measurement of the cortical rim, even in the 
absence of ischaemic parenchymal changes and/or clinical stroke.(Fierstra et al. 
2010).  The cortical rim in childhood thickens and thins in a regional, hemispheric 
and temporally specific manner.  In Chapter 9, our study of hBOLD CVR and 
cortical thicknesss in children with moyamoya, it was interesting to note the 
association between the presence of hemispheric steal and reduced (within 
patient) comparative cortical thickness.  Change in cortical thickness over time 
varied according to whether there was a history of revascularization surgery and 
also seemed to be influenced by age.  Maximal increase in the cortical rim 
occurred in those with a history prior to the first included CVR, and thinning 
appeared to occur in those without intervention.  The study was not powered to 
explore the relationship between these findings and cognitive outcomes.  Further 
study of the changes in cortical thickness over time in children with moyamoya and 
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examination of the association between these findings and cognitive outcome 
would inform us of the impact and import of chronic hypoperfusion in moyamoya.    
v) hBOLD CVR and Transient Cerebral Arteriopathy, as a model for 
Unilateral Non-progressive arteriopathy -   
In Chapter 10 I demonstrated that there was no significant abnormality in CVR 
outside the region of infarction in children with a moderate-severe chronic unilateral 
non-progressive stenosis.  Hence, there was no suggestion of chronic 
hypoperfusion as seen in moyamoya, in this group.  This was further supported by 
the finding of deficits in cognitive outcome that were mostly explained by age of 
stroke and lesion volume.  These findings are reassuring and do not support the 
need for revascularization surgery in this group.  
 
10.4. Conclusion 
The results of the thesis studies highlight the clinical need for a tool for assessment 
of ischaemic risk in this chronic, lifelong condition that is associated with recurrent 
strokes and poor outcome.  The thesis has demonstrated that qualitative methods 
of hypercapnic challenge BOLD CVR are feasible, repeatable and the method of 
analysing the scans reliable.  The latter in turn implied that the repeat parametric 
maps looked the same.  Interobserver reliability of scoring was high, supporting it’s 
utility in clinical practice. In this qualitative study we did not demonstrate 
repeatability or reliability of the BOLD CVR measures themselves. Qualitative 
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hBOLD CVR abnormalities were concordant with moyamoya laterality, and in 
unilateral moyamoya demonstrated tissue level microvascular dysfunction in the 
contralateral unaffected hemisphere.  Qualitative hBOLD CVR abnormalities 
demonstrated concordance with clinically important manifestations of ischaemia 
including stroke, transient ischaemic attacks, cortical thinning and IQ.  The lack of 
concordance with indices of executive function may have been related to 
underlying disease specifc pathology.  In addition the lack of association between 
moderate to severe stenosis in Transient Cerebral Arteriopathy as a model for the 
Non-progressive, unilateral arteriopathies is reassuring.    
There were however, a number of study limitations.  This study was an unfunded 
clinical research study with prospective enrolment conducted over a period of 13 
years.  During this period the MRI scanner used changed from a 1.5T scanner to a 
3.0T scanner.  Despite this prolonged period of recruitment, the numbers were still 
small and few of the results were statistically significant.  What the study was able 
to demonstrate was also limited by the challenge of obtaining reliable MR perfusion 
imaging or CO2 values in the group.  Therefore I was unable to quantitatively 
validate the tool.  
Although further longitudinal studies, in a larger cohort are required to confirm 
many of the findings, the results of this study of the use of qualitative hypercapnic 
challenge blood oxygen level dependent (BOLD) CVR brings us closer to 
answering the question asked by parents and carers of children with moyamoya, 
“When is my child going to have a stroke?”  Increased ability to use this tool to 
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identify children on the ischaemic precipice may allow us to intervene prior to an 
event, and maybe be able to answer, “Never”.  
 
11.5 Future Directions 
1) Validation of BH hBOLD CVR technique – I plan to do this first by conducting BH 
CVR studies with end-tidal CO2 monitoring, controlled CO2 delivery studies, and 
MR perfusion studies (ASL) in healthy children (age 7 – 17 years).   
Following this I plan to repeat the above CVR and perfusion studies in children with 
unilateral/probable moyamoya disease and unilateral NF1-moyamoya.   
Protocol development with respect to the use of different methods of capnic 
challenge such as paced breathing; hyperventialation; pre and post-processing 
methodology such as semi-automated and manual motion corredtion; use of 
processing pipelines; reporting and integration of studies into clinical practice  will 
be explored as part of this study. 
2)  GA hBOLD CVR studies – collaboration with anaesthetic and respiratory 
colleagues toward standardization of a CVR protocol with integrated CO2 and 
other physiologic monitoring is planned.  MRI measures of CBF and perfusion are 
also to be added.  This is essential to address the need to assess ischaemic risk in 
the developmentally non-compliant child, typically under the age of 7 years. 
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3)  Future longitudinal studies – these are required to demonstrate whether 
qualitative and/or semi-quantiative assessment of ishaemic risk can be achieved 
using hBOLD MRI CVR.  This will require funding.  
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